2015 Surveys catalog WEB, rev. 1/26/15
-
Upload
nguyenphuc -
Category
Documents
-
view
229 -
download
0
Transcript of 2015 Surveys catalog WEB, rev. 1/26/15
Table of Contents2015 Surveys and Anatomic Pathology Education Programs
1 New Developments ....................................... 3–8
2 Continuing Education.................................. 9–22Continuing Education Programs .................. 10Competency Assessment Program.............. 17QMEdTM Online Educational Courses ........... 20
3 Quality Management Tools ....................... 23-42Q-PROBESTM...................................................... 26Q-TRACKS®....................................................... 31Q-MONITORS® ................................................. 41
4 Point-of-Care Programs ............................. 43-48
5 General Chemistry and TherapeuticDrug Monitoring ........................................... 49-72
General Chemistry and TherapeuticDrug Monitoring .......................................... 50
Urine Chemistry ............................................... 61Special Chemistry........................................... 64
6 Endocrinology.............................................. 73-80
7 Blood Gas, Critical Care,and Oximetry ............................................... 81-84
8 Toxicology .................................................... 85-96
9 Accuracy-Based Programs..................... 97-102Accuracy-Based Programs ........................... 98Validated Materials...................................... 101
10 Instrumentation Validation Tools .......... 103-122Calibration Verification/Linearity................ 104Instrumentation Quality
Management Programs........................... 118
11 Hematology andClinical Microscopy................................ 123-138
Hematology .................................................. 124Clinical Microscopy...................................... 133
12 Reproductive Medicine ......................... 139-142Andrology and Embryology........................ 140
13 Coagulation ............................................. 143-150
14 Microbiology............................................ 151-178Bacteriology.................................................. 152Mycobacteriology........................................ 163Mycology....................................................... 164Parasitology................................................... 167Virology.......................................................... 171Molecular Microbiology............................... 173Infectious Disease Serology......................... 178
15 Immunology and Flow Cytometry ....... 179-190Immunology .................................................. 180Flow Cytometry............................................. 188
16 Transfusion Medicine, Viral Markers,and Parentage Testing ........................... 191-204
Transfusion Medicine.................................... 192Viral Markers .................................................. 201Parentage Testing ........................................ 204
17 Histocompatibility ................................... 205-210
18 Genetics and Molecular Pathology ...... 211-226Cytogenetics................................................. 212Biochemical and Molecular Genetics....... 215Next-Generation Sequencing..................... 221Molecular Oncology – Solid Tumors ........... 222Molecular Oncology – Hematologic ......... 225
19 Anatomic Pathology ............................... 227-250Surgical Pathology ....................................... 228General Immunohistochemistry.................. 237Predictive Markers ........................................ 239Specialty Anatomic Pathology................... 240Cytopathology ............................................. 242
20 Forensic Sciences ................................... 251-254
21 Analyte/Procedure Index...................... 255-298
22 Program Code Page Index ................... 299-302
You getmore
from thisbox.
1 Prepare staff with the insights and knowledgeof more than 500 pathology experts
2 Gain more than 100 CE credits—five times morethan any other program
3 Access education for every member ofyour team at no additional charge
Deliver excellence and value to your entire team with education by the experts!
Three more reasons to participate inthe CAP Surveys/EXCEL® Programs:
NEW
11 | New Developments
“It’s about building the trust of the clinical staff in thequality of our laboratory results. CAP proficiencytesting is more than what is in the box, it’s being onthe cutting edge of laboratory practices.”
New Developments
4 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
NEW
1 New Developments
Quality Management ToolsSubsection Name Program Code Page(s)
Q-PROBES Blood Bank Safety Practices QP151 27
Q-PROBES Clinical Test Utilization: Unnecessary Testing QP152 28
Q-PROBES Physician Satisfaction with Anatomic Pathology Services QP153 29
Q-PROBES Identification Errors QP154 30
General ChemistrySection Name Program Code Page(s)
General Chemistry and TherapeuticDrug Monitoring
Quality Cross Check—General Chemistry and TherapeuticDrug Monitoring
CZQ 53
General Chemistry and TherapeuticDrug Monitoring
B-Type Natriuretic Peptides, five challenges BNP5 55
General Chemistry and TherapeuticDrug Monitoring
Quality Cross Check—B-Type Natriuretic Peptides BNPQ 55
General Chemistry and TherapeuticDrug Monitoring
Troponin T, five challenges TNT5 56
General Chemistry and TherapeuticDrug Monitoring
Hemoglobin A1c, five challenges GH5 57
General Chemistry and TherapeuticDrug Monitoring
Hemoglobin A1c, five challenges, international only GH5I 57
Urine Chemistry Porphobilinogen, Urine UPBG 63
EndocrinologySection Name Program Code Page(s)
Endocrinology 25-OH Vitamin D VITD 76
New Developments
800-323-4040 | 847-832-7000 Option 1 | cap.org 5
NEW
1Blood Gas, Critical Care, and OximetrySection Name Program Code Page(s)
Blood Gas, Critical Care,and Oximetry
Quality Cross Check—Critical Care AqueousBlood Gas Series
AQQ, AQ2Q,AQ3Q, AQ4Q
83
Blood Gas, Critical Care,and Oximetry
Quality Cross Check—Blood Oximetry SOQ 84
Hematology and Clinical MicroscopySubsection Name Program Code Page(s)
Hematology Automated Hematology Differential for Mindray BC-5000 FH11 125
Hematology Automated Hematology Differential for Mindray BC-6000 FH12 125
Hematology Quality Cross Check—Automated Hematology SeriesFH3Q, FH4Q,FH6Q, FH9Q
126
Hematology Hematopathology Online Education HPATH/HPATH1 132
Clinical Microscopy Hemocytometer Fluid Count, international only HFCI 136
MicrobiologySubsection Name Program Code Page(s)
BacteriologyGram-Negative Blood Culture Panel for Molecular
Multiplex TestingGNBC 158
Bacteriology Stool Pathogen, without Shiga Toxin SPN 161
Mycobacteriology Molecular MTB Detection and Resistance MTBR 163
Molecular MicrobiologyC. trachomatis and N. gonorrhoeae DNA by Nucleic
Acid AmplificationHC7 174
Molecular Microbiology Bacterial Strain Typing, Gram-Negative Organisms BSTN 175
Molecular Microbiology Nucleic Acid Amplification, Organisms without MTB IDN 175
New Developments
6 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
NEW
1 Immunology and Flow CytometrySubsection Name Program Code Page(s)
Immunology Antichromatin Antibody ACA 182
Immunology Antiribosomal-P Antibody ARP 183
Immunology Heavy Chain/Light Chain Analysis HCA 185
Transfusion Medicine, Viral Markers, and Parentage TestingSubsection Name Program Code Page(s)
Transfusion Medicine Transfusion Medicine Competency Assessment—Eluate Test TMCAE 194
Transfusion Medicine Antibody Titer ABT3 196
Transfusion Medicine Red Blood Cell Antigen Typing RBCAT 200
HistocompatibilitySection Name Program Code Page(s)
Histocompatibility HLA Disease Association, Drug Risk DADR1, DADR2 209
New Developments
800-323-4040 | 847-832-7000 Option 1 | cap.org 7
NEW
1Genetics and Molecular PathologySubsection Name Program Code Page(s)
Next-Generation Sequencing Next-Generation Sequencing NGS 221
No CAP program for a test your laboratory performs?We’ve got you covered with this unique, complimentary program—only from the CAP!Sign up for this unique and complimentary service for those rare analytes for whichproficiency testing is not yet available. This service now includes all clinicallaboratory disciplines.• The CAP connects labs performing testing for which no formal
proficiency testing is available.• There is no charge for this service.• Participate at any time, no contract required.• A minimum of three labs performing the same analyte must participate
before the CAP can facilitate the sample exchange.• Each individual laboratory will receive its own results along with an anonymized summary
report for all participants.
Visit cap.org and choose the Laboratory Improvement Programs tab to register today!
Your Choice.Gain the expertise of your peers usingthe convenience of your mobile device.
Customize your reading experiencewith font control, brightness, margins,and quick navigation.
Enhance your learning by adding notes,highlights, and bookmarks.
See for yourself at ebooks.cap.org.
Available now—your favorite CAP Press booksin ebook format!
Continuing
Education
2
Continuing EducationContinuing Education Programs .........................................................................................................10Competency Assessment Program ......................................................................................................17QMEd™ Online Educational Courses..................................................................................................20
2 | Continuing Education
“The educational part comes when you get theresults and review them with the staff, especiallyif you have had issues—true issues. When eachCAP Survey comes back, we go over it with thewhole staff for their continuing education. Wesee if, and where, we went wrong or if we havemore to learn. The educational part is when youget the results back…CAP encourages people tobe current on their education and knowledge.”
Continuing Education Programs
10 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Con
tinui
ngEd
ucat
ion
2
Continuing Education Programs
Your laboratory demonstrates its commitment to quality by choosingCAP Surveys programs. You’ll find the same level of quality in the CAPContinuing Education Programs.Legend
This activity is eligible for continuing medical education (CME) credit.
This activity is eligible for continuing education (CE) credit.
This activity is eligible for continuing medical education (CME) credit or continuing education (CE) credit.
Information for Courses Bearing the CME Icon
AccreditationThe College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME)to provide continuing medical education for physicians.
CME Category 1The College of American Pathologists designates these enduring materials educational activities for a maximum of the statednumber of AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of theirparticipation in the activity.
Note to CME participants of enduring* materials courses:An AMA requirement mandates that all physicians wishing to claim CME credits must pass a scored assessment. All CAPenduring materials CME courses require participants to pass a scored assessment prior to claiming credit.
* Enduring courses are those courses that endure over time such as print or Internet courses.
CE (Continuing Education for Nonphysicians) for Courses Bearing the CE IconThe College of American Pathologists designates these educational activities for a maximum of the stated number of credits ofcontinuing education. Participants should claim only the credit commensurate with the extent of their participation in the activity.
The American Society for Clinical Pathology (ASCP) Board of Certification (BOC) Certification Maintenance Program (CMP)accepts this activity to meet its continuing education requirements. The states of California and Florida also approve these activitiesfor continuing education credit.
Cytotechnologists may apply the credits from the PAPCE/PAPJE/PAPKE/PAPLE/PAPME Series 1 or 2, PAP PT, and NGCprograms toward the required educational activities for the American Society of Cytopathology (ASC) Continuing Education CreditProgram (CECC) and the International Academy of Cytology (IAC).
Continuing Education Programs
800-323-4040 | 847-832-7000 Option 1 | cap.org 11
Continuing
Education
2
Surveys Continuing Education ActivitiesWhen your laboratory participates in CAP Surveys, every member of your team can enroll in education activities and earncontinuing education (CE) credit at no additional charge. Simply follow these steps:
1. Establish a free Web account.2. Complete a reading provided in the Participant Summary or Final Critique.3. Answer online learning assessment questions.
Each member of your staff can access the Surveys education activities for a maximum of 12 months.
Surveys Education ActivitiesProgram Name Program Code Source Catalog
Page(s)
General Chemistry and Therapeutic DrugsC1/C3/C3X,
CZ/CZX/CZ2X, C7Participant Summary 50
Toxicology T Participant Summary 86
Urine Toxicology UT Participant Summary 86
Urine Drug Testing, Screening UDS, UDS6 Participant Summary 88
CAP/AACC Forensic Urine Drug Testing, Confirmatory UDC Participant Summary 89
Drug Monitoring for Pain Management DMPM Participant Summary 95
Basic Hematology HE, HEP Participant Summary 124
Blood Cell Identification BCP Participant Summary 124
Hematology Automated Differentials FH Series FH1-FH12, FH1P-FH12P Participant Summary 125
Bone Marrow Cell Differential BMD Participant Summary 128
Virtual Body Fluid VBF Participant Summary 134
Coagulation, Limited CGL, CGDF Participant Summary 144
Bacteriology D Final Critique 152
Mycology F Final Critique 164
Electrophoresis SPE Participant Summary 68
Transfusion Medicine, Comprehensive, Limited J, J1 Participant Summary 192
Transfusion Medicine, Educational Challenges JE1, JATE1 Participant Summary 192, 193
Transfusion Medicine, Electronic Crossmatch EXM, EXM2 Participant Summary 195
Transfusion Medicine, Automated Testing JAT Participant Summary 192
CAP/NSH HistoQIP HQIP Final Critique 234
Continuing Education Programs
12 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Con
tinui
ngEd
ucat
ion
2
Surveys Self-Reported Training OpportunitiesWhen your laboratory participates in CAP Surveys, every member of your team can receive self-reported training opportunities.
Self-Reported Training Opportunities*Program Name Program Code Source Catalog
Page(s)
Hematology and Clinical Microscopy
Blood Cell Identification BCP Participant Summary 124
Bone Marrow Cell Differential BMD Participant Summary 128
Hematology Automated Differentials FH Series FH1-FH12, FH1P-FH12P Participant Summary 125
Basic Hematology HE, HEP Participant Summary 124
Hemoglobinopathy HG Participant Summary 128
Virtual Peripheral Blood Smear VPBS Participant Summary 130
Clinical Microscopy CMP, CMMP Participant Summary 133
Microbiology
Blood Parasite BP Participant Summary 168
Expanded Bacteriology DEX Participant Summary/Final Critique 153
Mycobacteriology E Participant Summary/Final Critique 163
Yeast F1 Participant Summary/Final Critique 164
Parasitology P Participant Summary/Final Critique 167
Ticks, Mites, and Other Arthropods TMO Participant Summary 169
Genetics and Molecular Pathology
CAP/ACMG Cytogenetics CY Participant Summary 212
CAP/ACMG FISH for Constitutional/HematologicDisorders
CYF Participant Summary 212
CAP/ACMG FISH for Paraffin-Embedded Tissue CYJ, CYK, CYL Participant Summary 213
CAP/ACMG Cytogenomic Microarray Analysis CYCGH Participant Summary 213
*Notes:
• CAP Self-Reported Training opportunities do not offer CE credit, but can be used towards fulfilling requirements for certificationmaintenance by agencies such as the American Society for Clinical Pathology (ASCP). Please verify with your certifying agency todetermine your education requirements.
• These opportunities are subject to change. Refer to the Participant Summary/Final Critique for availability.
Continuing Education Programs
800-323-4040 | 847-832-7000 Option 1 | cap.org 13
Continuing
Education
2
Maintenance of Certification (MOC)Maintenance of Certification (MOC) is the board certification program that involves continuous professional development andensures that an American Board of Pathology (ABP) board-certified pathologist is committed to lifelong learning and competencyin a specialty and/or subspecialty.
There are six competency categories defined by the American Board of Medical Specialties (ABMS) and endorsed by the ABP tofulfill specific MOC requirements. They are listed below with their descriptions.
All CAP education activities providing CME credits meet the MOC Part II: Lifelong Learning requirements. Some programs willmeet the requirements for Self-Assessment Module (SAM) and/or MOC Part IV at the laboratory or the individual levels. Programsthat meet Part IV are identified within the description of the program. Visit the CAP website for the current list of programs thatmeet the requirements for MOC Part II and Part IV.
Interpersonal and Communication SkillsDemonstrate interpersonal and communication skills that result in effective information exchange and teaming with patients,patients’ families, and professional associates.
Medical KnowledgeDemonstrate knowledge of established and evolving biomedical, clinical, and cognate sciences and the application of thisknowledge to pathology.
Practice-Based Learning and ImprovementDemonstrate ability to investigate and evaluate diagnostic and laboratory practices in your own lab, appraise and assimilatescientific evidence, and improve laboratory practices and patient care.
Patient CareDemonstrate a satisfactory level of diagnostic competence and provide appropriate and effective consultation in the context ofpathology services.
ProfessionalismDemonstrate a commitment to carrying out professional responsibilities, adherence to ethical principles, and sensitivity to diversepatient population.
Systems-Based PracticeDemonstrate understanding of and contribution to local, regional, and national health care systems, and support health care insystems-based practice definition.
This activity fulfills the SAM credit requirements for MOC and is therefore eligible for SAM credit. Participants whosuccessfully complete an online assessment may apply their earned credit(s) to the ABP’s SAM requirements.
Note to CME/CE participants: The AMA mandates that all education providers (such as the CAP) require participantspass assessment questions in an enduring* program in order to earn and claim CME credits. All participants inany activity granting CME/CE will be required to complete and pass assessment questions before claiming theircredits.
For CME/CE activities: Participants will have unlimited attempts to pass the assessment.
For CME/SAM activities ONLY: Participants will have three attempts to pass the assessment, with feedbackprovided after each attempt. Participants may not claim CME/SAM if they do not pass on the third attempt.
*Enduring programs are those courses that endure over time such as print or online courses.
Continuing Education Programs
14 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Con
tinui
ng E
duca
tion
2
Education Programs
Program Name Program CodeMaximum AMA PRA
CME Category 1 Credits™ Annually
Maximum CE Credits Annually
Format Catalog Page
Autopsy Pathology AUCD/AUCD1 12 NA CD-ROM 240
Clinical Pathology Improvement Program*
CPIP/CPIP1 15 NA Online 16
Online Digital Slide Program in Dermatopathology*
DPATH/DPATH1 14**** NA Online (DigitalScope) 231
Online Digital Slide Program in Fine-Needle Aspiration*
FNA/FNA1 10 10 Online (DigitalScope) 249
Fine-Needle Aspiration Glass Slide
FNAG/FNAG1 10 10 Glass Slides 250
Gynecologic Cytopathology – Fields of View
FOVK/FOVK1, FOVM/FOVM1
NA 10 Online 246
Forensic Pathology FR/FR1 12 12 CD-ROM 253
Hematopathology Online Education
HPATH/HPATH1 6 6 Online (DigitalScope) 132
Nongynecologic Cytopathology Education**
NGC/NGC1 25 25Glass Slides
With Online Cases (DigitalScope)
248
Neuropathology Program NP/NP1 10**** NA CD-ROM 241
Gynecologic Cytopathology PAP Education Program***
PAPCE/APAPCEPAPJE/APAPJEPAPKE/APAPKEPAPLE/APAPLE
PAPME/APAPMESeries 1 or 2
8 8 Glass Slides 245
Glass Slide Cytopathology PAP PT Program (with Glass Slide PAP Education)***
PAPCPT/APAPCPTPAPJPT/APAPJPTPAPKPT/APAPKPTPAPLPT/APAPLPT
PAPMPT/APAPMPT
8 8 Glass Slides 243
Practicum in Cancer Surgical Pathology*
PCSP/PCSP1 5**** NA Online (DigitalScope) 233
Online PAP EducationPEDK/APEDK, PEDL/APEDL,
PEDM/APEDM8 8 Online (DigitalScope) 244
Performance Improvement Program in Surgical Pathology
PIP/PIP1 40 NA Glass Slides 228
*Program is available for purchase online. Go to cap.org and choose the Learning tab.**NGC provides up to 20 CME/CE credits for the glass slides and 5 CME/CE credits for the online slide portion of the program.*** PAP provides up to 8 CME/CE credits for glass slides.**** SAM credits are included in CME totals for the appropriate programs.
Discontinued
Continuing Education Programs
800-323-4040 | 847-832-7000 Option 1 | cap.org 15
Continuing Education
2
Education Programs
Program Name Program CodeMaximum AMA PRA
CME Category 1 Credits™ Annually
Maximum CE Credits Annually
Format Catalog Page
Online Performance Improvement Program in Surgical Pathology*
PIPW/PIPW1 40 NA Online (DigitalScope) 229
Glass Slide Cytopathology PAP PT Program (with Online PAP Education)
PTGDK/APTGDK PTGDL/APTGDL
PTGDM/APTGDM 8 8
Glass Slides With Online Cases (DigitalScope)
242
Nongynecologic Cytopathology Intraoperative Touch Imprint/Crush Preparation Program*
TICP/TICP1 10**** 10 Online (DigitalScope) 247
Online Virtual Biopsy Program* VBP/VBP1 23**** NA Online (DigitalScope) 230
*Program is available for purchase online. Go to cap.org and choose the Learning tab.**** SAM credits are included in CME totals for the appropriate programs.
System RequirementsMany of our education programs utilize online whole slide images that simulate the use of a microscope. This allows you to scan and use multiple magnifications to view the image.
To best view these programs, we recommend the following.
•OperatingSystem:Windows(XP,Vista,Windows7).MacOSXisnotsupported. •BrowserVersion:InternetExplorer7.xornewer.InIEversions10and11,openin“CompatibilityView.”Goto
http://windows.microsoft.comformoreinformation. •Pop-upblockersmustbeturnedofftoaccesstheactivity.Also,cap.orgmustbeaddedasatrustedwebsite.
Note:Gotocap.orgforthemostup-to-dateinformationonsystemrequirements.
The download speed and the appearance of the activity will vary depending on the type and speed of your Internet connection, computer’s power, and browser. The use of a Macintosh is not recommended regardless of the browser version.
ProgramsusingDigitalScoperequireaone-timedownloadandinstallationoffreesoftware,MicrosoftSilverlight.Foradditionaldetails, go to cap.org and choose the Laboratory Improvement Programs tab.
Discontinued
Continuing Education Programs
16 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Con
tinui
ngEd
ucat
ion
2
Clinical Pathology Improvement Program (CPIP)The Clinical Pathology Improvement Program (CPIP) delivers 12 online clinical laboratory cases to study—one per month—and anopportunity to earn up to 15 CME/SAM credits annually. Assess and improve clinical pathology skills and fulfill Maintenance ofCertification (MOC) requirements.
CPIP cases feature real-life case scenarios, including images and clinical background. Participants work through sequentially-revealed information and a series of prompts to arrive at a resolution—just as in the laboratory.
Cases include thought-provoking questions with feedback and a multiple-choice post-test. Participants who earn passing scores onpost-tests may apply their earned credits to the ABP’s MOC SAM requirements.
Clinical Pathology Improvement ProgramCPIP/CPIP1
Program Name Program Code Cases/Year
CPIP/CPIP1
Online cases in clinical pathology z 12
Additional InformationPathologists and residents can use CPIP online to assess and improve their skills inclinical pathology.
• Case topics may originate from the ABP s general listing suggested for MOCincluding laboratory administration and operations, transfusion medicine,chemistry, coagulation, hematology, immunology, microbiology, and moleculargenetic pathology.
• Cases may include patient history, case-related static images, and wholeslide images.
• Monthly individual CPIP cases can also be purchased online. Go to cap.org andchoose the Learning tab. To purchase both CPIP and CPIP1, please call800-323-4040 or 847-832-7000 option 1.
Program Information• One online clinical laboratory
case per month
• CPIP1 - Additionalpathologist (within thesame institution) reportingoption with CME/SAM credit;must order in conjunctionwith CPIP
• Earn a maximum of 15CME/SAM credits (AMA PRACategory 1 Credits™) per year
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Twelve cases per year; yourCAP shipping contact will benotified via email when theactivity is available
Competency Assessment Program
800-323-4040 | 847-832-7000 Option 1 | cap.org 17
Continuing
Education
2Program Adds Safety & Compliance CoursesOnline Competency Assessment Program helps you meet CAP Laboratory Accreditation Program requirements andCLIA-mandated competency assessment regulations. Also available for 2015 are Safety & Compliance courses specific to theclinical laboratory.
Competency Assessment Program includes:• Competency assessment courses with customized training and CE credit• Reassessment courses• A library of educational training courses (Pro Courses) with CE credit• Instrument-specific observation chec lists for competency and training• Course-building and modifying tools• Management trac ing and reporting• Individual transcripts
Safety & Compliance Courses for the LaboratoryThe package includes all seven courses, which are appropriate for annual laboratory compliance training and for clinicallaboratory science students prior to clinical rotations. Access Safety & Compliance courses throughout the subscription period;the CAP updates these courses when necessary to reflect changes in regulations or best practices.
• OSHA Bloodborne Pathogens• OSHA Chemical Hygiene• OSHA Electrical Safety• OSHA Fire Safety• OSHA Formaldehyde• Tuberculosis Awareness• Medical Errors and Patient Safety
Note: You must purchase the Safety & Compliance course package in conjunction with the Competency Assessment Programsubscription; it is not available for purchase separately.
The Safety & Compliance courses listed above do not offer CE credit.
New for 2015!• Two levels of assessment courses for Blood Ban /Transfusion Medicine and Microbiology modules one for generalists and
one for specialists!• Competency Profiles. This new functionality will allow administrators to create profiles to document the six areas of
competency as defined by CLIA and the CAP Laboratory Accreditation Program. Learn more about Competency Profile atcap.org.
Please see next pages for all course descriptions. For more information, visit cap.org and choose the Learning tab.
Competency Assessment Program
Competency Assessment Program
18 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Con
tinui
ngEd
ucat
ion
2
Assessment Course ScheduleDiscipline January 2015 Release July 2015 Release
Blood Banking/Transfusion Medicine Antibody screen and identification Transfusion reactions
Chemistry Liver and renal testingChemistry quality control, calibration,
and reportable range
Hematology and Coagulation Common coagulation tests Platelet testing, morphology, and disorders
Histology Safety issues in the histology laboratory Special stains
Immunology Qualitative HIV testingMolecular amplification methods for
detection of infectious diseases
MicrobiologyGram stain: organism detection and
differentiationUrine and body fluid cultures
Phlebotomy/Specimen ProcessingChallenges of phlebotomy: pediatricblood collection, alternate sites, and
difficult draws
Specimen collection for workplace urinedrug testing programs and forensic drug
and alcohol testing
Point-of-Care TestingPoint-of-care whole blood prothrombin
time and INR (PT/INR) testingCardiac biomarkers
Quality Programs/Management Monitoring the quality control program Competency evaluation
Safety Fire and electrical safety Ergonomics
Urinalysis/Body Fluids Cerebrospinal fluid analysis Semen analysis
Pro Course ScheduleDiscipline January 2015 Release July 2015 Release
Blood Banking/Transfusion Medicine Direct antiglobulin test ABO typing discrepancies
Chemistry Clinical toxicology Electrolytes, acid, base, and anion gap
Hematology and Coagulation Erythrocyte morphology White blood cell inclusions
Histology Immunohistochemistry part 2 Histology specimen handling
ImmunologyMonitoring the testing process
in immunologyHuman chorionic gonadotropin and
fetal fibronectin
Microbiology Genital cultures The microbiology of wounds
Phlebotomy/Specimen Processing Phlebotomy professionalism and ethics Routine venipuncture performance
Point-of-Care Testing Provider performed testing Point-of-care urine reagent strip testing
Quality Programs/Management Document control New instrument method validation
Safety Hazardous chemicals Laboratory waste and spill management
Urinalysis/Body Fluids Microscopic urinalysis part 2 Serous and synovial fluids
Competency Assessment Program
800-323-4040 | 847-832-7000 Option 1 | cap.org 19
Continuing
Education
2
Safety & Compliance CoursesOSHA Bloodborne Pathogens Addresses the OSHA Bloodborne Pathogens standard as it applies to clinical and medicallaboratories. Covers major bloodborne pathogens, including hepatitis B and HIV. Focuses on proper handling of sharps, personalprotective equipment (PPE), engineering controls such as microbiological safety cabinets, and proper work practices like hand-washing.
OSHA Chemical Hygiene Describes the OSHA Chemical Hygiene Standard and helps satisfy OSHA requirements for annualtraining. Explains Haz-Com, the National Fire Protection Agency diamond, the Safety Data Sheet, and common-sense laboratorysafety rules applied to clinical laboratory practice.
OSHA Electrical Safety Addresses electrical safety and electrical hazards commonly found in the clinical laboratory. Coversprevention and safety measures, fighting electrical fires, and treatment of electrical injuries.
OSHA Fire Safety Teaches the basics of fire safety in the clinical laboratory, including classes of fire and key acronyms such asPASS and RACE. Addresses fire prevention, drills, and firefighting techniques.
OSHA Formaldehyde Covers essentials for any laboratory that uses formaldehyde or formalin. Shares facts aboutformaldehyde, safety risks, proper handling procedure, monitoring, spill clean-up, and personal protective equipment.
Tuberculosis Awareness Provides background information about spread of TB, PPD testing procedures, CDC guidelines, andmethods of control.
Medical Errors and Patient Safety Includes potential causes of medical errors in the clinical laboratory, important legislationand definitions, and steps laboratory professionals can take to reduce the impact of medical errors in their workplace. Servesas an ideal part of an effective medical error reduction program and is appropriate for both experienced and newer laboratorypersonnel.Note: The Safety & Compliance courses are not available for purchase separately. The courses listed above do not offer CE credit.
CAP QMEd™ online educational courses—make quality yourcompetitive position and patient care advantageThe seven QMEd courses can help you understand how to plan and resource your laboratory’squality management system. Every course is highly interactive and delivered to your desktop. Youcan learn at your own location, on your own time, and at your own pace. Courses are availablefor one year. You may share the login with everyone in your laboratory.
QMEd courses include:1. 15189 Walkthrough2. QMS Implementation Roadmap3. Root Cause Analysis4. Internal Auditing5. Document Control6. Quality Manual Development7. Management Review
Choose CAP QMEd courses on your 2015 Surveys order form.
20 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Con
tinui
ngEd
ucat
ion
2
QMEd™ Online Educational Courses
Learn quality tools and techniques with case examples frommedical laboratories.Program information
• CAP uality Management Educational Resources ( MEd) courses help you improve your processes and eliminate waste.• CAP MEd courses help you build a quality management system—one piece at a time—that sustains your continuous
improvement and Lean efforts.• CAP MEd courses are delivered online via a highly interactive user interface that allows you to learn at your own pace.• All CAP MEd courses are licensed for one year, allow sharing of logins, and include continuing education (CE) credit.
CAP online interactive QMEd courses will help you:• nderstand the concept of a uality management system• Self-assess your current MS against international uality standards• Plan and resource for the development of your MS• Interpret ISO 15189 re uirements• Improve your document control system• Perform internal audits using tracer audit and process audit methods• Implement and refine occurrence management with root cause analysis• rite an effective uality manual• Measure, analyze, and set goals with senior management
About the Courses15189 WalkthroughOrder ISOEDWTDesigned for lab quality managers (along with your medical and administrative decision makers) considering implementation ofan ISO 15189 program. Summarizes each section of the standard, while clarifying its intent and key requirements. Hear directlyfrom CAP 15189SM assessors who offer context and examples of how technical problems relate to more fundamental deficienciesin the quality management system.
2 CE credits available
QMS Implementation RoadmapOrder ISOEDRMOutlines the practical steps necessary to build, implement, and maintain a quality management system that meets the ISO 15189standard. Gain perspective on practices (and pitfalls) straight from CAP 15189 assessors, as well as CAP 15189-accredited labs.Designed for lab quality managers, plus your implementation team members.
2 CE credits available
Root Cause AnalysisOrder ISOEDRCLearn real-world methodology to conduct a root cause analysis, along with the tools necessary to implement it. Learn from actualexamples of complete root cause analysis based on projects in labs like yours. You will even perform key steps based on aparticipant case study. The course is designed for laboratory quality managers and implementation team members.
6 CE credits available
QMEd™ Online Educational Courses
800-323-4040 | 847-832-7000 Option 1 | cap.org 21
Continuing
Education
2
QMEd™ Online Educational Courses
Internal AuditingOrder ISOEDIAIncrease your capabilities for internal auditing with a proven methodology for process audits, tracer audits, and laser audits. Learnfrom CAP 15189 assessors how to prepare for interviews, communicate findings to your quality management team, and use auditsto drive process improvements.
3 CE credits available
Document ControlOrder ISOEDDCThis how-to course on document control systems details how to control documents in a way that meets ISO 15189 re uirements,how to accomplish document control even with minimal resources (such as spreadsheets), and how document control contributes tocost containment. All this from CAP 15189 assessors who give examples and commentary on common pitfalls and issues.
2 CE credits available
Quality Manual DevelopmentOrder ISOEDQMThis course provides guidance on how to go beyond a quality plan to develop a manual that organizes and communicates yourlaboratory’s quality management system. You will see an example of an effectively structured and written manual so you canorganize and create your own. Plus, CAP 15189 assessors show you approaches to link your quality policy to quality objectivesand metrics.
2 CE credits available
Management ReviewOrder ISOEDMRThis course interprets the ISO 15189 requirements for management review. The CAP 15189 assessors discuss how to structure thereview meeting, communicate results of quality assessments, and prompt strategic decisions from management—all in the contextof the overall health of your organization.
2 CE credits available
Make sure your laboratory team is ready to meet the challenges ahead. Sign up now for this comprehensive set of learning tools.
For more information, visit cap.org and choose the Laboratory Improvement Programs tab or call 800-323-4040or 847-832-7000 option 1.
Multitasker.Managing competency for your staff placesdemands on your resources.
Now there is a resource that multitasks for you!
The Competency Assessment Programmakes it easy to:
• Develop and manage all si elements ofcompetency assessment
• Create educational resources for alllaboratory staff
• Provide valuable training for new hires• tay current with laboratory safety and
compliance requirements• Provide management with employee
performance reports• Enhance your continuing education program• Be inspection ready
Competency Assessment Program gives youand your staff more time to focus on betterpatient results.
Quality M
anagement Tools
3
Quality Management ToolsQ-PROBES™ ...................................................................................................................................26Q-TRACKS®.....................................................................................................................................31
Clinical Pathology Monitors ...........................................................................................................33Anatomic Pathology Monitors ........................................................................................................39
Q-MONITORS® ...............................................................................................................................41
New Programs New
Blood Bank Safety Practices (QP151).................................................................................................27Clinical Test Utilization: Unnecessary Testing (QP152) .........................................................................28Physician Satisfaction with Anatomic Pathology Services (QP153) .........................................................29Identification Errors (QP154) .............................................................................................................30
Discontinued ProgramsTechnical Staffing Ratios (QP141)Validating Laboratory Results in Electronic Health Records (QP142)Physician Satisfaction with Clinical Laboratory Services (QP143)Use and Effectiveness of Delta Checks (QP144)Laboratory Management Index Program (LMB)CAP LINKS (IMR1-4, IMRPT, IMRLP, IMRLM)
3 | Quality Management Tools
“I like being associated with the CAP becauseit is an organization with a great reputation forhelping laboratories improve.”
24 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Quality Management Tools
Quality ManagementToolsUse the CAP’s Quality Management Tools (QMT) to improve the Total Testing Process byidentifying quality improvement opportunities of selected key processes in the clinical and anatomicpathology laboratories, examining preanalytical, analytical and postanalytical phases:
• Establish realistic goals by comparing performance against similar institutions withcomparable demographics
• Monitor progress through unique and robust quality indicators on a periodical basis
• Make effective quality management decisions based on practical and in-depthindividual reports provided to participants
• Improve efficiencies to allow time for more patient-centric activities
• Easily integrate quality management into your daily work processes withpredesigned monitoring tools developed by laboratory professionals and scientists
Q-PROBES™ A One-Time Opportunity to Perform In-Depth Quality Assessment
Q-TRACKS® A Program for Continuous Quality Monitoring
Q-MONITORS® Customized Quality Monitors Program
Q-PROBES, Q-TRACKS, and Q-MONITORS activities meet the American Board of Pathology MOC Part IV PracticePerformance Assessment requirements.
800-323-4040 | 847-832-7000 Option 1 | cap.org 25
Quality M
anagement Tools
3
Quality Management Tools
Q-PROBES, Q-TRACKS, andQ-MONITORSoffer a comprehensive collection of tools tocomplement your quality management program needs.*
Select Q-PROBES, Q-TRACKS, andQ-MONITORS studies to supportyour quality improvement initiatives.
Prea
naly
tic
Ana
lytic
Post
anal
ytic
Ana
tom
icPa
thol
ogy
Clin
ical
Path
olog
y
Turn
arou
ndTim
e
Patie
ntSa
fety
Mic
robi
olog
y
Tran
sfus
ion
Med
icin
e
Che
mist
ry/
Hem
atol
ogy
Cus
tom
erSa
tisfa
ctio
n
Q-PROBES
Blood Bank Safety Practices (QP151) z z z z
Clinical Test Utilization: Unnecessary Testing(QP152)
z z z
Physician Satisfaction with Anatomic Pathology Services(QP153)
z z z z z
Identification Errors (QP154) z z z z z z
Q-TRACKS
Patient Identification Accuracy (QT1) z z z z
Blood Culture Contamination (QT2) z z z z
Laboratory Specimen Acceptability (QT3) z z z
In-Date Blood Product Wastage (QT4) z z z
Gynecologic Cytology Outcomes:Biopsy Correlation Performance (QT5)
z z z z z
Satisfaction With Outpatient Specimen Collection (QT7) z z z
Stat Test Turnaround Time Outliers (QT8) z z z z z
Critical Values Reporting (QT10) z z z z
Turnaround Time of Troponin (QT15) z z z z z z
Corrected Results (QT16) z z z z z z z
Outpatient Order Entry Errors (QT17) z z z
Mislabeled Cases, Specimens, Blocks, and Slides inSurgical Pathology (QT19)
z z z
Q-MONITORS
Monitoring of Troponin Metrics for Suspected MI (QM1) z z z z z z z z
*The CAP requires accredited laboratories to have a quality management plan that covers all areas of the laboratory and includesbenchmarking key measures of laboratory performance (GEN.13806, GEN.20316, COM.04000). The Joint Commission requiresaccredited hospitals to regularly collect and analyze performance data (PI.01.01.01, PI.02.01.01). CLIA requires laboratories to monitor,assess, and correct problems identified in preanalytic, analytic, and postanalytic systems (§493.1249, §493.1289, §493.1299).
Q-PROBES
26 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Q-PROBES
A One-Time Opportunity to Perform In-Depth QualityAssessment
1 Q-PROBES studies are available only one time annually and may not be repeated in the future.
Pilot quality monitoring—Use Q-PROBES short-term comprehensive quality studies1 to learnhow to start monitoring and measuring key processes that you may not have followed in the pastor that are not commonly monitored in most laboratories. Q-PROBES studies analyze hot topicsand industry trends to keep the laboratory current.
Gain experience in data collection and analysis—Participants will collect data duringpredetermined dates. Based on submitted data, the CAP provides personalized reports with theindividual participant’s performance compared against other participants.
Strengthen your quality assessment expertise—CAP’s pathologist experts providein-depth discussion and identify best practices for laboratories to strive for. In addition,consolidated results of the studies are carefully reviewed and analyzed to be published inthe form of scientific articles. Such articles give participants an extra layer of informationto be utilized for further analysis.
Participants in the Q-PROBES program receive:
• sers guide
• Templates and instructions for data collection
• Individual report, how to interpret the results guide,overall aggregated data
• Data Analysis and Criti ue that includes datadistributions and analysis of laboratory practices and commentaries from pathologist expertson improvement opportunities
• Access to the scientific articles that are published with the results of the studies
Q-PROBES activities meet the American Board of Pathology MOC Part IV Practice PerformanceAssessment requirements.
Q-PROBES
800-323-4040 | 847-832-7000 Option 1 | cap.org 27
Quality M
anagement Tools
3
Blood Bank Safety Practices QP151Transfusion of ABO incompatible red blood cells can be a lethal error and is most commonly due to patient or specimenmisidentification. Since the rate of incompatible ABO transfusions at any single institution is very low, this study will focus onthe frequency of specimen identification errors that can lead to incompatible ABO transfusion.
ObjectivesDetermine the rates of mislabeled specimens submitted for ABO typing and of ABO result discrepancies (wrong-blood-in-tube);compare rates between laboratories.
Data CollectionFrom a 30-day review of all specimens submitted for ABO typing, participants will record the number of mislabeled specimens,the number of ABO typing results with a historical type on record, the number of current specimen results that are discrepantfrom the historical results, and the total number of RBC transfusions.
A mislabeled specimen will be defined as any specimen that does not meet the requirements of the institution’s labeling policy.
For the most recent calendar or fiscal year, the number of RBC units transfused, the total number of specimens submitted forABO typing, and the number of ABO results that were discrepant from the historical results will also be recorded.
Performance Indicators• Primary:
o Percent of mislabeled ABO specimens• Secondary:
o Percent of ABO typing result discrepancieso Percent of correct historical ABO typeso Percent of mislabeled ABO specimens that are rejected
New
This is a one-time study conducted in the first quarter.
Q-PROBES
28 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Clinical Test Utilization: Unnecessary Testing QP152In spite of well-known concerns and costs associated with inappropriate laboratory testing, implementation of effective solutionsis challenging. Educational interventions tend to be transient while use of automated testing algorithms, menu restrictions,feedback or other strategies that may effectively diminish inappropriate laboratory testing are not in widespread use. Collectinginformation about testing patterns is vital for evaluating inappropriate utilization and developing policies and procedures toimprove testing practices.
ObjectivesAssess laboratory testing utilization by evaluating results from previous tests that indicate additional testing may beunnecessary.
Data CollectionParticipants will retrospectively collect data from the most recent 30 to 40 patients with completed orders for free PSA, factor VLeiden and positive anti-HAV testing. Current testing date and previous testing date and results (as applicable) will be recorded.Participants will also complete a questionnaire about their test utilization practices, policies, and procedures.
Performance Indicators• Percent of inappropriate tests performed• Percent of free PSA tests performed when recently tested total PSA is outside of the range for accurately interpreting free PSA
results• Percent of anti-HAV tests performed when previous test results were positive• Percent of factor V Leiden mutation tests performed when the patient had already been tested
New
This is a one-time study conducted in the second quarter.
Q-PROBES
800-323-4040 | 847-832-7000 Option 1 | cap.org 29
Quality M
anagement Tools
3
Physician Satisfaction with Anatomic Pathology Services QP153Although patients are the principle end-users of anatomic pathology services, clinicians enjoy a preferred customer status andtheir opinions are an essential component in developing a customer-oriented pathology department. Surveying clinicians willprovide valuable information for anatomic pathology quality improvement activities.
ObjectivesAssess clinician satisfaction with anatomic pathology services and correlate it with the laboratory workload, performanceimprovement activities, and customer support services.
Data CollectionClinicians will be asked to complete a standardized questionnaire regarding their perception of anatomic pathology services.Questions on services will include timeliness of reporting, diagnostic accuracy, communication, educational activities,accessibility, responsiveness to problems, and courtesy of staff. Clinical questionnaires will be available by two modes ofaccess: electronic distribution with direct return to the CAP, or by use of hard copy response forms. Data from the first 50returned questionnaires will be submitted for analysis.
Performance Indicators• Primary:
o Overall mean satisfaction score
• Secondary:o Mean satisfaction score for anatomic pathology service categories
New
This is a one-time study conducted in the third quarter.
Q-PROBES
30 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Identification Errors QP154Identification errors in the laboratory have the potential to cause serious patient adverse events. These errors may involvemisidentification of a patient or of a specimen. The laboratory’s ability to recognize these errors before results are releasedcontributes to a culture of patient safety and minimizes the adverse consequences of identification errors.
ObjectivesExamine how well your laboratory prevents identification errors by detecting them before results are released to caregivers.Participants will receive their overall identification error rate and their rates of error detection before and after results arereleased to primary caregivers. These rates will be compared to the error rates from all participating institutions. This study willalso seek to identify institutional processes and factors more likely to be found in laboratories that detect a high proportion ofidentification errors before results are released.
Data CollectionOver five weeks, participants will collect data on all patient and specimen identification errors detected by their laboratorybefore results were released, and also on identification errors that come to their attention after results were released.Participants will record whether they know of any patient harm that resulted from any of the identification errors. In addition,laboratories will have the option of tracking the reason for the identification errors.
This study includes all types of testing, both clinical and anatomic pathology, and tests from all patient locations (eg, inpatient,outpatient, outreach).
Performance Indicators• Primary:
o Overall identification error rateo Rate of identification errors detected before release of resultso Rate of identification errors detected after release of results
• Secondary:o Breakdown of identification error detection time (before or after release of results)o Breakdown of reasons for identification error
New
This is a one-time study conducted in the fourth quarter.
Q-TRACKS
800-323-4040 | 847-832-7000 Option 1 | cap.org 31
Quality M
anagement Tools
3
Q-TRACKS
A Program for Continuous Quality MonitoringIdentify and monitor opportunities for quality improvement over timeUse established Q-TRACKS programs to identify opportunities to quantitate your quality improvement measures.
Evaluate quality improvementsMeasure the effectiveness and impact of implemented changes in key processes. The individual reports include performance ofquality indicators over time, benchmarking information, trends, and suggested areas for improvement.
Step 1:Establish realistic benchmarks by comparing yourlaboratory to others like yours.
Step 2:Identify improvement opportunities.
Step 3:Monitor improvement over time toensure accurate results, patient safety,and quality patient care.
Q-TRACKS: QT3 - Laboratory Specimen AcceptabilityTrend Analysis Report: January-March
Q-TRACKS: QT3 - Laboratory Specimen AcceptabilityExternal Comparison Report: January-March
(most like you)
Q-TRACKS
32 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Q-TRACKS activities meet the American Board of Pathology MOC Part IV Practice PerformanceAssessment requirements.
Participants in the Q-TRACKS program receive:• sers guide
• Templates and instructions for data collection
• uarterly reports that include fingerprint clusters, customer-defined groups, and all institutioncomparisons
• Peer directory
• Annual summary report
Laboratory Administration for PathologistsElizabeth A. Wagar, MD, FCAPRichard E. Horowitz, MD, FCAP, andGene P. Siegal, MD, PhD, FCAP, editorsItem number: PUB312Hardcover; 300 pages; 100+ figures, tables, and photographs; 2011
Quality Management in Anatomic Pathology: Promoting PatientSafety through Systems Improvement and Error ReductionRaouf E. Nakhleh, MD, FCAP, andPatrick L. Fitzgibbons, MD, FCAP, editorsItem number: PUB118Softcover; 198 pages; 70+ exhibits and tables; 2005
Quality Management in Clinical Laboratories: Promoting PatientSafety through Risk Reduction and Continuous ImprovementPaul Valenstein, MD, FCAP, editorItem number: PUB214Softcover; 265 pages; 80+ exhibits and tables; 2005
PRESS
To orderVisit cap.org and choose the Shop tab or call the CAP CustomerContact Center at 800-323-4040 or 847-832-7000 option 1.
Also available as ebooks! Visit ebooks.cap.org
Quality Management Resources from CAP Experts
Q-TRACKS
800-323-4040 | 847-832-7000 Option 1 | cap.org 33
Quality M
anagement Tools
3Patient Identification Accuracy QT1
In order to report accurate laboratory results and meet The Joint Commission National Patient Safety Goal #1: “Identify patientscorrectly,” institutions must properly identify patients. Since most laboratories perform testing away from the patient, patientidentification, and labeling of specimens and coordination with test requisitions must be performed accurately and completely.By continuously monitoring for wristband errors, participants can promptly identify and correct problems that may interfere withpatient care services.
ObjectivesAssess the incidence of wristband errors within individual institutions, compare performance between participating institutions,and identify improvement opportunities.
Data CollectionOn six predetermined days per month, participants will monitor patient wristband identification for all phlebotomies performedat their institution. Phlebotomists will tally the total number of wristbands checked, the number of errors found, and the typesof wristband error. This monitor includes all routinely wristbanded patients. Include emergency department patients only if theemergency department routinely applies wristbands to these patients.
Performance Indicator Performance Breakdown• ristband error rate ( ) • Brea down of wristband error types ( )
Blood Culture Contamination QT2Despite advances in blood culture practices and technology, false-positive blood culture results due to contaminants continue tobe a critical problem. Blood culture contamination rate, the primary indicator of preanalytic performance in microbiology, isassociated with increased length of hospital stay, additional expense, and the administration of unnecessary antibiotics. TheCAP and other accrediting organizations require you to monitor and evaluate key indicators of quality for improvementopportunities. Use this monitor to help meet this requirement.
ObjectiveDetermine the rate of blood culture contamination using standardized criteria for classifying contaminants.
Data CollectionOn a monthly basis, participants will tabulate the total number of blood cultures processed and the total number of contaminatedblood cultures. Blood cultures from neonatal patients are tabulated separately. For the purposes of this study, participantswill consider a blood culture to be contaminated if they find one or more of the following organisms in only one of a seriesof blood culture specimens: Coagulase-negative Staphylococcus; Micrococcus; Alpha-hemolytic viridans group streptococci;Propionibacterium acnes; Corynebacterium sp. (diptheroids); or Bacillus sp. Participants have the option to monitor institution-specific subgroups, for example, a specific department or patient population.
Performance Indicators• Neonatal contamination rate ( )• Other contamination rate ( )• Overall contamination rate ( )
Q-TRACKS Clinical Pathology Monitors
Look for your input forms approximately three weeks prior to the quarter.
Q-TRACKS
34 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Laboratory Specimen Acceptability QT3A substantial amount of rework, diagnostic and therapeutic delay, and patient inconvenience can result from specimenrejection. Patient redraws may result from unlabeled, mislabeled, and incompletely labeled specimens; clotted and/orhemolyzed specimens; or insufficient specimen quantity. By continuously monitoring specimen acceptability, collection, andtransport, laboratories can promptly identify and correct problems.
ObjectiveIdentify and characterize unacceptable blood specimens that are submitted to the chemistry and hematology/coagulationsections of the clinical laboratory for testing.
Data CollectionThis monitor includes all blood specimens submitted for testing to the chemistry and hematology departments of the clinicallaboratory. On a weekly basis, participants will record the total number of specimens received, the number of rejectedspecimens, and the primary reason each specimen was rejected.
Performance Indicator Performance Breakdown• Specimen rejection rate ( ) • Brea down of reasons for rejection ( )
In-Date Blood Product Wastage QT4Blood for transfusion is a precious resource. At a minimum, wastage of blood that is not out-of-date represents a financial lossto the health care system. More ominously, systemic wastage of blood may reflect an environment of care that is out of controland could pose risks to patient safety.
ObjectiveCompare the rates of blood product wastage (ie, units discarded in-date) in participating hospitals and track rates ofimprovement over time.
Data CollectionOn a monthly basis, participants will use blood bank records to obtain information on the total number of units transfusedfor each type of blood component. Participants will track the number and type of blood units that are wasted in-date and thecircumstances of wastage. This monitor includes the following types of blood components: red blood cells (allogeneic), frozenplasma, platelet concentrates, single donor platelets, and cryoprecipitate.
Performance Indicators Performance Breakdown• Overall blood wastage rate ( ) • Brea down of circumstances of wastage ( )• astage rates by blood component type ( )
Look for your input forms approximately three weeks prior to the quarter.
Q-TRACKS
800-323-4040 | 847-832-7000 Option 1 | cap.org 35
Quality M
anagement Tools
3
Satisfaction With Outpatient Specimen Collection QT7Specimen collection is one of the few areas of laboratory medicine that involves direct outpatient contact. As a result, patientsatisfaction with this service is a vital indicator of quality laboratory performance. The CAP’s Laboratory AccreditationProgram requires measurement of patient satisfaction with laboratory services (GEN.20335). Use this monitor to help meet thisrequirement.
ObjectiveAssess patient satisfaction with outpatient phlebotomy services by measuring patients’ assessment of waiting time, discomfortlevel, courteous treatment, and overall satisfaction.
Data CollectionOn a monthly basis, participants will provide copies of a standardized questionnaire to a minimum of 25 outpatients (maximumof 99 outpatients) using predetermined data collection criteria. This monitor includes any outpatient undergoing venipuncture.This monitor excludes patients seen in the emergency department, ambulatory surgery area, urgent care facility, chest paincenter, 23-hour short-stay facility, employee health department, outpatient health screening fair/promotion, dialysis center,nursing home, or extended care facility.
Performance Indicators• Overall patient satisfaction score• Patients more than satisfied ( )
Stat Test Turnaround Time Outliers QT8The stat test turnaround time (TAT) outlier rate, expressed as a percentage of tests missing target reporting times, is a measureof outcomes that evaluates how well the laboratory meets patient and clinician needs. This monitor helps meet CAP Checklistrequirement GEN.20316, “The QM program includes monitoring key indicators of quality in the preanalytic, analytic, andpostanalytic phases.”
ObjectiveMonitor the frequency that stat test TAT intervals exceed institutional stat test TAT expectations.
Data CollectionBefore beginning data collection, participants will establish a specimen receipt-to-report deadline for emergency department(ED) stat potassium tests. On six predetermined days per month, participants will monitor the TAT of up to 10 randomlyselected ED stat potassium tests on each of three, eight-hour shifts (up to 180 tests per month) and track the number of ED statpotassium results reported later than the established reporting deadline. This monitor includes stat potassium testsordered as part of a panel and excludes stat potassium levels that are requested on body fluids other than blood, as part oftimed or protocol studies, or after the specimen arrives in the laboratory.
Performance Indicator Performance Breakdowns• Stat test TAT outlier rate ( ) • Brea down of outliers by shift ( )
• Brea down of outliers by day of wee ( )
Look for your input forms approximately three weeks prior to the quarter.
Q-TRACKS
36 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Critical Values Reporting QT10Laboratories commonly refer to critical values as results requiring immediate notification to the physician or caregiver fornecessary patient evaluation or treatment. Regulations from agencies and accreditors such as the CMS, The JointCommission, and the CAP (GEN.20316, COM.30000) mandate that laboratories develop and implement an alert systemfor critical values. Use this monitor to document compliance with your laboratory’s alert plan.
ObjectiveEvaluate the documentation of successful critical values reporting in the general laboratory for inpatients (including dischargedinpatients) and outpatients.
Data CollectionOn a monthly basis, participants will evaluate 120 inpatient, 20 discharged inpatient, and 120 outpatient critical values.Data collection will include general chemistry, hematology, and coagulation analytes on the critical values list. Retrospectively,participants will record the total number of critical values monitored and the number with documentation of successfulnotification. In addition, participants will provide the number of critical values that were not communicated within three hours,the number of failed notifications due to laboratory oversight, and the number of successful notifications to licensed caregivers.This monitor will exclude critical values for cardiac markers, drugs of abuse, therapeutic drug levels, urinalysis, blood gases,point-of-care tests, and tests performed at reference laboratories.
Performance Indicators• Total critical values reporting rate ( )• Inpatient critical values reporting rate ( )• Discharged inpatient critical values reporting rate ( )• Outpatient critical values reporting rate ( )• Failed notification (< hours) rate ( )
Look for your input forms approximately three weeks prior to the quarter.
Q-TRACKS
800-323-4040 | 847-832-7000 Option 1 | cap.org 37
Quality M
anagement Tools
3
Turnaround Time of Troponin QT15The swiftness with which physicians establish diagnoses of acute myocardial infarction (AMI) in patients presenting to theemergency department (ED) with chest pain may determine the type and predict the outcome of therapy those patients willreceive. Included in the total time consumed in establishing diagnoses of AMI are the component intervals required to measurebiochemical markers of myocardial injury. One of the most critical biochemical markers is troponin. Use this monitor to helpmeet CAP Checklist requirement GEN.20316 QM Indicators of Quality.
ObjectiveDetermine the median order-to-report turnaround time (TAT) of troponin (I or T) ordered to rule out myocardial infarction andthe percent of troponin results reported by each institution’s established deadline.
Data CollectionOn six predetermined days per month, participants will record TATs (in minutes) for three randomly selected troponinspecimens obtained from ED patients on each of three traditional shifts, a total of nine measurements. Participants will measureTATs from the time of test order to the time results are available to ED personnel.
Performance Indicators• Median troponin order-to-report TAT (minutes)• Troponin TAT compliance rate ( )
Corrected Results QT16The CAP developed this Q-TRACKS monitor in recognition of the importance of timely detection and correction of erroneouslaboratory results. Accuracy in laboratory results is critical to the effectiveness of a physician’s plan of care for a patient. Anerroneous result can delay or alter patient treatment; therefore, detection of erroneous results should be a priority in everylaboratory and should be monitored as a key quality indicator. Help measure your compliance with CLIA 493.1299,Postanalytic Systems Quality Assessment, with this monitor.
ObjectiveMonitor the number of corrected test results within individual institutions and compare performance with that of all institutionsand those institutions similar to yours.
Data CollectionOn a monthly basis, participants will monitor the number of corrected test results and the total number of billable tests for thatmonth. Include test results for all patients in all care settings with the following exclusions: anatomic pathology tests, narrativephysician-interpreted tests (eg, bone marrow biopsies and peripheral smear reports), and point-of-care tests.
Performance Indicator• Test result correction rate (per 10,000 billable tests)
Look for your input forms approximately three weeks prior to the quarter.
Q-TRACKS
38 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Outpatient Order Entry Errors QT17Order accuracy bears an obvious relationship to the quality of laboratory testing. When the laboratory fails to complete arequested test, it delays the diagnostic evaluation, potentially extending a patient’s hospital stay and prolonging therapy.When the laboratory completes a test that was not requested, the cost of care increases, patients may be subjected tounnecessary phlebotomy, and laboratory efficiency declines.
ObjectiveMeasure the incidence of incorrectly interpreted and entered outpatient physician test orders into the laboratory informationsystem, compare performance across institutions, and track performance over time.
Data CollectionOn six preselected weekdays per month, participants will compare eight outpatient requisitions or order sheets to the ordersentered into the laboratory’s information system to determine if any order entry errors occurred. Order entry error categoriesinclude requesting physician errors; incorrect, missing, and extra test errors; test priority errors; and copy or fax result errors.This monitor excludes tests performed in transfusion medicine or anatomic pathology. This monitor also excludes tests from thefollowing patient care settings: inpatient, emergency department, ambulatory surgery, urgent care, chest pain center, 23-hourshort-stay facility, employee health department, outpatient screening fair/promotion, and dialysis center.
Performance Indicators Performance Breakdown• Overall outpatient order entry error rate ( ) • Brea down of error types ( )• Order entry error rates by type ( )
Look for your input forms approximately three weeks prior to the quarter.
Q-TRACKS
800-323-4040 | 847-832-7000 Option 1 | cap.org 39
Quality M
anagement Tools
3Gynecologic Cytology Outcomes: Biopsy Correlation Performance QT5
The correlation of cervicovaginal cytology (Pap test) findings with cervical biopsy results is a significant part of thecytopathology laboratory’s quality assurance program. By monitoring this correlation, the laboratory can identify and addresspotential problems requiring improvement, thereby ensuring better patient results.
ObjectiveQuantify the correlation between the findings of cervicovaginal cytology and corresponding histologic material.
Data CollectionOn a monthly basis, participants will record the number of true-positive, false-positive, and false-negative cytology-biopsycorrelations. The false-negative correlations will be classified into four error categories: screening errors, interpretive errors,screening and interpretive errors, and adequacy determination errors. Participants will also record the biopsy diagnoses forPap tests with an interpretation of atypical squamous cells (ASC-US and ASC-H) or atypical glandular cells (AGC). This monitorincludes cervical biopsy specimens submitted to the laboratory that have a corresponding satisfactory or satisfactory but limitedPap test within three months of the biopsy.
Performance Indicators• Predictive value of positive cytology ( )• Sensitivity ( )• Screening/interpretation sensitivity ( )• Sampling sensitivity ( )• Percent positive for ASC- S interpretations• Percent positive for ASC-H interpretations• Percent positive for AGC interpretations
Q-TRACKS Anatomic Pathology Monitors
Look for your input forms approximately three weeks prior to the quarter.
Q-TRACKS
40 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Mislabeled Cases, Specimens, Blocks, and Slidesin Surgical Pathology QT19
Mislabeling of surgical pathology specimens has potential catastrophic consequences for patient care. By continuouslymonitoring the rate of mislabeled specimens, participants will be able to identify problems and variables associated withmislabeled specimens, blocks, and slides. This Q-TRACKS monitor will also help participating laboratories fulfill The JointCommission National Patient Safety Goal #1: “Identify patients correctly” in the discipline of surgical pathology.
ObjectivesDetermine the rates of mislabeled cases, specimens, blocks, and slides and the rate at which mislabeling errors led to acorrected report and compare performance to other institutions.
Data CollectionProspectively track each time a specimen container, block or slide is relabeled or renumbered due to an identification error;and if, as a result, a corrected report is issued. Participants will also report the number of cases processed each month and thenumber of blocks and slides (including special stains) that are processed during the same time period. Data will be collectedmonthly.
This Q-TRACKS monitor is limited to routine histology processing.
Performance Indicators• Rate of mislabeled events (mislabeled cases, specimens, bloc s, and slides) per case• Percent of errors that resulted in a corrected report• Rate of mislabeled cases• Rate of mislabeled specimens• Rate of mislabeled bloc s• Rate of mislabeled slides
Look for your input forms approximately three weeks prior to the quarter.
Q-MONITORS
800-323-4040 | 847-832-7000 Option 1 | cap.org 41
Quality M
anagement Tools
3
Q-MONITORS
A Program for a Customized Comprehensive AssessmentEvaluate quality improvements in your laboratoryWith today’s focus on reducing medical errors, achieving and maintaining excellence is key tosuccess. Using continuous monitoring, Q-MONITORS provide a comprehensive assessment of keyprocesses in your institution.
Structure your data collection and analysis for successUse Q-MONITORS to help build and improve data collection and analyze processes thatcontribute to quality of care, patient safety, and outcomes. Observe performance trends overtime to identify and monitor opportunities for quality improvement through quantitative qualitymeasures.
Establish realistic laboratory benchmarks and performance goalsQ-MONITORS are customized programs that address process-, outcome-, and structure-orientedquality assurance issues. Establish benchmarks through external database comparisons andcompare your performance to establish goals for performance improvement.
Q-MONITORS
42 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Qua
lity
Man
agem
ent T
ools
3
Q-MONITORS Customized Quality Monitoring Program
Monitoring of Troponin Metrics for Suspected MI QM1Patients presenting to the emergency department (ED) with chest pain must be evaluated quickly. Rapid serum troponinmeasurement is an important part of ED practice that can provide decisive information for patient management. Reducingdelays in troponin testing has been reported to result in shorter length of stay in the ED and more rapid initiation of anti-ischemictreatment. Emergency departments and chest pain centers should, therefore, have effective procedures for ensuring optimalturnaround time (TAT) for troponin and a process for ongoing monitoring to ensure that performance meets expectations.
ObjectiveDetermine and monitor troponin TATs for patient arrival to result availability and/or up to six time intervals within the totaltesting process for patients presenting to the ED with chest pain.
Data CollectionSix days per month, collect data from nine patients presenting to the ED with chest pain and tested for troponin level. Dataincludes time of patient arrival, troponin test order, specimen collection, laboratory receipt, and result availability. It is notnecessary to provide data from each TAT component. Participants select which TAT metrics to monitor, with the option tomonitor all metrics.
Participants will also complete a questionnaire about clinical and laboratory practices related to troponin testing.
MetricsDepending on the data submitted, the following metrics will be provided. In addition, TAT benchmarking, as compared to allinstitutions, will be provided for both point-of-care and clinical laboratory testing for patient arrival to result availability andspecimen collection to result availability.• Patient arrival to result availability• Specimen collection to result availability• Test order to result availability• Patient arrival to test order• Test order to specimen collection• Specimen collection to laboratory receipt• Laboratory receipt to result availability
Performance indicators• Median TAT for troponin testing intervals (monthly)• Test order to result availability compliance rate (if applicable)• Specimen collection to result availability compliance rate (if applicable)
Look for your input forms approximately three weeks prior to the quarter.
Point-of-Care
Programs
4
Point-of-Care Programs
Discontinued ProgramsPOC H. pylori Antibody Competency (POC13)
4 | Point-of-Care Programs
“I think the CAP is fantastic and I’m proud to beassociated with an organization that is so interestedin high quality patient care. The CAP is not justa proficiency testing provider—the CAP is somuch more.”
Point-of-Care Programs
44 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Poin
t-of
-Car
ePr
ogra
ms
4
Point-of-Care Programs
POC Competency Challenges are designed to improve waived test results. These programs will evaluateinstrument and method performance, troubleshoot, assess staff competency, and provide information totrain staff. Expected results will be provided. These programs are not proficiency testing programs andparticipants will not return results to the CAP.
POC Competency Challenges may have limited availability and stability.
POC Competency ChallengesPOC1, POC2, POC3, POC4
Program Name Program Code Challenges/Shipment
POC1 POC2 POC3 POC4
POC hCG Competency z 10
POC Glucose Competency z 10
POC Urine Dipstick Competency z 10
POC Strep Screen Competency z 10
POC Competency ChallengesPOC5, POC6, POC7, POC8, POC9
Program Name Program Code Challenges/Shipment
POC5 POC6 POC7 POC8 POC9
POC PT/INR, i-STATCompetency
z 10
POC PT/INR, CoaguChek XS PlusCompetency
z 10
POC Waived Chemistry, Glucoseand HgB Competency
z 10
POC Influenza A/B AntigenDetect Competency
z 10
POC Fecal Occult BloodCompetency
z 10
Program Information• POC1 - One positive 10.0-mL
liquid urine specimen
• POC2 - One abnormal2.5-mL whole blood specimen
• POC - One abnormal10.0-mL li uid urinespecimen
• POC - One 1.0-mL positiveliquid specimen
• Each program will providematerial to test up to 10 staff
• Shipments available uponrequest
Program Information• POC5 - Five abnormal 1.0-mL
lyophilized plasma specimens
• POC6 - Five abnormal 0. -mLlyophilized plasma specimensand five correspondingdiluents
• POC7- One abnormal 1.0-mLwhole blood specimen. Foruse with the HemoCue® B,HemoCue 201, and StanbioHemoPoint® H2 instruments
• POC8 - One 1.5-mL vialpositive for influenza A;One 1.5-mL vial positive forinfluenza B
• POC9 - One positive 2.0-mLfecal specimen
• Each program will providematerial to test up to 10 staff
• Shipments available uponrequest
Point-of-Care Programs
800-323-4040 | 847-832-7000 Option 1 | cap.org 45
Point-of-Care
Programs
4
POC Competency ChallengesPOC10, POC11, POC12
Program Name Program Code Challenges/Shipment
POC10 POC11 POC12
POC Blood Gases Competency z 10
POC Blood Gases, i-STATCompetency
z 10
POC Plasma Cardiac MarkersCompetency
z 10
POC Competency ChallengesPOC14, POC15, POC16
Program Name Program Code Challenges/Shipment
POC14 POC15 POC16
POC Medtronic ACT/ACT,i-STAT Competency
z 5
POC Hemochron r IL GEMACT-LR Competency
z 5
POC Hemochron r Signature ILGEM PCL ACT Competency
z 5
Program Information• POC10 - Ten abnormal
2.5-mL a ueous blood gasspecimens and ten 2.5-mLhematocrit/hemoglobinspecimens
• POC11 - Ten abnormal2.5-mL a ueous specimensfor blood gas andhematocrit/hemoglobintesting
• POC12- One abnormal1.5-mL plasma specimen;compatible with plasmabased tests, such as AlereTriage and i-STAT instruments
• Shipments available uponrequest
Program Information• POC1 - Five abnormal
1.7-mL lyophilized wholeblood specimens with fivecorresponding diluentsand one calcium chloridediluent vial; compatible withMedtronic HemoTec ACT/ACT, Medtronic Hepcon HMS,i-STAT Celite ACT, i-STATKaolin ACT
• POC15 - Five abnormal0.5-mL unitized specimens;compatible with IL GEMPCL Plus ACT-LR and ITCHemochron Jr./SignatureACT-LR
• POC16- Five abnormal0.5-mL unitized specimens;compatible with IL GEM PCLPlus ACT and ITC HemochronJr./Signature ACT+
• Shipments available uponrequest
Point-of-Care Programs
46 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Poin
t-of
-Car
ePr
ogra
ms
4
In many hospitals today, laboratory testing has shifted from the central main laboratoryto inpatient rooms, emergency departments, and intensive care units. We have developedthis section in response to this shift and the increased use of point-of-care instrumentsin the hospital. This section will help you select the most appropriate proficiency testingprograms for staff members who work near patient and bedside testing in the hospitalsetting. For additional information about selecting the right programs for your institution,contact the CAP at 800- 2 - 0 0 or 8 7-8 2-7000 option 1.
Use the charts to select the proficiency testing programs that meet your testing needs.
Critical Care Aqueous Blood Gas and OximetrySurvey Name Program Code Page Number
Critical Care Aqueous Blood GasA , A 2, A ,
A82
Blood Oximetry SO 8
ChemistrySurvey Name Program Code Page Number
B-Type Natriuretic Peptides BNP, BNP5 55
Hemoglobin A1c GH2, GH5, GH5I 57
Limited Chemistry, aived LC 58
Neonatal Bilirubin NB, NB2 58
Plasma Cardiac Markers PCARM 59
Whole Blood Glucose BG, B2 59
CoagulationSurvey Name Program Code Page Number
Activated Clotting TimeCT, CT1, CT2,
CT , CT51 6
Platelet Function PF1 1 7
Drug-Specific Platelet Aggregation PIA 1 9
Thromboelastogram TEG 1 7
Whole Blood D-Dimer WBDD 1 9
Whole Blood Prothrombin Time/INRP , P , P6,
P9, P101 8
Point-of-Care Programs
800-323-4040 | 847-832-7000 Option 1 | cap.org 47
Point-of-Care
Programs
4
Hematology and Clinical MicroscopySurvey Name Program Code Page Number
Amniotic Fluid Lea age (Nitrazine test) AFL 1
Blood Cell Counts HE, HEP, FH series 12 , 125
Clinical Microscopy CMP, CMMP 1
Erythrocyte Sedimentation Rate ESR, ESR1 12
Gastric Occult Blood GOCB 1 6
Occult Blood OCB 1 7
Rapid Total White Blood Cell Count RWBC 1 0
Reticulocytes RT, RT2, RT , RT 129
Rupture of Fetal Membranes Testing ROM1 1 7
Waived Combination HCC 59
ImmunologySurvey Name Program Code Page Number
Anti-HCV, Waived RHCVW 202
Anti-HIV-1, Anti-HIV-1/2, aived AHIVW 202
Infectious Mononucleosis, Waived IMW 181
MicrobiologySurvey Name Program Code Page Number
Group A Strep Antigen Detection D6, D9 156
ToxicologySurvey Name Program Code Page Number
Urine Drug Screen DS6 88
Point-of-Care Programs
48 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Poin
t-of
-Car
ePr
ogra
ms
4
We created the following charts to help you select the most appropriate CAP Surveys to meet your testing needs. These charts arenot intended to be construed as approval or disapproval of any commercial product or instrument. Please contact aCAP Customer Contact representative at 800- 2 - 0 0 or 8 7-8 2-7000 option 1 or your instrument manufacturer for othercompatibility questions. Select the compatible Survey for your instrument and cartridge from the charts.
Abbott Point-of-Care i-STAT®
Recommended CAP Survey
i-STAT Cartridge Survey Name Program Code Page Number
Blood Gas+
G
Critical Care AqueousBlood Gas
A 82
CG A 82
EG6 A 82
EG7 A 82
CG8 A 82
Chemistry+
G
Critical Care AqueousBlood Gas
A 82
Crea A 82
E A 82
EC A 82
6 A 82
EC8 A 82
CHEM8 A 82
Coagulation
Celite ACTActivated Clotting Time
CT5 1 6Kaolin ACT CT5 1 6
PT/INR Whole Blood Coagulation P 1 8
Cardiac Markers
CKMB
Plasma Cardiac Markers
PCARM, PCARMX 59
BNP PCARM, PCARMX 59
cTnl PCARM, PCARMX 59
Alere Triage®
Recommended CAP Survey
Alere Triage Cartridge Survey Name Program Code Page Number
Triage® Cardiac Panel Plasma Cardiac Markers PCARM, PCARMX 59
Triage BNP
B-Type Natriuretic Peptides,Plasma Cardiac Markers
BNP, BNP5, PCARM,PCARMX
55, 59
Triage CardioProfilER® BNP, BNP5, PCARM,PCARMX
55, 59
Triage Profiler Shortness of BreathBNP, BNP5, PCARM,
PCARMX55, 59
Triage TOX Drug ScreenUrine Drug Screen
DS, DS6 88
Triage Drugs of Abuse Panel DS, DS6 88
General C
hemistry and Therapeutic D
rug Monitoring
5
General Chemistry and Therapeutic Drug MonitoringGeneral Chemistry and Therapeutic Drug Monitoring...........................................................................50Urine Chemistry ...............................................................................................................................61Special Chemistry ............................................................................................................................64
New Programs New
Quality Cross Check, General Chemistry and Therapeutic Drug Monitoring (CZQ) ................................ 53B-Type Natriuretic Peptides, five challenges (BNP5) ............................................................................ 55Quality Cross Check, B-Type Natriuretic Peptides (BNPQ) ................................................................... 55Troponin T, five challenges (TNT5).................................................................................................... 56Hemoglobin A1c, five challenges (GH5)............................................................................................. 57Hemoglobin A1c, five challenges, international only (GH5I) ................................................................. 57Porphobilinogen, Urine (UPBG) ........................................................................................................ 63
Program ChangesSecond instrument reporting no longer offered
General Chemistry and Therapeutic Drug Monitoring (CZ2X) ............................................................50B-Type Natriuretic Peptides (BNP)...................................................................................................55See programs CZQ and BNPQ................................................................................................53, 55
Deleted AnalytesLimited Chemistry, Waived (LCW) .....................................................................................................58
Alanine Aminotransferase (ALT)Aspartate Aminotransferase (AST)
Discontinued ProgramsGeneral Chemistry and Therapeutic Drug Monitoring (CZ2)
See Survey CZX .................................................................................................................................. 50Commutable Frozen Serum (CFS)
5 General Chemistry andTherapeutic Drug Monitoring
“The CAP’s proficiency testing quality is everythingto us. The last thing I want is for a clinician to doubtmy results.”
General Chemistry and Therapeutic Drug Monitoring
50 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
General Chemistry and Therapeutic Drug MonitoringAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
General Chemistry and Therapeutic DrugsC1, C3/C3X, CZ/CZX/CZ2X, Z
Analyte Program Code Challenges/Shipment
C1 C3/C3XCZ/CZX/
CZ2X Z
Alanine aminotransferase(ALT/SGPT) z z z 5
Albumin z z z 5
Alkaline phosphatase z z z 5
Amylase z z z 5
Aspartate aminotransferase(AST/SGOT) z z z 5
Bilirubin, direct z z z 5
Bilirubin, total z z z 5
Calcium z z z 5
Chloride z z z 5
Cholesterol z z z 5
Cortisol z z z 5
Creatine kinase (CK) z z z 5
Creatinine z z z 5
Glucose z z z 5
HDL cholesterol z z z 5
Human chorionic gonadotropin(hCG), quantitative z z z 5
Iron z z z 5
Lactate dehydrogenase (LD) z z z 5
LDL cholesterol z z z 5
Lipoprotein (a) z z z 5
Magnesium z z z 5
Pancreatic amylase z z z 5
Potassium z z z 5
Protein, total z z z 5
Sodium z z z 5
T3, free (triiodothyronine, free) z z z 5
T3, total (triiodothyronine, total) z z z 5
T3, uptake and related tests z z z 5
T4, free (thyroxine, free) z z z 5
Continued on the next pageGeneral Chemistry and Therapeutic Drugs Surveys do not fulfill the CAP accreditationrequirements for neonatal bilirubin proficiency testing. See Surveys NB, NB2 on page 58.
Program Information• Five 5.0-mL li uid serum
specimens
• Conventional andInternational System ofUnits (SI) reporting offered
• Three shipments per year
Additional volume optionsC - General Chemistry withten 5.0-mL specimensC - General Chemistry andTDM with ten 5.0-mL specimens
C 2 - General Chemistryand TDM with fifteen 5.0-mLspecimens
For second instrument reportingoptions, see the uality CrossChec program, C , onpage 5 .
General Chemistry and Therapeutic Drug Monitoring
800-323-4040 | 847-832-7000 Option 1 | cap.org 51
General C
hemistry and Therapeutic D
rug Monitoring
5
General Chemistry and Therapeutic DrugsC1, C3/C3X, CZ/CZX/CZ2X, Z continued
Analyte Program Code Challenges/Shipment
C1 C3/C3XCZ/CZX/
CZ2X Z
T4, total (thyroxine, total) z z z 5
Thyroid-stimulatinghormone (TSH) z z z 5
Triglycerides z z z 5
Urea nitrogen (BUN) z z z 5
Uric acid z z z 5
Acid phosphatase z z 5
Ammonia z z 5
Apolipoprotein A1 z z 5
Apolipoprotein B z z 5
Calcium, ionized z z 5
Carbon dioxide z z 5
Ferritin z z 5
Gamma glutamyl transferase (GGT) z z 5
Iron binding capacity,total (measured)
z z 5
Iron binding capacity, unsaturated(measured)
z z 5
Iron saturation (%) z z 5
Lactate z z 5
Lipase z z 5
Osmolality z z 5
Phosphorus (inorganic) z z 5
Prealbumin z z 5
Transferrin z z 5
Lithium z z z z 5
Acetaminophen z z 5
Ami acin z z 5
Caffeine z z 5
Carbamazepine z z 5
Carbamazepine, free z z 5
Digoxin z z 5
Digoxin, free z z 5
Disopyramide z z 5
Continued on the next pageGeneral Chemistry and Therapeutic Drugs Surveys do not fulfill the CAP accreditationrequirements for neonatal bilirubin proficiency testing. See Surveys NB, NB2 on page 58.
Program Information• Five 5.0-mL li uid serum
specimens
• Conventional andInternational System ofUnits (SI) reporting offered
• Three shipments per year
Additional volume optionsC - General Chemistry withten 5.0-mL specimens
C - General Chemistry andTDM with ten 5.0-mL specimens
C 2 - General Chemistryand TDM with fifteen 5.0-mLspecimens
For second instrument reportingoptions, see the uality CrossChec program, C , onpage 5 .
General Chemistry and Therapeutic Drug Monitoring
52 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
General Chemistry and Therapeutic DrugsC1, C3/C3X, CZ/CZX/CZ2X, Z continued
Analyte Program Code Challenges/Shipment
C1 C3/C3XCZ/CZX/
CZ2X Z
Ethosuximide z z 5
Gentamicin z z 5
Lidocaine z z 5
Methotrexate z z 5
N-acetylprocainamide (NAPA) z z 5
Phenobarbital z z 5
Phenytoin z z 5
Phenytoin, free z z 5
Primidone z z 5
Procainamide z z 5
Quinidine z z 5
Salicylate z z 5
Theophylline z z 5
Tobramycin z z 5
Valproic acid z z 5
Valproic acid, free z z 5
Vancomycin z z 5
General Chemistry and Therapeutic Drugs Surveys do not fulfill the CAP accreditationrequirements for neonatal bilirubin proficiency testing. See Surveys NB, NB2 on page 58.
Program Information• Five 5.0-mL li uid serum
specimens
• Conventional andInternational System ofUnits (SI) reporting offered
• Three shipments per year
Additional volume optionsC - General Chemistry withten 5.0-mL specimens
C - General Chemistry andTDM with ten 5.0-mL specimens
C 2 - General Chemistryand TDM with fifteen 5.0-mLspecimens
For second instrument reportingoptions, see the uality CrossChec program, C , onpage 5 .
General Chemistry and Therapeutic Drug Monitoring
800-323-4040 | 847-832-7000 Option 1 | cap.org 53
General C
hemistry and Therapeutic D
rug Monitoring
5
Quality Cross Check—GeneralChemistry and Therapeutic
Drug Monitoring CZQAnalyte Program Code Challenges/Shipment
CZQ
See Survey C analytes onpages 50-52
z 3
This program does not meet regulatory requirements for proficiency testing. See Survey CZon pages 50-52.
Additional InformationAs a trusted partner, you can rely on the CAP to provide the insight, nowledge andpeer-based educational coaching to protect your laboratory from regulatory sanctions.
• The CAP uality Cross Chec program complements CAP PT by offering moreopportunities to monitor and proactively identify instrument problems before theyimpact patient test results.
• This new offering will help you improve uality processes, reduce stress, raisecompetency of staff, and verify the performance of your instrument results.
CAP/AACC Immunosuppressive Drugs CSAnalyte Program Code Challenges/Shipment
CS
Cyclosporine z 3
Sirolimus (rapamycin) z 3
Tacrolimus z 3
Everolimus EVAnalyte Program Code Challenges/Shipment
EV
Everolimus z 3
Mycophenolic Acid MPAAnalyte Program Code Challenges/Shipment
MPA
Mycophenolic acid z 3
NewProgram Information• Three 5.0-mL li uid serum
specimens in duplicate
• Report up to three instruments
• Conventional andInternational System of nits(SI) reporting offered
• Two shipments per year
Program Information• Three 5.0-mL whole blood
specimens
• Two shipments per year
AACC
Program Information• Three 5.0-mL whole blood
specimens
• Two shipments per year
Program Information• Three 5.0-mL lyophilized
serum specimens
• Two shipments per year
General Chemistry and Therapeutic Drug Monitoring
54 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Therapeutic Drug Monitoring,Extended ZE
Analyte Program Code Challenges/Shipment
ZE
Clozapine z 3
Gabapentin z 3
Lamotrigine z 3
Levetiracetam z 3
Oxcarbazepine metabolite z 3
Teriflunomide z 3
onisamide z 3
Therapeutic Drug Monitoring, Special ZT, ZZTAnalyte Program Code Challenges/Shipment
ZT, ZZT
Amitriptyline z 3
Desipramine z 3
Imipramine z 3
Nortriptyline z 3
Tricyclics, total ( ualitative/ uantitative) z 3
Accuracy-Based Lipids ABLAnalyte Program Code Challenges/Shipment
ABL
Apolipoprotein A1 z 3
Apolipoprotein B z 3
Cholesterol* z 3
HDL cholesterol* z 3
LDL cholesterol z 3
Lipoprotein (a) z 3
Triglycerides* z 3
*This analyte will be evaluated against the Centers for Disease Control and Prevention (CDC)reference method.
Program Information• Three 5.0-mL serum specimens
• Two shipments per year
Program Information• T - Three 5.0-mL lyophilized
serum specimens
• T - Six 5.0-mL lyophilizedserum specimens
• Two shipments per year
Program Information• Three 1.0-mL human serum
specimens
• Two shipments per year
General Chemistry and Therapeutic Drug Monitoring
800-323-4040 | 847-832-7000 Option 1 | cap.org 55
General C
hemistry and Therapeutic D
rug Monitoring
5
B-Type Natriuretic Peptides BNP, BNP5Analyte Challenges/Shipment
Program Code
BNP BNP5
BNP 2 5
NT-pro BNP 2 5
Additional Information •Beginningwiththe2015proficiencytesting(PT)programyear,theCollege
ofAmericanPathologistsAccreditationProgramwillrequireallaccreditedlaboratoriesperformingnon-waivedtestingforBNPandNT-proBNP tocomplete15PTchallengesperyear.
•Forsecondinstrumentreportingoptions,seetheQualityCrossCheckprogram,BNPQbelow.
Quality Cross Check—B-Type Natriuretic Peptides BNPQ
Analyte Program Code Challenges/Shipment
BNPQ
BNP z 3
NT-pro BNP z 3
This program does not meet regulatory requirements for proficiency testing. See Surveys BNP or BNP5 above.
Additional InformationAsatrustedpartner,youcanrelyontheCAPtoprovidetheinsight,knowledgeand peer-basededucationalcoachingtoprotectyourlaboratoryfromregulatorysanctions. •TheCAPQualityCrossCheckprogramcomplementsCAPPTbyofferingmore
opportunitiestomonitorandproactivelyidentifyinstrumentproblemsbeforetheyimpactpatienttestresults.
•Thisnewofferingwillhelpyouimprovequalityprocesses,reducestress,raisecompetencyofstaff,andverifytheperformanceofyourinstrumentresults.
Program Information•BNP-Two1.0-mLliquid
plasmaspecimens;ConventionalandInternationalSystemofUnits(SI)reportingoffered;twoshipmentsperyear
•BNP5-Five1.0mLliquidplasmaspecimens;ConventionalandInternationalSystemofUnits(SI)reportingoffered;threeshipmentsperyear
Program Information•Threeliquidspecimensin
duplicate
•Reportuptothreeinstruments
•ConventionalandInternationalSystemofUnits(SI)reportingoffered
• Twoshipmentsperyear
New
General Chemistry and Therapeutic Drug Monitoring
56 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Harmonized Thyroid ABTHAnalyte Program Code Challenges/Shipment
ABTH
T3, free (triiodothyronine, free) z 3
T3, total (triiodothyronine, total) z 3
T , free (thyroxine, free) z 3
T , total (thyroxine, total) z 3
Thyroid-stimulating hormone (TSH) z 3
PRICE (USD)
Additional Information• Analytes will be evaluated using harmonization.• Specimens are collected by a modified application of Clinical Laboratory and
Standards Institute Guideline CLSI C 7-A, Preparation and Validation ofCommutable Frozen Human Serum Pools as Secondary Reference Materials forCholesterol Measurement Procedures; Approved Guideline.
Cardiac Markers CRT, CRTI, TNT, TNT5Analyte Program Code Challenges/
Shipment
CRT CRTI TNT TNT5
CK-MB, immunochemical z z 5
CK isoenzymes (C -BB, CK-MB,C -MM), electrophoretic
z 5
LD1, LD2, LD , LD , LD5,electrophoretic
z 5
LD1/LD2 ratio, calculationand interpretation
z 5
Myoglobin z z 2
Troponin I z z 5
Troponin T, two challenges z 2
Troponin T, five challenges z 5
Beginning with the 2015 proficiency testing (PT) program year, the College of AmericanPathologists Accreditation Program will require all accredited laboratories performingnon-waived testing for Troponin I and Troponin T to complete 15 PT challenges per year.
Program Information• Three 1.0-mL frozen human
specimens
• Two shipments per year
Program Information• CRT - Five 2.0-mL li uid
serum specimens
• CRTI - Ten 2.0-mL li uidserum specimens
• TNT - Two 2.0-mL li uidserum specimens
• TNT5 - Five 2.0-mL li uidserum specimens
• Three shipments per year
General Chemistry and Therapeutic Drug Monitoring
800-323-4040 | 847-832-7000 Option 1 | cap.org 57
General C
hemistry and Therapeutic D
rug Monitoring
5
Hemoglobin A1c GH2, GH5Analyte Challenges/Shipment
Program Code
GH2 GH5
Hemoglobin A1c 3 5
Additional Information •Beginningwiththe2015proficiencytesting(PT)programyear,theCollege
ofAmericanPathologistsAccreditationProgramwillrequireallaccreditedlaboratoriesperformingnon-waivedtestingforHemoglobinA1ctocomplete 15PTchallengesperyear.
•TheseSurveyswillbeevaluatedagainsttheNationalGlycohemoglobinStandardizationProgram(NGSP)referencemethod.
Hemoglobin A1c GH5IAnalyte Program Code Challenges/Shipment
GH5I
Hemoglobin A1c z 5
Additional Information •ThisprogrammeetstheCAP’sAccreditationProgramrequirementsfor
proficencytesting. •ThisSurveywillnotbeevaluatedagainsttheNationalGlycohemoglobin
StandardizationProgram(NGSP)referencemethod.SeeSurveyGH5tobe evaluatedagainsttheNGSPreferencemethod.
Glycated Serum Albumin GSAAnalyte Program Code Challenges/Shipment
GSA
Glycatedserumalbumin z 3
High-Sensitivity/Cardiac C-Reactive Protein HSCRPAnalyte Program Code Challenges/Shipment
HSCRP
High-sensitivity/CardiacC-reactiveprotein
z 3
Program Information•GH2-Three0.8-mL
liquidhumanwholebloodspecimens;twoshipments peryear
•GH5-Five0.8-mLliquidhumanwholebloodspecimens;threeshipmentsperyear
NewProgram Information•Five0.5-mLlyophilized
specimenswitha3.0-mLdropper-tippedvialofdiluent
•Designedforinternationallaboratoriesthathaveexperiencedsignificantshippingandreceiving issuesandrequirelongerspecimenstability
• Threeshipmentsperyear
Program Information•Three1.0-mLliquidserum
specimens
• Twoshipmentsperyear
Program Information•Three0.5-mLliquidserum
specimens
• Twoshipmentsperyear
General Chemistry and Therapeutic Drug Monitoring
58 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Homocysteine HMSAnalyte Program Code Challenges/Shipment
HMS
Homocysteine z 3
Ketones KETAnalyte Program Code Challenges/Shipment
KET
Beta-hydroxybutyrate z 2
Total etones z 2
Limited Chemistry, Waived LCWAnalyte Program Code Challenges/Shipment
LCW
Cholesterol z 3
Glucose z 3
HDL cholesterol z 3
LDL cholesterol z 3
Triglycerides z 3
Neonatal Bilirubin NB, NB2Analyte Challenges/Shipment
Program Code
NB NB2
Bilirubin, direct 2 2
Bilirubin, total 5 2
One human-based serum specimen will offer the value assigned using the referencemethod procedure (Clin Chem. 1985;31:1779-1789).
Program Information• Three 1.0-mL serum
specimens
• Two shipments per year
Program Information• Two 2.0-mL serum specimens
• For use with Acetest® andother ualitative/semi-uantitative methods using
the nitroprusside reaction fortotal etones testing
• Two shipments per year
Program Information• Three 2.0-mL li uid serum
specimens
• For use with waived methodssuch as the Cholestech LD ®
and Roche ACC -CHE ®
Instant Plus
• The glucose specimens arenot appropriate for use onother whole blood glucosemeters
• Two shipments per year
Program Information• NB - Five 1.0-mL human
serum specimens; threeshipments per year
• NB2 - Two 1.0-mL humanserum specimens; mustorder in conjunction with afive-challenge total bilirubinproficiency testing program tomeet regulatory re uirements;two shipments per year
General Chemistry and Therapeutic Drug Monitoring
800-323-4040 | 847-832-7000 Option 1 | cap.org 59
General C
hemistry and Therapeutic D
rug Monitoring
5
Plasma Cardiac Markers PCARM, PCARMXAnalyte Program Code Challenges/Shipment
PCARM PCARMX
BNP z z 5
CK-MB z z 5
D-dimer z z 2
Myoglobin z z 2
Troponin I z z 5
Beginning with the 2015 proficiency testing (PT) program year, the College of American Pathologists Accreditation Program will require all accredited laboratories performing non-waived testing for BNP and Troponin I to complete 15 PT challenges per year.
Waived Combination HCCAnalyte Program Code Challenges/Shipment
HCC
Glucose z 2
Hemoglobin z 2
Whole Blood Glucose WBG, WB2Analyte Challenges/Shipment
Program Code
WBG WB2
Glucose 5 3
Program Information•PCARM-Five1.5-mLliquid
EDTAplasmaspecimens
•PCARMX-AllSurveyPCARMspecimensinduplicate
• Threeshipmentsperyear
Program Information•Two1.0-mLwholeblood
specimens
•ForusewiththeHemoCue® B, HemoCue201,HemoCue301,andStanbioHemoPoint® H2 instruments
• Twoshipmentsperyear
Program Information•WBG-Five2.5-mLwhole
bloodspecimens;threeshipmentsperyear
•WB2-Three2.5-mLwholebloodspecimens;twoshipmentsperyear
•Reportupto20differentancillarytestingsitesorinstruments
General Chemistry and Therapeutic Drug Monitoring
60 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Improve the reliability of your patient results with CAP SurveyValidated Materials
se the same material that is sent in the Surveys program to
• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document correction of problems identified in Surveys• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures
Each laboratory receives a Survey Participant Summary, which includes readilyavailable results.
General Chemistry and TDM, Validated MaterialValidated Material Program Code Corresponding Survey Pages
Chemistry/TDM VM C VM C 50-52
Program Information• Five 5.0-mL li uid serum
specimens
MORE• Time for patient centric activities• Cost savings in staff time• uality assurance• Ability to receive reformat and resend data•Time for managers to spend on
management responsibilities
LESS• Clerical errors• Time spent inputting PT results• Checking and double-checking data entry• Delays between testing and releasing results• Proficiency Testing Compliance Notices• Missed submission deadlines.
Less is MOREWith the CAP’s e-LAB Solutions Connect™ automated proficiency testing (PT) service,
you’ll spend less time doing clerical work, giving you more time to focuson what matters most, accurate patient results.
To order choose e LAB SolutionsConnect Service (3572LM) in theNew Programs section of the2015 PT order form.
Now you can run PT more likea patient specimen.
Available in the US and Canada only.
Urine Chemistry
800-323-4040 | 847-832-7000 Option 1 | cap.org 61
General C
hemistry and Therapeutic D
rug Monitoring
5
Urine ChemistryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Urine Chemistry, General UAnalyte Program Code Challenges/Shipment
U
Amylase z 3
Calcium z 3
Chloride z 3
Creatinine z 3
Glucose z 3
Magnesium z 3
Nitrogen, total z 3
Osmolality z 3
Phosphorus z 3
Potassium z 3
Protein, total z 3
Sodium z 3
Urea nitrogen z 3
Uric acid z 3
rine albumin ( uantitative) z 3
rine albumin creatinine ratio z 3
Accuracy-Based Urine ABUAnalyte Program Code Challenges/Shipment
ABU
Calcium z 3
Creatinine z 3
rine albumin ( uantitative) z 3
rine albumin creatinine ratio z 3
Analytes may be evaluated against the reference method or by using harmonization.
Program Information• Six 15.0-mL urine specimens
• One mailing per yearwill include an additionalspecimen for uric acid testingfor a total of seven challengesper year
• Two shipments per year
Program Information• Three 5.0-mL human urine
specimens
• Two shipments per year
Urine Chemistry
62 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Kidney Stone Risk Assessment KSAAnalyte Program Code Challenges/Shipment
KSA
Citrate z 3
Cystine z 3
Oxalate z 3
Sulfate z 3
Urine Chemistry, Special N, NXAnalyte Program Code Challenges/Shipment
N, NX-methoxytyramines z 3
5-hydroxyindoleacetic acid z 317-hydroxycorticosteroids z 317- etosteroids z 3Aldosterone z 3Coproporphyrins z 3Cortisol, urinary free z 3Dopamine z 3Epinephrine z 3Homovanillic acid z 3Metanephrine z 3Norepinephrine z 3Normetanephrine z 3Uroporphyrin z 3Vanillylmandelic acid z 3
Myoglobin, Urine MYGAnalyte Program Code Challenges/Shipment
MYGMyoglobin, urine ( ualitative anduantitative)
z 2
Program Information• Three 15.0-mL li uid urine
specimens
• Two shipments per year
Program Information• N - Six 10.0-mL lyophilized
urine specimens and three10.0-mL li uid urinespecimens
• N - All lyophilized Survey Nspecimens in duplicate andthree 10.0-mL li uid urinespecimens
• Two shipments per year
Program Information• Two 1.0-mL urine specimens
• Two shipments per year
Urine Chemistry
800-323-4040 | 847-832-7000 Option 1 | cap.org 63
General C
hemistry and Therapeutic D
rug Monitoring
5
Porphobilinogen, Urine UPBGAnalyte Program Code Challenges/Shipment
UPBG
Porphobilinogen z 3
Improve the reliability of your patient results with CAP Survey Validated Materialsse the same material that is sent in the Surveys program to
• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document correction of problems identified in Surveys• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures
Each laboratory receives a Survey Participant Summary, which includes readily available results.
Urine Chemistry, Validated MaterialsValidated Material Program
Code Corresponding Survey Page
rine Chemistry (Special) VM NVM N, N 62
rine Chemistry (General) VM UVM U 61
Program Information• Three 5-mL urine specimens
• Two shipments per year
• For use with ualitative anduantitative methods
New
Program Information• NVM - Six 10.0-mL lyophilized
and three 10.0-mL li uidurine specimens
• VM - Six 15.0-mL urinespecimens
Knowing that I have beenable to solve a customer’sproblem inspires meespecially since they aredoing such vital work.
– Debbie
“ “
CAP Customer Contact Center representativesunderstand the importance of what you do.
Special Chemistry
64 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Special ChemistryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
1,5-Anhydroglucitol AGAnalyte Program Code Challenges/Shipment
AG
1,5-anhydroglucitol z 3
Aldolase ADLAnalyte Program Code Challenges/Shipment
ADL
Aldolase z 2
Angiotensin-Converting Enzyme ACEAnalyte Program Code Challenges/Shipment
ACE
Angiotensin-converting enzyme( uantitative)
z 2
Program Information• Three 1.0-mL li uid serum
specimens
• Two shipments per year
Program Information• Two 1.5-mL li uid serum
specimens
• Two shipments per year
Program Information• Two 2.0-mL lyophilized serum
specimens
• Two shipments per year
Special Chemistry
800-323-4040 | 847-832-7000 Option 1 | cap.org 65
General C
hemistry and Therapeutic D
rug Monitoring
5
Body Fluid Chemistry FLDAnalyte Program Code Challenges/Shipment
FLD
Albumin z 3
Amylase z 3
CA19-9 z 1
CEA z 1
Cholesterol z 3
Creatinine z 3
Glucose z 3
Lactate z 3
Lactate dehydrogenase (LD) z 3
pH z 3
Protein, total z 3
Triglycerides z 3
Urea nitrogen z 1 per year
Body Fluid Chemistry 2 FLD2Analyte Program Code Challenges/Shipment
FLD2
Al aline phosphatase z 3
Bilirubin z 3
Calcium z 3
Chloride z 3
Lipase z 3
Potassium z 3
Sodium z 3
Uric acid z 3
Program Information• Three .0-mL simulated li uid
body fluid specimens
• Two shipments per year
Program Information• Three .0-mL li uid body fluid
specimens
• Two shipments per year
Special Chemistry
66 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Cadmium CDAnalyte Program Code Challenges/Shipment
CD
Beta-2-microglobulin, urine z 3
Cadmium, urine z 3
Cadmium, whole blood z 3
Creatinine, urine z 3
This Survey meets the Occupational Safety and Health Administration (OSHA) guidelines forproficiency testing (OSHA standard-29 CFR 1910.1027AppF).
Cerebrospinal Fluid Chemistry andOligoclonal Bands M, OLI
Analyte Program Code Challenges/Shipment
M OLI
Albumin, uantitative z z 3
Electrophoresis (albuminand gamma globulin)
z z 3
Glucose z z 3
IgG, uantitative z z 3
Lactate z z 3
Lactate dehydrogenase (LD) z z 3
Protein, total z z 3
Oligoclonal bands z 3
Cystatin C CYSAnalyte Program Code Challenges/Shipment
CYS
Cystatin C z 2
Program Information• Three 5.0-mL whole blood
specimens and three 15.0-mLurine specimens
• Conventional and InternationalSystem of nits (SI)reporting offered
• Six shipments per year
Program Information• M - Three 5.0-mL simulated
li uid spinal fluid specimens
• OLI - Three 5.0-mL simulatedli uid spinal fluid specimensand three paired serumspecimens
• Two shipments per year
Program Information• Two 1.0-mL li uid serum
specimens
• Two shipments per year
Special Chemistry
800-323-4040 | 847-832-7000 Option 1 | cap.org 67
General C
hemistry and Therapeutic D
rug Monitoring
5
Fecal Fat FCFSAnalyte Program Code Challenges/Shipment
FCFS
Fecal fat, ualitative z 2
Fructosamine FTAnalyte Program Code Challenges/Shipment
FT
Fructosamine z 2
Glucose-6-Phosphate Dehydrogenase G6PDSAnalyte Program Code Challenges/Shipment
G6PDS
G6PD ( ualitative and uantitative) z 2
Lipoprotein-Associated Phospholipase A2 PLAAnalyte Program Code Challenges/Shipment
PLA
Lipoprotein-associated phospholipase(Lp-PLA2)
z 2
Program Information• Two 10.0-g simulated fecal
fat specimens
• For microscopic detectionof neutral fats (triglycerides)and/or split fats (total freefatty acids)
• Two shipments per year
Program Information• Two 1.0-mL li uid serum
specimens
• Two shipments per year
Program Information• Two 0.5-mL lyophilized
hemolysate samples
• Two shipments per year
Program Information• Two 0.5-mL li uid specimens
• Two shipments per year
Special Chemistry
68 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Lipoprotein and Protein ElectrophoresisLPE, SPE, UBJP
Analyte Program Code Challenges/Shipment
LPE SPE UBJP
Lipoprotein electrophoresis z 2
IgA, uantitation z 2
IgG, uantitation z 2
IgM, uantitation z 2
M-protein (Paraprotein)identification z 2
Protein, total z 2
Protein electrophoresis z 2
Protein electrophoresis patterninterpretation
z 2
Urine Bence Jones proteins z 2
Lamellar Body Count LBCProcedure Program Code Challenges/Shipment
LBC
Lamellar body count z 3
Lung Maturity LM, LM1Analyte/Procedure Program Code Challenges/Shipment
LM LM1
Bilirubin ( OD 50) z 1
Fluorescent polarization assay z z 3
Lecithin sphingomyelin (L S) ratio z z 3
Phosphatidylglycerol (PG) z z 3
Program Information• LPE - Two 1.0-mL li uid serum
specimens
• SPE - Two 1.0-mL lyophilizedserum specimens
• B P - Two 10.0-mL urinespecimens
• Two shipments per year
Program Information• Three 2.0-mL simulated li uid
amniotic fluid specimens
• For use with LBC methodsperformed on all hematologyanalyzers
• Two shipments per year
Program Information• LM - Three 5.0-mL simulated
li uid aminotic fluidspecimens
• LM1 - Four 5.0-mL simulatedli uid amniotic fluid specimens
• Two shipments per year
Special Chemistry
800-323-4040 | 847-832-7000 Option 1 | cap.org 69
General C
hemistry and Therapeutic D
rug Monitoring
5
Plasma Hemoglobin PHGAnalyte Program Code Challenges/Shipment
PHG
Plasma hemoglobin z 2
Procalcitonin PCTAnalyte Program Code Challenges/Shipment
PCT
Procalcitonin z 3
Pseudocholinesterase C7Analyte Program Code Challenges/Shipment
C7
Pseudocholinesterase z 1
Salivary Cortisol SALCAnalyte Program Code Challenges/Shipment
SALC
Salivary cortisol z 3
Program Information• Two 2.0-mL li uid specimens
• Two shipments per year
Program Information• Three 1.0-mL lyophilized
serum specimens
• Two shipments per year
Program Information• One 2.0-mL lyophilized
serum specimen
• Three shipments per year
Program Information• Three 1.0-mL synthetic oral
fluid specimens
• Two shipments per year
Special Chemistry
70 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Testosterone and Estradiol Accuracy Survey ABSAnalyte Program Code Challenges/Shipment
ABS
Calcium z 4
Cortisol z 4
Estradiol z 4
Testosterone z 4
Thyroid-stimulating hormone (TSH) z 4
Additional Information• The Centers for Disease Control and Prevention (CDC) will set target values for
testosterone and estradiol using the established reference methods.• Calcium, cortisol, and TSH data will be provided by peer groups to determine the
degree of harmonization in the field.
Total Bile Acids TBLAAnalyte Program Code Challenges/Shipment
TBLA
Total bile acids z 3
Trace Metals RAnalyte Program Code Challenges/Shipment
R
Aluminum z 3
Chromium z 3
Copper z 3
Manganese z 3
Selenium z 3
inc z 3
Program Information• Four 1.0-mL human serum
specimens
• One shipment per year
Program Information• Three 2.0-mL li uid serum
specimens
• Two shipments per year
Program Information• Three 5.0-mL li uid serum
specimens
• Two shipments per year
Special Chemistry
800-323-4040 | 847-832-7000 Option 1 | cap.org 71
General C
hemistry and Therapeutic D
rug Monitoring
5
Trace Metals, Urine TMUAnalyte Program Code Challenges/Shipment
TMU
Aluminum z 3
Arsenic z 3
Chromium z 3
Cobalt z 3
Copper z 3
Lead z 3
Manganese z 3
Mercury z 3
Selenium z 3
Thallium z 3
inc z 3
Sweat Analysis Series SW1, SW2, SW3, SW4Analyte Program Code Challenges/Shipment
SW1, SW2, SW3, SW4
Chloride z 3
Conductivity z 3
Osmolality z 3
Sodium z 3
For method compatibility, see chart below.
Compatibility Matrix for Sweat Analysis SeriesMethod/Procedure Program Code Materials Included
SW1 SW2 SW3 SW4
Orion direct electrode zPrecut 2-cm diameter
hatman filter papers
escor Macroduct™ &Nanoduct® Systems
z22-gauge blunt-tippedneedles
CF Indicator System® zPolystyrene boats andchloride-free sponges
All other methodologies zNo additionalmaterials provided
Program Information• Three 10.0-mL urine
specimens
• Two shipments per year
Program Information• Three 5.0-mL simulated li uid
human sweat specimens
• Two shipments per year
Special Chemistry
72 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
eral
Che
mist
ry a
nd Th
erap
eutic
Dru
g M
onito
ring
5
Viscosity VAnalyte Program Code Challenges/Shipment
V
Viscosity z 2
Soluble Transferrin Receptor STFRAnalyte Program Code Challenges/Shipment
STFR
Soluble transferrin receptor (sTfR) z 3
Improve the reliability of your patient results with CAP SurveyValidated Materials
se the same material that is sent in the Surveys program to
• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document correction of problems identified in Surveys• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures
Each laboratory receives a Survey Participant Summary, which includes readilyavailable results.
Special Chemistry, Validated MaterialsValidated Material Program Code Corresponding Survey Page
Cerebrospinal Fluid VM MVM M 66
Program Information• Two 10.0-mL serum
specimens
• Two shipments per year
Program Information• Three 2.5-mL li uid human
serum specimens
• Two shipments per year
Program Information• Three 5.0-mL simulated li uid
spinal fluid specimens
Endocrinology
6
Endocrinology
New Programs New
B-Type Natriuretic Peptides, five challenges (BNP5) .............................................................................74Quality Cross Check, B-Type Natriuretic Peptides (BNPQ) ....................................................................7525-OH Vitamin D (VITD) ...................................................................................................................76
Program ChangesSecond instrument reporting no longer offered
B-Type Natriuretic Peptides (BNP)See program BNPQ .....................................................................................................................75
6 | Endocrinology
“The CAP proficiency testing allows us as a laboratoryto look at how we compare with our peers and italso builds the trust of the clinical staff that we arereporting good quality results.”
Endocrinology
74 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Endo
crin
olog
y
6
EndocrinologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Ligand Assay, General K, KKAnalyte Program Code Challenges/Shipment
K, KK
Alpha-fetoprotein (AFP) z 5
CEA z 3
Cortisol z 5
Ferritin z 3
Folate, serum z 3
hCG, quantitative z 5
IgE z 5
Prostate-specific antigen (PSA) z 2
Prostate-specific antigen,complexed (cPSA)
z 2
Prostate-specific antigen, free z 2
Prostatic acid phosphatase (PAP) z 3
T3, free (triiodothyronine, free) z 3
T3, total (triiodothyronine, total) z 5
T3 uptake and related tests z 5
T4, free (thyroxine, free) z 5
T4, total (thyroxine, total) z 5
Thyroid-stimulating hormone (TSH) z 5
Vitamin B12 z 3
B-Type Natriuretic Peptides BNP, BNP5Analyte Challenges/Shipment
Program Code
BNP BNP5
BNP 2 5
NT-pro BNP 2 5
Additional Information• Beginning with the 2015 proficiency testing (PT) program year, the College of
American Pathologists Accreditation Program will re uire all accredited laboratoriesperforming non-waived testing for BNP and NT-pro BNP to enroll in Survey BNP5.
• For second instrument reporting options, see the uality Cross Chec program,BNP , on page 75.
Program Information• - Five 5.0-mL li uid serum
specimens; two 5.0-mLlyophilized serum specimensfor PSA assays
• - All Survey specimensin duplicate
• Conventional andInternational System ofUnits (SI) reporting offered
• Three shipments per year
Program Information• BNP - Two 1.0-mL li uid
plasma specimens;Conventional andInternational System of Units(SI) reporting offered; twoshipments per year
• BNP5 - Five 1.0 mLli uid plasma specimens;Conventional andInternational System of Units(SI) reporting offered; threeshipments per year
Endocrinology
800-323-4040 | 847-832-7000 Option 1 | cap.org 75
Endocrinology
6
Quality Cross Check—B-TypeNatriuretic Peptides BNPQ
Analyte Program Code Challenges/Shipment
BNPQ
BNP z 3
NT-pro BNP z 3
This program does not meet regulatory requirements for proficiency testing. See Surveys BNPor BNP5 on page 74.
Additional InformationAs a trusted partner, you can rely on the CAP to provide the insight, nowledge andpeer-based educational coaching to protect your laboratory from regulatory sanctions.
• The CAP uality Cross Chec program complements CAP PT by offering moreopportunities to monitor and proactively identify instrument problems before theyimpact patient test results.
• This new offering will help you improve uality processes, reduce stress, raisecompetency of staff, and verify the performance of your instrument results.
Ligand Assay, Special Y, YY, DYAnalyte Program Code Challenges/Shipment
Y, YY DY
11-deoxycortisol z 3
17-hydroxyprogesterone z 3
Androstenedione z 3
DHEA sulfate z 3
Estradiol z 3
Estriol, unconjugated (uE3) z 3
Follicle-stimulating hormone (FSH) z 3
Growth hormone (GH) z 3
IGF-1 (somatomedin C) z 3
Luteinizing hormone (LH) z 3
Progesterone z 3
Prolactin z 3
Testosterone z 3
Testosterone, bioavailable z 3
Testosterone, free z 3
Sex hormone-binding globulin (SHBG) z 3
Program Information• Three li uid specimens in
duplicate
• Report up to three instruments
• Conventional andInternational System of Units(SI) reporting offered
• Two shipments per year
New
Program Information• Y - Six 5.0-mL li uid serum
specimens (two duplicate sets)
• YY - Nine 5.0-mL li uidserum specimens (threeduplicate sets)
• DY - Must order in conjunctionwith Survey Y or YY
• Conventional andInternational System ofUnits (SI) reporting offered
• Two shipments per year
Endocrinology
76 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Endo
crin
olog
y
6
Antimüllerian Hormone AMHAnalyte Program Code Challenges/Shipment
AMH
Antim llerian hormone (AMH) z 3
25-OH Vitamin D VITDAnalyte Program Code Challenges/Shipment
VITD
25-OH vitamin D, total z 3
Bone and Growth BGSAnalyte Program Code Challenges/Shipment
BGS
IGF-1 (somatomedin C) z 3
Osteocalcin z 3
Accuracy-Based Vitamin D ABVDAnalyte Program Code Challenges/Shipment
ABVD
25-OH vitamin D (D2 and D ) z 3
Additional Information• The Centers for Disease Control and Prevention (CDC) will establish reference targets
using isotope-dilution LC-MS/MS method.• Specimens are collected by a modified application of Clinical Laboratory and
Standards Institute Guideline CLSI C 7-A, Preparation and Validation ofCommutable Frozen Human Serum Pools as Secondary Reference Materialsfor Cholesterol Measurement Procedures; Approved Guideline.
Program Information• Three 1.0-mL lyophilized
serum specimens
• Two shipments per year
Program Information• Three 1.0-mL serum
specimens
• Two shipments per year
New
Program Information• Three 1.0-mL li uid serum
specimens
• Conventional andInternational System ofUnits (SI) reporting offered
• Two shipments per year
Program Information• Three 1.0-mL human li uid
serum specimens
• Serum is from multidonorendogenous pools
• Two shipments per year
Endocrinology
800-323-4040 | 847-832-7000 Option 1 | cap.org 77
Endocrinology
6
Bone and Mineral Metabolism, Urine BUAnalyte Program Code Challenges/Shipment
BU
C-telopeptide (CTx) z 2
Creatinine z 2
Deoxypyridinoline (DPD) z 2
N-telopeptide (NTx) z 2
Pyridinoline (PYD) z 2
Bone Markers and VitaminsBMV1, BMV2, BMV3, BMV4, BMV5, BMV6
Analyte Program Code Challenges/Shipment
BMV1 BMV2 BMV3 BMV4 BMV5 BMV6
1,25 dihydroxyvitamin D
z 3
Bone specific al alinephosphatase
z 3
Vitamin A z 3
Vitamin E z 3
C-telopeptide (CTx) z 3
N-telopeptide (NTx) z 3
Erythropoietin EPOAnalyte Program Code Challenges/Shipment
EPO
Erythropoietin z 2
Fetal Fibronectin FFAnalyte Program Code Challenges/Shipment
FF
Fetal fibronectin z 2
Program Information• Two 2.0-mL lyophilized
human urine specimens
• Conventional andInternational System ofUnits (SI) reporting offered
• Two shipments per year
Program Information• BMV1 through BMV -
Three 5.0-mL li uid serumspecimens for each program
• BMV5 and BMV6 - Three1.0-mL li uid serum specimensfor each program
• Two shipments per year
Program Information• Two 1.5-mL serum specimens
• Two shipments per year
Program Information• Two 1.2-mL specimens
• Two shipments per year
Endocrinology
78 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Endo
crin
olog
y
6
C-Peptide, Gastrin, Insulin, and PTH Assays INGAnalyte Program Code Challenges/Shipment
ING
C-peptide z 3
Gastrin z 3
Insulin z 3
Parathyroid hormone (PTH) z 3
Maternal Screening FP, FPXAnalyte Program Code Challenges/Shipment
FP, FPX
Alpha-fetoprotein (AFP), amniotic fluid z 2
Alpha-fetoprotein (AFP), serum z 5
Dimeric inhibin A (DIA) z 5
Estriol, unconjugated (uE3) z 5
Human chorionic gonadotropin (hCG),quantitiative z 5
The CAP designed this Survey for laboratories using AFP and hCG for prenatal screeningpurposes only. For all other applications, see Survey K or KK on page 74.
First TrimesterMaternal Screening FP1T, FP1B
Analyte Program Code Challenges/Shipment
FP1T FP1B
Total hCG z 5
Free beta hCG z 5
PAPP-A z z 5
The CAP designed these Surveys for laboratories using hCG for prenatal screening purposesonly. For all other applications, see Survey K or KK on page 74.
Program Information• Three 5.0-mL lyophilized
serum specimens
• Conventional andInternational System ofUnits (SI) reporting offered
• Two shipments per year
Program Information• FP - Five 1.0-mL li uid serum
specimens; two 1.0-mLsimulated amniotic fluidspecimens
• FP - All Survey FP serumspecimens in duplicate; two1.0-mL simulated amnioticfluid specimens
• Three shipments per year
Program Information• FP1T - Five 1.0-mL serum
specimens
• FP1B - Five 1.0-mL serumspecimens
• Three shipments per year
Endocrinology
800-323-4040 | 847-832-7000 Option 1 | cap.org 79
Endocrinology
6
Pharmacogenetics PGX, PGX1, PGX2Analyte/Procedure Program Code Challenges/
Shipment
PGX PGX1 PGX2
CYP2C19 z 2
CYP2C9 z 2
CYP2D6 z 2
UGT1A1 z 2
VKORC1 z 2
IL28B (rs12979860) z 3
HLA-B*5701 z 3
Additional InformationSurvey PG 2 is designed for laboratories that provide HLA-B*5701 testing to identify risof hypersensitivity to abacavir. The intended response is ualitative (presence/absenceof the allele). This Survey is not appropriate for laboratories that perform molecular HLAtyping. For HLA typing proficiency testing, please consult the HLA Molecular Typing(ML, DML) Surveys.
RBC Folate FOLAnalyte Program Code Challenges/Shipment
FOL
RBC folate z 2
Renin and Aldosterone RAPAnalyte Program Code Challenges/Shipment
RAP
Aldosterone z 3
Renin z 3
Program Information• PG - Two 25.0- g extracted
DNA specimens
• PG 1, PG 2 - Three 25.0- gextracted DNA specimens
• Includes allele detection(genotyping) and/orinterpretive challenges
• Two shipments per year
Program Information• Two 2.0-mL whole blood
specimens
• Three shipments per year
Program Information• Three 2.0-mL lyophilized
plasma specimens
• Conventional andInternational System ofUnits (SI) reporting offered
• Two shipments per year
Endocrinology
80 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Endo
crin
olog
y
6
Tumor Markers TM, TMXAnalyte Program Code Challenges/Shipment
TM, TMX
Adrenocorticotropic hormone (ACTH) z 3
Beta-2-microglobulin z 3
CA 15-3 z 3
CA 19-9 z 3
CA 27.29 z 3
CA 72- z 3
CA 125 z 3
Calcitonin z 3
Thyroglobulin z 3
Improve the reliability of your patient results with CAP SurveyValidated Materials
se the same material that is sent in the Surveys program to
• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document correction of problems identified in Surveys• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures
Each laboratory receives a Survey Participant Summary, which includes readilyavailable results.
Endocrinology, Validated MaterialsValidated Material Program Code Corresponding Survey Page
Ligands (General) VM VM 7
Ligands (Special) VM YVM Y 75
Program Information• TM - Three 2.0-mL li uid
serum specimens
• TM - All Survey TMspecimens in duplicate
• Two shipments per year
Program Information• VM - Five 5.0-mL li uid
serum specimens; two 5.0-mLlyophilized serum specimensfor PSA assays; threeshipments per year
• YVM - Six 5.0-mL li uidserum specimens (twoduplicate sets); two shipmentsper year
BloodG
as, CriticalC
are, andO
ximetry
7
Blood Gas, Critical Care, and Oximetry
New Programs New
Quality Cross Check—Critical Care Aqueous Blood Gas Series (AQQ, AQ2Q, AQ3Q, AQ4Q) .............83Quality Cross Check—Blood Oximetry (SOQ).....................................................................................84
Program ChangesSecond instrument reporting no longer offered
Critical Care Aqueous Blood Gas (AQ, AQ2, AQ3, AQ4)Blood Oximetry (SO)See programs AQQ, AQ2Q, AQ3Q, AQ4Q and SOQ ............................................................83, 84
7 | Blood Gas, Critical Care, and Oximetry
“If you’re talking to a physician, and they’requestioning things, CAP Surveys results are one ofthe tools you have to go to and say, ‘Here’s why wefeel we’re putting out good results, and here’s thedata to back that up.’ Using the CAP Surveys givesme the confidence to have that discussion.”
Blood Gas, Critical Care, and Oximetry
82 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Bloo
dG
as, C
ritic
alC
are,
and
Oxi
met
ry
7
Blood Gas, Critical Care, and OximetryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Critical Care Aqueous Blood GasAQ, AQ2, AQ3, AQ4
Analyte Program Code Challenges/Shipment
AQ AQ2 AQ3 AQ4
Calcium, ionized z z z z 2
Chloride z z z z 5
Hematocrit z z z z 5
Hemoglobin, estimated z z z z 5
Lactate z z z z 2
Magnesium, ionized z z 2
PCO2 z z z z 5
pH z z z z 5
PO2 z z z z 5
Potassium z z z z 5
Sodium z z z z 5
tCO2 z z z z 5
Creatinine z z 5
Glucose z z 5
Urea nitrogen (BUN) z z 5
For second instrument reporting options, see the Quality Cross Check programs, AQQ, AQ2Q,AQ3Q, and AQ4Q, on page 83.
Program Information• A , A 2 - Ten 2.5-mL
aqueous specimens (twoduplicate sets) and ten2.5-mL specimens forhematocrit testing (twoduplicate sets); appropriatefor all methods except i-STAT®
• A , A - Ten 2.5-mLspecimens (two duplicate sets)for i-STAT methods only
• Three shipments per year
Do you usean i-STAT
instrument?
Yes
No Order Survey AQ or AQ2
Order SurveyAQ3 or AQ4
Blood Gas, Critical Care, and Oximetry
800-323-4040 | 847-832-7000 Option 1 | cap.org 83
BloodG
as, CriticalC
are, andO
ximetry
7
Quality Cross Check—Critical CareAqueous Blood Gas AQQ, AQ2Q, AQ3Q, AQ4Q
Analyte Program Code Challenges/Shipment
AQQ AQ2Q AQ3Q AQ4Q
Calcium, ionized z z z z 3
Chloride z z z z 3
Hematocrit z z z z 3
Hemoglobin, estimated z z z z 3
Lactate z z z z 3
Magnesium, ionized z z 3
PCO2 z z z z 3
pH z z z z 3
PO2 z z z z 3
Potassium z z z z 3
Sodium z z z z 3
tCO2 z z z z 3
Creatinine z z 3
Glucose z z 3
Urea nitrogen (BUN) z z 3
These programs do not meet regulatory requirements for proficiency testing. See Surveys AQ,AQ2, AQ3, or AQ4 on page 82.
Additional InformationAs a trusted partner, you can rely on the CAP to provide the insight, knowledge, andpeer-based educational coaching to protect your laboratory from regulatory sanctions.
• The CAP uality Cross Chec program complements CAP PT by offering moreopportunities to monitor and proactively identify instrument problems before theyimpact patient test results.
• This new offering will help you improve uality processes, reduce stress, raisecompetency of staff, and verify the performance of your instrument results.
Program Information• A , A 2 - Nine 2.5-mL
specimens (three duplicatesets) and nine 2.5-mLspecimens for hematocrittesting (three duplicate sets);appropriate for all methodsexcept i-STAT®
• A , A - Nine 1.7-mLspecimens (three duplicatesets) for i-STAT methods only
• Report up to three instruments
• Two shipments per year
New
Blood Gas, Critical Care, and Oximetry
84 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Bloo
dG
as, C
ritic
alC
are,
and
Oxi
met
ry
7
Blood Oximetry SOAnalyte Program Code Challenges/Shipment
SO
Carboxyhemoglobin z 5
Hematocrit, estimated z 5
Hemoglobin, total z 5
Methemoglobin z 5
Oxyhemoglobin z 5
Additional Information• This Survey is not compatible with Oxicom-2000, -2100, or - 000 whole
blood oximeters.• For second instrument reporting options, see the uality Cross Chec program,
SO , on page 8 .
Quality Cross Check—Blood Oximetry SOQ
Analyte/Procedure Program Code Challenges/Shipment
SOQ
Carboxyhemoglobin z 3
Hematocrit, estimated z 3
Hemoglobin, total z 3
Methemoglobin z 3
Oxyhemoglobin z 3
This program does not meet regulatory requirements for proficency testing. See Survey SOabove.
Additional InformationAs a trusted partner, you can rely on the CAP to provide the insight, knowledge, andpeer-based educational coaching to protect your laboratory from regulatory sanctions.
• The CAP uality Cross Chec program complements CAP PT by offering moreopportunities to monitor and proactively identify instrument problems before theyimpact patient test results.
• This new offering will help you improve uality processes, reduce stress, raisecompetency of staff, and verify the performance of your instrument results.
Program Information• Five 1.7-mL stabilized
human hemoglobin solutionspecimens
• Three shipments per year
Program Information• Nine li uid specimens (three
duplicate sets)
• Report up to three instruments
• Two shipments per year
New
Toxicology
8
Toxicology
New Programs New
Drug-Facilitated Crime (DFC) ...........................................................................................................a95
New Analyte Additions Toxicology (T) and Urine Toxicology (UT)............................................................................................86CAP/AACC Forensic Urine Drug Testing, Confirmatory (UDC) ..............................................................89Oral Fluid for Drugs of Abuse (OFD) ..................................................................................................90Vitreous Fluid, Postmortem (VF) ..........................................................................................................90Trace Metals, Urine (TMU) ................................................................................................................92Forensic Toxicology, Criminalistics (FTC) .............................................................................................93Drug Monitoring for Pain Management (DMPM) ..................................................................................95
8 | Toxicology
“ We use CAP Surveys for continuing education. Why? Because not every staff member works on every proficiency test and it’s a chance to get everybody together to see if we have everything right or wrong—just a chance to stop and take a few minutes to go over what we’re doing.”
Toxicology
86 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Toxi
colo
gy
8
ToxicologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Toxicology TAnalyte Program Code Challenges/Shipment
T
See drug listing on next page z 5
Urine Toxicology UTAnalyte Program Code Challenges/Shipment
UT
See drug listing on next page z 5
Program Information• A total of five specimens
consisting of 20.0-mLlyophilized serum and50.0-mL li uid urinespecimens
• For laboratories performingualitative and uantitative
drug analysis withconfirmation testing
• Three shipments per year
Program Information• Five 50.0-mL li uid urine
specimens
• For laboratories performingualitative drug analysis with
confirmation testing
• Three shipments per year
Toxicology
800-323-4040 | 847-832-7000 Option 1 | cap.org 87
Toxicology
8
6-acetylmorphine (6-AM)
7-aminoclonazepam
7-aminoflunitrazepam
Acetaminophen
Alpha-hydroxyalprazolam
Alprazolam
Amitriptyline
Amphetamine
Amphetamine group
Atenolol
Atropine
Barbiturate group
Benzodiazepinegroup
Benzoylecgonine
Brompheniramine
Buprenorphine
Bupropion
Butalbital
Cannabinoids
Carbamazepine
Carbamazepine-10,11-epoxide
Carisoprodol
Chlordiazepoxide
Chlorpheniramine
Chlorpromazine
Citalopram
Clomipramine
Clonazepam
Clozapine
Cocaethylene
Cocaine
Codeine
Cotinine
Cyclobenzaprine
Delta-9-THC (serum only)
Delta-9-THC-COOH
Desal ylflurazepam
Desipramine
Desmethylclomipramine
Dextromethorphan
Diazepam
Dihydrocodeine
Diltiazem
Diphenhydramine
Doxepin
Doxylamine
Duloxetine
Ecgonine ethyl ester
Ecgonine methyl ester
Ephedrine
Fentanyl
Flunitrazepam
Fluoxetine
Flurazepam
Hydrocodone
Hydromorphone
Hydroxyzine
Ibuprofen
Imipramine
etamine
Lamotrigine
Lidocaine
Lorazepam
Lysergic acid diethylamide(LSD)
Maprotiline
Meperidine
Mephedrone
Meprobamate
Methadone
Methadonemetabolite (EDDP)
Methamphetamine
Methotrimeprazine
Methylenedioxy-amphetamine (MDA)
Methylenedioxy-methamphetamine(MDMA)
Methylenedioxy-pyrovalerone (MDPV)
Methylphenidate
Metoprolol
Mirtazapine
Morphine
N-desmethyltramadol
Naproxen
Nicotine
Norbuprenorphine
Norchlordiazepoxide
Norcodeine
Norcyclobenzaprine
Nordiazepam
Nordoxepin
Norfentanyl
Norfluoxetine
Nor etamine
Normeperidine
Norpropoxyphene
Norsertraline
Nortrimipramine
Nortriptyline
Norverapamil
O-desmethyltramadol
Olanzapine
Opiate group
Oxazepam
Oxycodone
Oxymorphone
Paroxetine
Phencyclidine
Phenethylamine
Pheniramine
Phenobarbital
Phentermine
Phenylephrine
Phenylpropanolamine
Phenytoin
Propoxyphene
Propranolol
Pseudoephedrine
Quetiapine
Quinidine
Quinine
Ranitidine
Salicylates
Sertraline
Strychnine
Temazepam
Tramadol
Trazodone
Tricyclic group
Trimipramine
Valproic acid
Venlafaxine
Verapamil
olpidem
T, UT Drug ListingChallenges will include a mix of drugs from the list below.
Toxicology
88 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Toxi
colo
gy
8
CAP/AACC Urine Drug Testing, Screening UDS, UDS6
Analyte Program Code
Challenges/Shipment
UDS UDS6 Limited
Acetaminophen 5 3
Amphetamine 5 3
Amphetamine/methamphetamine group 5 3
Barbiturate group 5 3
Benzodiazepine group 5 3
Benzoylecgonine/cocaine metabolites 5 3
Buprenorphine 5 3
Delta-9-THC-COOH 5 3
Ethanol 5 3
Fentanyl 5 3
Lysergic acid diethylamide (LSD) 5 3
Methadone 5 3
Methadone metabolite (EDDP) 5 3
Methamphetamine 5 3
Methaqualone 5 3
Methylenedioxymethamphetamine (MDMA) 5 3
Opiate group 5 3
Oxycodone 5 3
Phencyclidine 5 3
Propoxyphene 5 3
Tricyclic group 5 3
Urine Drug Adulterant/Integrity Testing DAIAnalyte Program Code Challenges/Shipment
DAI
Creatinine z 3
Glutaraldehyde z 3
Nitrite z 3
Oxidants z 3
pH z 3
Specific gravity z 3
Program Information•UDS-Five10.0-mLliquid
urine specimens; three shipments per year
•UDS6-Three10.0-mLliquid urine specimens; two shipments per year
•Forlaboratoriesperforming immunoassay or other nonconfirmation methods
•Participantswillhaveaccessto the AACC quarterly newsletter, Clinical & Forensic Toxicology News
AACC
Program Information•Three25.0-mLurine
specimens
•Twoshipmentsperyear
Toxicology
800-323-4040 | 847-832-7000 Option 1 | cap.org 89
Toxicology
8
CAP/AACC Forensic Urine Drug Testing,Confirmatory UDC
Analyte Program Code Challenges/Shipment
UDC
6-acetylmorphine (6-AM) z 10
Alpha-hydroxyalprazolam z 10
Amphetamine z 10
Benzoylecgonine z 10
Buprenorphine z 10
Butalbital z 10
Codeine z 10
Delta-9-THC-COOH z 10
Hydrocodone z 10
Hydromorphone z 10
Lorazepam z 10
Methadone z 10
Methadone metabolite (EDDP) z 10
Methamphetamine z 10
Metha ualone z 10
Methylenedioxyamphetamine (MDA) z 10
Methylenedioxyethylamphetamine(MDEA)
z 10
Methylenedioxymethamphetamine (MDMA) z 10
Morphine z 10
Norbuprenorphine z 10
Nordiazepam z 10
Norpropoxyphene z 10
Oxazepam z 10
Oxycodone z 10
Oxymorphone z 10
Phencyclidine z 10
Phenobarbital z 10
Propoxyphene z 10
Secobarbital z 10
Temazepam z 10
Adulterant/Integrity Indicator
Creatinine z 10
pH z 10
Specific gravity z 10
Program Information• Ten 50.0-mL li uid urine
specimens
• For laboratories performingdrug screening, confirmation,uantitation, and adulteration
testing
• Participants will have accessto the AACC uarterlynewsletter, Clinical & ForensicToxicology News
• Four shipments per year
AACC
Toxicology
90 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Toxi
colo
gy
8
Oral Fluid for Drugs of Abuse OFDAnalyte Program Code Challenges/Shipment
OFD
Amphetamine Group z 5
Amphetamine z 5
Methamphetamine z 5
Methylenedioxyamphetamine (MDA) z 5
Methylenedioxymethamphetamine (MDMA) z 5
Cocaine and/or metabolite z 5
Benzoylecgonine z 5
Cocaine z 5
Cannabinoids z 5
Delta-9-THC z 5
Delta-9-THC-COOH z 5
Methadone z 5
Opiate Group z 5
6-acetylmorphine (6-AM) z 5
Codeine z 5
Hydrocodone z 5
Hydromorphone z 5
Morphine z 5
Oxycodone z 5
Oxymorphone z 5
Phencyclidine (PCP) z 5
Vitreous Fluid, Postmortem VFAnalyte Program Code Challenges/Shipment
VF
Acetone z 3
Chloride z 3
Creatinine z 3
Ethanol z 3
Glucose z 3
Potassium z 3
Sodium z 3
Vitreous urea nitrogen z 3
Program Information• Five 2.0-mL oral fluid
specimens
• For laboratories performingdrug screening, confirmation,and uantitation
• Four shipments per year
Program Information• Three 5.0-mL synthetic
vitreous fluid specimens
• Two shipments per year
Toxicology
800-323-4040 | 847-832-7000 Option 1 | cap.org 91
Toxicology
8
Serum Drug Screening SDSAnalyte Program Code Challenges/Shipment
SDS
Acetaminophen ( uantitative) z 3
Acetone (semi uantitative and ualitative) z 3
Barbiturate group ( ualitative) z 3
Benzodiazepine group ( ualitative) z 3
Salicylate ( uantitative) z 3
Total tricyclic antidepressants ( ualitative) z 3
CAP/AACC Alcohol/Ethylene Glycol/VolatilesAL1*, AL2
Analyte Program Code Challenges/Shipment
AL1*Whole Blood
AL2Serum
Acetone z z 5
Ethanol z z 5
Ethylene glycol z z 5
Isopropanol z z 5
Methanol z z 5
*The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Survey AL1.
Ethanol Biomarkers ETBAnalyte Program Code Challenges/Shipment
ETB
Ethyl glucuronide (EtG) z 3
Ethyl sulfate (EtS) z 3
Program Information• Three 2.0-mL serum
specimens
• For laboratories performingimmunoassay or othernonconfirmatory methods
• Two shipments per year
Program Information• AL1 - Five 5.0-mL li uid
whole blood specimens;conventional reporting
• AL2 - Five 2.0-mL li uid serumspecimens; conventional andInternational System of nits(SI) reporting offered
• For uantitative methods only
• Three shipments per year
AACC
Program Information• Three 10.0-mL synthetic urine
specimens
• Two shipments per year
Toxicology
92 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Toxi
colo
gy
8
CAP/AACC Blood Lead BLAnalyte Program Code Challenges/Shipment
BL
Lead z 5
This Survey meets the Occupational Safety and Health Administration (OSHA) requirements for proficiency testing [OSHA lead standards-29 CFR 1910.1025(j)(2)(iii)].
Cadmium CDAnalyte Program Code Challenges/Shipment
CD
Beta-2-microglobulin, urine z 3
Cadmium, urine z 3
Cadmium, whole blood z 3
Creatinine, urine z 3
This Survey meets the Occupational Safety and Health Administration (OSHA) guidelines for proficiency testing (OSHA standard-29 CFR 1910.1027AppF).
Trace Metals, Urine TMUAnalyte Program Code Challenges/Shipment
TMU
Aluminum z 3
Arsenic z 3
Chromium z 3
Cobalt z 3
Copper z 3
Lead z 3
Manganese z 3
Mercury z 3
Selenium z 3
Thallium z 3
Zinc z 3
Program Information•Five6.0-mLliquidnonhuman
whole blood specimens
•Conventionaland International System of Units (SI) reporting offered
•Threeshipmentsperyear
AACC
Program Information•Three6.0-mLwholeblood
specimensandthree11.0-mLurine specimens
•ConventionalandInternationalSystem of Units (SI) reporting offered
•Sixshipmentsperyear
Program Information•Three10.0-mLurine
specimens
•Twoshipmentsperyear
Toxicology
800-323-4040 | 847-832-7000 Option 1 | cap.org 93
Toxicology
8
Forensic Toxicology, Criminalistics FTCAnalyte Program Code Challenges/Shipment
FTC
See drug listing below z 4
The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Survey FTC.
Program Information• Three 20.0-mL whole blood
specimens and one 20.0-mLsynthetic urine specimen
• Two shipments per year
6-acetylmorphine (6-AM)
7-aminoclonazepam
7-aminoflunitrazepam
Acetaminophen
Alpha-hydroxyalprazolam
Alprazolam
Amitriptyline
Amphetamine
Benzoylecgonine
Butalbital
Carisoprodol
Chlorpheniramine
Clonazepam
Cocaethylene
Cocaine
Codeine
Cyclobenzaprine*
Delta-9-THC
Delta-9-THC-COOH
Desipramine
Desmethylcyclobenzaprine
Diazepam
Diphenhydramine
Doxepin
Ecgonine ethyl ester
Ecgonine methyl ester
Ephedrine
Fentanyl*
Fluoxetine
Flurazepam*
Gamma-hydroxybutyrate (GHB)
Hydrocodone
Hydromorphone
Imipramine
etamine
Lorazepam
Lysergic acid diethylamide (LSD)
Meperidine*
Meprobamate
Methadone
Methadone metabolite (EDDP)
Methamphetamine
Methylenedioxyamphetamine (MDA)
Methylenedioxymethamphetamine(MDMA)
Morphine*
N-desmethyltramadol
Nordiazepam
Nordoxepin
Norfluoxetine
Nor etamine
Norpropoxyphene
Norsertraline
Nortriptyline
Oxazepam
Oxycodone
Oxymorphone
Paroxetine
Phencyclidine
Phenethylamine
Phenobarbital
Phentermine
Phenytoin
Propoxyphene
Pseudoephedrine
Secobarbital
Sertraline
Temazepam
Tramadol*
Trazodone
olpidem
*and/or metabolite(s)
FTC Drug ListingChallenges will include a mix of drugs from the list below.
Toxicology
94 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Toxi
colo
gy
8
Synthetic Cannabinoid/Designer Drugs SCDDAnalyte Program Code Challenges/Shipment
SCDD
Synthetic Cannabinoid/Designer Drugs z 3
PRICE (USD)
Additional InformationSynthetic cannabinoids and designer drug stimulants are widespread and constantly changing in respect to the available chemical moieties. In order to stay contemporary, the CAP has decided to modify the compounds in this program in accordance with the appearance and prevalence of new compounds.
Program Information• Three 10.0-mL urine
specimens
• For laboratories that perform screening and confirmatory testing for the compounds found in this program
• Two shipments per year
4-methylethcathinone (4-MEC)
5F-PB-22 3-carboxyindole metabolite
AB CHMINACA pentanoic acid metabolite
AB FUBINACA oxobutanoic acid metabolite
AB-PINACA N-pentanoic acid metabolite
ADBICA N-pentanoic acid metabolite
ADB-PINACA N-pentanoic acid metabolite
AKB-48 N-pentanoic acid metabolite
Alpha-PVP (α-Pyrrolidinopentiophenone)
AM-2201 N-(4-hydroxypentyl) metabolite
BB-22 3-carboxyindole metabolite
Butylone
Ethylone
JWH-018 N-Pentanoic Acid
MAM 2201 pentanoic acid metabolite
Mephedrone
Methylenedioxypyrovalerone (MDPV)
Methylone
PB-22 3-carboxyindole metabolite
UR-144 N-pentanoic acid metabolite
XLR-11 4-hydroxypentyl metabolite
SCDD Drug ListingChallenges will include a mix of drugs from the list below.
For the most current list of drugs, please go to cap.org and select Laboratory Improvement.
Toxicology
800-323-4040 | 847-832-7000 Option 1 | cap.org 95
Toxicology
8
Drug Monitoring for Pain Management DMPMAnalyte Program Code Challenges/Shipment
DMPM
See drug listing below z 3
Program Information•Three40.0-mLurine
specimens
• Forlaboratoriesofferingscreeningand/orconfirmatorytestingfor painmanagement
•Includesclinicalcasesandquestionsalongwithdetaileddescriptionsofhowtointerpret test results
•Twoshipmentsperyear
AmphetamineGroup
6-acetylmorphine(6-AM)
7-aminoclonazepam
Alpha-hydroxyalprazolam
Alprazolam
Amphetamine
BarbiturateGroup
BenzodiazepineGroup
Benzoylecgonine
Buprenorphine
Buprenorphineand/ormetabolites
Butalbital
Cannabinoids
Carisoprodol
Carisoprodoland/ormetabolites
Clonazepam
Cocaine
Cocaineand/ormetabolites
Codeine
Delta-9-THC-COOH
Diazepam
Fentanyl
Fentanyland/ormetabolites
Hydrocodone
Hydromorphone
Lorazepam
Lorazepamglucuronide
Meperidine
Meperidineand/ormetabolites
Meprobamate
Methadone
Methadonemetabolite(EDDP)
Methamphetamine
Methylenedioxyamphetamine(MDA)
Methylenedioxymethamphetamine(MDMA)
Morphine
N-desmethyltramadol
Norbuprenorphine
Nordiazepam
Norfentanyl
Normeperidine
Noroxycodone
Noroxymorphone
Norpropoxyphene
OpiateGroup
Oxazepam
Oxycodone
Oxymorphone
Propoxyphene
Propoxypheneand/ormetabolites
Temazepam
Tramadol
Tramadoland/ormetabolites
DMPM Drug ListingChallengeswillincludeamixofdrugsfromthelistbelow.
Toxicology
800-323-4040 | 847-832-7000 Option 1 | cap.org a95
Toxicology
8 8
Drug-Facilitated Crime DFCAnalyte Program Code Challenges/Shipment
DFC
See drug listing below z 3
Program Information•Three25.0-mLurine
specimens
•Forlaboratoriesperformingqualitativeurinedruganalysiswithconfirmationtesting
•Designedforlaboratoriesperformingtestingfordrugsassociatedwithdrug-facilitatedcrimes,whichtargetdrugsatmuchlowerconcentrationsthaninothertoxicologySurveys
•Twoshipmentsperyear
New
11-carboxy-THC
4-hydroxytriazolam
7-aminoclonazepam
7-aminoflunitazepam
alpha-hydroxyalprazolam
Amitriptyline
Amobarbital
Amphetamine
Benzoylecgonine
Brompheniramine
Butalbital
Carisoprodol
Chlorpheniramine
Citalopram/escitalopram
Clonidine
Codeine
Cyclobenzaprine
Desipramine
Dextromethorphan
Diphenhydramine
Doxepin
Doxylamine
Fentanyl
Fluoxetine
Gammahydroxybutyrate(GHB)
Hydrocodone
Hydromorphone
Imipramine
Ketamine
Lorazepam
Meperidine
Meprobamate
Methadone
MethadoneMetabolite(EDDP)
Methamphetamine
Methylenedioxyamphetamine(MDA)
Methylenedioxymethamphetamine(MDMA)
Morphine
Nordoxepin
Norfluoxetine
Norketamine
Normeperidine
Norpropoxyphene
Norsertraline
Nortriptyline
Oxazepam
Oxycodone
Oxymorphone
Paroxetine
Pentobarbital
Phencyclidine(PCP)
Phenobarbital
Phenytoin
Propoxyphene
Scopolamine
Secobarbital
Sertraline
Temazepam
Tetrahydrozoline
Tramadol
ValproicAcid
Zaleplon
Ziprasidone
Zolpidem
Zopiclone/Eszopiclone
DFC Drug ListingChallengeswillincludeamixofdrugsfromthelistbelow.
Toxicology
96 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Toxi
colo
gy
8
Improve the reliability of your patient results with CAP Survey Validated Materialsse the same material that is sent in the Surveys program to
• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document correction of problems identified in Surveys• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures
Each laboratory receives a Survey Participant Summary, which includes readily available results.
Toxicology, Validated MaterialsValidated Material Program Code Corresponding Survey Page
Serum Alcohol/EthyleneGlycol/Volatiles VM
AL2M AL2 91
Blood Lead VM BLM BL 92
rine Drug Testing (Screening) VM DSM DS 88
Program Information• AL2M - Five 2.0-mL li uid
serum specimens
• BLM - Five 6.0-mL li uidnonhuman whole bloodspecimens
• DSM - Five 10.0-mL li uidurine specimens
• Three shipments per year
Find a practical guide to toxicology laboratory operationswith this resourceClinical Toxicology Testing:A Guide for Laboratory Professionals
Complex issues face the laboratory director or pathologist whooffers toxicology services. This thorough reference book will guideboth experienced physicians and those in training through thepharmacological principles, testing menus, and methodologies fortoxicology testing.
PRESS
To orderVisit cap.org and choose the Shop tab;or call the CAP Customer Contact Centerat 800-323-4040 or 847-832-7000 option 1.
Item number: PUB220ISBN: 978-0-9837068-1-6Softcover; 304 pages; 2012
Also available as an ebook! Visit ebooks.cap.org
Accuracy-Based
Programs
9
Accuracy-Based ProgramsAccuracy-Based Programs.................................................................................................................98Validated Materials........................................................................................................................101
New Programs New
Hemoglobin A1c, five challenges (GH5)............................................................................................100
Discontinued ProgramsCommutable Frozen Serum (CFS)
9 | Accuracy-Based Programs
“What we do is so exact that we want to knowit’s correct. CAP proficiency testing validates ourlaboratory process so we feel confident that we aresending out the correct results.”
Accuracy-Based Programs
98 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Acc
urac
y-Ba
sed
Prog
ram
s
9
Accuracy-Based ProgramsAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Accuracy-Based Lipids ABLAnalyte Program Code Challenges/Shipment
ABL
Apolipoprotein A1 z 3
Apolipoprotein B z 3
Cholesterol* z 3
HDL cholesterol* z 3
LDL cholesterol z 3
Lipoprotein (a) z 3
Triglycerides* z 3
*This analyte will be evaluated against the Centers for Disease Control and Prevention (CDC)reference method.
Accuracy-Based Vitamin D ABVDAnalyte Program Code Challenges/Shipment
ABVD
25-OH vitamin D (D2 and D3) z 3
Additional Information• The Centers for Disease Control and Prevention (CDC) will establish reference targets
using isotope-dilution LC-MS/MS method.• Specimens are collected by a modified application of Clinical Laboratory and
Standards Institute Guideline CLSI C37-A, Preparation and Validation ofCommutable Frozen Human Serum Pools as Secondary Reference Materialsfor Cholesterol Measurement Procedures; Approved Guideline.
Program Information• Three 1.0-mL human serum
specimens
• Two shipments per year
Program Information• Three 1.0-mL human li uid
serum specimens
• Serum is from multidonorendogenous pools
• Two shipments per year
Accuracy-Based Programs
800-323-4040 | 847-832-7000 Option 1 | cap.org 99
Accuracy-Based
Programs
9
Testosterone and Estradiol Accuracy Survey ABSAnalyte Program Code Challenges/Shipment
ABS
Calcium z 4
Cortisol z 4
Estradiol z 4
Testosterone z 4
Thyroid-stimulating hormone (TSH) z 4
Additional Information• The Centers for Disease Control and Prevention (CDC) will set target values for
testosterone and estradiol using the established reference methods.• Calcium, cortisol, and TSH data will be provided by peer groups to determine the
degree of harmonization in the field.
Accuracy-Based Urine ABUAnalyte Program Code Challenges/Shipment
ABU
Calcium z 3
Creatinine z 3
rine albumin ( uantitative) z 3
rine albumin creatinine ratio z 3
Analytes may be evaluated against the reference method or by using harmonization.
Creatinine AccuracyCalibration Verification/Linearity LN24
Analyte Program Code
LN24 LN24 Target Range
Creatinine z 0.6 .0 mg/dL
Estimated glomerularfiltration rate (eGFR)
z
LN Express service is available.
Additional InformationThe College of American Pathologists (CAP) and the National idney Disease EducationProgram (N DEP) have an initiative to harmonize clinically reported creatinine values.This initiative is analogous to what the federal health agencies and the clinical laboratorycommunity did to improve the accuracy of cholesterol and glycohemoglobin testing.
Program Information• Four 1.0-mL human serum
specimens
• One shipment per year
Program Information• Three 5.0-mL human urine
specimens
• Two shipments per year
Program Information• Six 1.0-mL human serum
specimens
• Two shipments per year
Accuracy-Based Programs
100 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Acc
urac
y-Ba
sed
Prog
ram
s
9
Harmonized Thyroid ABTHAnalyte Program Code Challenges/Shipment
ABTH
T , free (triiodothyronine, free) z 3
T3, total (triiodothyronine, total) z 3
T , free (thyroxine, free) z 3
T , total (thyroxine, total) z 3
Thyroid-stimulating hormone (TSH) z 3
PRICE (USD)
Additional Information• Analytes will be evaluated using harmonization.• Specimens are collected by a modified application of Clinical Laboratory and
Standards Institute Guideline CLSI C37-A, Preparation and Validation ofCommutable Frozen Human Serum Pools as Secondary Reference Materials forCholesterol Measurement Procedures; Approved Guideline.
Hemoglobin A1c AccuracyCalibration Verification/Linearity LN15
Analyte Program Code
LN15 LN15 Target Range
Hemoglobin A1c z 5 12
CAP-assigned target values derived from Hemoglobin A1c measurements assayed byNational Glycohemoglobin Standardization Program (NGSP) secondary reference laboratories.
LN Express service is available.
Hemoglobin A1c GH2, GH5Analyte Challenges/Shipment
Program Code
GH2 GH5
Hemoglobin A1c 3 5
Additional Information• Beginning with the 2015 proficiency testing (PT) program year, the College of
American Pathologists Accreditation Program will re uire all accredited laboratoriesperforming non-waived testing for Hemoglobin A1c to enroll in Survey GH5.
• These Surveys will be evaluated against the National GlycohemoglobinStandardization Program (NGSP) reference method.
Program Information• Three 1.0-mL frozen human
specimens
• Two shipments per year
Program Information• Six 0.8-mL li uid human
whole blood specimens
• Two shipments per year
Program Information• GH2 - Three 0.8-mL
li uid human whole bloodspecimens; two shipmentsper year
• GH5 - Five 0.8-mL li uidhuman whole bloodspecimens; three shipmentsper year
Validated Materials
800-323-4040 | 847-832-7000 Option 1 | cap.org 101
Accuracy-Based
Programs
9
Validated MaterialsImprove the reliability of your patient results with CAP Survey Validated Materials
se the same material that is sent in the Surveys program to
• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document correction of problems identified in Surveys• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures
Each laboratory receives a Survey Participant Summary, which includes readily available results.
Chemistry, Validated MaterialsValidated Material Validated Material Code Corresponding Survey Page
Chemistry/TDM VM CZVM CZ 50
Cerebrospinal Fluid VM MVM M 66
Urine Chemistry (Special) VM NVM N, N 62
Urine Chemistry (General) VM UVM U 61
Coagulation, Validated MaterialValidated Material Validated Material Code Corresponding Survey Page
Coagulation (Limited) VM CGM CGL 144
Calibration Verification/Linearity, Validated MaterialsValidated Material Validated Material Code Corresponding Survey Page
Chemistry, Lipid, Enzyme Calibration Verification/Linearity VM LN2VM LN2 106
Chemistry, Lipid, Enzyme Calibration Verification/Linearity;All Bec man (except A ) and Vitros VM
LN2VM1 LN2BV 106
TDM Calibration Verification/Linearity VM LDM LN 107
Ligand Assay Calibration Verification/Linearity VM LLM LN5 108
rine Chemistry Calibration Verification/Linearity VM LUM LN6 108
Validated Materials
102 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Acc
urac
y-Ba
sed
Prog
ram
s
9
Cytogenetics, Validated MaterialValidated Material Validated Material Code Corresponding Survey Page
Cytogenetics VM CYM CY 212
Endocrinology, Validated MaterialsValidated Material Validated Material Code Corresponding Survey Page
Ligands (General) VM VM 74
Ligands (Special) VM YVM Y 75
Toxicology, Validated MaterialsValidated Material Validated Material Code Corresponding Survey Page
Serum Alcohol/Ethylene Glycol/Volatiles VM AL2M AL2 91
Blood Lead VM BLM BL 92
Urine Drug Testing (Screening) VM UDSM UDS 88
Instrumentation Validation Tools
10
Instrumentation Validation ToolsCalibration Verification/Linearity .....................................................................................................104Instrumentation Quality Management Programs .................................................................................118
Program ChangesInternational System of Units (SI) reporting now available. See specific program for availability
10 | Instrumentation Validation Tools
“The CAP has proficiency testing available for justabout every test we do and I really like using theirlinearity and calibration verification programs.Everything blends well together.”
Calibration Verification/Linearity
104 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Inst
rum
enta
tion
Valid
atio
n To
ols
10
The CAP CVL programOur program will help you meet CLIA regulations and CAP Laboratory Accreditation Program requirements forcalibration verification and analytical measurement range (AMR) validation under 42 CFR493.1255(b)(3) for mostanalytes. In addition, you will receive a linearity assessment to help identify instrument/method performance issuesbefore they can affect your patient results.
With your enrollment in the CAP CVL program you will receive:
• Testing Kito Kit instructions—Contain important information to help you complete testing and accurately report your resultso Result formo Specimens—The majority of CAP CVL programs offer human-based materials to closely mimic your patient results
• Customized Report Packageo Executive Summary—A quick overview of both your calibration verification and linearity results for all reported
analyteso Calibration Verification evaluationo Linearity evaluation
• Receive your linearity evaluations through LN ExpressSM, our expedited delivery service, within two businessdays for select CVL programs by logging in to e-LAB Solutions™
o Linearity Troubleshooting Reporto Participant Summary—A summary of laboratory performance that includes peer group statistics and enhanced
diagnostic information for early insight into potential problems
• Additional Toolso Calibration Verification/Linearity Program User’s Guide—Get assistance in interpreting your evaluations and
reports as well as helpful troubleshooting information with suggested actions. Also available online by logging into e-LAB Solutions
o Calibration Verification Troubleshooting Guide—The guide provides suggested actions if you receive acalibration verification result of Different, or if your evaluation result is Verified over a range that does notinclude all of your reported results
o Calibration Verification/Linearity Surveys Investigation Checklist for Problematic Results—Interpretative checklistsare included to help with troubleshooting and documentation
Calibration Verification/Linearity
Calibration Verification/Linearity
800-323-4040 | 847-832-7000 Option 1 | cap.org 105
Instrumentation Validation Tools
10
Your Total Calibration Verification/Linearity (CVL) SolutionCVL Program Page
No.Corresponding
Proficiency Testing SurveyPageNo. Validated Material Page
No.LN2 - Chemistry, Lipid, Enzyme CVL 106
C1, C3/C3X,CZ/CZX/CZ2X
50LN2VM 121
LN2BV - Chemistry, Lipid, Enzyme all Beckman(except AU), Vitros CVL
106 LN2VM1 121
LN3 - TDM CVL 107 CZ/CZX/CZ2X/Z 50 LDM 121LN5 - Ligand Assay CVL 108
K/KK 74 LLM 121LN5S - Ligand Assay all Siemens ADVIA(Centaur, CP, and XP) CVL
108
LN6 - Urine Chemistry CVL 108 U 61 LUM 121LN7 - Immunology CVL 109 IG/IGX 180LN8 - Reproductive Endocrinology CVL 109 Y/YY 75LN9 - Hematology CVL 110 FH series, HE series 125,124LN11 - Serum Ethanol CVL 110 AL2 91LN12 - C-Reactive Protein CVL 110 CRP 180LN13, LN13C - Blood Gas/Critical Care CVL 111 AQ, AQ2, AQ3, AQ4 82LN14 - Whole Blood Ethanol CVL 111 AL1 91LN15 - Hemoglobin A1c Accuracy CVL 111 GH2 57LN16 - Homocysteine CVL 112 HMS 58LN17 - Whole Blood Glucose CVL 112 WBG, WB2 59LN18 , LN19 Reticulocyte CVL 112 RT, RT2, RT3, RT4 129LN20 - Urine Albumin CVL 112 U 61LN21 - High-Sensitivity C-Reactive Protein CVL 113 HSCRP 57LN22 - Flow Cytometry CVL 113 FL 188LN23 - Prostate-Specific Antigen CVL 113 K/KK 74
LN24 - Creatinine Accuracy CVL 114C1, C3/C3X,
CZ/CZX/CZ2X50
LN25, LN27 - Troponin I and T CVL 114 CRT, CRTI, TNT 56LN30 - B-Type Natriuretic Peptides CVL 114 BNP 55LN31 - Immunosuppressive Drugs CVL 115 CS 53
LN32 - Ammonia CVL 115C1, C3/C3X,
CZ/CZX/CZ2X50
LN33 - Serum Myoglobin CVL 115 CRT, CRTI 56LN34 - Tumor Markers CVL 115 TM/TMX 80LN35 - Thrombophilia CVL 116 CGS2 145LN36 - Heparin CVL 116 CGS4 145LN37 - von Willebrand Factor Antigen CVL 116 CGS3 145LN38 - CMV Viral Load CVL 116 VLS, VLS2 173LN39 - HIV Viral Load CVL 116 HIV, HV2 173LN40 - Vitamin D CVL 116 BGS 76LN41 - Procalcitonin CVL 117 PCT 69LN42 - D-Dimer CVL 117 CGL, CGDF 144
All CVL Surveys provide individual evaluation reports by analytes, an Executive Summary, and graphical plots for linearity andcalibration verification.
Calibration Verification/Linearity
106 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Inst
rum
enta
tion
Valid
atio
n To
ols
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher valuesthan the ranges listed.
Chemistry, Lipid, EnzymeCalibration Verification/Linearity LN2, LN2BV
Analyte ProgramCode LN2 LN2BV Units
LN2,LN2BV
(AllInstruments)
All Beckman(except AU) Vitros
Albumin z 1.5–9.0 g/dL
Calcium z 4.0–18.0 mg/dL
Chloride z 60–180 mmol/L
CO2 z 7–40 mmol/L
Creatinine z 0.3–32.0 mg/dL
Glucose z 20–780 mg/dL
Iron z 10–950 µg/dL
Magnesium z 0.3–10.0 mg/dL
Osmolality z 200–600 mOsm/kg H2O
Phosphorus z 0.5–20.0 mg/dL
Potassium z 1.5–13.0 mmol/L
Protein z 1.5–10.0 g/dL
Sodium z 90–215 mmol/L
Urea nitrogen z 3–190 mg/dL
Uric acid z 1–25 mg/dL
Alkaline phosphatase z 25–1,800 25–1,000 25–1,100 U/L
ALT (SGPT) z 10–900 10–650 30–700 U/L
Amylase z 30–1,800 30–900 30–800 U/L
AST (SGOT) z 10–900 10–500 10–700 U/L
Creatine kinase z 25–2,000 25–1,200 25–700 U/L
CK-2 (MB) Mass z 1–250 1–300 1–200 ng/mL
Gamma glutamyltransferase
z 10–1,400 10–900 10–1,100 U/L
Lactatedehydrogenase
z 50–1,800 50–700 185–3,000 U/L
Lipase z 20–1,400 20–190 150–2,500 U/L
Bilirubin, direct z 0.1–10.0 mg/dL
Bilirubin, total z 0.2–25.0 mg/dL
Cholesterol z 35–625 mg/dL
HDL z 7–120 mg/dL
Triglycerides z 20–700 mg/dL
LN Express service is available.
Program Information• Seven 5.0-mL li uid serum
specimens for basic chemistry,six 3.0-mL liquid serumspecimens for direct and totalbilirubin, seven 2.0-mL liquidserum specimens for lipids,and seven 5.0-mL liquidserum specimens for enzymes
• LN2 Appropriate for mostmajor instruments
• LN2BV Appropriate forBeckman (except AU) andVitros instruments only
• Conventional andInternational System of Units(SI) reporting offered
• Two shipments per year
Calibration Verification/Linearity
800-323-4040 | 847-832-7000 Option 1 | cap.org 107
Instrumentation Validation Tools
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher valuesthan the ranges listed.
Therapeutic Drug MonitoringCalibration Verification/Linearity LN3
Analyte Program CodeLN3 LN3 Target Ranges
Acetaminophen z 20–450 µg/mL
Amikacin z 2–45 µg/mL
Carbamazepine z 2–18 µg/mL
Digoxin z 0.5–4.4 µg/mL
Gentamicin z 1–11 µg/mL
Lidocaine z 1–10 µg/mL
Lithium z 0.3–4.0 mmol/L
N-acetylprocainamide (NAPA) z 2–25 µg/mL
Phenobarbital z 8–70 µg/mL
Phenytoin z 5–35 µg/mL
Primidone z 1–22 µg/mL
Procainamide z 2–18 µg/mL
Quinidine z 0.4–7.0 µg/mL
Salicylates z 7–90 mg/mL
Theophylline z 5–35 µg/mL
Tobramycin z 1–12 µg/mL
Valproic acid z 15–140 µg/mL
Vancomycin z 7–90 µg/mL
LN Express service is available.
Program Information• Six .0-mL li uid serum
specimens
• A seventh .0-mL li uid serumspecimen for acetaminophenand vancomycin
• Conventional andInternational System of Units(SI) reporting offered
• Two shipments per year
Calibration Verification/Linearity
108 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Inst
rum
enta
tion
Valid
atio
n To
ols
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher valuesthan the ranges listed.
Ligand Calibration Verification/Linearity LN5, LN5SAnalyte Program Code Target Ranges
LN5, LN5S* LN5 Target Ranges LN5S Target RangesAFP z 0.5–900.0 ng/mL
CEA z 0.5–750.0 ng/mL 0.5–90.0 ng/mL
Cortisol z 1–65 µg/dL
Ferritin z 2–1,000 ng/mL
Folate z 1.3–20 ng/mL
Human chorionicgonadotropin (hCG)
z 5–14,000 mIU/mL
T3, total (triidothyronine) z 0.5–7.0 ng/mL
T4, total (thyroxine) z 1–24 ng/mL
Thyroid-stimulatinghormone (TSH)
z 0.01–100 µU/mL
Vitamin B12 z 100–2,200 pg/mL
*The LN5S CVL will allow Siemens ADVIA Centaur users to report other major instruments if needed.
LN Express service is available.
Urine Chemistry Calibration Verification/LinearityLN6
Analyte Program Code
LN6 LN6 Target Ranges
Amylase z 40–1,500 U/L
Calcium z 5–30 mg/dL
Chloride z 20–330 mmol/L
Creatinine z 20–460 mg/dL
Glucose z 25–640 mg/dL
Osmolality z 30–1,800 mOsm/kg H20
Phosphorus z 15–200 mg/dL
Potassium z 7–225 mmol/L
Protein, total z 10–235 mg/dL
Sodium z 20–340 mmol/L
Urea nitrogen z 20–2,000 mg/dL
Uric acid z 6–150 mg/dL
LN Express service is available.
Program Information• LN5 - Eight .0-mL li uid
serum specimens; appropriatefor most major instrumentsexcept Siemens ADVIACentaur
• LN5S - Thirteen .0-mL li uidserum specimens; appropriatefor Siemens ADVIA Centaur,XP, and CP users
• Conventional andInternational System of Units(SI) reporting offered
• Two shipments per year
Program Information• Eighteen .0-mL li uid urine
specimens
• Two shipments per year
Calibration Verification/Linearity
800-323-4040 | 847-832-7000 Option 1 | cap.org 109
Instrumentation Validation Tools
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher values than the ranges listed.
Immunology Calibration Verification/Linearity LN7
Analyte Program Code
LN7 LN7 Target Ranges
Alpha-1-antitrypsin z 25–616 mg/dL
Complement C3 z 21–420 mg/dL
Complement C4 z 5–100 mg/dL
IgA z 32–650 mg/dL
IgG z 150–3,000 mg/dL
IgM z 25–450 mg/dL
Transferrin z 38–950 mg/dL
LN Express service is available.
Reproductive Endocrinology Calibration Verification/Linearity LN8
Analyte Program Code
LN8 LN8 Target Ranges
Estradiol z 25–4,500 pg/mL
Follicle-stimulating hormone (FSH) z 3–190 mIU/mL
Human chorionic gonadotropin (hCG) z 5–8,000 mIU/mL
Luteinizing hormone (LH) z 2–190 mIU/mL
Progesterone z 1–50 ng/mL
Prolactin z 3–315 ng/mL
Testosterone z 20–1,500 ng/dL
LN Express service is available.
Program Information•Six2.0-mLliquidserum
specimens
•Twoshipmentsperyear
Program Information•Seven4.0-mLliquidserum
specimens
•ConventionalandInternational System of Units (SI) reporting offered
•Twoshipmentsperyear
Calibration Verification/Linearity
110 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Inst
rum
enta
tion
Valid
atio
n To
ols
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher valuesthan the ranges listed.
Hematology Calibration Verification/LinearityLN9
Analyte Program Code
LN9 LN9 Target Ranges
Hemoglobin z 1.5–24.0 g/dL
Platelet count z 10–2,500 x 109/L
RBC count z 0.5–8.00 x 1012/L
WBC count z 0.5–350.0 x 109/L
LN Express service is available.
Serum Ethanol Calibration Verification/LinearityLN11
Analyte Program Code
LN11 LN11 Target Range
Serum ethanol z 15–550 mg/dL
LN Express service is available.
C-Reactive ProteinCalibration Verification/Linearity LN12
Analyte Program Code
LN12 LN12 Target Range
C-reactive protein z 7–280 mg/L
LN Express service is available.
Program Information• Twenty .0-mL li uid
specimens
• Two shipments per year
Program Information• Seven .0-mL li uid serum
specimens
• Conventional andInternational System of Units(SI) reporting offered
• Two shipments per year
Program Information• Seven 1.0-mL li uid serum
specimens
• Not appropriate for reportinghigh-sensitivity C-reactiveprotein (hsCRP)
• Two shipments per year
Calibration Verification/Linearity
800-323-4040 | 847-832-7000 Option 1 | cap.org 111
Instrumentation Validation Tools
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher valuesthan the ranges listed.
Blood Gas/Critical CareCalibration Verification/Linearity LN13, LN13C
Analyte ProgramCode
ProgramCode
LN13 LN13Target Ranges LN13C LN13C
Target Ranges
PCO2 z 12–91 mm Hg z 12–91 mm Hg
pH z 6.83–7.82 z 6.83–7.82
PO2 z 18–490 mm Hg z 18–490 mm Hg
Calcium, ionized z 0.15–3.3 mmol/L
Chloride z 62–148 mmol/L
Glucose z 10–465 mg/dL
Lactate z 0.2–18 mmol/L
Magnesium, ionized z 0.1–2.4 mmol/L
Potassium z 0.5–10.7 mmol/L
Sodium z 83–172 mmol/L
Whole Blood EthanolCalibration Verification/Linearity LN14
Analyte Program Code
LN14 LN14 Target Range
Ethanol z 15–400 mg/dL
LN Express service is available.
Hemoglobin A1c AccuracyCalibration Verification/Linearity LN15
Analyte Program Code
LN15 LN15 Target Range
Hemoglobin A1c z 5%–12%
CAP-assigned target values derived from Hemoglobin A1c measurements assayed byNational Glycohemoglobin Standardization Program (NGSP) secondary reference laboratories.
LN Express service is available.
Program Information• Ten 2.5-mL ampules of
aqueous specimens
• Single instrument reportingonly
• Two shipments per year
Program Information• Six .0-mL li uid whole blood
specimens
• Two shipments per year
Program Information• Six 0.8-mL li uid human
whole blood specimens
• Two shipments per year
Calibration Verification/Linearity
112 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Inst
rum
enta
tion
Valid
atio
n To
ols
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher values than the ranges listed.
Homocysteine Calibration Verification/Linearity LN16
Analyte Program Code
LN16 LN16 Target Range
Homocysteine z 5–65 µmol/L
LN Express service is available.
Whole Blood Glucose Calibration Verification/Linearity LN17
Analyte Program Code
LN17 LN17 Target Range
Whole blood glucose z 50–400 mg/dL
LN Express service is available.
Reticulocyte Calibration Verification/Linearity LN18, LN19
Instrument/Method Program Code Program Code
LN18 LN18 Target Ranges
LN19 LN19 Target Ranges
Coulter Gen•S™, LH 500, LH 700 series, and UniCel DxH
z 0.3%–27.0%
All other instruments z 0.3%–24.0%
Pierceable caps z z
LN Express service is available.
Urine Albumin Calibration Verification/Linearity LN20
Analyte Program Code
LN20 LN20 Target Range
Urine albumin z 10–350 mg/L
Urine creatinine z 20–500 mg/dL
Program Information• Six 1.0-mL liquid serum
specimens
• Two shipments per year
Program Information• Five 2.0-mL liquid whole
blood specimens
• Report up to 10 different ancillary testing sites or instruments
• Two shipments per year
Program Information• LN18 - Five 2.5-mL liquid
whole blood specimens with pierceable caps
• LN19 - Five 1.0-mL liquid whole blood cell specimens with pierceable caps
• Two shipments per year
Program Information• Six 5.0-mL urine specimens
• Two shipments per year
Calibration Verification/Linearity
800-323-4040 | 847-832-7000 Option 1 | cap.org 113
Instrumentation Validation Tools
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher valuesthan the ranges listed.
High-Sensitivity C-Reactive ProteinCalibration Verification/Linearity LN21
Analyte Program Code
LN21 LN21 Target Range
High-sensitivity C-reactive protein z 0.5–6.0 mg/L
LN Express service is available.
Flow Cytometry Calibration Verification/LinearityLN22
Analyte Program Code
LN22 LN22 Target Ranges
CD3+ z 50%–70% positive
CD3+ T lymphocytes absolute z 350–4,000 cells/µL
CD3+/CD4+ z 1%–40% positive
CD3+/CD4+ T lymphocytes absolute z 6–2,000 cells/µL
CD3+/CD8+ z 25%–40% positive
CD3+/CD8+ T lymphocytes absolute z 250–1,600 cells/µL
Prostate-Specific AntigenCalibration Verification/Linearity LN23
Analyte Program Code
LN23 LN23 Target Range
Prostate-specific antigen z 0.1–90.0 ng/mL
Program Information• Six 1.0-mL li uid serum
specimens
• For high-sensitivity methodsonly
• Two shipments per year
Program Information• Seven 1.0-mL li uid whole
blood specimens
• Two shipments per year
Program Information• Twelve 1.0-mL li uid serum
specimens
• Two shipments per year
Calibration Verification/Linearity
114 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Inst
rum
enta
tion
Valid
atio
n To
ols
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher valuesthan the ranges listed.
Creatinine AccuracyCalibration Verification/Linearity LN24
Analyte Program Code
LN24 LN24 Target Range
Creatinine z 0.6–4.0 mg/dL
Estimated glomerularfiltration rate (eGFR)
z
LN Express service is available.
Additional InformationThe College of American Pathologists (CAP) and the National Kidney Disease EducationProgram (NKDEP) have an initiative to harmonize clinically reported creatinine values.This initiative is analogous to what the federal health agencies and the clinical laboratorycommunity did to improve the accuracy of cholesterol and glycohemoglobin testing.
Troponin Calibration Verification/LinearityLN25, LN27
Analyte Program Code Program Code
LN25 LN25 Target Ranges LN27 LN27 Target Ranges
Troponin I z 0.05–60.00 ng/mL
Troponin T z 0.1–27.00 ng/mL
B-Type Natriuretic PeptidesCalibration Verification/Linearity LN30
Analyte Program Code
LN30 LN30 Target Ranges
BNP z 30–3,500 pg/mL
NT-pro BNP z 50–30,000 pg/mL
LN Express service is available.
Program Information• Six 1.0-mL human serum
specimens
• Two shipments per year
Program Information• LN25 - Seven 2.0-mL li uid
serum specimens
• LN27 - Six 2.0-mL li uidserum specimens
• Two shipments per year
Program Information• Six 1.0-mL li uid plasma
specimens for BNP andNT-pro BNP
• A seventh 1.0-mL li uidplasma specimen for NT-proBNP only
• Conventional andInternational System of Units(SI) reporting offered
• Two shipments per year
Calibration Verification/Linearity
800-323-4040 | 847-832-7000 Option 1 | cap.org 115
Instrumentation Validation Tools
10
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher valuesthan the ranges listed.
Immunosuppressive DrugsCalibration Verification/Linearity LN31
Analyte Program Code
LN31 LN31 Target Ranges
Cyclosporine z 60–1,200 ng/mL
Tacrolimus z 1.5–30.0 ng/mL
Ammonia Calibration Verification/Linearity LN32Analyte Program Code
LN32 LN32 Target Range
Ammonia z 13–900 µmol/L
LN Express service is available.
Serum Myoglobin Calibration Verification/LinearityLN33
Analyte Program Code
LN33 LN33 Target Range
Myoglobin z 25–900 ng/mL
LN Express service is available.
Tumor Markers Calibration Verification/LinearityLN34
Analyte Program Code
LN34 LN34 Target Range
CA 125 z 1–1,000 U/mL
CA 15-3 z 2–190 U/mL
CA 19-9 z 10–900 U/mL
LN Express service is available.
Program Information• Seven 2.0-mL li uid whole
blood hemolysate specimens
• Two shipments per year
Program Information• Seven 2.0-mL li uid serum
specimens
• Two shipments per year
Program Information• Seven 1.0-mL li uid serum
specimens
• Two shipments per year
Program Information• Seven .0-mL li uid serum
specimens
• Two shipments per year
Calibration Verification/Linearity
116 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Inst
rum
enta
tion
Valid
atio
n To
ols
10
Coagulation Calibration Verification/Linearity LN35, LN36, LN37
Analyte Program Code
LN35 LN36 LN37 Target Ranges
Antithrombin activity z 10%–130%
Protein C activity z 10%–100%
Heparin, low molecular weight z 0.1–2.0 U/mL
Heparin, unfractionated z 0.1–1.3 U/mL
von Willebrand factor antigen z 5%–140%
The LN35, LN36, and LN37 CVL programs meet the CAP Accreditation requirements HEM.38009, 38010, and 38011.
LN Express service is available.
Viral Load Calibration Verification/Linearity LN38, LN39
Analyte Program Code
LN38 LN39 Target Ranges
CMV viral load z 0.3M–1.0M IU/L
HIV viral load z 0–10M copies/L
LN Express service is available.
Vitamin D Calibration Verification/Linearity LN40
Analyte Program Code
LN40 Target Ranges
25-OH vitamin D, total z 4–120 ng/mL
LN Express service is available.
Program Information• LN35,LN37-Six1.0-mL
frozen plasma specimens per mailing
• LN36-Twelve1.0-ml frozen plasma specimens per mailing,whichincludesix for low molecular weight heparinandsixforunfractionated heparin
•Twoshipmentsperyear; ships on dry ice
Program Information• LN38-Six1.5-mLfrozen
plasma specimens
•Twoshipmentsperyear;shipson dry ice
• LN39-Six2.5-mLfrozenplasma specimens
•Twoshipmentsperyear
Program Information•Six1.0-mLserumspecimens
•ConventionalandInternationalSystemofUnits(SI)reportingoffered
• Twoshipmentsperyear
Please note that the ranges listed are an estimate of the values recovered. Some instruments may recover lower or higher values than the ranges listed.
Calibration Verification/Linearity
800-323-4040 | 847-832-7000 Option 1 | cap.org 117
Instrumentation Validation Tools
10
Procalcitonin CalibrationVerification/Linearity LN41
Analyte Program Code
LN41 Target Ranges
Procalcitonin z 0.3-200 ng/mL
LN Express service is available.
D-Dimer CalibrationVerification/Linearity LN42
Analyte Program Code
LN42 Target Ranges
D-dimer z 200-4,500 ng/mL FEU
LN Express service is available.
Program Information• Six 1.0-mL frozen plasma
specimens
• Two shipments per year; shipson dry ice
Program Information• Six 1.0-mL plasma specimens
• Two shipments per year
I’m a cancer survivor.I always try to rememberthe person I am assistingis crucial to gettingaccurate patient results.It is that simple.
– Patrick
“
“
CAP Customer Contact Center representativesunderstand the importance of what you do.
Instrumentation Quality Management Programs
118 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Inst
rum
enta
tion
Valid
atio
n To
ols
10
Instrumentation Quality Management Programs
Instrumentation IChallenges Program Code
I
A Shipment B Shipment C Shipment
Adjustable micropipettecalibration verification/linearity
z z
Analytical balance check z z
Gravimetric pipette calibration z z
Microtiter plate linearity z z
Refractometer calibration z z
Spectrophotometer (stray light check) z z
Absorbance check – UV wavelength z
Fluorescent intensity check –fluorescent microscopes
z
Ocular micrometer calibration z
Osmometer study z
Peak absorbance measurement z
pH meter check z
Photometric calibration – visiblewavelength
z
WARNING: The Instrumentation (I) Survey specimens may contain corrosive or toxic substances,environmental hazards, or irritants.
Program Information• Designed to assess
instruments not routinelychallenged during theproficiency testing process
• Includes appropriatematerials to assess importantfunctional parameters,including accuracy andlinearity
• Three shipments per year
Instrumentation Quality Management Programs
800-323-4040 | 847-832-7000 Option 1 | cap.org 119
Instrumentation Validation Tools
10
Interfering Substance Survey IFSAnalyte Program Code
IFS
BilirubinInterferent
HemoglobinInterferent Lipid Interferent
Alanine aminotransferase (ALT/SGPT) z z z
Albumin z z z
Alkaline phosphatase z z z
Amylase z z z
Aspartate aminotransferase (AST/SGOT) z z z
Calcium z z z
Chloride z z z
CK2 (MB) mass z z z
Creatine kinase (CK) z z z
Creatinine z z z
Gamma glutamyl transferase (GGT) z z z
Glucose z z z
Iron z z z
Lactate dehydrogenase (LD) z z z
Lipase z z z
Magnesium z z z
Osmolality z z z
Phosphorus z z z
Potassium z z z
Protein, total z z z
Sodium z z z
Urea nitrogen (BUN) z z z
Uric acid z z z
The material expires December 1, 2015.
Program Information• Eighteen 10.0-mL li uid
serum specimens
• Designed for verifiyingmanufacturing interferencespecifications andinvestigating discrepantresults caused by interferingsubstances
• Submit results any time prior tothe material's expiration date
• One shipment per year
Instrumentation Quality Management Programs
120 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Inst
rum
enta
tion
Valid
atio
n To
ols
10
Serum Carryover SCOAnalyte Program Code
SCO
Creatinine z
hCG z
Lactate dehydrogenase (LD) z
Phenytoin z
The material expires May 1, 2016.
Urine Toxicology Carryover UTCOAnalyte Program Code
UTCO
Benzoylecgonine z
Delta-9-THC-COOH z
Opiates z
Propoxyphene z
The material expires May 1, 2016.
Program Information• One 10.0-mL li uid serum
specimen (low level) and one5.0-mL liquid serum specimen(high level)
• Designed to screen forinstrument sample probecarryover
• One shipment per year
Program Information• Two 0.0-mL urine specimens
(low and high levels)
• Designed to screen forinstrument sample probecarryover
• One shipment per year
Instrumentation Quality Management Programs
800-323-4040 | 847-832-7000 Option 1 | cap.org 121
Instrumentation Validation Tools
10
Improve the reliability of your patient results with CAP CVL Validated MaterialsUse the same material that is sent in the CVL program to:
• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document corrective actions• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures
Each laboratory receives a Participant Summary, which includes readily available results.
Calibration Verification/Linearity, Validated MaterialsValidated Material Program Code Corresponding Survey Page
Chemistry, Lipid,Enzyme CalibrationVerification/Linearity VM
LN2VM LN2 106
Chemistry, Lipid,Enzyme CalibrationVerification/Linearity;All Beckman (except AU)and Vitros VM
LN2VM1 LN2BV 106
TDM CalibrationVerification/Linearity VM
LDM LN3 107
Ligand Assay CalibrationVerification/Linearity VM
LLM LN5 108
Urine Chemistry CalibrationVerification/Linearity VM
LUM LN6 108
Program Information• LN2VM, LN2VM1 - Seven
5.0-mL liquid serumspecimens for basic chemistry,six 3.0-mL liquid serumspecimens for direct and totalbilirubin, seven 2.0-mL liquidserum specimens for lipids,and seven 5.0-mL liquidserum specimens for enzymes
• LDM - Six .0-mL li uidserum specimens
• LLM - Eight .0-mL li uidserum specimens; appropriatefor most major instrumentsexcept for Siemens ADVIACentaur
• L M - Eighteen .0-mL li uidurine specimens
• Two shipments per year
Also available as ebooks! Visit ebooks.cap.org
Put fast identificationof cells, fungi, andparasites at yourfingertipsThese laminated guides are aquick, easy reference foraccurate, confidentidentification.
• Portable (5" x 6.5" or 6.5" x 7")
• Durable—heavy-duty towithstand years ofbenchtop use
Visit cap.org and choose the Shop tabto view sample pages and order.*
*CAP distributor customers—contactyour distributor to order
Hematology
andC
linicalMicroscopy
11
Hematology and Clinical MicroscopyHematology ..................................................................................................................................124Clinical Microscopy .......................................................................................................................133
New Programs New
Automated Hematology Differential for Mindray BC-5000 (FH11) .......................................................125Automated Hematology Differential for Mindray BC-6000 (FH12) .......................................................125Quality Cross Check, Automated Hematology Series (FH3Q, FH4Q, FH6Q, FH9Q) .............................126Hematopathology Online Education (HPATH/HPATH1) ......................................................................132Hemocytometer Fluid Count, international only (HFCI) ........................................................................136
Program ChangesSecond instrument reporting no longer offered
Automated Hematology Series (FH1/FH1P to FH10/FH10P and HE/HEP)See programs FH3Q, FH4Q, FH6Q, FH9Q ..................................................................................126
11 | Hematology and Clinical Microscopy
“I appreciate that there are so many CAP proficiencytests and we like the quality of the specimens andthe breadth of the specimens that are available. TheCAP has such big peer groups that I feel good aboutseeing what others are doing for the many analytesand many instruments.”
Hematology
124 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hem
atol
ogy
and
Clin
ical
Mic
rosc
opy
11
HematologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Basic Hematology HE, HEPAnalyte/Procedure Program Code Challenges/Shipment
HE HEP
Blood cell identification z 10
Hematocrit z z 5
Hemoglobin z z 5
MCV, MCH, and MCHC z z 5
Platelet count z z 5
RDW z z 5
Red blood cell count z z 5
White blood cell count z z 5
Blood Cell Identification BCPProcedure Program Code Challenges/Shipment
BCP
Blood cell identification z 10
Erythrocyte Sedimentation RateESR, ESR1, ESR2, ESR3
Procedure Program Code Challenges/Shipment
ESR ESR1 ESR2 ESR3
All methods except the Sedimat 15®,Sedimat 15 Plus, Alifax®,and ALCOR
z 3
Sedimat 15, Sedimat 15 Plus z 3
Alifax z 3
ALCOR iSED z 3
Program Information• Five .0-mL whole blood
specimens
• HEP - Ten images, eachavailable as photographs,images on a CD-ROM, andonline images
• Three shipments per year
Program Information• Ten images, each available
as photographs, images onCD-ROM, and online images
• Three shipments per year
Program Information• ESR, ESR1 - Three 6.0-mL
whole blood specimens
• ESR2 - Three .0-mL simulatedwhole blood specimens
• ESR - Three .5-mL wholeblood specimens
• Two shipments per year
Hematology
800-323-4040 | 847-832-7000 Option 1 | cap.org 125
Hematology
andC
linicalMicroscopy
11
Hematology Automated Differential SeriesFH1-FH12, FH1P-FH12P
Analyte/Procedure Program Code Challenges/Shipment
FH1-FH12 FH1P-FH12P
Blood cell identification z 10
Hematocrit z z 5
Hemoglobin z z 5
Immature granulocyte parameter z z 5 (FH9 only)
Large unstained cell (L C) z z 5 (FH only)
MCV, MCH, and MCHC z z 5
Nucleated red blood cell count (nRBC) z z 5 (FH and FH9)
Platelet count z z 5
RDW z z 5
Red blood cell count z z 5
White blood cell count z z 5
WBC differential z z 5
For second instrument reporting options, see the Quality Cross Check programs, FH3Q, FH4Q,FH6Q, and FH9Q on page 126.
Program Information• Five whole blood specimens
with pierceable caps
• FHP series - Ten images, eachavailable as photographs,images on a CD-ROM, andonline images
• For method compatibility,see instrument matrix onpage 127
• Three shipments per year
Hematology Benchtop Reference Guide (HBRG)• More than 50 different cell identifications, including
common and rare cells• Detailed descriptions for each cell morphology• Six tabbed sections for easy reference
o Erythrocyteso Erythrocyte Inclusionso Granulocytic (Myeloid) and Monocytic Cellso Lymphocytic Cellso Platelets and Megakaryocytic Cellso Microorganisms and Artifacts
• A durable and water-resistant format—5" x 6½" andspiral bound to withstand years of benchtop use
Add code HBRG to your Surveys order form.
Also available as an ebook! Visit ebooks.cap.org
Hematology
126 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hem
atol
ogy
and
Clin
ical
Mic
rosc
opy
11
Quality Cross Check—Hematology Automated Differential Series
FH3Q, FH4Q, FH6Q, FH9QAnalyte/Procedure Program Code Challenges/
Shipment
FH3Q FH4Q FH6Q FH9Q
Hematocrit z z z z 3
Hemoglobin z z z z 3
Immature granulocyte parameter z z z z (FH9 only)
Large unstained cells (L C) z z z z (FH9 only)
MCV, MCH, MCHC z z z z 3
Nucleated red blood cell count(nRBC)
z z z z(FH and
FH9 only)
Platelet count z z z z 3
RDW z z z z 3
Red blood cell count z z z z 3
hite blood cell count z z z z 3
BC differential z z z z 3
These programs do not meet regulatory requirements for proficiency testing. See the FH serieson page 125.
Additional informationAs a trusted partner, you can rely on the CAP to provide the insight, nowledge, andpeer-based educational coaching to protect your laboratory from regulatory sanctions.
• The CAP uality Cross Chec program complements CAP PT by offering moreopportunities to monitor and proactively identify instrument problems before theyimpact patient test results.
• This new offering will help you improve uality processes, reduce stress, raisecompetency of staff, and verify the performance of your instrument results.
NewProgram Information• Three whole blood specimens
with pierceable caps
• Report up to three instruments
• For method compatibility,see instrument matrix onpage 127
• Two shipments per year
Hematology
800-323-4040 | 847-832-7000 Option 1 | cap.org 127
Hematology and C
linical Microscopy
11
Hematology Automated Differential Series, Instrument MatrixInstrument FH and FHQ Series
FH1 FH2 FH3/ FH3Q
FH4/ FH4Q
FH6/ FH6Q
FH9/ FH9Q FH10 FH11 FH12
Horiba ABX 9000+, 9018+, 9020+ z
Sysmex K-series, KCP-1, KX-21/21N, poc H-100i, XP-series z
Abbott Cell-Dyn® 1200, 1600, 1700, 1800, Emerald™ z
Horiba ABX Micros z
Siemens ADVIA® 60 z
Coulter® AcT™, MD, ONYX™, S880, S-plus V, ST, STKR, T-series
z
Drew Scientific DC-18, I-1800, Excell 10/16/18 DREW3 z
CDS/Medonic M-Series z
Mindray BC - 2800, 3000/3200 series z
Abbott Cell-Dyn 3000, 3200, 3500, 3700, 4000, Sapphire™, Ruby™
z
Drew Scientific Excell 22, 2280 z
Siemens ADVIA 120, 120 w/SP1, 2120 z
Coulter Gen-S™, HmX, LH500, LH750, LH755, LH780, LH785, MAXM™, MAXM A/L, STKS, VCS™, Unicel DxH
z
Sysmex XE-2100, XE-2100D, XE-2100L, XE-2100C, XE-2100DC, XE-5000, XN-Series, XT-1800i, XT-2000i, XS-800i, XS-1000i, XS-1000iC, XS-1000iAL, XT-4000i
z
Horiba ABX Pentra 60, 80, 120 z
Coulter AcT 5 diff (AL, CP, OV) z
Mindray BC-5000 series z
Mindray BC-6000 series z
Blood Parasite BPProcedure Program Code Challenges/Shipment
BP
Thin/thick blood film sets* z 5
*This Survey will include corresponding thick films when available.
Program Information•FiveGiemsa-stainedblood
film sets, photographs, and/or online images
•Avarietyofbloodparasites,including Plasmodium, Babesia, Trypanosoma, and filarial worms
•Threeshipmentsperyear
Hematology
128 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hem
atol
ogy
and
Clin
ical
Mic
rosc
opy
11
Bone Marrow Cell Differential BMDProcedure Program Code Challenges/Shipment
BMD
Bone marrow differential, includingmyeloid erythroid ratio
z 1
Bone marrow cell identification z 5
Bone marrow interpretive uestions z 1-
Additional Information• Examine a whole slide image that includes a 500 bone marrow differential count and
annotated cells for identification.• DigitalScope technology simulates the use of a microscope by enabling the user to
scan and adjust magnification of the whole slide image.• Evaluate cell morphology and identify specific cells in bone marrow.• See system re uirements on page 15.
Fetal Red Cell Detection HBFProcedure Program Code Challenges/Shipment
HBF
leihauer-Bet e, flow cytometry z 2
Rosette fetal screen z 2
Hemoglobinopathy HGProcedure Program Code Challenges/Shipment
HG
Hemoglobin identification anduantification
z
Dry lab educational challenges z 2
Hemoglobin A2 uantitation z
Hemoglobin F uantitation z 1
Sic ling test z
Program Information• One online bone marrow
aspirate whole slide imagethat includes five annotatedcells for identification
• Powered by DigitalScopetechnology
• Two online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Program Information• Two 1.2-mL li uid whole
blood specimens
• Not designed for F celluantitation
• Two shipments per year
Program Information• Four 0.5-mL stabilized red
blood cell specimens
• Two dry lab educationalchallenges (case histories,electrophoresis patterns, andclinical interpretationuestions)
• Two shipments per year
Hematology
800-323-4040 | 847-832-7000 Option 1 | cap.org 129
Hematology and C
linical Microscopy
11
Reticulocyte RT, RT2, RT3, RT4Instrument/Method Program Code Challenges/Shipment
RT RT2 RT3 RT4
Abbott Cell-Dyn 3200, 3500, 3700, Ruby z 3
Coulter STKS, MAXM, GenS, HmX, LH500, LH700 series, Unicel DxH z 3
Sysmex XE-2100, XE-2100C, XE-5000, XN Series, XT-2000i, XT-4000i z 3
Abbott Cell-Dyn Sapphire, Siemens ADVIA 120/2120 and all other automated and manual methods
z 3
Pierceable caps z z 3
Sickle Cell Screening SCSProcedure Program Code Challenges/Shipment
SCS
Sickling test z 3
Transfusion-Related Cell Count TRCProcedure Program Code Challenges/Shipment
TRC
Platelet count (platelet-rich plasma) z 5
WBC count z 4
Dry challenge z 2
WBC counts must be performed using a Nageotte chamber, fluorescence microscopy or by flow cytometry.
Waived Combination HCCAnalyte Program Code Challenges/Shipment
HCC
Glucose z 2
Hemoglobin z 2
Program Information•RT,RT2-Three1.0-mL
stabilized red blood cell specimens
•RT3,RT4-Three2.0-mLstabilized red blood cell specimens
• Includespercentageandabsolute result reporting
•Twoshipmentsperyear
Program Information•Three1.0-mLstabilized
human erythrocyte specimens
•Twoshipmentsperyear
Program Information•Five1.2-mLsuspensionsof
platelet-rich plasma
•Two1.0-mLvialsleukocyte- reduced platelet material
•Two1.0-mLvialsleukocyte- reduced red blood cells
•Threeshipmentsperyear
Program Information•Two1.0-mLwholeblood
specimens
•ForusewiththeHemoCue® B, HemoCue 201, HemoCue 301, and Stanbio HemoPoint® H2 instruments
•Twoshipmentsperyear
Hematology
130 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hem
atol
ogy
and
Clin
ical
Mic
rosc
opy
11
Rapid Total White Blood Cell Count RWBCProcedure Program Code Challenges/Shipment
RWBC
Rapid total white blood cell count z 5
Virtual Peripheral Blood Smear VPBSProcedure Program Code Challenges/Shipment
VPBS
WBC differential z 3
Platelet estimate z 3
RBC morphology z 3
Blood cell identification z 15
Additional Information • Examine whole slide images that include a 100 WBC differential count and annotated
cells for identification. • DigitalScope technology simulates the use of a microscope by enabling the user to
scan and adjust magnification of the whole slide image. • Evaluate and identify red blood cell (RBC) morphology and identify specific white
blood cells (WBC) in peripheral blood. • See system requirements on page 15.
Program Information• Five 2.0-mL whole blood
specimens
• For use with the HemoCue WBC instrument
• Three shipments per year
Program Information• Three online whole slide
images that include 15 annotated cells for identification
• Powered by DigitalScope technology
• Two online activities per year; your CAP shipping contact will be notified via email when the activity is available
Look for your online Surveys programs via emailWhen you order the CAP’s online Surveys programs for 2015, we will notify your CAP shipping contact when they are available for assignment and distribution within your laboratory.
This earth-friendly, paperless approach supports green initiatives, saving paper and energy resources.
Hematology
800-323-4040 | 847-832-7000 Option 1 | cap.org 131
Hematology
andC
linicalMicroscopy
11
Expanded VirtualPeripheral Blood Smear EHE1
Procedure Program Code Challenges/Shipment
EHE1
BC differential z 2
Platelet estimate z 2
RBC morphology z 2
BC morphology z 2
Blood cell identification z 10
Interpretive uestions z 1-2
Additional Information• More challenging and/or complex testing• Examine of whole slide images that include a 100 BC/differential count and
annotated cells for identification• DigitalScope technology simulates the use of a microscope by enabling the user to
scan and adjust magnification of the whole slide image• Comprehensive case studies• Ability to recognize and integrate problem-solving s ills through the use of
interpretive uestions• Evaluate and identifiy red blood cell (RBC) morphology and identify specific white
blood cells ( BC) in peripheral blood• See system re uirements on page 15.
Program Information• Two online whole slide images
that include 10 annotatedcells for identification
• Powered by DigitalScopetechnology
• Two online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Body Fluids Benchtop Reference Guide (BFBRG)• Thirty-six color images, including common and rare cells,
crystals, and other cell inclusions• Detailed descriptions of each cell including facts,
cell morphology and inclusions• Nine tabbed sections for easy reference
o Erythroid Serieso Lymphoid Serieso Myeloid Serieso Mononuclear Phagocytic Serieso Lining Cellso Miscellaneous Cellso Crystalso Microorganismso Miscellaneous Findings
• A durable and water-resistant format—5" x 6½" andspiral bound to withstand years of benchtop use
Add code BFBRG to your Surveys order form.
Also available as an ebook! Visit ebooks.cap.org
Hematology
132 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hem
atol
ogy
and
Clin
ical
Mic
rosc
opy
11
Hematopathology Online EducationHPATH/HPATH1
Program Program Code Challenges/Shipment
HPATH/HPATH1
Hematopathology online case review z 5
Additional InformationHPATH educates pathologists and hematologists to assess and improve their diagnostics ills in hematopathology.
• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.
• Cases are peripheral blood and bone marrow whole slide images.• Cases may include results of ancillary studies such as histochemistry, immunology,
immunohistochemistry, and molecular tests, where appropriate.• See system re uirements on page 15.
NewProgram Information• HPATH - Five diagnostic
challenges/whole slideimages with clinicalhistory; for each additionalpathologist/hematologist,purchase HPATH1
• HPATH1 - Reporting optionwith CME/SAM/CE credit foreach additional pathologistand hematologist (withinthe same institution); mustorder in conjunction withSurvey HPATH
• Earn a maximum of 6CME/SAM credits (AMAPRA Category 1 Credits™)per pathologist and amaximum of 6 CE credits perhematologist for completionof an entire year
• This activity meets theABP MOC Part IV PracticePerformance Assessmentre uirements
• Powered by DigitalScopetechnology
• One online activity per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Clinical Microscopy
800-323-4040 | 847-832-7000 Option 1 | cap.org 133
Hematology
andC
linicalMicroscopy
11
Clinical MicroscopyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Clinical Microscopy CMP, CMP1Analyte/Procedure Program
CodeProgram
CodeChallenges/
Shipment
CMP CMP1
Bilirubin z z 3
Blood or hemoglobin z z 3
Glucose z z 3
hCG urine ( ualitative) z z 3
etones z z 3
Leu ocyte esterase z z 3
Nitrite z z 3
Osmolality z z 3
pH z z 3
Protein ( ualitative) z z 3
Reducing substances z z 3
Specific gravity z z 3
robilinogen z z 3
rine sediment photographs z z
Body fluid photographs z z 6
Clinical Microscopy Miscellaneous CMMPProcedure Program Code Challenges/Shipment
CMMP
Fern test (vaginal) z 1
OH preparation (s in or vaginal) z 1
Nasal smear z 1
Pinworm preparation z 1
Stool for leu ocytes z 1
Vaginal wet preparation(for spermatozoa, trichomonas,clue cells, and epithelial cells)
z 1
Program Information• CMP - Three 10.0-mL li uid
urine specimens; for use withall instruments except iCHEM
• CMP1 - Three 12.0-mL li uidurine specimens; for use withiCHEM instruments
• CMP, CMP1 - Ten images,each available asphotographs, images onCD-ROM, and online images
• Two shipments per year
Program Information• Six images, each available as
photographs, images onCD-ROM, and online imagesfor evaluating provider-performed microscopy
• Two shipments per year
Clinical Microscopy
134 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hem
atol
ogy
and
Clin
ical
Mic
rosc
opy
11
Virtual Body Fluid VBFProcedure Program Code Challenges/Shipment
VBF
Total nucleated cells differential z 2
Body fluid cell identification z 10
Additional Information• Examine whole slide images that include a differential count and annotated
cells for identification.• DigitalScope technology simulates the use of a microscope by enabling the user to
scan and adjust magnification of the whole slide image.• Evaluate cell morphology and identify specific cells in a body fluid.• See system re uirements on page 15.
Amniotic Fluid Leakage AFLProcedure Program Code Challenges/Shipment
AFL
pH interpretation z 3
Automated Body Fluid ABF1, ABF2, ABF3Procedure Program Code Challenges/Shipment
ABF1 ABF2 ABF3
Red blood cell count z z z 2
hite blood cell count z z z 2
For method compatibility, see instrument matrix below.
Automated Body Fluid, Instrument MatrixInstrument ABF Series
ABF1 ABF2 ABF3
Siemens ADVIA120/2120/2120i
z
Coulter LH 700 Series,nicel DxH
z
Sysmex E-2100, N-series,T-1800i, T-2000i, E-5000,T- 000i
z
IRIS i ® 200 z
Program Information• Two online whole slide body
fluid images that inlcude10 annotated cells foridentification
• Powered by DigitalScopetechnology
• Two online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Program Information• Three 2.0-mL li uid
specimens
• For use with nitrazine paperand the Amniotest™
• Two shipments per year
Program Information• Two .0-mL simulated body
fluid specimens
• Two shipments per year
Clinical Microscopy
800-323-4040 | 847-832-7000 Option 1 | cap.org 135
Hematology
andC
linicalMicroscopy
11
Automated Urinalysis UAA, UAA1Analyte Program Code Challenges/Shipment
UAA UAA1
Casts, semi uantitative z z 2
Crystals, semi uantitative z 2
Epithelial cells, semi uantitative z 2
Red blood cells, uantitative z z 2
hite blood cells, uantitative z z 2
Crystals BFC, URC, BCRProcedure Program Code Challenges/Shipment
BFC URC BCR
Body fluid crystal identification z 2
rine crystal identification z 2
Bile crystal identification z 2
Dipstick Confirmatory DSCAnalyte/Procedure Program Code Challenges/Shipment
DSC
Bilirubin z 2
Sulfosalicylic acid (SSA) z 2
Fecal Fat FCFSAnalyte Program Code Challenges/Shipment
FCFS
Fecal fat, ualitative z 2
Program Information• AA Two 10.0-mL li uid
urine specimens for use withIRIS instruments
• AA1 - Two 12.0-mL li uidurine specimens for use withSysmex instruments
• Two shipments per year
Program Information• BFC - Two 1.5-mL simulated
body fluid specimens (eg,synovial fluid)
• RC - Two 1.5-mL urinespecimens
• BCR - Two 1.5-mL bile fluidspecimens
• Two shipments per year
Program Information• Two 12.0-mL li uid urine
specimens
• For use with methods toconfirm positive bilirubin andprotein dipstic results
• Two shipments per year
Program Information• Two 10.0-g simulated fecal
fat specimens
• For microscopic detectionof neutral fats (triglycerides)and/or split fats (total freefatty acids)
• Two shipments per year
Clinical Microscopy
136 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hem
atol
ogy
and
Clin
ical
Mic
rosc
opy
11
Fetal Hemoglobin APTAnalyte Program Code Challenges/Shipment
APT
Fetal hemoglobin z 2
Gastric Occult Blood GOCBAnalyte Program Code Challenges/Shipment
GOCB
Gastric occult blood z 3
Gastric pH z 3
Glucose-6-Phosphate Dehydrogenase G6PDSAnalyte Program Code Challenges/Shipment
G6PDS
G6PD ( ualitative and uantitative) z 2
Hemocytometer Fluid Count HFCProcedure Program Code Challenges/Shipment
HFC
Cytopreparation differential z 3
Red blood cell fluid count z 3
hite blood cell fluid count z 3
Hemocytometer Fluid Count HFCIProcedure Program Code Challenges/Shipment
HFCi
Red blood cell fluid count z 3
hite blood cell fluid count z 3
Differential z 3
This program meets the CAP’s Accreditation Program requirements.
Program Information• Two 1.2-mL simulated gastric
fluid specimens
• Two shipments per year
Program Information• Three 2.0-mL simulated
gastric specimens
• Two shipments per year
Program Information• Two 0.5-mL lyophilized
hemolysate samples
• Two shipments per year
Program Information• Three 1.0-mL simulated body
fluid specimens
• Two shipments per year
Program Information• Three 2.0-mL simulated body
fluid specimens
• Designed for internationallaboratories that haveexperienced significantshipping and receivingissues and need longerprogram stability
• Two shipments per year
New
Clinical Microscopy
800-323-4040 | 847-832-7000 Option 1 | cap.org 137
Hematology
andC
linicalMicroscopy
11
Lamellar Body Count LBCProcedure Program Code Challenges/Shipment
LBC
Lamellar body count z 3
Occult Blood OCBAnalyte Program Code Challenges/Shipment
OCB
Occult blood z 3
Rupture of Fetal Membranes Testing ROM1Procedure Program Code Challenges/Shipment
ROM1
Rupture of fetal membranes z 3
Special Clinical Microscopy SCM1, SCM2Analyte/Procedure Program Code Challenges/Shipment
SCM1 SCM2
rine hemosiderin, Prussian blue z 3
rine eosinophils, right stain z 3
Ticks, Mites, and Other Arthropods TMOProcedure Program Code Challenges/Shipment
TMO
Tic , mite, and arthropod identification z 3
Program Information• Three 2.0-mL simulated li uid
amniotic fluid specimens
• For use with LBC methodsperformed on all hematologyanalyzers
• Two shipments per year
Program Information• Three 2.0-mL simulated fecal
specimens
• Two shipments per year
Program Information• Three 0.5-mL, simulated
vaginal specimens formethods such as Amnisureand Clinical Innovations
• Two shipments per year
Program Information• Three images, each available
as photographs and onlineimages
• Two shipments per year
Program Information• Three images, each available
as photographs and onlineimages
• Two shipments per year
Clinical Microscopy
138 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hem
atol
ogy
and
Clin
ical
Mic
rosc
opy
11
Urine Albumin (Microalbumin)/Creatinine UMCAnalyte/Procedure Program Code Challenges/Shipment
UMC
Creatinine z 2
rine albumin (microalbumin)creatinine ratio
z 2
rine albumin (microalbumin),semi uantitative
z 2
For quantitative reporting, refer to Survey U, page 61.
Worm Identification WIDProcedure Program Code Challenges/Shipment
WID
orm identification z 3
Program Information• Two 5.0-mL li uid urine
specimens
• For use with dipstic andsemi uantitative methods only
• Two shipments per year
Program Information• Three images, each available
as photographs and onlineimages
• Two shipments per year
Put fast identification of cells at your fingertipsUrinalysis Benchtop Reference Guide (UABRG)• Thirty-four different cell identifications, including
common and rare cells• Detailed descriptions for each cell morphology• Eight tabbed sections for easy reference
o Urinary Cellso Urinary Castso Urinary Crystals
At Acid pAt eutral or Acid pAt eutral or Alkaline p
o Organismso Miscellaneous/Exogenous
• A durable and water-resistant format—5" by 6½" andspiral bound to withstand years of benchtop use.
Add code UABRG to your Surveys order form.
Also available as an ebook! Visit ebooks.cap.org
ReproductiveM
edicine
12
Reproductive MedicineAndrology and Embryology ............................................................................................................140
12 | Reproductive Medicine
“The CAP covers everything and their Surveys arethorough. They are at the cutting edge and givegood comparative data which we use for ourperformance improvement. I will continue to useCAP PT for our entire test menu—I feel that it is justanother good measure to ensure that we’re turningout quality results for our patients.”
Andrology and Embryology
140 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Repr
oduc
tive
Med
icin
e
12
Andrology and EmbryologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Semen Analysis SC, SC1, PV, SM, SV, ASAProcedure Program Code Challenges/
Shipment
SC SC1 PV SM SV ASA
Sperm count & presence/absence(manual methods and CASA systems)
z 2
Sperm count & presence/absence(automated methods)
z 2
Postvasectomy sperm count &presence/absence
z 2
Sperm morphology z 2
Sperm viability z 2
Antisperm antibody IgG z 2
Sperm Motility, Morphology, and ViabilitySMCD, SM1CD, SM2CD
Procedure Program Code Challenges/Shipment
SMCD SM1CD SM2CD
Sperm count z 2
Sperm motility/forwardprogression
z 2
Sperm morphology z 2
Sperm viability z 2
Additional Information• DigitalScope technology simulates the use of a microscope by enabling the user to
scan and adjust the magnification of the whole slide image.
Program Information• SC - Two 0. -mL stabilized
human sperm specimens
• SC1- Two 1.0-mL stabilizedhuman sperm specimens
• PV - Two 0. -mL stabilizedhuman sperm specimenswith counts appropriate forpostvasectomy testing
• SM - Two prepared slidesfor staining
• SV - Two eosin-nigrosin-stained slides
• ASA - Two 0. -mL serumspecimens
• Two shipments per year
Program Information• SMCD - One CD-ROM with
video clips
• SM1CD - Two challenges,each available as imageson CD-ROM and onlinewhole slide images poweredby DigitalScope® technology
• SM2CD - Two challenges,each available as imageson CD-ROM and onlinewhole slide images poweredby DigitalScope technology
• Two shipments per year
Andrology and Embryology
800-323-4040 | 847-832-7000 Option 1 | cap.org 141
ReproductiveM
edicine
12
Embryology EMBProcedure Program Code Challenges/Shipment
EMB
Embryo transfer and quality assessment(three- and five-day-old embryos)
z 4
Ligand Assay, Special Y, YY, DYAnalyte Program Code Challenges/Shipment
Y, YY DY
11-deoxycortisol z
17-hydroxyprogesterone z
Androstenedione z
DHEA sulfate z
Estradiol z
Estriol, unconjugated (uE ) z
Follicle-stimulating hormone (FSH) z
Growth hormone (GH) z
IGF-1 (somatomedin C) z
Luteinizing hormone (LH) z
Progesterone z
Prolactin z
Testosterone z
Testosterone, bioavailable z
Testosterone, free z
Sex hormone-binding globulin (SHBG) z
Antimüllerian Hormone AMHAnalyte Program Code Challenges/Shipment
AMH
Antim llerian hormone (AMH) z
Program Information• One CD-ROM with video
clips
• Two shipments per year
Program Information• Y - Six 5.0-mL li uid serum
specimens (two duplicate sets)
• YY - Nine 5.0-mL li uidserum specimens (threeduplicate sets)
• DY - Must order in conjunctionwith Survey Y or YY
• Conventional andInternational System ofUnits (SI) reporting offered
• Two shipments per year
Program Information• Three 1.0-mL lyophilized
serum specimens
• Two shipments per year
Deliver the best in patient care when youintegrate the CAP’s proficiency testing,accreditation, and education programs• Provide comprehensive, scientifically endorsed laboratory
standards, proficiency testing/EQA, and educational programs• Offer a comprehensive view of the laboratory for ongoing
monitoring of quality performance• Educate laboratory staff with a complete offering of programs
supported by peer groups and scientific leaders that provide aunique balance of regulatory and educational coaching
• Take the guesswork out of laboratory compliance• Gain global quality recognition• Reduce the risk of inaccurate and unreliable test results
CAP accreditation programs customized to meet your patient careneeds include:• Laboratory Accreditation• Reproductive Laboratory Accreditation• Forensic Drug Testing Accreditation• Biorepository Accreditation• CAP 15189™ Accreditation
To learn more, visit cap.org and choose the LaboratoryImprovement Programs tab.
“Participating in CAPLaboratory mprovementPrograms, which aredeveloped by leadingexperts, provides confidencethat your laboratory is doingthe right thing. The CAPaccreditation checklistsystem is an incredibleresource for keeping up withdaily management, newCL A and CAP requirementsand ensuring that you’reperforming high qualitytesting. No other proficiencytesting provider developsprograms for the newesttechnologies as rapidly andeffectively as the CAP.”
Elizabeth Wagar, MD, FCAPProfessor & Chair,Department ofLaboratory edicineThe niversity of Te as DAnderson Cancer Center
Accreditation ProficiencyTesting/EQA
CAP Education
Coagulation
13
13 | Coagulation
“As an executive director, it’s important to me tokeep proficiency testing with the CAP to standardizePT throughout all my laboratories—that way I cansee and understand when there are problems inparticular laboratories.”
Coagulation
144 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Coa
gula
tion
13
CoagulationAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Analyte Listing 50:50 mixing study, PT and APTT
Activated partial thromboplastin time
Activated protein C resistance
Alpha-2-antiplasmin
Anti-beta-2-glycoprotein (IgG and IgM)
Antiphospholipid antibody (IgG, IgM, and IgA)
Antithrombin activity/antigen
Dilute prothrombin time
Dilute Russell’s viper venom time
Euglobulin test
Factors II, V, VII, VIII, IX, X, XI, XII, and XIII
Factor VIII assay
Fibrin monomer
Fibrinogen activity
Fibrinogen antigen
Heparin-induced thrombocytopenia (HIT)
High molecular weight kininogen
Kaolin-activated APTT
Kaolin clotting time
Lupus anticoagulant
Plasminogen activator inhibitor
Plasminogen activity/antigen
Prekallikrein
Protein C
Protein S
Prothrombin fragment 1.2
Prothrombin time
Reptilase time
Thrombin-antithrombin
Thrombin time
Tissue plasminogen activator
von Willebrand factor activity: - Collagen binding - Glycoprotein Ib binding - Ristocetin cofactor
von Willebrand factor antigen
von Willebrand multimer analysis
Coagulation, Limited CGL, CGDFAnalyte Program Code Challenges/Shipment
CGL CGDF
Activated partial thromboplastin time z 5
Fibrinogen z 5
International normalized ratio (INR)* z 5
Prothrombin time z 5
D-dimer z z 2 per year
Fibrin(ogen) degradation products, plasma
z z 2 per year
Fibrin(ogen) degradation products, serum z z 2 per year
*Participants reporting INR results will receive a special evaluation to assess the INR calculation.
Coagulation, Extended CGE, CGEXAnalyte Program Code Challenges/Shipment
CGE, CGEX
See analyte listing below z 2
Program Information• CGL - Five 1.0-mL lyophilized
plasma specimens; three shipments per year; one 1.0-mL lyophilized plasma specimen; one 1.0-mL serum specimen; two shipments per year
•CGDF-One1.0-mLserumspecimen; one 1.0-mL lyophilized plasma specimen; two shipments per year
Program Information•CGE-Six1.0-mL
lyophilized plasma specimens (three duplicate vials for each challenge)
•CGEX-Ten1.0-mLlyophilized plasma specimens (five duplicate vials for each challenge)
•Twoshipmentsperyear
Coagulation
800-323-4040 | 847-832-7000 Option 1 | cap.org 145
Coagulation
13
Coagulation Special Testing Series CGS1, CGS2, CGS3, CGS4, CGS5, CGS6
Module/Analyte Challenges/Shipment
Program Code
CGS1 CGS2 CGS3 CGS4 CGS5 CGS6
Activated partial thromboplastin time*
2 2 3
International normalized ratio (INR)
2 3
Prothrombin time* 2 3
Lupus Anticoagulant and Mixing Studies Module
Dilute Russell’s viper venom time 2
Lupus anticoagulant (confirmation and screen)
2
50:50 mixing studies, PT and APTT 2
Thrombophilia Module
Activated protein C resistance
2
Antithrombin (activity, antigen)
2
Protein C (activity, antigen) 2
Protein S (activity, free antigen, total antigen)
2
von Willebrand Factor Antigen Module
Factor VIII assay 2
von Willebrand factor (antigen, activity, multimers)
2
Heparin Module
Heparin activities using methodologies including Anti Xa (unfractionated low molecular weight, and hybrid curve)
3
Thrombin time 3
Heparin-Induced Thrombocytopenia Module
Appropriate with methods such as Gen-Probe Lifecodes PF4 IgG and Gen-Probe Lifecodes PF4 Enhanced® assays
2
Appropriate with the Akers Biosciences, Inc. PIFA® Heparin/Platelet Factor 4 Rapid Assay
3
*Not appropriate for meeting regulatory requirements, see page 144.
Program Information•CGS1,CGS2,CGS3-Atotal
of two 2.0-mL lyophilized plasma specimens
•CGS4-Three1.0-mL lyophilized plasma specimens
•CGS5-Two60.0-µLserum specimens
•CGS6-Three50.0-µLlyophilized serum specimens
•Twoshipmentsperyear
Coagulation
146 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Coa
gula
tion
13
Dabigatran, Fondaparinux,Rivaroxaban Anticoagulant Monitoring
DBGN, FNPX, RVBNAnalyte Program Code Challenges/Shipment
DBGN FNPX RVBN
Activated partial thromboplastin time* z z z 3
Prothrombin time* z z z 3
Thrombin time z 3
Dabigatran z 3
Fondaparinux z 3
Rivaroxaban z 3
*Not appropriate for meeting regulatory requirements, see page 144.
Activated Clotting Time SeriesCT, CT1, CT2, CT3, CT5
Instrument/Cartridge Program Code Challenges/Shipment
CT CT1 CT2 CT3 CT5
Helena Actalyke® z 3
Helena Cascade POC z 3
IL Gem® PCL ACT z 3
IL Gem PCL ACT-LR z 3
IL GEM PCL Plus ACT z 3
IL GEM PCL Plus ACT-LR z 3
ITC Hemochron® CA510/FTCA510 z 3
ITC Hemochron FTK-ACT z 3
ITC Hemochron Jr. Signature/ACT+ z 3
ITC Hemochron Jr. Signature/ACT-LR
z 3
ITC Hemochron P214/P215 z 3
i-STAT® Celite® and Kaolin ACT z 3
Medtronic HemoTecACT/ACTII/ACT Plus HR-ACT
z 3
Medtronic HemoTecACT/ACTII/ACT Plus LR-ACT
z 3
Medtronic HemoTecACT/ACTII/ACT Plus R-ACT
z 3
Medtronic Hepcon HMS, HMS Plus z 3
Sienco Sonoclot® z 3
Program Information• Three 1.0-mL lyophilized
specimens
• Two shipments per year
Program Information• CT - Three .0-mL lyophilized
whole blood specimens
• CT1 - Three 1.7-mL lyophilizedwhole blood specimens
• CT2, CT - Three 0.5-mLlyophilized whole bloodspecimens
• CT5 - Three 1.7-mL lyophilizedwhole blood specimens
• Two shipments per year
Coagulation
800-323-4040 | 847-832-7000 Option 1 | cap.org 147
Coagulation
13
Platelet Function* PF, PF1Instrument/Method Program Code Challenges/Shipment
PF PF1
Platelet aggregation z 2
PFA-100 z 2
Helena Plateletworks® z 2
*This Survey requires the draw of a normal donor sample.
Thromboelastogram TEGInstrument/Method Program Code Challenges/Shipment
TEG
Thromboelastogram z 2
Coagulation Calibration Verification/LinearityLN35, LN36, LN37
Analyte Program Code
LN35 LN36 LN37 Target Ranges
Antithrombin activity z 10%–130%
Protein C activity z 10%–100%
Heparin, low molecular weight z 0.1–2.0 U/mL
Heparin, unfractionated z 0.1–1.3 U/mL
von Willebrand factor antigen z 5%–140%
The LN35, LN36, and LN37 CVL programs meet the CAP Accreditation requirementsHEM.38009, 38010, and 38011.
LN Express service is available.
Program Information• PF - Four .2 sodium citrate
vacuum tubes; two 10.0-mLplastic tubes; two vials ofspecified agonists
• PF1 - Four .2 sodiumcitrate vacuum tubes; two10.0-mL plastic tubes
• Second instrument/methodreporting requires thepurchase of an additional kit
• Two shipments per year
Program Information• Two 1.0-mL lyophilized whole
blood specimens
• For use with the Haemonetics™
Thromboelastograph® andROTEM® delta hemostasisanalyzers
• Two shipments per year
Program Information• Six 1.0-mL frozen plasma
specimens per program
• Two shipments per year; shipson dry ice
Coagulation
148 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Coa
gula
tion
13
D-Dimer CalibrationVerification/Linearity LN42
Analyte Program Code
LN42 Target Ranges
D-dimer z 200-4,500 ng/mL FEU
LN Express service is available.
Whole Blood CoagulationWP3, WP4, WP6, WP9, WP10
Analyte Challenges/Shipment
Program Code
WP3 WP4 WP6 WP9 WP10
International normalized ratio (INR) 5 5 5 5 3
Prothrombin time 5 5 5 5 –
For method compatibility, see instrument matrix below.
Whole Blood Coagulation, Instrument MatrixInstrument Program Code
WP3 WP4 WP6 WP9 WP10
Abbott CoaguSense™ z
Helena Cascade POC Citrated z
Helena Cascade POC Noncitrated z
ITC Hemochron Jr. Signature/Signature +, SignatureElite and Jr. II – Citrated cuvette
z
ITC Hemochron Jr. Signature/Signature +, SignatureElite and Jr. II – Noncitrated cuvette
z
IL GEM PCL, PCL Plus – Citrated z
IL GEM PCL, PCL Plus – Noncitrated z
i-STAT z
Roche CoaguChek XS Plus and XS Pro z
Roche CoaguChek XS System z
Program Information• Six 1.0-mL plasma specimens
• Two shipments per year
Program Information• P - Five 1.0-mL lyophilized
plasma specimens
• P , P6 - Five 0.5-mLlyophilized whole bloodspecimens
• P9 - Five 0. -mL lyophilizedplasma specimens
• Three shipments per year
• P10 - Three 0. -mLlyophilized plasma specimens;two shipments per year
Coagulation
800-323-4040 | 847-832-7000 Option 1 | cap.org 149
Coagulation
13
Program Information• Two 0.5-mL whole blood
specimens
• For use with the SimpliRED®
and Clearview® SimplifyD-dimer methods
• Two shipments per year
Program Information• Three lyophilized specimens
with diluents
• For use with the AccumetricsVerifyNow® System
• it includes sufficient materialto perform one assay; multipleassay reporting requires thepurchase of additional kits
• Two shipments per year
Program Information• Three 0.5-mL lyophilized
urine specimens
• For use with Aspirin or s
• Two shipments per year
Program Information• One .2 sodium citrate and
two heparin vacuum tubes;two 3.5-mL plastic tubes;one vial of 0.2M CaCl2
• For use with the HaemoneticsPlatelet Mapping® assay
• Two shipments per year
Whole Blood D-Dimer WBDDAnalyte Program Code Challenges/Shipment
WBDD
D-dimer, qualitative z 2
Drug-Specific Platelet Aggregation PIAProcedure Program Code Challenges/Shipment
PIA
Aspirin assay z 3
PRU test z 3
llb/llla assay z 3
11-Dehydrothromboxane B2 TBXAnalyte Program Code Challenges/Shipment
TBX
11-dehydrothromboxane B2 z 3
Platelet Mapping* PLTMAnalyte Program Code Challenges/Shipment
PLTM
AA % aggregation/inhibition z 2
ADP % aggregation/inhibition z 2
*This Survey requires the draw of a normal donor sample.
Coagulation
150 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Coa
gula
tion
13
Improve the reliability of your patient results with CAP Survey Validated MaterialsUse the same material that is sent in the Surveys program to:
• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document correction of problems identified in Surveys• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures
Each laboratory receives a Survey Participant Summary, which includes readily available results.
Coagulation, Validated MaterialValidated Material Program Code Corresponding Survey Page
Coagulation VM CGM CGL 144
Program Information• Five 1.0-mL lyophilized
plasma specimens; threeshipments per year; one1.0-mL lyophilized plasmaspecimen and one 1.0-mLserum specimen; twoshipments per year
Everyday, I’m impressedby our customers’commitment to qualitypatient care.
– Lynne
“ “
CAP Customer Contact Center representativesunderstand the importance of what you do.
Microbiology
14
MicrobiologyBacteriology ..................................................................................................................................152Mycobacteriology ..........................................................................................................................163Mycology......................................................................................................................................164Parasitology ..................................................................................................................................167Virology........................................................................................................................................171Molecular Microbiology..................................................................................................................173Infectious Disease Serology .............................................................................................................178
New Programs New
Gram-Negative Blood Culture Panel for Molecular Multiplex Testing (GNBC) .......................................158Stool Pathogen, without Shiga Toxin (SPN) .......................................................................................161Molecular MTB Detection and Resistance (MTBR)...............................................................................163C. trachomatis and N. gonorrhoeae DNA by Nucleic Acid Amplification (HC7) ...................................174Bacterial Strain Typing, Gram-Negative Organisms (BSTN) ................................................................175Nucleic Acid Amplification, Organisms without MTB (IDN).................................................................175
Discontinued ProgramsBreakpoint Implementation Tool (BIT)
14 | Microbiology
“In my state, especially, we’re very regulated and haveall these regulatory agencies coming in. The CAP isthe recognized laboratory standard and it’s great tobe compared with a large peer group. I’ve been amanager in a laboratory without the CAP and withthe CAP, and I will tell you that it is better to be withthe CAP!”
Bacteriology
152 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
BacteriologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Guide for Ordering Appropriate Bacteriology SurveysProcedure Program Code
D D4 D2 D7 D3 D1Bacterial identification z z z z z z
Gram stain z z z z z
Antimicrobial susceptibility testing z z z z
Bacterial antigen detection z z
Participants must report five specimens for each mailing to meet CLIA requirements for thesubspecialty of bacteriology. See the following pages for more detailed information abouteach Survey.
Bacteriology DProcedure Program Code Challenges/Shipment
DAntimicrobial susceptibility testing z 1 graded, 1 ungraded
Bacterial antigen detection z 2
Bacterial identification z 5
Gram stain z 1
Additional InformationAntigen detection challenges will be included in the following shipments:
• Shipment A C. difficile antigen/toxin and spinal fluid meningitis panel• Shipment B Spinal fluid meningitis panel and Group A Streptococcus• Shipment C C. difficile antigen/toxin and Group A Streptococcus
Program Information• Five swabs (in duplicate) with
diluents for culture
• Two specimens for bacterialantigen detection from thefollowing:
One swab for Group AStreptococcus
One 1.0-mL lyophilizedspecimen for spinal fluidmeningitis testing
One 0.5-mL lyophilizedspecimen for Clostridiumdifficile, for use with rapidor molecular testing methods
• Three shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Bacteriology
800-323-4040 | 847-832-7000 Option 1 | cap.org 153
Microbiology
14
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Expanded Bacteriology DEXAnalyte Program Code Challenges/Shipment
DEX
Live organisms z 2
Additional InformationExpanded Bacteriology (DEX) is an educational opportunity that provides:
• Culture and susceptibility testing challenges for microbiology laboratories thatperform complete identification and susceptibility of bacterial isolates including lesscommon or problematic bacteria
• More exposure to emerging bacterial pathogens and novel resistance mechanisms• Ability to recognize and identify organisms that exhibit multiple drug-resistance
patterns• Recovery and identification of mixed pathogens such as yeast, aerobic, and
anaerobic bacteria in cultures containing multiple organisms
Microbiology Bench ToolsCompetency MBT
Procedure Program Code Challenges/Shipment
MBT
Bacterial identification z 6
Antimicrobial susceptibility testing z 2
Additional InformationMicrobiology Bench Tools for Competency (MBT) is a supplemental module forcompetency assessment and an educational resource for microbiology laboratories.The module:
• Provides organisms that challenge the basic elements of testing at the microbiologybench, including direct observation, monitoring, recording, and reporting of testresults
• Can be used for both competency and educational purposes, including teaching andtraining pathology residents, new employees, medical, and MT/MLT students
• Provides identification and susceptibility results for supervisor use
This is not a proficiency testing program and participants will not return results to the CAP.
Program Information• Two swabs (in duplicate)
with diluents to performbacterial identification andsusceptibility (when directed)
• Three shipments per year
Program Information• Six challenges with diluents
for culture
• Results will be provided withthe kit to assess personnelcompetency
• Two shipments per year
Bacteriology
154 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
GC, Throat, and Urine Cultures D1, D2, D3, D7Procedure Program Code Challenges/
Shipment
D1 D2 D3 D7
Antimicrobialsusceptibilitytesting
z z 1
Bacterialidentification z z z z 5
Gram stain z z z 1
Culture source: Throat Urine Cervical Throat/Urine
Microbiologiclevel:
Presence orabsence ofGroup A
Streptococ-cus deter-mination
Organismsidentified tothe extentof your
laboratory’sprotocol
Presence orabsence ofNeisseriagonor-rhoeae
determina-tion
Combinationof two throat
and threeurine culturespecimens
Limited Bacteriology D4Procedure Program Code Challenges/Shipment
D4
Antimicrobial susceptibility testing z 1
Bacterial antigen detection z 1
Bacterial identification z 5
Gram stain z 1
Culture source: Microbiologic level
GC culturePresence or absence ofNeisseria gonorrhoeae
determination
Throat culturePresence or absence ofGroup A Streptococcus
determination
Urine cultureOrganisms identifiedto the extent of yourlaboratory’s protocol
Program Information• Five loop specimens
(in duplicate) with diluents
• Three shipments per year
Program Information• Five loop specimens (in
duplicate) with diluents andone swab specimen
• Two throat culture specimens,two urine culture specimens,one susceptibility specimen,one GC culture specimen,and one bacterial antigendetection specimen for GroupA Streptococcus
• Three shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Bacteriology
800-323-4040 | 847-832-7000 Option 1 | cap.org 155
Microbiology
14
Gram Stain D5Procedure Program Code Challenges/Shipment
D5
Gram stain z 5
Virtual Gram Stain VGS1, VGS2Procedure Program Code Challenges/Shipment
VGS1 VGS2
Virtual Gram stain basic z 3
Virtual Gram stain advanced z 3
Additional Information• Virtual Gram Stain Basic Competency (VGS1) is for general and new laboratory
technologists/technicians. Participants will assess the quality of specimens and stainsand will report artifacts and detailed gram-positive and gram-negative morphology.Challenges will include specimens such as CSF, body fluids and positive bloodcultures.
• Virtual Gram Stain Advanced Competency (VGS2) is for experienced laboratorytechnologists/technicians and microbiologists. Participants will receive challengingimages of sputum, body fluids, and other specimens to assess the quality, quantity, andtypical morphology of both gram-positive and gram-negative organisms appropriatefor the site.
• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.
• See system re uirements on page 15.
Program Information• Five air-dried, methanol-fixed
unstained glass slides
• Three shipments per year
Program Information• Three online whole slide
images
• Results included in the it toassess personnel competency
• Powered by DigitalScopetechnology
• Two shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Bacteriology
156 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Rapid Strep A Antigen Detection D6Procedure Program Code Challenges/Shipment
D6
Group A Streptococcus antigen detection z 5
Rapid Strep A Antigen Detection, Waived D9Procedure Program Code Challenges/Shipment
D9
Group A Streptococcus antigen detection z 2
Group B Strep Detection D8Procedure Program Code Challenges/Shipment
D8
Group B Streptococcus detection z 5
Program Information• Five swab specimens
• Three shipments per year
Program Information• Two swab specimens
• Two shipments per year
Program Information• Five swab specimens with
diluents
• Compatible with culture andmolecular methods
• Three shipments per year
Check on your PT shipment with CAPTRAKerSM
Our CAPTRAKer electronic shipment tracking program* gives your labthe ability to locate your PT kit in an instant!
• Alerts you that your CAP PT kits have been shipped
• Allows you to track your shipment through a link
• Results in less worries
To begin receiving CAPTRAKer emails, send your name, CAP account number, and email addressto [email protected].
*CAP distributor customers—contact your distributor for your PT shipping information
SM
Bacteriology
800-323-4040 | 847-832-7000 Option 1 | cap.org 157
Microbiology
14
Bacterial Antigen Detection LBAS, SBASProcedure Program Code Challenges/Shipment
LBAS SBAS
Legionella pneumophilaantigen detection
z 2
Streptococcus pneumoniaeantigen detection
z 2
Blood Culture BCSProcedure Program Code Challenges/Shipment
BCS
Blood culture bacterial detection z 2
Blood Culture,Staphylococcus aureus BCS1
Analyte Program Code Challenges/Shipment
BCS1
Staphylococcus aureus z 3
Program Information• Two li uid simulated clinical
specimens
• Two shipments per year
Program Information• Two challenges with diluents
for inoculation of bloodculture bottles
• Two shipments per year
Program Information• Three specimens with diluents
for inoculation of bloodculture bottles
• Compatible with methods forrapid detection of S. aureus/MRSA/MSSA from positiveblood culture bottles
• Two shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Bacteriology
158 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Blood Culture Panels for Molecular Multiplex TestingGNBC, GPBC
Procedure Program Code Challenges/Shipment
GNBC GPBC
Identification of gram-negativeorganisms such as Acinetobacter,Citrobacter, Enterobacter, Proteus,Haemophilus, Klebsiella, Neisseria,Pseudomonas, Serratia, E. coli, andcommon resistance mechanisms isolatedfrom positive blood culture bottles
z 3
Identification of gram-positive organismssuch as Staphylococcus, Streptococcus,Enterococcus, Listeria, and commonresistance mechanisms isolated frompositive blood culture bottles
z 3
These Surveys are not for the inoculation of blood culture bottles.
PNA FISH PNA1, PNA2, PNA3, PNA4Analyte Program Code Challenges/Shipment
PNA1 PNA2 PNA3 PNA4
Staphylococcus z 3
Yeast z 3
Enterococcus z 3
Gram-negative rods z 3
Campylobacter CAMPAnalyte Program Code Challenges/Shipment
CAMP
Campylobacter z 2
Program Information• Three 1.0-mL li uid simulated
blood culture fluid specimens
• For laboratories usingmolecular multiplex panels
• Two shipments per year
Program Information• Three challenges with diluents
for inoculation of blood culturebottles
• Two shipments per year
Program Information• Two swabs with diluents
• For use with rapid antigen,culture-based testing, andmolecular methods
• Two shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Bacteriology
800-323-4040 | 847-832-7000 Option 1 | cap.org 159
Microbiology
14
Chlamydia trachomatis HC1, HC3Procedure Program Code Challenges/Shipment
HC1 HC3
Antigen detection (DFA) z 5
Antigen detection (EIA) z 5
Fecal Lactoferrin FLACAnalyte Program Code Challenges/Shipment
FLAC
Fecal lactoferrin z 3
Helicobacter pylori Antigen, Stool HPSProcedure Program Code Challenges/Shipment
HPS
Helicobacter pylori antigen detection z 2
Laboratory Preparedness Exercise LPXAnalyte Program Code Challenges/Shipment
LPX
Live organisms z 3
Additional InformationThe Laboratory Preparedness Exercise (LPX) was developed as a collaborative effort betweenthe College of American Pathologists, the Centers for Disease Control and Prevention(CDC), and the Association of Public Health Laboratories (APHL). Laboratories will be sentlive organisms that either exhibit characteristics of bioterrorism agents or demonstrateepidemiologic importance and will be expected to respond following Laboratory ResponseNetwor Sentinel Laboratory Guidelines if a bioterrorism agent is suspected. All agentsprovided are excluded from the CDC’s select agent list. These may include strains ofBacillus anthracis, Yersinia pestis, Francisella tularensis, and Brucella abortus that have beenmodified and are safe for testing in a laboratory that contains a certified Class II BiologicalSafety Cabinet and is capable of handling Category A and B agents.
Program Information• HC1 - Five 5-well slide
specimens; for the detection ofchlamydial elementary bodiesby DFA
• HC - Five 2.0-mL li uidspecimens
• Three shipments per year
Program Information• Three simulated stool
specimens
• For use with rapid methods
• Two shipments per year
Program Information• Two 0.5-mL fecal suspensions
• Two shipments per year
Program Information• Three specimens with diluents
• Not available to internationalcustomers due to UnitedStates export law restrictions
• Two shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Bacteriology
160 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Methicillin-Resistant Staphylococcus aureusScreen MRS
Procedure Program Code Challenges/Shipment
MRS
MRSA detection z 2
Methicillin-Resistant Staphylococcus aureusScreen MRS5
Procedure Program Code Challenges/Shipment
MRS5
MRSA detection z 5
Rapid Urease RURAnalyte Program Code Challenges/Shipment
RUR
Urease z 3
Program Information• Two swab specimens with
diluents
• For use with molecular methodsand culture-based testing
• Two shipments per year
Program Information• Five swab specimens with
diluents
• For use with molecular methodsand culture-based testing
• Three shipments per year
Program Information• Three simulated gastric
biopsy specimens
• For use with methodssuch as CLOTEST®
• Two shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Bacteriology
800-323-4040 | 847-832-7000 Option 1 | cap.org 161
Microbiology
14
Stool Pathogen SP, SPN, SP1Analyte/Procedure Program Code Challenges/Shipment
SP SPN SP1
Adenovirus 40/41 z z 2
C. difficile z z 2
Rotavirus z z 2
Shiga toxin z 2
Norovirus z 1
Shiga Toxin STAnalyte Program Code Challenges/Shipment
ST
Shiga toxin z 2
Bacterial Vaginosis BVProcedure Program Code Challenges/Shipment
BV
Bacterial vaginosis detection z 3
Program Information• SP - Two 1.0-mL li uid
specimens; for use with rapidor molecular testing methods;not available to internationalcustomers due to UnitedStates export law restrictions
• SPN - Two 1.0-mL li uidspecimens; for use with rapidor molecular testing methods;intended for internationallaboratories
• SP1 - One 1.0-mL li uidspecimen
• Two shipments per year
Program Information• Two 0.5-mL li uid specimens
• For use with direct shiga toxintesting only; not compatiblewith culture methods,cytotoxicity assays, or PCR
• Not available to internationalcustomers due to UnitedStates export law restrictions
• Two shipments per year
Program Information• Three 1.0-mL li uid
challenges
• For OSOM® BVBlue users
• Two shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Bacteriology
162 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Vaginitis Screen VS, VS1Analyte Program Code Challenges/Shipment
VS VS1
Candida sp. z 5
Gardnerella vaginalis z 5
Trichomonas vaginalis z z 5
Vaginitis Screen, Virtual Gram Stain VS2Procedure Program Code Challenges/Shipment
VS2
Interpretation of Gram-stained vaginalsmears
z 3
Additional Information• DigitalScope technology simulates the use of a microscope by enabling the user to
scan and adjust magnification of the whole slide image.
• See system re uirements on page 15.
Vancomycin-Resistant Enterococcus VREProcedure Program Code Challenges/Shipment
VRE
Vancomycin-resistant Enterococcus(VRE) detection
z 2
Program Information• VS - Five swabs for DNA
probe technology; BD Affirm™
VP III probe detection method;three shipments per year
• VS1 - Five swabs for DNAprobe technology; SekisuiOSOM Trichomonas RapidTest and Gen-Probe APTIMA®
Trichomonas vaginalismethods; two shipmentsper year
Program Information• Three online whole slide
images
• Powered by DigitalScopetechnology
• Two activities per year; yourCAP shipping contact will benotified via email when theactivity is available
Program Information• Two swabs with diluents
• For use with molecularmethods and culture-basedtesting
• Two shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Mycobacteriology
800-323-4040 | 847-832-7000 Option 1 | cap.org 163
Microbiology
14
MycobacteriologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Mycobacteriology EProcedure Program Code Challenges/Shipment
E
Acid-fast smear z 1
Antimycobacterial susceptibility testing z 1 graded, 1 ungraded
Mycobacterial identification* z 5
*This procedure requires identification of Mycobacterium tuberculosis.
Limited Mycobacteriology E1Procedure Program Code Challenges/Shipment
E1
Acid-fast smear z 5
Mycobacterial culture z 5
Molecular MTB Detection and ResistanceMTBR
Procedure Program Code Challenges/Shipment
MTBR
Mycobacterium tuberculosis detection z 3
Rifampin resistance z 3
Program Information• Five simulated clinical
isolates with diluents and onespecimen for performing anacid-fast bacillus smear
• Identification may beperformed by culture ormolecular methods
• Two shipments per year
Program Information• Five simulated specimens
for acid-fast smears and/orfor the determination of thepresence or absence ofacid-fast bacillus by culture
• Two shipments per year
Program Information• Three simulated sputum
specimens for use withmolecular methods
• Not suitable for culture
• Two shipments per year
New
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Mycology
164 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
MycologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Mycology FProcedure Program Code Challenges/Shipment
F
Antifungal susceptibility testing z 1
Cryptococcal antigen detection z 2 per year
Mold and yeast identification z 5
Yeast F1Procedure Program Code Challenges/Shipment
F1
Antifungal susceptibility testing z 1
Cryptococcal antigen detection z 2 per year
Yeast identification z 5
Program Information• Five loops for culture (in
duplicate) with diluentsand one 1.0-mL simulatedcerebrospinal fluid specimen(A and B shipments only)
• Identification of yeast andmold may be performed byculture or molecular methods
• Three shipments per year
Program Information• Five loops for culture (in
duplicate) with diluentsand one 1.0-mL simulatedcerebrospinal fluid specimen(A and B shipments only)
• Identification of yeast maybe performed by culture ormolecular methods
• Three shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Mycology
800-323-4040 | 847-832-7000 Option 1 | cap.org 165
Microbiology
14
Candida Culture F3Procedure Program Code Challenges/Shipment
F3
Yeast identification z 5
Galactomannan FGALAnalyte Program Code Challenges/Shipment
FGAL
Galactomannan - Aspergillus z 3
Fungal Serology FSERProcedure Program Code Challenges/Shipment
FSER
Serological detection of specificfungal antibodies
z 3
Fungal Smear FSMProcedure Program Code Challenges/Shipment
FSM
KOH preparation/calcofluor white z 3
Program Information• Five loops for culture (in
duplicate) with diluents
• Contains Candida species
• Identification of Candidaspecies may be performed byculture, molecular, and rapidmethods
•Three shipments per year
Program Information• Three li uid specimens
• For use with methods such asBio-Rad Platelia™
• Two shipments per year
Program Information• Three serum specimens
• For use with immunodiffusionmethods
• Designed for the detectionof antibodies to Aspergillus,Blastomyces, Coccidiodes,and Histoplasma
• Two shipments per year
Program Information• Three slides
• Two shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Mycology
166 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
India Ink INDProcedure Program Code Challenges/Shipment
IND
India Ink z 2
Pneumocystis jiroveci PCP1, PCP2, PCP3, PCP4
Procedure Program Code Challenges/Shipment
PCP1 PCP2 PCP3 PCP4
PCP – Calcofluor white stain z 3
PCP DFA stain z 3
PCP Giemsa stain z 3
PCP GMS stain z 3
Program Information• Two li uid specimens
• Two shipments per year
Program Information• Three images, each available
as photographs and onlineimages
• Two shipments per year
Put fast indentification of fungi at your fingertipsMycology Benchtop Reference Guide (MBRG)• More than 70 fungal identifications of yeast and molds
commonly encountered in the clinical laboratory• Detailed descriptions of the most significant morphologic
elements, ecology, and clinical significance• Color images of macroscopic and
microscopic morphologies• Six tabbed sections for easy reference
o Yeast and Yeast-Like Fungio Molds With Narrow, Hyaline Hyphaeo Dimorphic Fungio Dermatophyteso Zygomyceteso Dematiaceous Molds
• A durable and water-resistant format— 6½" x 7" andspiral bound to withstand years of benchtop use
Add code MBRG to your Surveys order form.
Also available as an ebook! Visit ebooks.cap.org
Parasitology
800-323-4040 | 847-832-7000 Option 1 | cap.org 167
Microbiology
14
ParasitologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Parasitology P, P3, P4, P5Procedure Program Code
P P3 P4 P5
Fecal suspension (wet mount) z z z
Fecal suspension (Giardia and/orCryptosporidium immunoassay andmodified acid-fast stain)
z z z z
Giemsa-stained blood smear z
Preserved slide (for permanent stain) z z
Additional Information• The proficiency testing materials used for the Parasitology Surveys contain formalin
as a preservative.• Modified acid-fast stain results do not meet CLIA re uirements for parasite identification.
Program Information• P - Five specimens consisting
of thin and thick films forblood and tissue parasiteidentification; preserved slidesfor permanent stain; 0.75-mLfecal suspensions for directwet mount examination,photographs, and/or onlineimages; two 0.75-mL fecalsuspensions for Giardiaand/or Cryptosporidiumimmunoassay testing andmodified acid-fast stain
• P - Five 0.75-mL fecalsuspensions for directwet mount examination,photographs, and/or onlineimages; one 0.75-mL fecalsuspension for Giardiaand/or Cryptosporidiumimmunoassay testing andmodified acid-fast stain
• P - Five specimens consistingof 0.75-mL fecal suspensionsfor direct wet mountexamination, preservedslides for permanent stain,photographs, and/or onlineimages; one 0.75-mL fecalsuspension for Giardiaand/or Cryptosporidiumimmunoassay testing andmodified acid-fast stain
• P5 - Five 0.75-mL fecalsuspensions for Giardiaand/or Cryptosporidiumimmunoassay testing andmodified acid-fast stain
• Three shipments per year
Parasitology
168 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Blood Parasite BPProcedure Program Code Challenges/Shipment
BP
Thin/thick blood film sets* z 5
*This Survey will include corresponding thick films when available.
Rapid Malaria RMALProcedure Program Code Challenges/Shipment
RMAL
Rapid malaria detection z 3
Program Information• Five Giemsa-stained blood
film sets, photographs,and/or online images
• A variety of blood parasites,including Plasmodium,Babesia, Trypanosoma, andfilarial worms
• Three shipments per year
Program Information• Three antigen specimens
• Two shipments per year
Put fast identification of parasites at your fingertipsParasitology Benchtop Reference Guide (PBRG)• More than 70 identifications for parasites commonly
encountered in the clinical laboratory• Detailed descriptions of the parasite morphology, ecology,
and clinical significance• Color images of microscopic morphologies using routine
parasitology stains and preparations• Color images of macroscopic worms routinely submitted to
the clinical laboratory• Five tabbed sections for easy reference
o Blood Parasiteso Intestinal Protozoao Intestinal Helminthso Miscellaneous Specimenso Macroscopic Worms
A durable and water-resistant format—6½" by 7" and spiral boundto withstand years of benchtop use.
Add code PBRG to your Surveys order form.
Also available as an ebook! Visit ebooks.cap.org
Parasitology
800-323-4040 | 847-832-7000 Option 1 | cap.org 169
Microbiology
14
Ticks, Mites, and Other Arthropods TMOProcedure Program Code Challenges/Shipment
TMO
Tick, mite, and arthropod identification z 3
Worm Identification WIDProcedure Program Code Challenges/Shipment
WID
Worm identification z 3
Program Information• Three images, each available
as photographs and onlineimages
• Two shipments per year
Program Information• Three images, each available
as photographs and onlineimages
• Two shipments per year
Virology and Molecular Microbiology Testing
170 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Do youperformmoleculartesting onChlamydiaor GC only?
Do youperformnucleic acidamplificationother thanGC?
Do youperformviral loadtestingonly?
Do youperformmolecularmultiplexing?
Do you perform any of the followingvirology testing?n virology culturen virology antigen testingn virology antibody testing
Select fromthefollowingSurveys:
n HC6,HC6X,HC7Chlamydia/GCNucleic AcidAmplification
Select fromthefollowingSurveys:n IDO, ID1,
ID1T,ID2, IDNNucleic AcidAmplification
n BSTE,BSTN,BSTSBacterialStrain Typing
Select fromthefollowingSurveys:n HIV,
HV2HIV Viral Load
n HCVN,HCV2,HBVL,HBVL5HepatitisViral Load
n VLS,VLS2Viral Load
Select fromthefollowingSurveys:n IDR
InfectiousDiseaseRespiratoryPanel
n GIPGastro -intestinalPanel
n GNBC,GPBCBlood CulturePanels
SelectVR1
SelectVR2
SelectVR4
SelectHC2
SelectHC4
For Comprehensive VirologyCulture Testing
For Virology AntigenTesting by Immunofluorescence
For Virology Antigen by EIA orLatex Agglutination
For Herpes Simplex VirusAntigen Detection by DFA
For Herpes Simplex VirusCulture Testing
Yes Yes Yes Yes Yes
Virology Molecular Microbiology
Virology and Molecular Microbiology Testingse this flowchart as a guide for ordering the appropriate Virology and Molecular Microbiology Surveys for your laboratory s
testing menu. For the subspecialty of virology, you must test five specimens per mailing. If you have any uestions, please callthe Customer Contact Center at 800-323-4040 or 847-832-7000 option 1.
SelectVR3/VR3M
For Viral Serology Testing
Virology
800-323-4040 | 847-832-7000 Option 1 | cap.org 171
Microbiology
14
VirologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Virology Culture VR1Procedure Program Code Challenges/Shipment
VR1
Chlamydia trachomatis culture z 1
Viral isolation/identification z 5
Educational challenge z 1 per year
Virology Antigen Detection (DFA) VR2Analyte/Procedure Program Code Challenges/Shipment
VR2 A B C
Adenovirus antigen z 1 1
Cytomegalovirus antigen z 1 1
Herpes simplex virus (HSV) antigen z 1 1
Influenza A antigen z 1 1
Influenza B antigen z 1
Parainfluenza antigen z 1 1
Respiratory syncytial virus (RSV)antigen z 1 1
Varicella-zoster antigen z 1 1
Educational challenge z 1
Program Information• Five 0.5-mL specimens for
viral culture and one 0.5-mLspecimen for Chlamydiatrachomatis culture
• Three shipments per year
Program Information• Five 5-well slide specimens
• Three shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
172 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Virology
Virology Antigen Detection (Non-DFA) VR4Analyte Program Code Challenges/Shipment
VR4
Adenovirus (Not 40/41) antigen z 5
Influenza A antigen z 5
Influenza B antigen z 5
Respiratory syncytial virus (RSV) antigen z 5
Rotavirus antigen z 5
Herpes Simplex Virus HC2, HC4Procedure Program Code Challenges/Shipment
HC2 HC4*
Antigen detection (DFA) z 5Culture z 5
*The biohazard warning applies to Survey HC4.
Program Information•Five1.5-mLspecimens
• Forusewithenzymeimmunoassayand/orlatexagglutinationmethods
• Threeshipmentsperyear
Program Information•HC2-Five5-wellslide
specimens
•HC4-Five2.0-mLlyophilizedspecimens
• Threeshipmentsperyear
RefertotheOrderingInformationprovidedforinformationregardingadditionaldangerousgoodsandrelatedfees.
Molecular Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org 173
Microbiology
14
Molecular MicrobiologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Hepatitis Viral LoadHCVN, HCV2, HBVL, HBVL5
Analyte/Procedure Challenges/Shipment
Program Code
HCVN, HCV2 HBVL HBVL5
HCV genotyping 1
HCV, qualitative 1
HCV viral load 5
HBV viral load 2 5
HIV Viral Load HIV, HV2, HIVGProcedure Program Code Challenges/Shipment
HIV, HV2 HIVG
HIV-RNA viral load z 5
HIV genotyping z 1
Viral Load VLS, VLS2Analyte/Procedure Program Code Challenges/Shipment
VLS VLS2
BK viral load z z 2
CMV viral load z z 2
EBV viral load z z 2
Adenovirus viral load z 2
HHV6 viral load z 2
Program Information• HCVN - Five 0.5-mL li uid
plasma specimens
• HCV2 - Five 1.5-mL li uidplasma specimens
• HBVL - Two 1.25-mL plasmaspecimens
• HBVL5 - Five 2.0-mL plasmaspecimens
• Three shipments per year
Program Information• HIV - Five 0.5-mL plasma
specimens
• HV2 - Five 2.5-mL plasmaspecimens
• HIVG - One 1.0-mL plasmaspecimen
• Three shipments per year
Program Information• VLS - Six 1.0-mL EDTA
plasma specimens; twoshipments per year
• VLS2 - Ten 2.0-mL EDTAplasma specimens;three shipments per year
Molecular Microbiology
174 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Viral Load Calibration Verification/Linearity LN38, LN39
Analyte Program Code
LN38 LN39 Target Ranges
CMV viral load z 0.3M–1.0M IU/L
HIV viral load z 0–10M copies/L
LN Express service is available.
C. trachomatis and N. gonorrhoeae HC6, HC6X, HC7
Procedure Program Code Challenges/Shipment
HC6, HC6X HC7
Nucleic acid amplification (NAA) z z 5
Human Papillomavirus HPVAnalyte Program Code Challenges/Shipment
HPV
Human papillomavirus z 2
For laboratories using Digene, SurePath, and/or ThinPrep collection media, see page 246.
Program Information• LN38-Six1.5-mLfrozen
plasma specimens
•Twoshipmentsperyear;shipsondryice
• LN39-Six2.5-mLfrozenplasma specimens
•Twoshipmentsperyear;shipsondryice
Program Information•HC6-Threeswabspecimens
andtwo1.0-mLsimulatedurine specimens
•HC6X-Threeswabspecimens;twosimulatedurine specimens (in duplicate)
•HC7-Fivesimulatedbodyfluidspecimens;designedforCepheid users
•ForSurveysHC6andHC6X,useeachswabtoperformboth C. trachomatis and N. gonorrhoeae testing
•Threeshipmentsperyear
Program Information•Twosimulatedcervical
specimens contained in Digene transport media
•ForDigeneHybridCaptureonly
• Twoshipmentsperyear
RefertotheOrderingInformationprovidedforinformationregardingadditionaldangerousgoodsandrelatedfees.
Molecular Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org 175
Microbiology
14
Bacterial Strain Typing BSTE, BSTN, BSTSAnalyte Program Code Challenges/Shipment
BSTE BSTN BSTS
Enterococcus z 2Gram-negative organisms* z 2Staphylococcus z 2
*Gram-negative organisms include Klebsiella sp., Acinetobacter sp., and Pseudomonas aeruginosa.
Nucleic Acid Amplification, Organisms IDO, IDNAnalyte/Procedure Program Code Challenges/Shipment
IDO IDN
Bordetella pertussis/parapertussis* z z 1
Legionella pneumophila/Chlamydophila pneumoniae*
z z 1
Methicillin-resistant Staphylococcus aureus z z 1
Molecular typing (bacterial isolates) z z 1
Mycobacterium tuberculosis z 1
Mycoplasma pneumoniae z z 1
Vancomycin-resistant Enterococcus z z 1
*Bordetella pertussis/parapertussis and Legionella pneumophila/Chlamydophila pneumoniae will be included in the following shipments: Shipment A: Bordetella pertussis and Chlamydophila pneumoniae Shipment B: Bordetella parapertussis and Legionella pneumophila
Program Information•Twosetsofloopswithdiluents
• Twoshipmentsperyear
Program Information•IDO-Sevenliquidorswab
simulated clinical isolate specimens and two diluents
•IDN-Sixliquidorswabsimulated clinical isolate specimens and two diluents; designed for international laboratories that cannot receiveMTB
•Twoshipmentsperyear
RefertotheOrderingInformationprovidedforinformationregardingadditionaldangerousgoodsandrelatedfees.
Molecular Microbiology
176 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Nucleic Acid Amplification, Viruses ID1, ID1TAnalyte Program Code Challenges/Shipment
ID1 ID1T
Cytomegalovirus z 1
Enterovirus z 1
Epstein-Barr virus z 1
Herpes simplex virus z 1
Human herpesvirus 6 z 1
Human herpesvirus 8 z 1
Parvovirus B19 z 1
Varicella-zoster virus z 1
BK virus z 1
JC virus z 1
Nucleic Acid Amplification, Respiratory ID2Analyte Program Code Challenges/Shipment
ID2
Adenovirus z 1
Coronavirus/Rhinovirus* z 1
Human metapneumovirus z 1
Influenza virus* z 1
Parainfluenza virus z 1
Respiratory syncytial virus z 1
*Coronavirus/Rhinovirus and influenza virus will be included in the following shipments
• Shipment A Coronavirus and Influenza A• Shipment B Rhinovirus and Influenza B
Program Information• ID1- Eight 1.0-mL li uid
specimens
• ID1T - Two 1.0-mL li uidspecimens
• Two shipments per year
Program Information• Six 1.0-mL li uid specimens
• Two shipments per year
Molecular Microbiology
800-323-4040 | 847-832-7000 Option 1 | cap.org 177
Microbiology
14
Infectious Disease Respiratory Panelfor Molecular Multiplex Testing IDR
Analyte Program Code Challenges/Shipment
IDR
Adenovirus z 5
Human metapneumovirus z 5
Influenza A z 5
Influenza B z 5
Parainfluenza z 5
Respiratory syncytial virus z 5
Rhinovirus/Enterovirus z 5
Educational challenge (Bocavirus,Coronavirus, or Parainfluenza 4)
z 5
Gastrointestinal Panel for MolecularMultiplex Testing GIP
Analyte Program Code Challenges/Shipment
GIP
Campylobacter z 3
Clostridium difficile, toxin A/B z 3
Cryptosporidium z 3
Enterotoxigenic E. coli (ETEC) LT/ST z 3
Escherichia coli 0157 z 3
Giardia z 3
Norovirus GI/GII z 3
Rotavirus A z 3
Salmonella z 3
Shiga-like toxin producingE. coli (STEC) stx1/stx2
z 3
Shigella z 3
Program Information• Six li uid specimens
• Designed for molecularmultiplex panel users
• Three shipments per year
Program Information• Three 1.0-mL simulated stool
specimens
• Designed for molecularmultiplex panel users
• Not available to internationalcustomers due to UnitedStates export law restrictions
• Two shipments per year
Infectious Disease Serology
178 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Mic
robi
olog
y
14
Infectious Disease SerologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Infectious Disease Serology VR3, VR3MAnalyte Program Code Challenges/Shipment
VR3 VR3M
Cytomegalovirus (CMV) IgG, IgM, andtotal antibodies
z 1
Epstein-Barr virus (EBV) VCA IgG, IgMEBNA IgG, IgM, and total antibodiesEA IgG
z 1
Helicobacter pylori IgG, IgA, andtotal antibodies
z 1
Herpes simplex virus (HSV) IgG antibody z 1
Mycoplasma pneumoniae IgG, IgM, andtotal antibodies
z 1
Mumps IgG z 1
Rubeola virus (English measles) IgGantibody
z 1
Toxoplasma gondii IgG, IgM, andtotal antibodies
z 1
Varicella-zoster virus IgG andtotal antibodies
z 1
Tick-Transmitted Diseases TTDAnalyte Program Code Challenges/Shipment
TTD
Antibodies to tick-transmitted diseaseorganisms
z 3
Program Information• VR - Eight 0.5-mL
lyophilized plasma specimens
• VR M - One 0.5-mLlyophilized plasma specimen
• Two shipments per year
Program Information• Three 0. -mL li uid specimens
• Designed for the detectionof antibodies to Borreliaburgdorferi, Babesiamicroti, and Anaplasmaphagocytophilum
• Two shipments per year
Imm
unology and Flow C
ytometry
15Immunology and Flow CytometryImmunology...................................................................................................................................180Flow Cytometry..............................................................................................................................188
New Programs New
Antichromatin Antibody (ACA) ........................................................................................................182Antiribosomal-P Antibody (ARP) .......................................................................................................183Heavy Chain/Light Chain Analysis (HCA) ........................................................................................185
Discontinued ProgramsRare Flow Antigen Validation, CD103 (RFAV2)
15 | Immunology and Flow Cytometry
“The data we receive from CAP often drives changesthat are necessary to improve our performance.”
Immunology
180 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Imm
unol
ogy
and
Flow
Cyt
omet
ry
15
ImmunologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
ImmunologyANA, ASO, CRP, HCG, IM, RF/RFX, RUB/RUBX, IL
Analyte Program Code Challenges/Shipment
ANA ASO CRP HCG IM RF/RFX
RUB/RUBX IL
Antinuclear antibody(ANA)* z z 5
Antistreptolysin O (ASO)* z z 5
C-reactive protein(qualitative/quantitative)
z z 2
hCG, serum (qualitative/quantitative) z z 5
Infectious mononucleosis z z 5
Rheumatoid factor* z z 5
Rubella (IgG)* z z 5
*Antinuclear antibody, Antistreptolysin O, Rheumatoid factor, and Rubella are regulatedanalytes and are graded for both qualitative and quantitative methods. Semiquantitativeand/or titer results for these analytes are ungraded/educational in this Survey and do notmeet regulatory requirements.
Immunology, General IG/IGXAnalyte Program Code Challenges/Shipment
IG/IGX
Alpha1-antitrypsin z 5
Complement C3 z 5
Complement C4 z 5
Haptoglobin z 5
IgA z 5
IgE z 5
IgG z 5
IgM z 5
Total kappa/lambda ratio z 5
Program Information• ANA and R B - Five 0.5-mL
liquid serum specimens
• ASO, HCG, and RF - Five1.0-mL li uid serumspecimens
• CRP - Two 0.5-mL li uidserum specimens; notappropriate for high-sensitivity CRP (hsCRP)methods
• IM - Five 0.6-mL li uid serumspecimens
• RF - All Survey RF specimensin duplicate
• R B - All Survey R Bspecimens in duplicate
• IL - All immunology specimensexcept RF and R B
• Three shipments per year
Program Information• IG - Ten 1.0-mL li uid serum
specimens
• IG - All Survey IG specimensin duplicate
• Three shipments per year
Immunology
800-323-4040 | 847-832-7000 Option 1 | cap.org 181
Imm
unology and Flow C
ytometry
15
Immunology, Special; Immunology Special, Limited;and H. pylori IgG Antibody S2, S4, S5
Analyte Program Code Challenges/Shipment
S2 S4 S5 A B C
Anticentromere antibody z 1 1
Anti-DNA antibody (ds) z z 1 1 1
Antiglomerular basementmembrane (GBM), IgG antibody
z 1 1
Antimitochondrial antibody z 1 1 1
Antineutrophil cytoplasmic antibody(ANCA, anti-MPO, anti-PR )
z 1 1
Anti-RNP antibody z 1 1 1
Anti-Sm antibody z 1 1 1
Anti-Sm/RNP antibody z 1 1 1
Antismooth muscle antibody z 1 1 1
Anti-SSA antibody z 1 1
Anti-SSB antibody z 1 1
Anti-SSA/SSB antibody z 1 1
Antithyroglobulin antibody z z 1 1 1
Antithyroid microsomal antibody z z 1 1 1
Antithyroid peroxidase antibody z z 1 1 1
Ceruloplasmin z z 1 1
Haptoglobin z z 1 1
Helicobacter pylori, IgG antibody z z
z
12
12
IgD z z 1 1 1
IgG z z 1 1
IgG subclass proteins z z 1 1
Prealbumin (transthyretin) z z 1 1
Total kappa/lambda ratio z z 1 1
Transferrin z z 1 1
Infectious Mononucleosis, Waived IMWAnalyte Program Code Challenges/Shipment
IMW
Infectious mononucleosis, waived z
Program Information• S2 - A minimum of seven
(0.5 to 1.0-mL/vial) li uidserum specimens
• S - A minimum of three(0.5 to 1.0-mL/vial) serumspecimens
• Three shipments per year
• S5 - Two 1.0-mL serumspecimens; two shipmentsper year
Program Information• Three 0.6-mL serum
specimens
• Two shipments per year
Immunology
182 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Imm
unol
ogy
and
Flow
Cyt
omet
ry
15
Antichromatin Antibody ACAAnalyte Program Code Challenges/Shipment
ACA
Antichromatin antibody z
Antifilamentous Actin IgG AntibodyFCN
Analyte Program Code Challenges/Shipment
FCN
Antifilamentous actin (f-actin)IgG antibody
z
Antihistone Antibody AHTAnalyte Program Code Challenges/Shipment
AHT
Antihistone antibody z
Antimitochondrial M2 Antibody HAnalyte Program Code Challenges/Shipment
H
Antimitochondrial M2antibody (AMA-M2)
z 2
Antiparietal Cell Antibody APCAnalyte Program Code Challenges/Shipment
APC
Antiparietal cell antibody z 2
Program Information• Three 0.5-mL serum
specimens
• Two shipments per year
New
Program Information• Three 0.5-mL serum
specimens
• Two shipments per year
Program Information• Three 0.5-mL serum
specimens
• Two shipments per year
Program Information• Two 1.0-mL serum specimens
• Two shipments per year
Program Information• Two 1.0-mL serum specimens
• Two shipments per year
Immunology
800-323-4040 | 847-832-7000 Option 1 | cap.org 183
Imm
unology and Flow C
ytometry
15
Antiphospholipid Antibody ACLAnalyte Program Code Challenges/Shipment
ACL
Anticardiolipin antibody(polyclonal, lgG, lgM, and lgA)
z
Beta-2-glycoprotein I(polyclonal, lgG, lgM, and lgA)
z
Antiphosphatidylserine Antibody APSAnalyte Program Code Challenges/Shipment
APS
Anticardiolipin antibody (polyclonal,IgG, IgM, and IgA)
z
Antiphosphatidylserine antibody(IgG, IgM, and IgA)
z
Beta-2-glycoprotein I (polyclonal,IgG, IgM, and IgA)
z
Antiribosomal-P Antibody ARPAnalyte Program Code Challenges/Shipment
ARP
Antiribosomal-P antibody z
Anti-Saccharomyces cerevisiae Antibody ASCAnalyte Program Code Challenges/Shipment
ASC
Anti-Saccharomyces cerevisiae antibody,lgG and lgA
z 2
Program Information• Three 0.5-mL lyophilized
serum specimens
• Two shipments per year
Program Information• Three 0.5-mL lyophilized
serum specimens
• Two shipments per year
Program Information• Three 0.5-mL serum
specimens
• Two shipments per year
New
Program Information• Two 1.0-mL serum specimens
• Two shipments per year
Immunology
184 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Imm
unol
ogy
and
Flow
Cyt
omet
ry
15
Celiac Serology CESAnalyte Program Code Challenges/Shipment
CES A B
Antiendomysial antibody, IgA and lgG z 2
Antiendomysial antibody screen, lgA and lgG z 2
Antigliadin antibody, lgA and lgG z 2
Antideamidated gliadin peptide antibody,lgA and lgG
z 2
Antideamidated gliadin peptide antibodyscreen, IgA and IgG
z 2
Antitissue transglutaminase antibody,lgA and lgG
z 2
Antideamidated gliadin peptide andantitissue transglutaminase antibody screen,IgA and IgG
z 2
Cyclic-Citrullinated PeptideAntibody (Anti-CCP) CCP
Analyte Program Code Challenges/Shipment
CCP
Anti-CCP z 2
Cytokines CTKNAnalyte Program Code Challenges/Shipment
CTKN
Interferon (IFN)-gamma z
Interleu in (IL)-1 beta z
IL-2 z
IL-6 z
IL-8 z
IL-10 z
Tumor necrosis factor (TNF)-alpha z
Vascular endothelial growth factor (VEGF) z
Program Information• Each shipment will contain the
appropriate number of0. -mL serum specimens
• Two shipments per year
Program Information• Two 1.0-mL serum specimens
• Two shipments per year
Program Information• Three 2.0- to .0-mL
lyophilized serum specimens
• Two shipments per year
Immunology
800-323-4040 | 847-832-7000 Option 1 | cap.org 185
Imm
unology and Flow C
ytometry
15
Diagnostic Allergy SEAnalyte/Procedure Program Code Challenges/Shipment
SE
IgE, multiallergen screen ( ualitative) z 5
IgE, total z 5
Lateral flow immunoassay z 5
Specific allergens z 25
Educational challenges z 2 per year
Heavy Chain/Light ChainAnalysis HCA
Analyte Program Code Challenges/Shipment
HCA
IgA appa z
IgA lambda z
IgA appa/lambda ratio and ratiointerpretation
z
IgG appa z
IgG lambda z
IgG appa/lambda ratio and ratiointerpretation
z
IgM appa z
IgM lambda z
IgM appa/lambda ratio and ratiointerpretation
z
This program will target uni ue junctional epitopes between the constant regions ofimmunoglobulin heavy and light chains and will allow laboratories to identify the differentlight chain types of each immunoglobulin class.
High-Sensitivity/Cardiac C-Reactive Protein HSCRPAnalyte Program Code Challenges/Shipment
HSCRP
High-sensitivity/Cardiac C-reactive protein z
Program Information• Five 2.0-mL serum specimens
• Includes common allergensfrom North America as wellas less frequently testedallergens
• Also compatible with theImmunoCAP® Rapid InhalantProfile 1 device for allergentesting
• Three shipments per year
Program Information• Three 1.0-mL serum
specimens
• Two mailings per year
New
Program Information• Three 0.5-mL li uid serum
specimens
• Two shipments per year
Immunology
186 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Imm
unol
ogy
and
Flow
Cyt
omet
ry
15
Liver-Kidney Microsomal Antibody (Anti-LKM) LKMAnalyte Program Code Challenges/Shipment
LKM
Anti-L M z 2
M. tuberculosis-Stimulated Infection Detection QFAnalyte Program Code Challenges/Shipment
QF
M. tuberculosis z 2
Rheumatic Disease Special Serologies RDSAnalyte Program Code Challenges/Shipment
RDS
Anti- o-1 (antihistidyl t-RNA synthetase) z 1
Anti-Scl-70 (anti-DNA topoisomerase) z 1
Syphilis Serology GAnalyte Program Code Challenges/Shipment
G
Syphilis z 5
Use with VDRL, RPR, MHA-TP/TP-PA/PK-TP, EIA, CMIA, multiplex flow immunoassay,FTA-ABS, and USR methods. Laboratories performing syphilis serology on CSF specimensmay also use this Survey.
Total Hemolytic Complement CH50Analyte Program Code Challenges/Shipment
CH50
Total hemolytic complement, 50 lysis z 2
Total hemolytic complement, 100 lysis z 2
Program Information• Two 1.0-mL serum specimens
• Two shipments per year
Program Information• Two 1.0-mL lyophilized
specimens and onelyophilized mitogen control
• For use with theuantiFERON®-TB method
only
• Two shipments per year
Program Information• Two 1.0-mL serum specimens
• Two shipments per year
Program Information• Five 1.5-mL serum specimens
• Three shipments per year
Program Information• Two 0.5-mL lyophilized
serum specimens
• Two shipments per year
Immunology
800-323-4040 | 847-832-7000 Option 1 | cap.org 187
Imm
unology and Flow C
ytometry
15
Viscosity VAnalyte Program Code Challenges/Shipment
V
Viscosity z 2
Serum Free Light Chains SFLCAnalyte Program Code Challenges/Shipment
SFLC
appa serum free light chain z
Lambda serum free light chain z
appa/lambda serum free lightchain ratio and ratio interpretation
z
Program Information• Two 10.0-mL serum
specimens
• Two shipments per year
Program Information• Three 1.0-mL serum
specimens
• Two shipments per year
Rely on this reference for a rapidly growing fieldFlow Cytometry in Evaluation of Hematopoietic Neoplasms: A Case-Based Approach is a practical, case-based guide to flow cytometricanalysis in the workup of hematopoietic neoplasms presenting inthe peripheral blood, marrow, lymphoid tissue, and extranodal sites.Using multicolor techniques pioneered by Brent Wood, the textdemonstrates a unique approach to diagnosis of hematopoieticmalignancies as well as identification of small abnormal populationsin the posttherapy setting (minimal residual disease testing).
This text provides pathologists, residents, laboratory technologists,and hematologists with both a study guide and an atlas forregular consultation in the clinical flow cytometry laboratory.
To orderVisit cap.org and choose the Shop tabor call the CAP Customer Contact Centerat 800-323-4040 or 847-832-7000 option 1.
Item number: PUB221ISBN: 978-0-9837068-2-3Hardcover; 176 pages; 2012
PRESS
Also available as an ebook! Visit ebooks.cap.org
Flow Cytometry
188 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Imm
unol
ogy
and
Flow
Cyt
omet
ry
15
Flow CytometryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Flow Cytometry FL, FL1, FL2Procedure Program Code Challenges/Shipment
FL FL1 FL2
DNA content and cell cycle analysis z z
Lymphocyte immunophenotyping z z
This Survey is not appropriate for hematology analyzers with monoclonal antibody analysis.
Flow Cytometry—ImmunophenotypicCharacterization of Leukemia/Lymphoma
FL3, FL3CDProcedure Program Code Challenges/Shipment
FL3 FL3CD
Leu emia/lymphoma z 2
Leu emia/lymphoma list modechallenge (CD-ROM)
z 2
Additional Information• Becton Dic inson (BD) Cell uest users may need FACSConvert™ software, which
is standard on most operating systems, to view the BD list mode files on theFL CD CD-ROM.
• Survey FL features DigitalScope technology that simulates the use of a microscope byenabling the user to scan and adjust magnification of the whole slide image.
• See system re uirements on page 15.
Program Information• FL1 - Three 1.5-mL whole
blood specimens
• FL2 - Three 1.1-mLspecimens; two fixed cell linespecimens and onecalibrator for DNA contentand cell cycle analysis
• FL - All Survey FL1 and FL2specimens
• Three shipments per year
Program Information• FL - Two .5-mL whole
blood specimens and/or celllines simulating leukemia/lymphoma; images of tissuesections, bone marrow, and/or peripheral blood smearswith clinical histories
• Online whole slide imagespowered by DigitalScopetechnology
• FL CD - CD-ROM containingtwo cases of leu emia/lymphoma with clinicalhistories, digital images,and ungated list mode files;allows users to examinegating strategies and interpretantibody staining patterns;the files are in standard FCS2.0 format and wor wellwith Cell uest™, FACSCanto/Diva™, Expo 2, R(C) P,and other software capableof reading the FCS 2.0 files(with the exception ofSystem II and Paint-A-Gate™
software)
• Two shipments per year
Flow Cytometry
800-323-4040 | 847-832-7000 Option 1 | cap.org 189
Imm
unology and Flow C
ytometry
15
Flow Cytometry, CD34+ FL4Analyte Program Code Challenges/Shipment
FL4
CD z 2
Flow Cytometry, Interpretation Only FL5Procedure Program Code Challenges/Shipment
FL5
Flow cytometry, interpretation only z 2
Survey FL5 is for laboratories that receive flow cytometry analyses from referring laboratories toperform the interpretation of patient results.
Flow Cytometry – ImmunophenotypicCharacterization of Paroxysmal Nocturnal
Hemoglobinuria PNHAnalyte/Procedure Program Code Challenges/Shipment
PNH
PNH RBC analysis z 2
PNH BC analysis z 2
Additional InformationThe PNH Survey complies with the recommendations from the Guidelines for theDiagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria and RelatedDisorders by Flow Cytometry for RBC (eg, CD59 and CD2 5a) and BC (eg, CD15,CD2 , CD 5, and FLAER) analysis. Due to the uni ue nature of these human, donor-based materials, the shipping dates are subject to change. If this should occur, the CAPwill provide notification prior to the originally scheduled shipping date.
Fetal Red Cell Detection HBFProcedure Program Code Challenges/Shipment
HBF
leihauer-Bet e, flow cytometry z 2
Rosette fetal screen z 2
Program Information• Two 1.5-mL stabilized human
CD specimens
• Two shipments per year
Program Information• Two cases consisting of gated
dot plots, clinical histories,and pertinent laboratory data,as well as images of tissuesections, bone marrow, and/or peripheral blood smears
• Two shipments per year
Program Information• Two 0.5-mL whole blood
specimens for RBC andBC analysis
• Two shipments per year
Program Information• Two 1.2-mL li uid whole
blood specimens
• Not designed for F cellquantitation
• Two shipments per year
Flow Cytometry
190 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Imm
unol
ogy
and
Flow
Cyt
omet
ry
15
Rare Flow Antigen Validation, CD1a RFAV1Analyte Program Code Challenges/Shipment
RFAV1
CD1a z 1
Survey RFAV1 does not meet the regulatory requirements for proficiency testing.
Additional InformationThis Survey meets the CAP Accreditation Chec list item FLO.2 7 7, which re uiressemiannual testing of antigens.
ZAP-70 Analysis by Flow Cytometry ZAP70Analyte Program Code Challenges/Shipment
ZAP70
eta chain-associated protein inase 70 z
Additional InformationThis Survey tests for intracellular AP-70 staining of cell lines co-stained with panT- and B-cell mar ers. It allows for assessment of the laboratory s staining techni ues andthe antibody clone used for AP-70 detection.
Program Information• One .5-mL cell line
specimen
• Two shipments per year
Program Information• Three .5-mL cell line
specimens
• Two shipments per year
Download My PT Shipping Calendar to access your customizedshipping scheduleAccess your customized shipping calendar* through e-LAB Solutions™.Not enrolled in e-LAB Solutions? Go to cap.org to get started.
*CAP distributor customers—contact your distributor for your PT shipping scheduleS
O L U T IO
NS
. . . . . . . . . . .
..
..
..
..
..
..
...
-LAB TM
TransfusionM
edicine,ViralMarkers,and
ParentageTesting
16
Transfusion Medicine, Viral Markers, and Parentage TestingTransfusion Medicine......................................................................................................................192Viral Markers ................................................................................................................................201Parentage Testing ..........................................................................................................................204
New Programs New
Transfusion Medicine Competency Assessment—Eluate Test (TMCAE) ..................................................194Antibody Titer (ABT3) .....................................................................................................................196Red Blood Cell Antigen Typing (RBCAT) ...........................................................................................200
Discontinued ProgramsParentage/Relationship Testing (PAR)
See Survey PARF ..................................................................................................................................... 204
16 Transfusion Medicine, Viral Markers,and Parentage Testing
“In my state especially, we’re very regulated, andhave all these regulatory agencies coming in. TheCAP is the recognized laboratory standard andit’s great that you are compared to a large peergroup. I’ve been a manager in a laboratory withoutthe CAP and with the CAP, and I will tell you that itis better to be with the CAP!”
Transfusion Medicine
192 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Tran
sfus
ion
Med
icin
e,Vi
ralM
arke
rs,a
ndPa
rent
age
Test
ing
16
Transfusion MedicineAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Transfusion Medicine, Comprehensive/Limited J, J1Procedure Program Code Challenges/Shipment
J J1
ABO grouping z z 5
Rh typing z z 5
Antibody detection z 5
Antibody identification z 5
Compatibility testing z 5
Red blood cell antigen typing z 1
Transfusion Medicine Automated Testing JATProcedure Program Code Challenges/Shipment
JAT
ABO grouping z 5
Antibody detection z 5
Antibody identification z 5
Compatibility testing z 5
Rh typing z 5
Transfusion Medicine Educational Challenges JE1Analyte/Program Program Code Challenges/Shipment
JE1
Educational challenge z 1
Program Information• - Five 2.0-mL red blood
cell suspensions; five .0-mLcorresponding serumspecimens; one 2.0-mL donorred blood cell suspension
• 1 - Five 2.0-mL redblood cell suspensions; five.0-mL corresponding serum
specimens
• Three shipments per year
Program Information• Five bar-coded .0-mL
blood specimens and one.0-mL blood specimen for
compatibility testing
• Three shipments per year
Program Information• One educational challenge,
which may consist of apaper challenge and/or wetspecimen for ABO grouping,Rh typing, antibody detection,antibody identification,compatibility testing, antigentyping, and/or directantiglobulin testing
• Must purchase in conjunctionwith Survey
• Three shipments per year
Transfusion Medicine
800-323-4040 | 847-832-7000 Option 1 | cap.org 193
TransfusionM
edicine,ViralMarkers,and
ParentageTesting
16
Transfusion Medicine Automated,Educational Challenges JATE1
Analyte/Program Program Code Challenges/Shipment
JATE1
Eduational challenge z 1
Expanded TransfusionMedicine Exercises ETME1
Procedure Program Code Challenges/Shipment
ETME1
Expanded challenges z 2
Additional InformationSurvey ETME1 is an educational opportunity that offers
• More challenging and/or complex antibody identification• Comprehensive case studies in transfusion medicine• Simulated collaboration with other professionals, including those within or outside
your institution• A method for determining the laboratory s ability to recognize and integrate problem
solving s ills in transfusion medicineThe wet challenge may consist of specimens for ABO grouping, Rh typing, antibodydetection, antibody identification, compatibility testing, antigen typing, direct antiglobulintesting, antibody titer, and/or antibody elution.
Program Information• One educational challenge,
which may consist of apaper challenge and/or wetspecimen for ABO grouping,Rh typing, antibody detection,antibody identification,and/or compatibility testing
• Must purchase in conjunctionwith Survey AT
• Three shipments per year
Program Information• ETME1 - One paper
challenge and one wetchallenge consisting of aserum specimen(s) and/orred blood cell suspensions
• Two shipments per year
Transfusion Medicine
194 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Tran
sfus
ion
Med
icin
e,Vi
ralM
arke
rs,a
ndPa
rent
age
Test
ing
16
Transfusion Medicine Competency Assessment—Comprehensive Transfusion Medicine TMCA
Procedure Program Code Challenges/Shipment
TMCA
ABO grouping z 2
Antibody detection z 2
Antibody identification z 2
Compatibility testing z 2
Rh typing z 2
Survey TMCA does not meet the regulatory requirements for proficiency testing.
Transfusion Medicine Competency Assessment—Direct Antiglobulin Test TMCAD
Procedure Program Code Challenges/Shipment
TMCAD
Direct antiglobulin testing z 2
Survey TMCAD does not meet the regulatory requirements for proficiency testing.
Transfusion Medicine CompetencyAssessment—Eluate Test TMCAE
Procedure Program Code Challenges/Shipment
TMCAE
Antibody elution z 2
Survey TMCAE does not meet the regulatory requirements for proficiency testing.
Transfusion Medicine Competency Assessment—Fetal Red Cell Quantitation TMCAF
Procedure Program Code Challenges/Shipment
TMCAF
leihauer-Bet e, flow cytometry z 2
Rosette fetal screen z 2
Survey TMCAF does not meet the regulatory requirements for proficiency testing.
Program Information• Two 2.0-mL red blood cell
suspensions
• Two .0-mL correspondingserum specimens
• One 2.0-mL donor redblood cell suspension
• Three shipments per year;order shipments individuallyor for an entire year
Program Information• Two 2.0-mL red
blood cell suspensions
• Two shipments per year;order shipments individuallyor for an entire year
Program Information• Two 2.0-mL 50 red blood
cell suspensions
• Two shipments per year;order shipments individuallyor for an entire year
New
Program Information• Two 1.2-mL whole blood
specimens
• Two shipments per year;order shipments individuallyor for an entire year
Transfusion Medicine
800-323-4040 | 847-832-7000 Option 1 | cap.org 195
TransfusionM
edicine,ViralMarkers,and
ParentageTesting
16
Transfusion Medicine, Electronic Crossmatch EXMProcedure Program Code Challenges/Shipment
EXM
Electronic crossmatch z
Survey E M assists laboratories in monitoring the performance of their electroniccrossmatching system.
Transfusion Medicine Automated,Electronic Crossmatch EXM2
Procedure Program Code Challenges/Shipment
EXM2
Electronic crossmatch z
Survey E M2 assists laboratories in monitoring the performance of their electroniccrossmatching system.
Program Information• Three simulated, ISBT-128
labeled donor unit challengesand three corresponding redblood cell suspensions
• Must order in conjunction withSurvey
• Two shipments per year
Program Information• Three simulated, ISBT-128
labeled donor unit challengesand three corresponding redblood cell suspensions
• Must purchase in conjunctionwith Survey AT
• Two shipments per year
The guidance I providefor PT ordering and resultsassures my customers thateverything will be okay.
– Tiffani
“ “
CAP Customer Contact Center representativesunderstand the importance of what you do.
Transfusion Medicine
196 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Tran
sfus
ion
Med
icin
e,Vi
ralM
arke
rs,a
ndPa
rent
age
Test
ing
16
Antibody Titer ABT, ABT1, ABT2, ABT3Analyte/Procedure Program Code Challenges/Shipment
ABT ABT1 ABT2 ABT3
Anti-A titer z z 1
Anti-B titer z 1
Anti-D titer z z 1
Program Information• ABT - One 2.0-mL plasma
specimen for anti-A titerwith one corresponding titercell ( to red bloodcell suspension); one 2.0-mLplasma specimen for anti-Dtiter with one correspondingtiter cell ( to red bloodcell suspension)
• ABT1- One 2.0-mL plasmaspecimen for anti-A titer withone corresponding titer cell( to red blood cellsuspension)
• ABT2 One 2.0-mL plasmaspecimen for anti-D titer withone corresponding titer cell( to red blood cellsuspension)
• ABT - One 2.0-mL plasmaspecimen for anti-B titer withone corresponding titer cell( to red blood cellsuspension)
• Two shipments per year
Transfusion Medicine
800-323-4040 | 847-832-7000 Option 1 | cap.org 197
TransfusionM
edicine,ViralMarkers,and
ParentageTesting
16
Bacterial Detection in Platelets BDP, BDP5Procedure Challenges/Shipment
Program Code
BDP BDP5
Bacterial culture and detection systems 2 5
Additional Information• The Centers for Medicare Medicaid Services (CMS) re uires proficiency testing for
bacterial detection in platelets.• Survey BDP is designed for donor centers/laboratories that are associated with
a CMS-certified microbiology laboratory with the same CLIA number and areparticipating in an approved proficiency testing program for bacterial detection.
• Survey BDP5 is designed for donor centers/laboratories that are performing bacterialdetection for the purposes of platelet unit screening and are not associated with aCMS-certified microbiology laboratory with the same CLIA number.
• See International Shipping information section in the Ordering InformationSupplement regarding additional dangerous goods shipping fees.
Bacterial Detection in Platelets, RapidBDPV, BDPV5
Procedure Challenges/Shipment
Program Code
BDPV BDPV5
Rapid immunoassay 2 5
Additional Information• The Centers for Medicare and Medicaid Services (CMS) re uires proficiency testing
for bacterial detection in platelets.• Survey BDPV is designed for donor centers/laboratories that are associated with
a CMS-certified microbiology laboratory with the same CLIA number and areparticipating in an approved proficiency testing program for bacterial detection.
• Survey BDPV5 is designed for donor centers/laboratories that are performingbacterial detection for the purposes of platelet unit screening and are not associatedwith a CMS-certified microbiology laboratory with the same CLIA number.
• See International Shipping information section in the Ordering InformationSupplement regarding additional dangerous goods shipping fees.
Program Information• BDP - Two lyophilized pellet
specimens with diluents; twoshipments per year
• BDP5 - Five lyophilized pelletspecimens with diluents; threeshipments per year
Program Information• BDPV - Two frozen
specimens; two shipmentsper year
• BDPV5 - Five frozenspecimens; three shipmentsper year
• For use with methods such asVerax Biomedical
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Transfusion Medicine
198 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Tran
sfus
ion
Med
icin
e,Vi
ralM
arke
rs,a
ndPa
rent
age
Test
ing
16
Cord Blood and Stem Cell Processing CBT, SCPProcedure Program Code Challenges/Shipment
CBT SCP
Absolute CD z 2
Absolute CD z z 2
Absolute CD 5 z 2
Bacterial culture z z 2
CD z 2
CD z z 2
CD 5 z z 2
BF -E z z 2
CF -E z z 2
CF -GEMM z z 2
CF -GM z z 2
Total CFC z z 2
Fungal culture z z 2
Hematocrit z z 2
Hemoglobin z z 2
Mononuclear cell count z z 2
Total nucleated cells z z 2
Total nucleated red cells z z 2
Viability z z 2
BC count z z 2
Additional Information• Because these materials are human donor-based, the ship date is subject to change.
If this should occur, notification will be provided prior to the scheduled date. In someinstances, the program may ship in two installments.
• Due to material stability, no replacements will be available.• See International Shipping information section in the Ordering Information
Supplement regarding additional dangerous goods shipping fees.
Direct Antiglobulin Testing DATProcedure Program Code Challenges/Shipment
DAT
Direct antiglobulin testing z
Program Information• CBT - Two 2.5-mL cord blood
specimens; designed forassays re uired for theproduction of umbilical cordblood stem cell programs
• SCP - Two .0-mL peripheralblood specimens; designedfor laboratories that processand assess the suitability ofstem cells
• Two shipments per year
Program Information• Three 2.0-mL red blood
cell suspensions
• Two shipments per year
Refer to the Ordering Information provided for information regarding additional dangerous goods and related fees.
Transfusion Medicine
800-323-4040 | 847-832-7000 Option 1 | cap.org 199
TransfusionM
edicine,ViralMarkers,and
ParentageTesting
16
Eluate Survey ELUProcedure Program Code Challenges/Shipment
ELU
Antibody elution z 2
Fetal Red Cell Detection HBFProcedure Program Code Challenges/Shipment
HBF
leihauer-Bet e, flow cytometry z 2
Rosette fetal screen z 2
Platelet Serology PSProcedure Program Code Challenges/Shipment
PS
Antibody detection z
Platelet crossmatch z
Platelet antibody identification z
A low concentration of sodium azide may be present in the specimens and may affectlymphocytotoxicity methods.
Red Blood Cell AntigenGenotyping RAG
Procedure Program Code Challenges/Shipment
RAG
Red cell antigen genotype withpredictive phenotype
z
Program Information• Two 2.0-mL 50 red blood
cell suspensions
• Two shipments per year
Program Information• Two 1.2-mL li uid whole
blood specimens
• Not designed for F celluantitation
• Two shipments per year
Program Information• Three .0-mL plasma
specimens
• For use with solid-phasered cell adherence, flowcytometry, EIA/ELISA, andRIA methods
• Two shipments per year
Program Information• Three 2.0-mL whole blood
specimens
• Two shipments per year
Transfusion Medicine
200 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Tran
sfus
ion
Med
icin
e,Vi
ralM
arke
rs,a
ndPa
rent
age
Test
ing
16
Red Blood Cell Antigen Typing RBCATProcedure Program Code Challenges/Shipment
RBCAT
Red blood cell antigen typing z 2
Additional InformationSurvey RBCAT is for donor centers and transfusion laboratories performing redcell phenotyping for the management of patients with complex serology includingalloimmunization, sic le cell disease and/or warm autoimmune hemolytic anemia.Challenges will include antigens such as Rh, ell, MNSs, Duffy, and idd bloodgroup system.
Transfusion-Related Cell Count TRCProcedure Program Code Challenges/Shipment
TRC
Platelet count (platelet-rich plasma) z 5
BC count z
Dry challenge z 2
WBC counts must be performed using a Nageotte chamber, fluorescence microscopy or byflow cytometry.
Program Information• Two 2.0-mL red blood cell
suspensions
• Two shipments per year
New
Program Information• Five 1.2-mL suspensions of
platelet-rich plasma
• Two 1.0-mL vials leu ocyte-reduced platelet material
• Two 1.0-mL vials leu ocyte-reduced red blood cells
• Three shipments per year
Viral Markers
800-323-4040 | 847-832-7000 Option 1 | cap.org 201
TransfusionM
edicine,ViralMarkers,and
ParentageTesting
16
Viral MarkersAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Viral Markers—Series 1 VM1Analyte Program Code Challenges/Shipment
VM1
Anti-HAV (total IgM and IgG) z 5
Anti-HAV (IgG) z 5
Anti-HBc (total: IgM and IgG) z 5
Anti-HBs z 5
Anti-HCV z 5
Anti-HIV-1 z 5
Anti-HIV-1/2 z 5
Anti-HIV-2 z 5
HBsAg z 5
Do not use Survey VM1 with rapid anti-HCV, anti-HIV-1, or anti-HIV-1/2 kits. See page 202 forSurveys appropriate for rapid methods.
Viral Markers—Series 2 VM2Analyte Program Code Challenges/Shipment
VM2
Anti-HBe z 5
HBeAg z 5
Viral Markers—Series 3 VM3Analyte Program Code Challenges/Shipment
VM3
Anti-CMV z
Anti-HTLV-I/II z
HIV-1 p2 antigen z
Program Information• Five .5-mL plasma specimens
• Three shipments per year
Program In formation• Five .5-mL plasma specimens
• Three shipments per year
Program Information• Three .5-mL plasma
specimens
• Two shipments per year
Viral Markers
202 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Tran
sfus
ion
Med
icin
e,Vi
ralM
arke
rs,a
ndPa
rent
age
Test
ing
16
Viral Markers—Series 4 VM4Analyte Program Code Challenges/Shipment
VM4
Anti-Trypanosoma cruzi (Chagas disease) z 2
Viral Markers—Series 5 VM5Analyte Program Code Challenges/Shipment
VM5
Anti-HAV (IgM) z 5
Anti-HBc (IgM) z 5
Viral Markers—Series 6 VM6Analyte Program Code Challenges/Shipment
VM6
Anti-HIV-1/2, HIV-1 p2 antigen z 5
Rapid Anti-HIV AHIV, AHIVWAnalyte/Procedure Program Code Challenges/Shipment
AHIV AHIVW
Anti-HIV-1, Anti-HIV-2, Anti-HIV-1/2 z 5
Anti-HIV-1, Anti-HIV-1/2,waived methods only
z 2
Anti-HCV, Rapid Methods RHCVWAnalyte/Procedure Program Code Challenges/Shipment
RHCVW
Anti-HCV, waived methods only z
Program Information• Two 1.0-mL plasma
specimens
• Two shipments per year
Program Information• Five 1.5-mL plasma
specimens
• Three shipments per year
Program Information• Five 0.5-mL serum specimens
• For use with methods such asthe Abbott ARCHITECT HIVCombo and the Bio-Rad GSHIV Combo assays
• Three shipments per year
Program Information• AHIV - Five 0.5-mL plasma
specimens; second methodreporting available; threeshipments per year
• AHIV - Two 0.5-mL plasmaspecimens; report up to fivedifferent locations within yourinstitution; two shipmentsper year
Program Information• Three 0.5-mL plasma
specimens
• Two shipments per year
Viral Markers
800-323-4040 | 847-832-7000 Option 1 | cap.org 203
TransfusionM
edicine,ViralMarkers,and
ParentageTesting
16
Nucleic Acid Testing NATAnalyte Program Code Challenges/Shipment
NAT
HBV z 5
HCV z 5
HIV z 5
est Nile virus z 5
Program Information• Five 6.0-mL plasma specimens
• Designed for blood donorcenters performing nucleicacid testing on donor units
• Compatible with HIV, HCV,and HBV multiplex assays
• Three shipments per year
Parentage Testing
204 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Tran
sfus
ion
Med
icin
e,Vi
ralM
arke
rs,a
ndPa
rent
age
Test
ing
16
Parentage Testing
Parentage/Relationship Testing PARFAnalyte/Procedure Program Code Challenges/Shipment
PARF
Calculation challenge (paper challenge) z 1
DNA testing (PCR) z
Program Information• Three blood-stained filter
paper paternity triospecimens; two buccal swabsfor a second alleged fatherchallenge
• Reporting for short tandemrepeats (STRs), Y-STRs, as wellas the conclusions provided
• Three shipments per year
Let them know you’ve earned the markThe CAP certification mark recognizes organizations worldwidefor achieving CAP accreditation. Today, this honor is sharedwith more than 7,600 laboratories. The mark is a way to displayto peers, patients, and the public that you’ve attained CAPaccreditation through the most respected and recognizedlaboratory accreditation program in the world.
The CAP certification mark may be displayed on your website, advertisements, laboratory reports,and in patient areas to communicate your CAP accreditation status.
To access and download your CAP certification mark, please log in to your e-LAB Solutions™account, or contact the CAP Customer Contact Center at [email protected].
Histocompatibility
17
New Programs New
Antibody Titer (ABT3) .....................................................................................................................208HLA Disease Association, Drug Risk (DADR1, DADR2) .......................................................................209
17 | Histocompatibility
“We really like the range of programs the CAP offers.Within each area we can see how we can becomemore efficient. It’s always reassuring to the physiciansto say we have never failed a proficiency testingchallenge from the CAP.”
Histocompatibility
206 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hist
ocom
patib
ility
17
HistocompatibilityAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
For laboratories conducting BOTH Class I and Class II HLA testing, see next page.
HLA Crossmatching, Antibody Screen, and AntibodyIdentification (Class I) MX1B, MX1C, MX1E
Procedure Program Code Challenges/Shipment
MX1B MX1C MX1E
Crossmatching z z 8
Antibody screen z z z 4
Antibody identification z z z 4
HLA Crossmatching, Antibody Screen, and AntibodyIdentification (Class II) MX2B, MX2C, MX2E
Procedure Program Code Challenges/Shipment
MX2B MX2C MX2E
Crossmatching z z 4
Antibody screen z z z 2
Antibody identification z z z 2
Program Information• M 1B - Four 0.25-mL
plasma specimens; two(approximately 1.0 x 106
cells) purified peripheralblood lymphocyte specimens
• M 1C - Four 0.50-mLplasma specimens; two(approximately .0 x 106
cells) purified peripheralblood lymphocyte specimens
• M 1E - Four 0. 0-mL plasmaspecimens; must be orderedin conjunction with SurveyM 1B or M 1C
• Multiple method reportingprovided
• Three shipments per year
Program Information• M 2B - Two 0.25-mL
plasma specimens; two(approximately 7.2 x 106
cells) purified peripheralblood lymphocyte specimens
• M 2C - Two 0.50-mLplasma specimens; two(approximately 9.6 x 106
cells) purified peripheralblood lymphocyte specimens
• M 2E - Two 0. 0-mL plasmaspecimens; must be orderedin conjunction with SurveyM 2B or M 2C
• Multiple method reportingprovided
• Three shipments per year
Histocompatibility
800-323-4040 | 847-832-7000 Option 1 | cap.org 207
Histocompatibility
17
HLA Crossmatching, Antibody Screen, and AntibodyIdentification (Class I/II) Combinations MXB, MXC
Procedure Corresponding Survey Program Code
MXB MXC
Crossmatching, antibody screen, andantibody identification, Class I
M 1B* z
Crossmatching, antibody screen, andantibody identification, Class II
M 2B* z
Crossmatching, antibody screen, andantibody identification, Class I
M 1C* z
Crossmatching, antibody screen, andantibody identification, Class II
M 2C* z
*See page 206 for specimen and analyte information.
HLA Molecular Typing ML, DL, DMLProcedure Program Code Challenges/Shipment
ML DL DML
Molecular HLA-A, -B, and -C typing (Class I) z z 5
Molecular HLA-DR, -D , and -DP typing(Class II)
z z 5
HLA Serologic Typing (Class I/II)ABO, HLAS, HLAS1
Procedure Program Code Challenges/Shipment
ABO HLAS HLAS1
ABO grouping (includes A subtyping) z 5
HLA serologic typing (Class I and Class II) z
HLA serologic typing (Class I only) z
Program Information• M B - Class I four 0.25-mL
plasma specimens, twopurified peripheral bloodlymphocyte specimens; ClassII two 0.25-mL plasmaspecimens, two purifiedperipheral blood lymphocytespecimens
• M C - Class I four 0.50-mLplasma specimens, twopurified peripheral bloodlymphocyte specimens; ClassII two 0.50-mL plasmaspecimens, two purifiedperipheral blood lymphocytespecimens
• Three shipments per year
Program Information• DL, ML - Five 1.5-mL whole
blood specimens in CPD-A
• DML - Ten 1.5-mL wholeblood specimens in CPD-A
• Serologic e uivalentsreporting available
• Three shipments per year
Program Information• ABO - Five 2.0-mL red
blood cell suspensions andfive .0-mL correspondingserum specimens; must beordered in conjunction withSurvey HLAS or HLAS1
• HLAS - Three .0-mLsuspensions of purifiedperipheral blood lymphocytes
• HLAS1 - Three 1.0-mLsuspensions of purifiedperipheral blood lymphocytes
• Three shipments per year
Histocompatibility
208 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Hist
ocom
patib
ility
17
HLA-B27 Typing B27Procedure Program Code Challenges/Shipment
B27
HLA-B27 typing z 5
Antibody Titer ABT, ABT1, ABT2, ABT3Analyte/Procedure Program Code Challenges/Shipment
ABT ABT1 ABT2 ABT3
Anti-A titer z z 1
Anti-B titer z 1
Anti-D titer z z 1
Monitoring Engraftment MEProcedure Program Code Challenges/Shipment
ME
Stem cell monitoring engraftment z 3
Program Information•Five2.0-mLwholeblood
specimens in CPD-A
•Twoshipmentsperyear
Program Information•ABT-One2.0-mLplasma
specimen for anti-A titer withonecorrespondingtitercell(3%to4%redbloodcellsuspension);one2.0-mLplasma specimen for anti-D titerwithonecorrespondingtitercell(3%to4%redbloodcell suspension)
• ABT1-One2.0-mLplasmaspecimenforanti-Atiterwithonecorrespondingtitercell(3%to4%redbloodcellsuspension)
•ABT2One2.0-mLplasmaspecimenforanti-Dtiterwithonecorrespondingtitercell(3%to4%redbloodcellsuspension)
• ABT3-One2.0-mLplasmaspecimenforanti-Btiterwithonecorrespondingtitercell(3%to4%redbloodcellsuspension)
•Twoshipmentsperyear
Program Information•Five1.5-mLwholeblood
specimens
•Designedforlaboratoriessupporting stem cell transplant andlaboratoriesmonitoringchimerismafterorgantransplantation
•Threeshipmentsperyear
Histocompatibility
800-323-4040 | 847-832-7000 Option 1 | cap.org 209
Histocompatibility
17
HLA Disease Association, Drug RiskDADR1, DADR2
Analyte Program Code Challenges/Shipment
DADR1 DADR2
HLA-A* 1 01 z
HLA-B*1 01 z
HLA-B*15 02 z
HLA-B*57 01 z
HLA-B*58 01 z
HLA-A*29 01 z
HLA-A*29 02 z
HLA-D A1*0 01 z
HLA-D A1*05 01 z
HLA-D B1*0 02 z
HLA-DRB1*0 01 z
HLA-DRB1*0 02 z
HLA-DRB1*0 02 z
HLA-DRB1*0 0 z
HLA-DRB1*0 06 z
HLA-DRB1*06 02 z
HLA-DRB1*08 02 z
HLA-DRB1*08 0 z
HLA-DRB1*1 0 z
HLA-DRB1*1 05 z
HLA-DRB1*1 08 z
HLA-DRB1*15 01 z
HLA-DRB1*15 02 z
D A1*0 /D B1*0 02 z
D A1*05/D B1*02 z
PRICE (USD)
Additional InformationThese Surveys will challenge the laboratory to accurately identify the presence or absenceof alleles associated with a variety of disease states (listed below) and/or the adversereactions to specific drugs.
Program Information• Three 0.1-mL specimens, each
containing 200 g/mL ofhuman DNA in media
• Two shipments per year
New
DADR1oCarbamezepine induced Stevens-
ohnson syndrome (CS )oAllopurinol Stevens- ohnson
syndrome (AS )oHypersensitivity to abacavir (HA)o Dapsone hypersensitivity (DH)
DADR2o Celiac disease (CD)o Narcolepsy (N)o Pemphigus vulgaris (PV)o Psoriasis (P)o Antiglomerular basement membrane
disease (ABM)o Birdshot retinochoroidopathy (BR)o Idiopathic myopathy (IM)
Are you ready for yourCAP inspection?The CAP Accreditation Readiness Assessment(CARA®) is an on-site evaluation and educationprogram for laboratories just beginning their pursuitof CAP accreditation. CARA focuses on:• Facilitating an in-depth understanding of
CAP requirements as they apply to your laboratory• Helping you manage the time and resources
necessary for compliance with CAP accreditationrequirements and preparation for your initial inspection
• Delivering on-site education when you’re ready for it
CARA provides a unique educational coachingexperience that leverages the expertise of the world’smost respected pathology organization.
More control. Zero risk. Give your laboratory its best opportunityto be prepared and be successful.
Email us at [email protected] to accelerate your quality journey.
“The Readiness Assessment [CARA] helped our labimmediately spot potential problems before our inspection.Our CAP inspection went like clockwork!”
Laboratory Director
Genetics
andM
olecularPathology
18
Genetics and Molecular PathologyCytogenetics..................................................................................................................................212Biochemical and Molecular Genetics................................................................................................215Next-Generation Sequencing...........................................................................................................221Molecular Oncology – Solid Tumors.................................................................................................222Molecular Oncology – Hematologic.................................................................................................225
New Programs New
Next-Generation Sequencing (NGS).................................................................................................221
New Analyte AdditionsMultigene Tumor Panel (MTP) ..........................................................................................................224
NRASPIK3CA
18 | Genetics and Molecular Pathology
“We want to use one vendor for all our proficiencytesting and the CAP provides the broad range ofSurveys needed. As new molecular testing becomesavailable, the CAP is first to provide proficiency testsso that we can be assured of providing the mostaccurate results for our patients and we do not haveto do alternative assessment.”
Cytogenetics
212 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
etic
san
dM
olec
ular
Path
olog
y
18
CytogeneticsAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
CAP/ACMG Cytogenetics CY, CYBKAnalyte/Procedure Program Code Challenges/Shipment
CY CYBK
Chromosome abnormality z z 6
Karyotype z z 6
Educational challenge, ungraded z z 1 per year
Additional InformationEach challenge includes a case history and images of metaphase cells that arerepresentative of each case. Each mailing will include three constitutional and threeneoplastic challenges.
CAP/ACMG Fluorescence In Situ HybridizationCYF, CYI
Disease/Procedure Program Code Challenges/Shipment
CYF CYI A B
Constitutional and HematologicDisorders
FISH for neoplastic disorder z 1 2
FISH for constitutional abnormality z 2 1
Urothelial Carcinoma
FISH for urothelial carcinoma z 2 2
Additional Information• CYF 2015-A
Hematologic disorder 20 deletion (two slides)Constitutional abnormality Prenatal aneuploidy probes (two slides)Constitutional abnormality (photograph)
• CYF 2015-BHematologic disorder – PML/RARA (two slides)Constitutional abnormality – Probes for the enumeration of sex chromosomes(two slides)Neoplastic disorder (photograph)
• CYF is prepared from cell suspension samples. For FISH in paraffin-embedded tissue,see page 213.
Program Information• CY - Online images of
metaphase cells; deliveredtwo times a year; your CAPshipping contact will benotified via email when theactivity is available
• CYB - Prints of metaphasecells; two shipments per year
Program Information• CYF - Four slides and one
photograph
• CYI - Two 250- L cell samplessuspended in ethanol fromtwo different specimens;participants use FISH to detectchromosome abnormalitiesusing probes for thecentromeres for chromosomes, 7, 17, and a locus-specific
probe for 9p21
• Two shipments per year
Cytogenetics
800-323-4040 | 847-832-7000 Option 1 | cap.org 213
Genetics
andM
olecularPathology
18
CAP/ACMG Fluorescence In Situ Hybridizationfor Paraffin-Embedded Tissue CYH, CYJ, CYK, CYLDisease/Procedure Program Code Challenges/
Shipment
CYH CYJ CYK CYL A B
Breast Cancer
HER2 gene amplification z 10 10
Brain/Glioma Tissue
1p/19q z 1 1
Solid Tumor
MYCN (2p2 ) gene amplification z 1
ALK (2p2 ) gene rearrangement z 1
Lymphoma Tissue
ALK (2p2 ) gene rearrangement z 1
IGH/BCL2 (1 2/18 21) generearrangement
z 1
CAP/ACMG Cytogenomic Microarray AnalysisCYCGH
Procedure Program Code Challenges/Shipment
CYCGH
Cytogenomic microarray analysisfor constitutional abnormality
z 2
Educational paper challengefor constitutional or neoplasticabnormality
z 1
Additional InformationParticipants will identify and characterize gains or losses and the cytogenetic location ofany abnormalities detected.
Program Information• CYH - Two unstained, five-
core tissue microarray slidese uivalent to 10 paraffin-embedded breast tissuespecimens; a duplicate set ofH&E stained tissue microarrayslides will also be provided
• CY - Four unstained slides;one H&E stained slide
• CY , CYL - Two unstainedslides; one H&E stained slide
• All specimens will be.0-micron tissue sections
mounted on positivelycharged glass slides
• Two shipments per year
Program Information• Two .0- g DNA specimens;
one educational paperchallenge
• Two shipments per year
Cytogenetics
214 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
etic
san
dM
olec
ular
Path
olog
y
18
Improve the reliability of your patient results with CAP Survey Validated Materialsse the same material that is sent in the Surveys program to
• Identify and troubleshoot instrument/method problems• Correlate results with other laboratories or instruments• Document correction of problems identified in Surveys• tilize material with confirmed results as an alternative external uality control• Identify potential proficiency testing failures
Each laboratory receives a Participant Summary, which includes readily available results.
Cytogenetics, Validated MaterialValidated Material Program Code Corresponding Survey Page
Cytogenetics VM CYM CY 212
Program Information• Prints of metaphase cells
Biochemical and Molecular Genetics
800-323-4040 | 847-832-7000 Option 1 | cap.org 215
Genetics
andM
olecularPathology
18
Biochemical and Molecular GeneticsAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
CAP/ACMG Biochemical Genetics BGL, BGL1Analyte/Procedure Program Code Challenges/Shipment
BGL BGL1
Acylcarnitines, ualitative anduantitative
z 1
Amino acids, ualitative anduantitative
z 1
Carnitine, ualitative and uantitative z 3
Glycosaminoglycans(mucopolysaccharides), ualitativeand uantitative
z 1
Organic acids, ualitative anduantitative
z 1
Educational challenge z 1
Program Information• BGL -
Acylcarnitines One 0.1-mLplasma specimen
Amino acids One 1.0-mLplasma or 2.0-mL urinespecimen
Glycosaminoglycans(mucopolysaccharides)One 2.0-mL urine specimen
Organic acids One 7.5-mLurine specimen
Educational challenge illconsist of any one of theBGL analytes
• BGL1 - Three 0. -mL serumspecimens
• Two shipments per year
Biochemical and Molecular Genetics
216 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
etic
san
dM
olec
ular
Path
olog
y
18
CAP/ACMG Alpha-1 Antitrypsin(SERPINA1) Genotyping AAT
Analyte/Procedure Program Code Challenges/Shipment
AAT
Alpha-1 antitrypsin genotyping z 3
This Survey will test for the M, S, and alleles.
CAP/ACMG Apolipoprotein EGenotyping APOE
Analyte/Procedure Program Code Challenges/Shipment
APOE
Apolipoprotein E (APOE) genotyping z 3
This Survey is designed for laboratories utilizing APOE testing for cardiovascular andAlzheimer diseases and will test for various variants (APOE e2, APOE e3, and APOE e ).
CAP/ACMG HemoglobinopathiesGenotyping HGM
Analyte/Procedure Program Code Challenges/Shipment
HGM
Alpha-thalassemia z 3
Beta-thalassemia z 3
Hemoglobin S/C z 3
Program Information• Three 10.0- g extracted
DNA specimens
• Two shipments per year
Program Information• Three 10.0- g extracted
DNA specimens
• Two shipments per year
Program Information• Three 50.0- g extracted
DNA specimens
• Two shipments per year
Biochemical and Molecular Genetics
800-323-4040 | 847-832-7000 Option 1 | cap.org 217
Genetics
andM
olecularPathology
18
CAP/ACMG Molecular GeneticsMGL1, MGL2, MGL3, MGL4, MGL5
Disease/GeneProgram Code Challenges/
ShipmentMGL1 MGL2 MGL3 MGL4 MGL5
Bloom syndrome z 3
BRCA1/2 z 3
Canavan z 3
Connexin 26 z 3
Cystic fibrosis z z /2(MGL5)
DMD/Bec er z 3
Factor V Leiden z 3
Familial dysautonomia z 3
Fanconi anemia complementationgroup C
z 3
Fragile X z 3
Friedreich ataxia z 3
Gaucher z 3
Glycogen storage disease type IA z 3
Hemochromatosis z 3
Hemoglobin S/C z 3
Huntington z 3
Methylene tetrahydrofolatereductase (MTHFR) 677C Tand 1298A C
z 3
Mucolipidosis IV z 3
Multiple endocrine neoplasiatype 2 (MEN2)
z 3
Myotonic dystrophy z 3
Niemann-Pic disease type A z 3
Plasminogen activator inhibitor(PAI)-1
z 3
Prader- illi/Angelman syndrome z 3
Prothrombin z 3
RhD z 3
Spinal muscular atrophy z 3
Spinocerebellar ataxia z 3
Tay-Sachs z 3
Module MGL is designed for laboratories testing for diseases/disorders related toAsh enazi ewish ancestry.
Program Information• MGL1, MGL2, MGL ,
MGL - A minimum ofthree 50.0- g extractedDNA specimens
• MGL5 - Two 50.0- gextracted DNA specimens
• Two shipments per year
Biochemical and Molecular Genetics
218 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
etic
san
dM
olec
ular
Path
olog
y
18
CAP/ACMG Inherited MetabolicDiseases IMD1, IMD2, IMD3
Analyte/Procedure Program Code Challenges/Shipment
IMD1 IMD2 IMD3
Mitochondrial DNA deletion syndromes z 3
MCAD z 3
Mitochondrial cytopathies* z 3
*Includes disorders/diseases such as Leber hereditary optic neuropathy and myoclonus epilepsywith ragged red fibers (MERRF).
CAP/ACMG Molecular Genetics SequencingSEC, SEC1
Procedure Program Code Challenges/Shipment
SEC SEC1
DNA se uencing interpretation challenge z 3
DNA se uencing z 3
Additional Information• Test your s ill at interpreting and reporting DNA se uence variants for inherited
disease using standard nomenclature.• Receive a summary and discussion of responses, including comments on the mutation
nomenclature, nown or expected outcomes from identified variants, and teachingpoints about genes/disorders represented.
Program Information• IMD1 - Three 50.0- L
DNA specimens (50.0-ng/L DNA PCR product that
encompasses the entiremitochondrial genome)
• IMD2, IMD - Three 50.0- gextracted DNA specimens
• Two shipments per year
Program Information• SEC - One CD-ROM
containing three DNAse uence electropherogramfiles with a range ofvariants, suitable for base-calling and analysis usinga range of commercial orpublic domain softwareprograms; also includescontrol se uences, normalDNA reference se uences,and nomenclature/mutationreferences
• SEC1 - Three 10.0- gextracted DNA specimens;one set of forward andreverse lyophilized primers
• Two shipments per year
Biochemical and Molecular Genetics
800-323-4040 | 847-832-7000 Option 1 | cap.org 219
Genetics
andM
olecularPathology
18
Pharmacogenetics PGX, PGX1, PGX2Analyte/Procedure Program Code Challenges/
Shipment
PGX PGX1 PGX2
CYP2C19 z 2
CYP2C9 z 2
CYP2D6 z 2
UGT1A1 z 2
VKORC1 z 2
IL28B (rs12979860) z 3
HLA-B*5701 z 3
Additional InformationSurvey PG 2 is designed for laboratories that provide HLA-B*5701 testing to identify risof hypersensitivity to abacavir. The intended response is ualitative (presence/absenceof the allele). This Survey is not appropriate for laboratories that perform molecular HLAtyping. For HLA typing proficiency testing, please consult the HLA Molecular Typing(ML, DML) Surveys.
CAP/ACMG Rett Syndrome (MECP2) RETTAnalyte/Procedure Program Code Challenges/Shipment
RETT
MECP2 genotyping z 3
CAP/ACMG ThrombophiliaMutations TPM
Analyte/Procedure Program Code Challenges/Shipment
TPM
Factor II z 3
Factor V z 3
Additional InformationThis Survey is designed for the Cepheid Gene pert factor II and factor V assays. DNAextraction for other assays/methods is NOT recommended.
Program Information• PG - Two 25.0- g extracted
DNA specimens
• PG 1, PG 2 - Three 25.0- gextracted DNA specimens
• Includes allele detection(genotyping) and/orinterpretive challenges
• Two shipments per year
Program Information• Three 10.0- g extracted DNA
specimens
• Two shipments per year
Program Information• Three 0.25-mL synthetic
whole blood specimens
• Two shipments per year
Biochemical and Molecular Genetics
220 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
etic
san
dM
olec
ular
Path
olog
y
18
Red Blood Cell AntigenGenotyping RAG
Procedure Program Code Challenges/Shipment
RAG
Red cell antigen genotype withpredictive phenotype
z 3
Program Information• Three 2.0-mL whole blood
specimens
• Two shipments per year
800-323-4040 | 847-832-7000 Option 1 | cap.org 221
Genetics
andM
olecularPathology
18
Next-Generation Sequencing
Next-Generation SequencingAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Next-Generation Sequencing NGSProcedure Program Code Challenges/Shipment
NGS
Next-generation se uencing z 1
Additional InformationLaboratories will have the ability to test up to 200 variants. For the full list of genes in thisprogram, please go to cap.org and choose the Laboratory Improvement Programs tab.
Program Information• One 10.0- g extracted DNA
specimen
• Methods-based challengefor laboratories using genepanels, exome, and wholegenome se uencing
• Two shipments per year
New
Give the CAP’s complimentary Sample Exchange Registry service a try!Sign up for this unique and complimentary service for those rare analytes for whichproficiency testing is not yet available. This service now includes all clinicallaboratory disciplines.• The CAP connects labs performing testing for which no formal
proficiency testing is available.• There is no charge for this service.• Participate at any time, no contract required.• A minimum of three labs performing the same analyte must participate
before the CAP can facilitate the sample exchange.• Each individual laboratory will receive its own results along with an anonymized summary
report for all participants.
Visit cap.org and choose the Laboratory Improvement Programs tab to register today!
Molecular Oncology – Solid Tumors
222 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
etic
san
dM
olec
ular
Path
olog
y
18
Molecular Oncology – Solid TumorsAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Defective DNA Mismatch Repair/HereditaryNonpolyposis Colorectal Cancer (HNPCC)
MSIProcedure Program Code Challenges/Shipment
MSI
Microsatellite instability testing(DNA amplification)
z 3
Laboratories performing DNA mismatch repair assessment by immunohistochemistry methodsshould see Survey MMR on page 237.
In Situ Hybridization ISH, ISH2Analyte/Procedure Program Code Challenges/Shipment
ISH ISH2
Epstein-Barr virus (EBV) z
Human papillomavirus (HPV) z
appa/Lambda (IG /IGL) z
HER2 (ERBB2) gene amplification(brightfield)
z 10
Laboratories performing FISH for interphase chromosomal targets in paraffin sections refer to theCytogenetics Surveys, page 213.
Program Information• Two 10.0-micron unstained
paraffin section slidesand one H&E slide; twophotograph challenges
• For laboratories performingmolecular testing using PCR
• Two shipments per year
Program Information• ISH - EBV, HPV Three -core
tissue microarray slides andone H E slide (each)
appa/Lambda Four -coretissue microarray slides andone H&E slide
• ISH2 - Two sets of 5-coretissue microarray slides
• Two shipments per year
Molecular Oncology – Solid Tumors
800-323-4040 | 847-832-7000 Option 1 | cap.org 223
Genetics
andM
olecularPathology
18
Neoplastic Cellularity NEOProcedure Program Code Challenges/Shipment
NEO
Online assessment of percentneoplastic cellularity
z 10
Sarcoma Translocation SARCGene Program Code Challenges/Shipment
SARC
Sarcoma translocation* (RT-PCR) z 3
*See translocation listing below.
Laboratories performing FISH for sarcoma translocation refer to the Cytogenetics Surveys,page 213.
Sarcoma Translocation ListingCOL1A1/PDGFB, t(17;22) EWSR1/WT1, t(11;22) PAX3/FOXO1 or PAX7/FOXO1
EWSR1/ATF1, t(12;22) FUS/DDIT3, t(12;16) SS18/SSX1, t( ;18)
EWSR1/ERG, t(21;22) PAX3/FOXO1, t(2;1 ) SS18/SSX2, t( ;18)
EWSR1/FLI1, t(11;22) PAX7/FOXO1, t(1;1 ) SS18/SSX1 or SS18/SSX2
EWSR1/FLI1 or EWSR1/ERG
Program Information• Ten challenges using whole
slide images
• A method-based preanalyticSurvey to assess competencyfor determining percentneoplastic cellularity
• Powered by DigitalScopetechnology
• Two online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Program Information• Snap-frozen cell pellet from
which approximately 5.0- gof RNA can be extracted
• Two shipments per year
Molecular Oncology – Solid Tumors
224 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Gen
etic
san
dM
olec
ular
Path
olog
y
18
Solid Tumor–Other BRAF, EGFR, KRAS, KITAnalyte Program Code Challenges/Shipment
BRAF EGFR KRAS KIT
BRAF z 3
EGFR z 3
KRAS z 3
KIT z 1
PDGFRA z 1
Multigene Tumor Panel MTPAnalyte Program Code Challenges/Shipment
MTP
BRAF z 3
EGFR z 3
KRAS z 3
NRAS z 3
PIK3CA z 3
Additional InformationSurvey MTP is designed for use with multiplex technologies such as next-generationse uencing where genes will be added as clinical utility and practices evolve. Thechallenges are mixtures and are more li ely to include mutations at lower relativeconcentrations than do the individual gene-specific Surveys. Laboratories using assaytechnologies that do not reliably detect mutations in small allelic fractions ( 25 ), such asmodified Sanger se uencing, should enroll in the gene-specific Surveys RAS, BRAF, andEGFR.
Glioma GLIAnalyte Program Code Challenges/Shipment
GLI
MGMT z 1
IDH1, IDH2 z 1
10 (PTEN) deletion z 1
Program Information• BRAF, EGFR, RAS -
Paraffin-embeddedsections or shavings
• IT/PDGFRA - Four10.0-micron unstainedparaffin section slides andone H&E slide
• For laboratories performingmolecular testing using PCR
• Two shipments per year
Program Information• gDNA for laboratories
performing molecular testingon multiple targets
• Two shipments per year
Program Information• Four 10.0-micron unstained
paraffin section slides andone H&E slide
• For laboratories performingmolecular testing using PCR
• Two shipments per year
Molecular Oncology – Hematologic
800-323-4040 | 847-832-7000 Option 1 | cap.org 225
Genetics
andM
olecularPathology
18
Molecular Oncology – HematologicAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Molecular Hematologic OncologyMHO, MHO1, MHO2, MHO3, MHO5
Procedure/Gene Program Code Challenges/Shipment
MHO, MHO1 MHO2, MHO3 MHO5
Lymphoid malignancy genotyping
IGH z 3
IGH/BCL2 major z 3
IGH/BCL2 minor z 3
IGH/CCND1 z 3
IGK z 3
TRB z 3
TRG z 3
Myeloid malignancy genotyping
CBFB/MYH11 z 1
FLT3 ITD z 1
FLT3 TKD z 1
JAK2 c.18 9G T(p.V617F) z 1
NPM1 z 1
PML/RARA z 1
RUNX1/RUNX1T1 z 1
DNA extraction andamplification from formalin-fixed, paraffin-embedded(FFPE) tissue
z 1
Minimal Residual Disease MRD, MRD1, MRD2Analyte Program Code Challenges/Shipment
MRD MRD1 MRD2
BCR/ABL1 p190 z 3
BCR/ABL1 p210 z 3
PML/RARA z 3
Program Information• MHO - One sample vial
containing purified DNA(200 g/mL per vial) for eachspecimen
• MHO1 - MHO specimens induplicate for additional DNAtesting
• MHO2 - Two sample vials;one with purified DNAcontaining 200 g/mL andone with purified RNA,containing 00 g/mL
• MHO - MHO2 specimen induplicate for additional DNAand RNA testing
• MHO5 - Five 10.0-micronparaffin sections; extractionand amplification from FFPEtissue will be assessed by amethod-based challenge
• Two shipments per year;ships on dry ice (dry icedoes not apply to MHO5 orinternational shipments)
Program Information• MRD, MRD1, MRD2 - Three
RNA specimens in distilledwater
• For laboratories diagnosingand monitoring leu emiatumor burden by measuringthe uantity of BCR/ABL1 orPML/RARA fusion transcripts
• Two shipments per year;ships on dry ice
Your Choice.Gain the expertise of your peers usingthe convenience of your mobile device.
Customize your reading experiencewith font control, brightness, margins,and quick navigation.
Enhance your learning by adding notes,highlights, and bookmarks.
See for yourself at ebooks.cap.org.
Available now—your favorite CAP Press booksin ebook format!
Anatom
icPathology
19
Anatomic PathologySurgical Pathology .........................................................................................................................228General Immunohistochemistry ........................................................................................................237Predictive Markers .........................................................................................................................239Specialty Anatomic Pathology .........................................................................................................240Cytopathology...............................................................................................................................242
New Programs New
Hematopathology Online Education (HPATH/HPATH1) ......................................................................232
19 | Anatomic Pathology
“The CAP is good about being the leader, doingresearch, and taking a role in developing theseprograms.”
Surgical Pathology
228 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
Surgical PathologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Performance Improvement Programin Surgical Pathology PIP/PIP1
Program Program Code Challenges/Shipment
PIP/PIP1
Surgical pathology case review z 10
Additional InformationPIP educates pathologists in general surgical pathology. This program:
• Provides a practical approach to continuing education• Gives pathologists a method to assess their diagnostic s ills and compare their
performance with that of their peers• Features PIP case selections that include
o A variety of neoplastic and nonneoplastic lesionso Inflammatory and infectious diseaseo Various sites, encompassing a variety of organ systems
Program Information• PIP - Ten diagnostic
challenges/H&E stained glassslides with clinical history;one individual response form
• PIP1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey PIP
• Earn a maximum of 0 CMEcredits (AMA PRA Category1 Credits™) per pathologist forcompletion of an entire year
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Four shipments per year
Surgical Pathology
800-323-4040 | 847-832-7000 Option 1 | cap.org 229
Anatom
icPathology
19
Online Performance Improvement Programin Surgical Pathology PIPW/PIPW1
Program Program Code Challenges/Shipment
PIPW/PIPW1
Surgical pathology case review z 10
Additional InformationPIP educates pathologists in general surgical pathology. Features of this onlineeducational program include:
• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.
• Pathologists can assess their diagnostic s ills and compare their performance withthat of their peers.
• Included PIP case selections featureo A variety of neoplastic and nonneoplastic lesionso Inflammatory and infectious diseaseo Various sites, encompassing a variety of organ systems
• See system re uirements on page 15.
Program Information• PIP - Ten diagnostic
challenges/whole slideH&E images with clinicalhistory; for each additionalpathologist, purchase PIPW1
• PIP 1 - Reporting option withCME credit for each additionalpathologist (within the sameinstitution); must order inconjunction with Survey PIPW
• Earn a maximum of 0 CMEcredits (AMA PRA Category1 Credits™) per pathologist forcompletion of an entire year
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Powered by DigitalScopetechnology
• Four online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Test Your Diagnostic Skills with Case of the MonthChallenge yourself and your staff with two new cases each monthdrawn from the CAP Online Performance Improvement Program inSurgical Pathology (PIPW) archives. You can also explore the CaseArchives for dozens of additional cases. Case information includes:• Specimen source• Clinical history• Laboratory findings• Representative whole slide image of the surgical specimen
Case of the Month uses DigitalScope® for unparalleled online viewing of whole slide images. CMEis not available for Case of the Month; CME is available with the PIPW program.
To access the Case of the Month, visit cap.org and choose the CAP Foundation tab.
Surgical Pathology
230 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
Online Virtual Biopsy Program VBP/VBP1Program Program Code Challenges/Shipment
VBP/VBP1
Online biopsy case review z 5
Additional InformationVBP educates pathologists to assess and improve their diagnostic s ills in surgicalpathology. Features of this online educational program include
• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.
• Cases may also include gross, radiographic, or endoscopic images.• Cases are from selected organ systems and may include a variety of
specimen types (eg, core biopsies, endoscopic biopsies, curettings, aspiratesmears). Activities with their corresponding topics are:o 2015-A Lung Biopsyo 2015-B Ear, Nose, Throat Biopsyo 2015-C Gynecologic Biopsyo 2015-D Surgical Pathology Biopsy (various sites)
• See system re uirements on page 15.
Program Information• VBP - Five diagnostic
challenges/whole slideimages with clinical history;for each additionalpathologist, purchase VBP1
• VBP1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey VBP
• Earn a maximum of23 CME/SAM credits(AMA PRA Category 1Credits™) per pathologist forcompletion of an entire year
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Powered by DigitalScopetechnology
• Four online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Surgical Pathology
800-323-4040 | 847-832-7000 Option 1 | cap.org 231
Anatom
icPathology
19
Online Digital Slide Program in DermatopathologyDPATH/DPATH1
Program Program Code Challenges/Shipment
DPATH/DPATH1
Online dermatopathology case review z 6
Additional InformationDPATH educates pathologists, dermatopathologists, and dermatologists to assessand improve their diagnostic s ills in dermatopathology. Features of this onlineeducational program include:
• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.
• Cases include static images.• See system re uirements on page 15.
Program Information• DPATH - Six diagnostic
challenges/whole slideimages with clinicalhistory; for each additionalpathologist, purchase DPATH1
• DPATH1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey DPATH
• Earn a maximum of1 CME/SAM credits(AMA PRA Category 1Credits™) per pathologist forcompletion of an entire year
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Powered by DigitalScopetechnology
• Two online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Surgical Pathology
232 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
Hematopathology Online EducationHPATH/HPATH1
Program Program Code Challenges/Shipment
HPATH/HPATH1
Hematopathology online case review z 5
Additional InformationHPATH educates pathologists and hematologists to assess and improve their diagnostics ills in hematopathology.
• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.
• Cases are peripheral blood and bone marrow whole slide images.• Cases may include results of ancillary studies such as histochemistry, immunology,
immunohistochemistry, and molecular tests, where appropriate.• See system re uirements on page 15.
NewProgram Information• HPATH - Five diagnostic
challenges/whole slideimages with clinicalhistory; for each additionalpathologist/hematologist,purchase HPATH1
• HPATH1 - Reporting optionwith CME/SAM/CE credit foreach additional pathologistand hematologist (withinthe same institution); mustorder in conjunction withSurvey HPATH
• Earn a maximum of 6CME/SAM credits (AMAPRA Category 1 Credits™)per pathologist and amaximum of 6 CE credits perhematologist for completionof an entire year
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Powered by DigitalScopetechnology
• One online activity per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Surgical Pathology
800-323-4040 | 847-832-7000 Option 1 | cap.org 233
Anatom
icPathology
19
Practicum inCancer Surgical Pathology PCSP/PCSP1
Program Program Code Challenges/Shipment
PCSP/PCSP1
Online surgical pathology cancercase review
z
Additional InformationPCSP educates pathologists in cancer case review and reporting.
• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.
• Cases review challenges in interpretation, staging, and cancer reporting.• Cases represent the following
oT Staging and Margins in Pancreatic Tumors Challenges and RecommendationsoStaging Invasive Breast Cancer Size Determination and Assessment of
Multiple TumorsoAdverse Histologic Parameters in Thyroid Carcinoma Pic ing Out the olf in
Sheep’s Clothingo Staging Cutaneous Melanoma: Impact of Previous Shave Biopsy
• See system re uirements on page 15.
Program Information• PCSP - One mailing
containing four diagnosticchallenges/whole slideH&E images with clinicalhistory; for each additionalpathologist purchase PCSP1
• PCSP1 - Reporting option withCME credit for each additionalpathologist (within the sameinstitution); must order inconjunction with Survey PCSP
• Earn a maximum of5 CME/SAM credits (AMAPRA Category 1 Credits™) perpathologist for completion ofan entire year
• Powered by DigitalScopetechnology
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• One online activity per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Surgical Pathology
234 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
CAP/NSH HistoQIP HQIPStain/Tissue Program Code Challenges/Shipment
HQIP A B
H E - Lung resection z 1
H E - Bone marrow core biopsy, noaspirates or smears
z 1
IHC - Napsin A (Lung adenocarcinoma) z 1
IHC - H. pylori, stomach (Positive tissuecontrol)
z 1
Special stain - Trichrome (Small bowelresection)
z 1
H E - Colon resection z 1
H E - Liver resection z 1
IHC - Smooth muscle myosin heavy chain(Breast resection)
z 1
IHC - CD 2 (Colon resection,adenocarcinoma)
z 1
Special stain - Reticulin (Liver resection) z 1
Additional InformationHistoQIP improves the preparation of histologic slides in all anatomic pathologylaboratories. In this educational program, participants will receive an evaluation specificto their laboratory, an education criti ue, and a Participant Summary that includes peercomparison data, evaluators comments, and performance benchmar ing data. An expertpanel of pathologists, histotechnologists, and histotechnicians will evaluate submittedslides for histologic technique using uniform grading criteria.
Program Information• Participant laboratories may
submit up to five stained andcoverslipped glass slides (onefrom each category) permailing
• Includes photographs andonline learning assessmentquestions
• Two shipments per year
Histologic PreparationsRichard W. Brown, MD, FCAPThis “how to” guide to good slide preparation was developedby the Histotechnology Committee of the College of AmericanPathologists in conjunction with the National Society forHistotechnology. Building on data and images from the NSH/CAPhistology quality assurance program, HistoQIP, the book presentsphotographic examples of well-prepared slides followed bynumerous examples of associated problems and their solutions.
PRESSTo order and see the table of contentsand sample pages:Visit cap.org and choose the Shop tab.
Item number: PUB123Softcover; 168 pages; 300+photomicrographs, figures,and tables; 2009
Also available as an ebook! Visit ebooks.cap.org
Surgical Pathology
800-323-4040 | 847-832-7000 Option 1 | cap.org 235
Anatom
icPathology
19
CAP/NSH HistoQIP - IHC HQIHCStain/Tissue Program Code Challenges/Shipment
HQIHC A B
IHC AE1/ (Bladder biopsy) z 1
IHC C 7 (Cervix biopsy) z 1
IHC Melan A (S in, punch biopsy) z 1
IHC i-67 (Stomach biopsy) z 1
IHC C 20 (Colon biopsy) z 1
IHC ER (Endometrium biopsy) z 1
IHC C 5/6 (S in, excisional biopsy) z 1
IHC p6 (Prostate biopsy) z 1
Additional InformationHisto IP - IHC improves the preparation of immunohistochemistry slides in all anatomiclaboratories involved in the handling of gastrointestinal, dermatologic, and urologicaltract biopsies. Participants will receive an evaluation specific to their laboratory anda Participant Summary. An expert panel of pathologists, histotechnologists, andhistotechnicians will evaluate submitted slides for histologic techni ue using uniformgrading criteria.
CAP/NSH HistoQIP Biopsy Series HQIPBXStain/Tissue Program Code Challenges/Shipment
HQIPBX A B
H E Bladder biopsy z 1
H E Cervical biopsy z 1
H E S in punch biopsy z 1
H E Stomach biopsy z 1
H E Colon biopsy z 1
H E Endometrial biopsy z 1
H E Prostate needle biopsy z 1
H E S in excisional biopsy (large excision) z 1
Additional InformationThe HistoQIP Biopsy Series is an additional program to improve the preparation ofhistologic slides in all anatomic pathology laboratories. Participants will receive anevaluation specific to their laboratory and a Participant Summary. An expert panel ofpathologists, histotechnologists, and histotechnicians will evaluate submitted slides forhistologic technique using uniform grading criteria.
Program Information• Participants may submit
up to four IHC stained andcoverslipped glass slides(one from each category) permailing
• Two shipments per year
Program Information• Participant laboratories may
submit up to four H E stainedand coverslipped glass slides(one from each category) permailing
• Two shipments per year
Surgical Pathology
236 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
CAP/NSH HistoQIP Specialty SeriesHQBX1, HQBX2, HQBX3
Stain/Tissue Program Code Challenges/Shipment
HQBX1 HQBX2 HQBX3 A B
Gastrointestinal Biopsy Module
H E Colon biopsy z 1 1
H E Esophageal biopsy z 1 1
H E Small intestinal biopsy z 1 1
H E Stomach biopsy z 1 1
Dermatologic Biopsy Module
H&E – Alopecia z 1 1
H E S in excisional biopsy(large excision)
z 1 1
H E S in punch biopsy z 1 1
H E S in shave biopsy z 1 1
Urogenital Tract Biopsy Module
H E Bladder biopsy (nonneoplastic) z 1 1
H E Bladder biopsy (with carcinoma) z 1 1
H E Prostate needle biopsy(nonneoplastic)
z 1 1
H E Prostate needle biopsy(with carcinoma)
z 1 1
Additional InformationThe HistoQIP Specialty Series includes modules to improve the preparation of histologicslides in all anatomic pathology laboratories involved in the handling of gastrointestinal,dermatologic and urogenital tract biopsies. Participants will receive an evaluationspecific to their laboratory and a Participant Summary. An expert panel of pathologists,histotechnologists, and histotechnicians will evaluate submitted slides for histologictechnique using uniform grading criteria.
Program Information• H B 1, H B 2, H B -
Participants may submit upto four H&E stained andcoverslipped glass slides(one from each category)per mailing
• Two shipments per year
General Immunohistochemistry
800-323-4040 | 847-832-7000 Option 1 | cap.org 237
Anatom
icPathology
19
General ImmunohistochemistryAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Immunohistochemistry MKProcedure Program Code Challenges/Shipment
MK
Immunohistochemistry z 16
The M program allows laboratories to compare their assay methodology and results withall participating laboratories.
DNA Mismatch Repair MMRProcedure Program Code Challenges/Shipment
MMR
DNA mismatch repair byimmunohistochemistry
z 1
If your laboratory performs DNA mismatch repair by molecular methods, see the MSI programon page 222.
CD117, CD20 ImmunohistochemistryTissue Microarray PM1, PM3
Analyte Program Code Challenges/Shipment
PM1 PM3
CD117 z 10
CD20 z 10
For ER/PgR testing, see the PM2 program on page 239.
Program Information• Glass slides with unstained
tissue sections from fourseparate cases; additionalslides provided for an H&Estain and negative control
• Two shipments per year
Program Information• Four .0-micron unstained
paraffin section slidesand one H&E slide for theimmunohistochemical analysisof DNA mismatch repairproteins MLH1, MSH2, MSH6,and PMS2
• Two shipments per year
Program Information• One 10-core tissue
microarray slide perpredictive mar er
• One shipment per year
General Immunohistochemistry
238 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
Immunohistochemistry TissueMicroarray Series PM5
Analyte Program Code Challenges/Shipment
PM5
AL z 10
GATA z 10
Additional InformationThis newly designed program will allow immunohistochemistry laboratories to evaluateappropriate assay performance on a wide array of tissues and/or tumor types.
Each year, the PM5 program will offer different immunohistochemistry mar ers to evaluateassay performance on a wide variety of tissues and/or tumor types. See list below.
CDX2CD30D2-40K 20Ki-67PAX 2PAX 8p63
Program Information• Two 10-core tissue microarray
slides, one for AL and onefor GATA
• One shipment per year
Predictive Markers
800-323-4040 | 847-832-7000 Option 1 | cap.org 239
Anatom
icPathology
19
Predictive MarkersAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
HER2 Immunohistochemistry HER2Analyte Program Code Challenges/Shipment
HER2
HER2 z 28
Additional InformationThe HER2 program fulfills the proficiency testing re uirement stated in the ASCO/CAPHER2 Testing Guideline. Due to the uni ue nature of these human, donor-basedmaterials, the shipping date is subject to change. If this should occur, the CAP willprovide notification prior to the originally scheduled shipping date.
Gastric HER2 GHER2Analyte Program Code Challenges/Shipment
GHER2
HER2 z 10
Additional InformationThe interpretive criteria for HER2 immunohistochemistry performed on gastroesophagealadenocarcinomas differs significantly from breast carcinoma. The GHER2 program willhelp participating laboratories understand these differences.
ER/PgR ImmunohistochemistryTissue Microarray PM2
Analyte Program Code Challenges/Shipment
PM2
Estrogen receptor (ER) z 20
Progesterone receptor (PgR) z 20
Additional InformationThe PM2 program fulfills the proficiency testing requirement stated in theASCO/CAP ER/PgR Testing Guideline. Due to the uni ue nature of these human,donor-based materials, the shipping date is subject to change. If this should occur,the CAP will provide notification prior to the originally scheduled shipping date.
Program Information• Two 1 -core tissue and
cell-line microarray slides
• Two shipments per year
Program Information• One 10-core tissue
microarray slide
• Two shipments per year
Program Information• Four 10-core microarray slides,
two for ER and two for PgR
• Two shipments per year
Specialty Anatomic Pathology
240 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
Specialty Anatomic PathologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Autopsy Pathology AUCD/AUCD1Procedure Program Code Challenges/Shipment
AUCD/AUCD1
Autopsy case analysis z 6
Each CD-ROM includes case description, gross and/or microscopic images, and casediscussion with sample death certificate, ey teaching points, and current references.
Program Information• One CD-ROM with six
autopsy cases; one individualresponse form
• A CD1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey A CD
• Earn a maximum of 12 CMEcredits (AMA PRA Category 1Credits™) per pathologist
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements and the CAPAccreditation chec listrequirement for professionalcompetency
• Two shipments per year
Autopsy & Forensic Anthology of Classic Pathology Images (AFA)This CD-ROM offering contains more than 2,000 classicimages from the CAP’s 1992–2010 Autopsy Pathology (AUCD)and the 1990–2010 Forensic Pathology (FR) programs.• View images in three different modes:
o List—Cases listed by program, year, patient age, and diagnosiso Browse—Images filtered by category (eg, cardiovascular,
CNS, external exam) and/or image type (eg, gross, H&E, scene)o Search—Access images based on matching key
words or word fragments• Customize the anthology by adding your own images and categories• Use only a standard Web browser—it runs on any operating
system—with no software to install
Add this valuable tool to your laboratory’s teaching library.Add code AFA to your Surveys order form.
Specialty Anatomic Pathology
800-323-4040 | 847-832-7000 Option 1 | cap.org 241
Anatom
icPathology
19
Neuropathology Program NP/NP1Procedure Program Code Challenges/Shipment
NP/NP1
Neuropathology case review z 8
Additional InformationThe Neuropathology program helps anatomic pathologists, neuropathologists, andtrainees assess and improve their diagnostic s ills and learn about new developmentsin neuropathology. Each shipment of this educational program includes eight casesthat cover the spectrum of neoplastic and nonneoplastic disorders affecting the centraland peripheral nervous systems, including infectious, degenerative, developmental,demyelinating, traumatic, toxic-metabolic, vascular, and neuromuscular diseases. Inaddition, each mailing will include a mini-symposium that focuses on a specific problemarea in neuropathology, which relates to four of the eight cases.
Program Information• One CD-ROM with eight
cases and a mini-symposium
• NP1 - Reporting optionwith CME credit for eachadditional pathologist (withinthe same institution); mustorder in conjunction withSurvey NP
• Earn a maximum of 10CME/SAM credits (AMAPRA Category 1 Credits™)per pathologist
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Two shipments per year
Experience a new level of pathology education with CAP SAMs• Outcomes-based learning at the cutting edge of pathology science• Peer reviewed by at least two subject matter experts• Highly interactive formats with immediate feedback
Visit cap.org and choose the Learning tab to learn more and register.
Cytopathology
242 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
ic P
atho
logy
19
CytopathologyAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Glass Slide Gynecologic Cytopathology PAP PT Program
with Online Education PTGDSlide Type Program Code Challenges Per Year
PTGDK PTGDM PTGDL Proficiency Testing Education
SurePath™ z z
10 glass slides 10 whole slide images
ThinPrep® z z
Individual Participant Response Form APTGDK APTGDM APTGDL
Ordering InformationYou will receive one shipment for proficiency testing (10 slides) and two additional shipments for your education (5 slides each).
Follow these steps to order your PAP Proficiency Testing and Online Education:1. Choose the Slide Type program code (refer to table above).2. Order one Individual Participant Response Form code for each participating
pathologist/cytotechnologist (eg, APTGDK).3. Select primary testing session option with two alternative date options using the
Gynecologic Cytology Proficiency Testing Order Details Form.4. Order PPTENR only if you are a laboratory possessing a CLIA license to perform
gynecologic cytology where all personnel are performing proficiency testing at another CLIA location.
Additional Information •Individualparticipantsreceiveintendedresponsesandslideannotationsimmediately
after submission of their education results. •DigitalScope technology simulates the use of a microscope by enabling the user to
scan and adjust magnification of the whole slide image. •The PAP Education Laboratory Kit, a tool that lets your staff collaboratively review the
whole slide images to help sharpen their interpretive and diagnostic skills, is included with PTGD.
•Seesystemrequirementsonpage15.
Program Information•PTGD-Tenglassslidesfor
proficiency testing and ten online whole slide images for education
•Earnamaximumof8CMEcredits (AMA PRA Category 1 CreditsTM) per pathologist andamaximumof8CEcredits per cytotechnologist for completing all challenges
•ThisactivitymeetstheABP MOC Part IV Practice Performance Assessment requirements
•Onlinewholeslideimagespowered by DigitalScope technology
•Oneshipmentforproficiencytesting (10 slides) and two online education activities per year (5 slides each); your CAP shipping contact will be notified via email when the online activities are available
Discontinued
Cytopathology
800-323-4040 | 847-832-7000 Option 1 | cap.org 243
Anatom
icPathology
19
Glass Slide Gynecologic Cytopathology PTProgram with Glass Slide PAP Education PAP PT
Slide Type Program Code Challenges Per Year
PAPCPT PAPKPT PAPMPT PAPLPT PAPJPT ProficiencyTesting Education
Conventional z z
10 10
SurePath z z z
ThinPrep z z z
IndividualParticipantResponse Form
APAPCPT APAPKPT APAPMPT APAPLPT APAPJPT
Ordering InformationYou will receive one shipment for proficiency testing (10 slides) and two additionalshipments for your education (5 slides each).
Follow these steps to order your PAP Proficiency Testing and PAP Education:1. Choose the following:
a. Slide Type program code (refer to table above)b. PAP Education series shipment dates (choose one)
• Series 1 o A mailing ships February 2015 o B mailing ships August 2015
• Series 2 o A mailing ships May 2015 o B mailing ships November 2015
Add the PAP Education series number after the Slide Type program code(eg, PAPCPT1).
2.Order one Individual Participant Response Form code for each participatingpathologist/cytotechnologist. Also include the PAP Education Series number after theprogram code (eg, APAPCPT1).
3. Select primary testing session option with two alternative date options using theGynecologic Cytology Proficiency Testing Order Details Form.
.Order PPTENR only if you are a laboratory possessing a CLIA license to performgynecologic cytology where all personnel are performing proficiency testing atanother CLIA location.
Additional Information• Participants can receive laboratory reference interpretations and performance for the
PAP Education slides within 20 minutes by fax.• The PAP Education component meets the CAP Laboratory Accreditation Program
requirement for participation in a peer educational program.
Program Information• Ten glass slides for proficiency
testing and ten glass slides foreducation
• Earn a maximum of 8 CMEcredits (AMA PRA Category1 CreditsTM) per pathologistand a maximum of 8 CEcredits per cytotechnologistfor completing all challenges
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Three shipments per year;one shipment for proficiencytesting (10 slides) and twoshipments for education (5slides each)
Cytopathology
244 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
ic P
atho
logy
19
Online Gynecologic Cytopathology Education Program PED
Slide Type Program Code Challenges Per Year
PEDK PEDM PEDL
10SurePath z z
ThinPrep z z
Individual Participant Response Form APEDK APEDM APEDL
Ordering InformationYou will receive two shipments for your online education (5 slides each).
Follow these steps to order your PED Education: 1. Choose the Slide Type program code (refer to table above).
2. Order one Individual Participant Response Form code for each participating pathologist/cytotechnologist (eg, APEDK).
Additional Information •DigitalScopetechnologysimulatestheuseofamicroscopebyenablingtheuserto
scan and adjust magnification of the whole slide image. •ThePAPEducationLaboratoryKit,atoolthatletsyourstaffcollaborativelyreviewthe
whole slide images to help sharpen their interpretive and diagnostic skills is included with PED.
•Participantsreceiveintendedresponsesandslideannotationsimmediatelyaftersubmission of their education results.
•PEDmeetstheCAPLaboratoryAccreditionProgramrequirementforparticipationina peer educational program.
•Seesystemrequirementsonpage15.
Program Information•Tenonlinewholeslideimages
•Earnamaximumof8CMEcredits (AMA PRA Category 1 CreditsTM) per pathologist andamaximumof8CEcredits per cytotechnologist for completing all challenges
•ThisactivitymeetstheABP MOC Part IV Practice Performance Assessment requirements
• PoweredbyDigitalScopetechnology
•Twoonlineactivitiesperyear (5 slides each); your CAP shipping contact will be notified via email when the activity is available
Discontinued
Cytopathology
800-323-4040 | 847-832-7000 Option 1 | cap.org 245
Anatom
icPathology
19
Cytopathology Glass Slide Education ProgramPAPCE, PAPJE, PAPKE, PAPLE, PAPME Series 1 or 2
Slide Type Program Code EducationChallenges Per Year
PAPCE PAPKE PAPME PAPLE PAPJE
Conventional z z
10
SurePath z z z
ThinPrep z z z
IndividualParticipantResponseForm
APAPCE APAPKE APAPME APAPLE APAPJE
Ordering Information
Follow these steps to order your PAP Education:1. Choose the following:
a. Slide Type program code (refer to table above)b. PAP Education series shipment dates (choose one)
• Series 1 o A mailing ships February 2015 o B mailing ships August 2015
• Series 2 o A mailing ships May 2015 o B mailing ships November 2015
Add the PAP Education series number after the Slide Type program code(eg, PAPCE1).
2.Order one Individual Participant Response Form code for each participatingpathologist/cytotechnologist. Also include the PAP Education series number after theprogram code (eg, APAPCE1).
Additional Information• Participants can receive laboratory reference interpretations and performance for the
PAP Education slides within 20 minutes by fax.• The PAP Education component meets the CAP Laboratory Accreditation Program
requirement for participation in a peer educational program.
Program Information• Ten glass slides for education
• Earn a maximum of 8 CMEcredits (AMA PRA Category1 CreditsTM) per pathologistand a maximum of 8 CEcredits per cytotechnologistfor completing all challenges
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Two shipments (five slideseach)
Cytopathology
246 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
Gynecologic Cytopathology – Fields of ViewFOVK/FOVK1, FOVM/FOVM1
Procedure Program Code Challenges/Shipment
FOVK/FOVK1 FOVM/FOVM1
Online review of SurePath slides z 5
Online review of ThinPrep slides z 5
Additional Information• The Fields of View online education program helps pathologists and cytotechnologists
assess and improve their s ills in image-assisted screening.• The Fields of View program helps participants understand the processes involved in
image-assisted gynecologic screening technologies.• Participants receive the reference interpretation for each case immediately after
completing the exercise.• See system re uirements on page 15.
Human Papillomavirus (High Risk) for CytologyCHPVD, CHPVM, CHPVK, CHPVJ
Analyte/Procedure Program Code Challenges/Shipment
CHPVD CHPVM CHPVK CHPVJ
HPV z z z z 5
High-ris HPVgenotyping (optional)
z z 5
Additional Information• Each laboratory should choose the Survey that best reflects the transport media
received in its facility. For Survey CHPV , participants must provide results for all threemedia types. If your laboratory receives two types of media, order the Survey that ismost appropriate for your specific laboratory (CHPVD, CHPVM, or CHPV ).
• For laboratories that perform HPV genotyping using ThinPrep PreservCyt Transportmedium on site, Survey CHPVM and select samples of Survey CHPVJ provide anopportunity to report specific HPV genotypes.
• The CAP does not report genotyping responses to the CMS.
Program Information• FOV - Five diagnostic
challenges/whole slideimages for SurePath users
• FOVM - Five diagnosticchallenges/whole slideimages for ThinPrep users
• FOV 1/FOVM1 - Reportingoption for each additionalpathologist/cytotechnologist(within the same institution);must order in conjunction withSurvey FOV or FOVM
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Earn a maximum of 10 CEcredits per cytotechnologist
• Two online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Program Information• Five simulated cervical
specimens
• CHPVD - Digene® SpecimenTransport Medium™ (STM)
• CHPVM - ThinPrepPreservCyt® TransportMedium
• CHPV - SurePathPreservative Fluid TransportMedium and correspondingvial of diluent
• CHPV - Combination ofDigene, ThinPrepPreservCyt, and SurePathtransport mediums
• Three shipments per year
Cytopathology
800-323-4040 | 847-832-7000 Option 1 | cap.org 247
Anatom
icPathology
19
Nongynecologic Cytopathology –Intraoperative Touch Imprint/CrushPreparation Program TICP/TICP1
Procedure Program Code Challenges/Shipment
TICP/TICP1
Online slide and image program in rapidassessment case review
z 5
Additional Information• The TICP Program is designed to familiarize surgical pathologists, cytopathologists,
and cytotechnologists with the cytomorphologic features of pathologic processesand tumors in touch-imprints and crush or scrape preparations. These specimensare prepared either for intraoperative consultation (frozen section) or rapid on-siteevaluation (ROSE) of core biopsies for ade uacy and/or interpretation. Participantswill learn to ma e an immediate ade uacy assessment, assign the process toa general category, and triage the specimen to appropriate ancillary studies.Participants will review digital whole-slides of the TICP preparations (hematoxylin
eosin, modified right-Giemsa, and/or Papanicolaou stains), static images ofthe preparation and ancillary studies, and clinical history/radiographic findings toreach a diagnosis. Each case has a complete description of entities in the differentialdiagnosis along with a discussion of the correct interpretation.
• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.
• Participants will receive immediate feedbac on interpretations, ancillary studies andcase-related ade uate assessment.
• The 2015 cases will be comprised of an eclectic mix of procedural touch preparationsand intraoperative consultations from various body sites.
• See system re uirements on page 15.
Program Information• TICP - Five online
assessment challenges withclinical history; for eachadditional pathologist orcytotechnologist, purchaseTICP1
• TICP1 Reporting option withCME/SAM/CE credit foreach additional pathologist/technologist (within the sameinstitution); must order inconjunction with Survey TICP
• Earn a maximum of 10CME/SAM credits (AMAPRA Category 1 CreditsTM)per pathologist and amaximum of 10 CE creditsper cytotechnologist forcompletion of an entire year
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Online whole slide imagespowered by DigitalScopetechnology
• Two online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Cytopathology
248 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
Nongynecologic CytopathologyEducation Program NGC/NGC1
Procedure Program Code Challenges/Shipment
NGC/NGC1
Nongynecologic cytopathologycase review – glass slides
z 5
Nongynecologic cytopathologycase review – online
z 5 per year
Additional Information• The Nongynecologic Cytopathology Education (NGC) program is an interlaboratory
educational opportunity to assess participants screening and interpretive s ills.The NGC program is unsuitable for proficiency testing as these cases are chosen fortheir educational value. Cases may incorporate static online images that incorporateradiology and multiple aspects of pathology to enhance the interpretation.
• Participants can access laboratory reference interpretations and performance for theglass slides within 20 minutes by fax, providing rapid educational feedbac , peercomparison, and additional review time.
• DigitalScope technology simulates the use of a microscope by enabling the user toscan and adjust magnification of the whole slide image.
• Additional online advanced education cases provide immediate feedbac oninterpretation selection, follow-up recommendations, and case-related educationalquestions.
• See system re uirements on page 15.
Program Information• NGC - Five glass slides; five
online advanced educationcases; one laboratoryresponse form and twoindividual response forms
• NGC1 - Reporting optionwith CME/CE credit foreach additional pathologist/cytotechnologist (within thesame institution); must orderin conjunction with SurveyNGC
• Earn a maximum of25 CME credits (AMA PRACategory 1 Credits™)per pathologist and amaximum of 25 CE creditsper cytotechnologist forcompleting the glass slidesand online cases
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Online whole slide imagespowered by DigitalScopetechnology
• Four shipments per year
Cytopathology
800-323-4040 | 847-832-7000 Option 1 | cap.org 249
Anatom
icPathology
19
Online Digital Slide Program inFine-Needle Aspiration FNA/FNA1
Procedure Program Code Challenges/Shipment
FNA/FNA1
Online program in fine-needleaspiration case review
z 5
Additional Information• This program focuses on FNA diagnostic dilemmas in practice. Online cases, which
consist of whole slide images and static images, provide immediate feedbac oninterpretation selection, ancillary studies selection, and case-related educationalquestions.
• Cases will focus on lung and head and nec pathology.• DigitalScope technology simulates the use of a microscope by enabling the user to
scan and adjust magnification of the whole slide image.• See system re uirements on page 15.
Program Information• FNA - Five online diagnostic
challenges; for eachadditional pathologist orcytotechnologist, purchaseFNA1
• FNA1 - Reporting optionwith CME/CE credit foreach additional pathologist/cytotechnologist (within thesame institution); must orderin conjuction with SurveyFNA
• Earn a maximum of 10 CMEcredits (AMA PRA Category1 Credits™) per pathologist anda maximum of 10 CE creditsper cytotechnologist
• This activity meets the ABPMOC Part IV PracticePerformance Assessmentrequirements
• Online whole slide imagespowered by DigitalScopetechnology
• Two online activities per year;your CAP shipping contactwill be notified via emailwhen the activity is available
Cytopathology
250 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
tom
icPa
thol
ogy
19
Fine-Needle Aspiration Glass SlideEducation Program FNAG/FNAG1
Procedure Program Code Challenges/Shipment
FNAG/FNAG1
Fine-needle aspiration glassslide case review
z 5
Additional Information• The Fine-Needle Aspiration Glass Slide Education program is an interlaboratory
educational opportunity to assess participants screening and interpretive s ills.FNAG cases may include more than one slide of varying stains and/orpreparations used on fine-needle aspirations.
• Cases may include static online images that incorporate radiology and multipleaspects of pathology to support the interpretation.
• Participants can access laboratory reference interpretations and performance for theglass slides within 20 minutes by fax, providing rapid educational feedbac , peercomparison, and additional review time.
Program Information• FNAG - Five cases consisting
of glass slides and selectedonline images, representing avariety of conditions; onelaboratory response form andtwo individual response forms
• FNAG1 - Reporting optionwith CME/CE credit foreach additional pathologist/cytotechnologist (within thesame institution); must order inconjunction with Survey FNAG
• Earn a maximum of 10 CMEcredits (AMA PRA Category1 Credits™) per pathologist/resident and a maximum of 10CE credits per cytotechnologist
• This activity meets the ABPMOC Part IV PracticePerformance Assessmentrequirements
• Two shipments per year
CAP Practical Guide to Gynecologic CytopathologyDavid C. Wilbur, MD, FCAPMichael R. Henry, MD, FCAPThis image-rich guide extensively covers the principles ofgynecologic cytopathology and takes a thorough look atpractical matters such as evaluation of patients and theirspecimens as well as criteria to determine specimen adequacy.Comprehensive reviews of the morphology of the vast majority ofentities both benign and malignant that are routinely identified inPap tests are presented.
PRESSTo order and see the table of contentsand sample pages:Visit cap.org and choose the Shop tabor call the CAP Customer Contact Centerat 800-323-4040 or 847-832-7000 option 1.
Item number: PUB121ISBN: 978-0-930304-94-2Softcover; 270 pages; 700+photomicrographs, figures,and tables; 2008
Also available as an ebook! Visit ebooks.cap.org
Forensic Sciences
20
20 | Forensic Sciences
“We use CAP proficiency testing to ensure theaccuracy of our results and the competencyof our staff.”
Program ChangesDNA Database (DNA, DNAF).........................................................................................................252
Discontinued Procedure: Mitochondrial DNA database analysis
Forensic Sciences
252 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Fore
nsic
Sci
ence
s
20
Forensic SciencesAnalytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
DNA Database DNA, DNAFProcedure Program Code Challenges/Shipment
DNA DNAF
Database analysis (whole blood) z 3
Database analysis (filter paper) z 3
The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Surveys DNA and DNAF.
Forensic Identity—Nuclear and MitochondrialDNA Analysis FID, FIDM
Procedure Program Code Challenges/Shipment
FID FIDM
Forensic nuclear DNA analysis z 3
Forensic mitochondrial DNA analysis z 2
The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Surveys FID and FIDM.
Program Information• DNA - Three 0.5-mL whole
blood specimens
• DNAF - Three blood-stainedfilter paper challenges
• Short tandem repeats (Au-STRand Y-STR)
• Two shipments per year
Program Information• FID - Simulated forensic case
work includes referencestandards for all suspects andvictims along with evidentiarymaterial such as vaginalswabs, semen stains, andcrime scene blood stains
• FIDM - One referencechallenge (blood stain) andone challenge formitochondrial DNA analysis(hair or nails)
• Two shipments per year
Forensic Sciences
800-323-4040 | 847-832-7000 Option 1 | cap.org 253
Forensic Sciences
20
Forensic Pathology FR/FR1Procedure Program Code Challenges/Shipment
FR/FR1
Forensic pathology cases z 6
Additional Information• Cases may include or reflect anthropologic materials, ballistics, dental identification,
DNA identification, environmental pathology, forensic evidence, injury pattern,natural death, medicolegal issues, toxicology, and trace evidence.
• FR/FR1 is for hospital-based pathologists, forensic pathologists, residents, fellows,and medical examiners/coroners. This educational program is also designed forinvestigators, analysts, and technicians/technologists.
Program Information• FR - One CD-ROM containing
six case studies illustratinggross and/or microscopicslides and questions related tomedicolegal decision making;one individual response form
• FR1 - Additional pathologist orinvestigator (within the sameinstitution) reporting option withCME or CE credit; must orderin conjunction with Survey FR
• Pathologists can earn amaximum of 12 CME credits(AMA PRA Category 1 Credits™)for completion of an entire year
• This activity meets theABP MOC Part IV PracticePerformance Assessmentrequirements
• Members of the AmericanBoard of Medicolegal DeathInvestigators, analysts, andtechnologists can earn amaximum of 12 CE credits forcompletion of an entire year
• Two shipments per year
Vitreous Fluid, Postmortem VFAnalyte Program Code Challenges/Shipment
VF
Acetone z 3
Chloride z 3
Creatinine z 3
Ethanol z 3
Glucose z 3
Potassium z 3
Sodium z 3
Vitreous urea nitrogen z 3
Program Information• Three 5.0-mL synthetic
vitreous fluid specimens
• Two shipments per year
Forensic Sciences
254 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Fore
nsic
Sci
ence
s
20Refer to Section 8, Toxicology, for a more comprehensive selection of toxicology offerings.
Forensic Toxicology, Criminalistics FTCAnalyte Program Code Challenges/Shipment
FTC
See drug listing below z 4
The American Society of Crime Laboratory Directors/Laboratory Accreditation Board ProficiencyReview Committee (ASCLD/LAB PRC) has approved Survey FTC.
Program Information• Three 20.0-mL whole blood
specimens and one 20.0-mLsynthetic urine specimen
• Two shipments per year
6-acetylmorphine (6-AM)
7-aminoclonazepam
7-aminoflunitrazepam
Acetaminophen
Alpha-hydroxyalprazolam
Alprazolam
Amitriptyline
Amphetamine
Benzoylecgonine
Butalbital
Carisoprodol
Chlorpheniramine
Clonazepam
Cocaethylene
Cocaine
Codeine
Cyclobenzaprine*
Delta-9-THC
Delta-9-THC-COOH
Desipramine
Desmethylcyclobenzaprine
Diazepam
Diphenhydramine
Doxepin
Ecgonine ethyl ester
Ecgonine methyl ester
Ephedrine
Fentanyl*
Fluoxetine
Flurazepam*
Gamma-hydroxybutyrate (GHB)
Hydrocodone
Hydromorphone
Imipramine
Ketamine
Lorazepam
Lysergic acid diethylamide (LSD)
Meperidine*
Meprobamate
Methadone
Methadone metabolite (EDDP)
Methamphetamine
Methylenedioxyamphetamine (MDA)
Methylenedioxymethamphetamine(MDMA)
Morphine*
N-desmethyltramadol
Nordiazepam
Nordoxepin
Norfluoxetine
Norketamine
Norpropoxyphene
Norsertraline
Nortriptyline
Oxazepam
Oxycodone
Oxymorphone
Paroxetine
Phencyclidine
Phenethylamine
Phenobarbital
Phentermine
Phenytoin
Propoxyphene
Pseudoephedrine
Secobarbital
Sertraline
Temazepam
Tramadol*
Trazodone
Zolpidem
*and/or metabolite(s)
FTC Drug ListingChallenges will include a mix of drugs from the list below.
Analyte/Procedure
Index
21
21 | Analyte/Procedure Index
“The CAP's Surveys analyte listings arecomprehensive—so when you're looking atnew tests you can go to the index to see acrossthe spectrum and it helps you pick what youmight want.”
Analyte/Procedure Index
256 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure IndexThe following Analyte/Procedure Index is a comprehensive listing of analytes and corresponding CAP program options.
Analytes/procedures in bold type whose corresponding program codes are bold are regulated for proficiency testing by theCenters for Medicare & Medicaid Services (CMS).
Laboratories must perform five challenges three times per year (as noted by boldface) for analytes that are regulated by the CMS.
The X in the LAP ENR column denotes the CAP programs that can be used to fulfill the proficiency testing enrollmentrequirements for CAP-accredited laboratories. Refer to the program description in this catalog to determine compatibilitywith your specific methodologies.
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
1,5-anhydroglucitol AG 1,5-Anhydroglucitol 641,25 dihydroxyVitamin D
BMV1 Bone Markers andVitamins
77
3-methoxytyramines N/NX Urine Chemistry,Special
62
5-hydroxyindoleaceticacid, qualitative
N/NX Urine Chemistry,Special
62
5-hydroxyindoleaceticacid, quantitative
X N/NX Urine Chemistry,Special
62
6-acetylmorphine(6-AM)
DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 867-aminoclonazepam DMPM Drug Monitoring for
Pain Management95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
7-aminoflunitrazepam FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
10q (PTEN) deletion GLI Glioma 22411-dehydrothromboxaneB2
TBX 11-Dehydro-thromboxane B2
149
11-deoxycortisol Y/YY Ligand Assay, Special 7517-hydroxycorticosteroids N/NX Urine Chemistry,
Special62
17-hydroxyprogesterone X Y/YY Ligand Assay, Special 7517-ketosteroids N/NX Urine Chemistry,
Special62
25-OH vitamin D X ABVD Accuracy-BasedVitamin D
76
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
25-OH vitamin D (cont.) LN40 Vitamin D Cal Ver/Lin 116X VITD 25-OH Vitamin D 76
50:50 mixing study,APTT
CGE/CGEX Coagulation, Extended 144
CGS1 Coag Special, Series 1 14550:50 mixing study, PT CGE/CGEX Coagulation, Extended 144
CGS1 Coag Special, Series 1 145ABO grouping X ABO HLA Serologic Typing 207
X J, J1 Transfusion Medicine 192X JAT Transfusion Medicine,
Automated192
JATE1 Transfusion Medicine,Automated, Educational
193
TMCA Transfusion Medicine,Competency Assessment
194
Acetaminophen X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FTC Forensic Toxicology,Criminalistics
93
LN3 TDM Cal Ver/Lin 107X SDS Serum Drug Screen 91
T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Acetone X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles
91
X AL2 Serum Alcohol/EthyleneGlycol/Volatiles
91
SDS Serum Drug Screen 91VF Vitreous Fluid, Post-
mortem90
Acid-fast smear X E Mycobacteriology 163X E1 Mycobacteriology, Ltd 163
Acid phosphatase X C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 257
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Acid phosphatase (cont.) CZQ Quality Cross Check,Chemistry and TDM
53
Activated clotting time X CT, CT1,CT2, CT3,CT5
ACT 146
POC14,POC15,POC16
Competency ActivatedClotting Time
45
Activated partialthromboplastin time
CGE/CGEX Coagulation, Extended 144
X CGL Coagulation, Ltd 144CGS1 Coag Special, Series 1 145CGS3 Coag Special, Series 3 145CGS4 Coag Special, Series 4 145DBGN Anticoagulant
Monitoring, Dabigatran146
FNPX AnticoagulantMonitoring,Fondaparinux
146
RVBN AnticoagulantMonitoring,Rivaroxaban
146
Activated protein Cresistance
CGE/CGEX Coagulation, Extended 144
CGS2 Coag Special, Series 2 145Acylcarnitine BGL Biochemical Genetics 215Adenovirus ID2 Nucleic Acid Amp,
Respiratory176
IDR Infectious DiseaseRespiratory Panel
177
VLS2 Viral Load 173X VR1 Virology Culture 171X VR2 Viral Antigen by DFA 171X VR4 Viral Antigen by EIA
and Latex172
Adenovirus 40/41 SP, SPN Stool Pathogen 161Adjustable micropipetteCal V/L
I Instrumentation 118
Adrenocorticotropichormone (ACTH)
X TM/TMX Tumor Markers 80
Alanine aminotrans-ferase (ALT/SGPT)
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Albumin X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD Body Fluid 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
SPE Protein Electrophoresis 68Albumin, CSF X M, OLI CSF Chemistry and
Oligoclonal Bands66
Albumin, urine ABU Accuracy-Based Urine 99LN20 Urine Albumin 112
X U Urine Chemistry,General
61
Albumin: creatinine ratio ABU Accuracy-Based Urine 99LN20 Urine Albumin Cal
Ver/Lin112
U Urine Chemistry,General
61
UMC Urine AlbuminCreatinine
138
Alcohol, serum X AL2 Serum Alcohol/EthyleneGlycol/Volatiles
91
LN11 Serum Ethanol CalVer/Lin
110
Alcohol, whole blood X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles
91
LN14 Whole Blood EthanolCal Ver/Lin
111
Aldolase ADL Aldolase 64Aldosterone, serum X RAP Renin and Aldosterone 79Aldosterone, urine X N/NX Urine Chemistry,
Special62
ALK PM5 ImmunohistochemistryTMA
238
Alkaline phosphatase(ALP)
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Analyte/Procedure Index
258 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Allele detection PGX, PGX1,PGX2
Pharmacogenetics 219
Allergens (specific) SE Diagnostic Allergy 185Alpha-1 antitrypsin X IG/IGX Immunology, General 180
LN7 Immunology Cal Ver/Lin 109Alpha-1 antitrypsingenotyping
AAT Alpha-1 antitrypsingenotyping
216
Alpha1 globulin SPE Protein electrophoresis 68Alpha2 globulin SPE Protein electrophoresis 68Alpha-2-antiplasmin CGE/CGEX Coagulation, Extended 144Alpha-fetoprotein (AFP),amniotic fluid
X FP/FPX Maternal Screen 78
Alpha-fetoprotein (AFP),serum
X FP/FPX Maternal Screen 78
X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
Alpha-hydroxyalprazolam
DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Alpha-PVP (a-Pyrrolidino-pentiophenone)
SCDD Synthetic Cannabinoid/Designer Drug
94
Alpha-thalassemia HGM Hemoglobinopathies,Molecular Methods
216
Alprazolam DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Aluminum X R Trace Metals 70TMU Trace Metals, Urine 92
AM-2201 N-(4-hydroxypentyl) metabolite
SCDD Synthetic Cannabinoid/Designer Drug
94
Amikacin X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107Amino acids, qualitative X BGL Biochemical Genetics 215Amino acids,quantitative
BGL Biochemical Genetics 215
Amitriptyline FTC Forensic Toxicology,Criminalistics
93
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Amitriptyline (cont.) T Toxicology 86UT Urine Toxicology 86
X ZT, ZZT TDM, Special 54Ammonia C3, C3X,
CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN32 Ammonia Cal Ver/Lin 115Amniotic fluid leakage(nitrazine)
AFL Amniotic Fluid Leakage 134
Amphetamine DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86UDS, UDS6 Urine Drug Screen 88
Amphetamine group DMPM Drug Monitoring forPain Management
95
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Amylase X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD Body Fluid 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Amylase, pancreatic X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Amylase, urine LN6 Urine Chemistry CalVer/Lin
108
X U Urine Chemistry,General
61
Analytical balance I Instrumentation 118
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 259
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Anaplasmaphagocytophilum
TTD Antibody Detection-Tick-Transmitted Diseases
178
Androstenedione X Y/YY Ligand Assay, Special 75Angiotensin convertingenzyme
ACE Angiotensin ConvertingEnzyme
64
Anti-A titer ABT, ABT1 Antibody Titer 196Anti-B titer ABT3 Antibody Titer 196Anti-beta-2-glycoprotein CGE/CGEX Coagulation, Extended 144Antibody detection X J, JAT Transfusion Medicine 192
JATE1 Transfusion Medicine,Automated, Educational
193
X PS Platelet Serology 199TMCA Transfusion Medicine,
Competency Assessment194
Antibody detection/identification (HLA)
X MX1B,MX1C,MX1E, MXB,MXC
HLA Analysis, Class I 206-207
X MX2B,MX2C,MX2E, MXB,MXC
HLA Analysis, Class II 206-207
Antibody identification ETME1 Expanded TransfusionMedicine Exercises
193
X J, JAT Transfusion Medicine 192JATE1 Transfusion Medicine,
Automated, Educational193
TMCA Transfusion Medicine,Competency Assessment
194
Antibody screen (HLA) MX1B,MX1C,MX1E, MXB,MXC
HLA Analysis, Class I 206-207
MX2B,MX2C,MX2E, MXB,MXC
HLA Analysis, Class II 206-207
Anticardiolipin IgA,qualitative
ACL, APS AntiphospholipidAntibody
183
Anticardiolipin IgA,quantitative
ACL, APS AntiphospholipidAntibody
183
Anticardiolipin IgG,IgM, polyclonal;qualitative
X ACL, APS AntiphospholipidAntibody
183
Anticardiolipin IgG,IgM, polyclonal;quantitative
ACL, APS AntiphospholipidAntibody
183
Anti-CCP CCP Cyclic CitrullinatedPeptide Antibody
184
Anticentromere antibody S2 Immunology Special 181Antichromatin Antibody ACA Antichromatin Antibody 182
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Anti-CMV, total X VM3 Viral Markers-Series 3 201X VR3 Infectious Disease
Serology178
Anti-CMV, IgG, IgM X VR3 Infectious DiseaseSerology
178
Anti-D titer ABT, ABT2 Antibody Titer 196Anti-DNA (ds) antibody,qualitative
X S2, S4 Immunology, Special 181
Anti-DNA (ds) antibody,quantitative
S2, S4 Immunology, Special 181
Anti-DNA topoisom-erase (Scl-70)
RDS Rheumatic DiseaseSpecial Serologies
186
Antiendomysial antibodyIgA, qualitative
X CES Celiac Serology 184
Antiendomysial antibodyIgA, quantitative
CES Celiac Serology 184
Antiendomysial antibodyIgG, qualitative
CES Celiac Serology 184
Antiendomysial antibodyIgG, quantitative
CES Celiac Serology 184
Antifungal susceptibilitytesting
X F Mycology 164
X F1 Yeast 164Antigen detection,bacterial
X D Bacteriology 152
X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156X D8 Group B Strep 156X D9 Rapid Group A Strep,
Waived156
X HC1 C. trachomatis by DFA 159X HC3 C. trachomatis by EIA 159X LBAS Legionella pneumophila 157X SBAS Streptococcus
pneumoniae157
X VS Vaginitis Screen 162Antigen detection, viral X HC2 HSV by DFA 172
X VR2 Viral Antigen Detectionby DFA
171
X VR4 Viral Antigen Detectionby EIA and Latex
172
Antigliadin antibodyIgA, IgG, qualitative
X CES Celiac Serology 184
Antigliadin antibodyIgA, IgG, quantitative
CES Celiac Serology 184
Antideamidated gliadinpeptide antibody, IgA,IgG, qual
X CES Celiac Serology 184
Antideamidated gliadinpeptide antibody, IgA,IgG, quant
CES Celiac Serology 184
Analyte/Procedure Index
260 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Antideamidated gliadinpeptide antibody screen,IgA, IgG
CES Celiac Serology 184
Antideamidatedgliadin peptide/tissuetransglutaminaseantibody screen, IgA, IgG
CES Celiac Serology 184
Antifilamentous actinIgG Antibody
FCN Antifilamentous ActinAntibody
182
Antiglomerular basementmembrane, qualitative
X S2 Immunology, Special 181
Antiglomerular basementmembrane, quantitative
S2 Immunology, Special 181
Anti-HAV, IgM X VM5 Viral Markers-Series 5 202Anti-HAV, total X VM1 Viral Markers-Series 1 201Anti-HBc, IgM X VM5 Viral Markers-Series 5 202Anti-HBc, total X VM1 Viral Markers-Series 1 201Anti-HBe X VM2 Viral Markers-Series 2 201Anti-HBs X VM1 Viral Markers-Series 1 201Anti-HCV RHCVW Anti-HCV, Rapid
Methods, Wavied202
X VM1 Viral Markers-Series 1 201Antihistidyl t-RNAsynthetase (Jo-1)
RDS Rheumatic DiseaseSpecial Serologies
186
Antihistone antibody AHT Antihistone Antibody 182Anti-HIV-1 X AHIV Anti-HIV Rapid
Methods202
X AHIVW Anti-HIV RapidMethods
202
X VM1 Viral Markers-Series 1 201Anti-HIV-2 X VM1 Viral Markers-Series 1 201
X AHIV Anti-HIV RapidMethods
202
Anti-HIV-1/2 X AHIV Anti-HIV RapidMethods
202
X AHIVW Anti-HIV RapidMethods
202
X VM1 Viral Markers-Series 1 201Anti-HIV 1/2, HIV-1p24 antigen
X VM6 Viral Markers-Series 6 202
Anti-HTLV-I/II X VM3 Viral Markers-Series 3 201Anti-Jo-1(antihistidylt-RNA synthetase)
RDS Rheumatic DiseaseSpecial Serologies
186
Anti-LKM LKM Liver-KidneyMicrosomal Antibody
186
Antimicrobialsusceptibility testing
X D Bacteriology 152
X D2 Urine Cultures 154X D4 Bacteriology, Ltd 154X D7 Throat, Urine Cultures 154
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Antimicrobialsusceptibility testing(cont.)
MBT Microbiology BenchTools Competency
153
Antimitochondrialantibody, qualitative
X S2 Immunology, Special 181
Antimitochondrial M2antibody
H Antimitochondrial M2Antibody
182
Anti-MPO S2 Immunology, Special 181Antimüllerian Hormone AMH Antimüllerian Hormone 76Antimycobacterialsusceptibility testing
X E Mycobacteriology 163
MTBR Molecular MTBDetection andResistance
163
Antineutrophilcytoplasmic antibody(ANCA)
S2 Immunology, Special 181
Antinuclear antibody(ANA)
X ANA, IL Immunology 180
Antiparietal cellantibody
APC Antiparietal CellAntibody
182
Antiphospholipidantibody
ACL AntiphospholipidAntibody
183
CGE/CGEX Coagulation, Extended 144Antiphosphatidylserineantibodies (IgG, IgMand IgA)
APS AntiphosphatidylserineAntibodies
183
Anti-PR3 S2 Immunology, Special 181Antiribosomal PAntibody
ARP Antiribosomal PAntibody
183
Anti-RNP antibody,qualitative
X S2 Immunology, Special 181
Anti-RNP antibody,quantitative
S2 Immunology, Special 181
Anti-Saccharomycescerevisiae antibody
ASC Anti-Saccharomycescerevisiae Antibody
183
Anti-Scl-70 (anti-DNAtopoisomerase)
RDS Rheumatic DiseaseSpecial Serologies
186
Anti-Sm antibody,qualitative
X S2 Immunology, Special 181
Anti-Sm antibody,quantitative
S2 Immunology, Special 181
Anti-Sm/RNP antibody,qualitative
X S2 Immunology, Special 181
Anti-Sm/RNP antibody,quantitative
S2 Immunology, Special 181
Antismooth muscleantibody
X S2 Immunology, Special 181
Antisperm antibody IgG X ASA Semen Analysis 140Anti-SSA antibody,qualitative
X S2 Immunology, Special 181
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 261
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Anti-SSA antibody,quantitative
S2 Immunology, Special 181
Anti-SSB antibody,qualitative
X S2 Immunology, Special 181
Anti-SSB antibody,quantitative
S2 Immunology, Special 181
Anti-SSA/SSB antibody,qualitative
X S2 Immunology, Special 181
Anti-SSA/SSB antibody,quantitative
S2 Immunology, Special 181
Antistreptolysin O (ASO) X ASO, IL Immunology 180Antithrombin (Activity, Ag) CGE/CGEX Coagulation, Extended 144
CGS2 Coag Special, Series 2 145LN35 Thrombophilia Cal
Ver/Lin116
Antithyroglobulinantibody, qualitative
X S2, S4 Immunology, Special 181
Antithyroglobulinantibody, quantitative
S2, S4 Immunology, Special 181
Antithyroid microsomal,qualitative
X S2, S4 Immunology, Special 181
Antithyroid microsomal,quantitative
S2, S4 Immunology, Special 181
Antithyroid peroxidase,qualitative
X S2, S4 Immunology, Special 181
Antithyroid peroxidase,quantitative
S2, S4 Immunology, Special 181
Antitissue transgluta-minase antibody IgA,qualitative
X CES Celiac Serology 184
Antitissue transgluta-minase antibody IgA,quantitative
CES Celiac Serology 184
Antitissue transgluta-minase antibody IgGqualitative
CES Celiac Serology 184
Antitissue transgluta-minase antibody IgGquantitative
CES Celiac Serology 184
Anti-Trypanosoma cruzi VM4 Viral Markers-Series 4 202Apolipoprotein A1 X ABL Accuracy-Based Lipids 98
X C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Apolipoprotein B X ABL Accuracy-Based Lipids 98X C3, C3X,
CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Apolipoprotein E(APOE) genotyping
APOE Apolipoprotein E(APOE) genotyping
216
Arsenic, urine TMU Trace Metals, Urine 92Arthropod identification TMO Ticks, Mites, and Other
Arthropods169
Aspartate aminotrans-ferase (AST/SGOT)
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Atenolol T Toxicology 86UT Urine Toxicology 86
Atropine T Toxicology 86UT Urine Toxicology 86
Automated WBCdifferential
X FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check ,Automated HematologySeries
126
Autopsy pathology AUCD/AUCD1
Autopsy Pathology,CD-ROM
240
B-type natriuretic peptides X BNP B-Type NatriureticPeptides, 2 Chall
55
X BNP5 B-Type NatriureticPeptides, 5 Chall
55
BNPQ Quality Cross Check,B-Type NatriureticPeptides
55
LN30 B-Type NatriureticPeptides Cal Ver/Lin
114
X PCARM,PCARMX
Plasma CardiacMarkers
59
POC12 Competency PlasmaCardiac Markers
45
Babesia microti TTD Antibody Detectionof Tick-TransmittedDiseases
178
Bacterial antigendetection
X D Bacteriology 152
X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156
Analyte/Procedure Index
262 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Bacterial antigendetection (cont.)
X HC1 C. trachomatis by DFA 159
X HC3 C. trachomatis by EIA 159X LBAS Legionella Antigen
Detection157
POC4 POC Strep ScreenCompetency
44
X SBAS S. pneumoniae AntigenDetection
157
X VS Vaginitis Screen 162Bacterial detection inplatelets
BDP, BDPV Bacterial detection,platelets
197
X BDP5,BDPV5
Bacterial detection,platelets
197
Bacterial identification X D Bacteriology 152X D1, D2, D3,
D7Throat, Urine, GCCultures
154
X D4 Bacteriology, Ltd 154X D8 Group B Strep 156
DEX Expanded Bacteriology 153X HC6/HC6X C. trachomatis/GC by
Nucleic Acid Amp174
X HC7 C. trachomatis/GCDNA by NAA
174
MBT Microbiology BenchTools Competency
153
MRS Methicillin-ResistantStaphylococcus aureusScreen
160
X MRS5 Methicillin-ResistantStaphylococcus aureusScreen
160
Bacterial strain typing BSTE Bacterial Strain Typing-Enterococcus
175
BSTN Bacterial Strain Typing-Gram-negative
175
BSTS Bacterial Strain Typing-Staphylococcus
175
Bacterial vaginosisscreen
BV Bacterial Vaginosis 161
VS2 Vaginitis Screen, VirtualGram Stain
162
Barbiturate group DMPM Drug Monitoring forPain Management
95
SDS Serum Drug Screen 91T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
BCR/ABL1 p190 X MRD1 Minimal ResidualDisease
225
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
BCR/ABL1 p210 X MRD Minimal ResidualDisease
225
Bence Jones protein UBJP Urinary Bence JonesProtein
68
Benzodiazepine group DMPM Drug Monitoring forPain Management
95
SDS Serum Drug Screen 91T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Benzoylecgonine DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86UTCO Urine Toxicology
Carryover120
Beta-2-glycoprotein I ACL, APS AntiphospholipidAntibody
183
Beta-2-microglobulin,serum
X TM/TMX Tumor Markers 80
Beta-2-microglobulin,urine
CD Cadmium 92
Beta-hydroxybutyrate X KET Ketones 58Beta globulin SPE Serum Electrophoresis 68Beta-thalassemia HGM Hemoglobinopathies,
Molecular Methods216
Bile crystal identification BCR Bile Crystals 135Bilirubin, confirmatoryurine
DSC Dipstick Confirmatory 135
Bilirubin, direct X C1, C3,C3X, CZ,CZ2X, CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN2 Chemistry, Lipid,Enzyme Cal Ver/Lin
106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
X NB, NB2 Neonatal Bilirubin 58Bilirubin, total X C1, C3, C3X,
CZ, CZ2X,CZX
Chemistry and TDM 50-52
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 263
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Bilirubin, total (cont.) CZQ Quality Cross Check,Chemistry and TDM
53
FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LM1 Lung Maturity 68LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
X NB, NB2 Neonatal Bilirubin 58Bilirubin, urine X CMP, CMP1 Clinical Microscopy 133
DSC Dipstick Confirmatory 135POC3 POC Urine Dipstick
Competency44
Bioavailable testosterone DY Ligand Assay, Special 75Biochemical genetics BGL, BGL1 Biochemical Genetics 215Bioterrorism agents LPX Laboratory
Preparedness Exercise159
BK virus ID1T Nucleic Acid Amp, JCand BK
176
VLS, VLS2 Viral Load 173Blood cell identification X BCP Blood Cell Identification 124
EHE1 Expanded VirtualPeripheral Blood Smear
131
X FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
X HEP Basic Hematology 124VPBS Virtual Peripheral Blood
Smear130
Blood cell identification-body fluid
VBF Virtual Body Fluid 134
Blood culture X BCS Blood Culture 157GNBC Gram-Negative Blood
Culture Panel158
GPBC Gram-Positive BloodCulture Panel
158
Blood cultureStaphylococcus aureus
BCS1 Blood CultureStaphylococcus aureus
157
Blood parasite X BP Blood Parasite 168X P Parasitology 167
Blood parasite, rapid RMAL Rapid Malaria 168Bloom syndrome X MGL4 Molecular Genetics 217Bocavirus IDR Infectious Disease
Respiratory Panel177
Body fluid (cell count) ABF1, ABF2,ABF3
Automated Body Fluid 134
X HFC, HFCI HemocytometerFluid Count
136
Body fluid (chemistry) FLD, FLD2 Body Fluid 65
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Body fluid (crystals) BFC Crystals 135Body fluid photographs CMP, CMP1 Clinical Microscopy 133Bone marrow celldifferential
BMD Bone Marrow CellDifferential
128
Bone marrow cellidentification
BMD Bone Marrow CellDifferential
128
Bone specific alkalinephosphatase
BMV2 Bone Markers andVitamins
77
Bordetella parapertussis IDN, IDO Nucleic Acid Amp,Organisms
175
Bordetella pertussis IDN, IDO Nucleic Acid Amp,Organisms
175
Borrelia burgdorferi TTD Antibody Detectionof Tick-TransmittedDiseases
178
BRAF BRAF Mutation testing 224MTP Multigene Tumor Panel 224
BRCA1/2 X MGL3 Molecular Genetics 217Brain tissue by FISH CYJ Fluorescence In Situ
Hybrid, Brain/GliomaTissue
213
Brightfield in situhybridization
X ISH2 In Situ Hybridization 222
Brompheniramine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Buprenorphine DMPM Drug Monitoring forPain Management
95
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Bupropion T Toxicology 86UT Urine Toxicology 86
Butalbital DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86C. difficile X D Bacteriology-Antigen
Detection152
GIP Gastrointestinal Panel 177SP, SPN Stool Pathogens- Rapid
and Molecular161
CA 15-3 LN34 Tumor Markers CalVer/Lin
115
Analyte/Procedure Index
264 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
CA 15-3 (cont.) X TM/TMX Tumor Markers 80CA 19-9 FLD Body Fluid 65
LN34 Tumor Markers CalVer/Lin
115
X TM/TMX Tumor Markers 80CA 27.29 X TM/TMX Tumor Markers 80CA 72-4 X TM/TMX Tumor Markers 80CA 125 LN34 Tumor Markers Cal
Ver/Lin115
X TM/TMX Tumor Markers 80Cadmium, urine X CD Cadmium 92Cadmium, whole blood X CD Cadmium 92Caffeine X CZ2X, CZX,
CZ, ZChemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Calcitonin X TM/TMX Tumor Markers 80Calcium ABS Accuracy-Based
Testosterone andEstradiol
99
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Calcium, urine ABU Accuracy-Based Urine 99LN6 Urine Chemistry Cal
Ver/Lin108
X U Urine Chemistry,General
61
Calcium, ionized X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
X C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN13C Blood Gas Cal Ver/Lin 111
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Calcium, ionized (cont.) POC10,POC11
POC Competency BloodGases
45
Calcofluor white FSM Fungal Smear 165Campylobacter CAMP Campylobacter 158
GIP Gastrointestinal Panel 177Canavan X MGL4 Molecular Genetics 217Candida culture X F3 Candida culture 165Candida sp., DNA probe X VS Vaginitis Screen 162Cannabinoids See Delta-9-THC-
COOH and Delta-9-THC
Carbamazepine X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107T Toxicology 86UT Urine Toxicology 86
Carbamazepine-10,11-epoxide
T Toxicology 86
UT Urine Toxicology 86Carbamazepine, free X CZ, CZ2X,
CZX, ZChemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Carboxyhemoglobin X SO Blood Oximetry 84SOQ Quality Cross Check,
Blood Oximetry84
Carisoprodol DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Carnitine BGL1 Biochemical Genetics 215Casts, urine UAA, UAA1 Automated Urinalysis 135CD1a RFAV1 Rare Flow Antigen
Validation CD1a190
CD3 X FL, FL1 Lymphocyte subsetimmunophenotyping
188
LN22 Flow Cytometry CalVer/Lin
113
SCP Stem Cell Processing 198CD4 X FL, FL1 Lymphocyte subset
immunophenotyping188
LN22 Flow Cytometry CalVer/Lin
113
CD8 X FL, FL1 Lymphocyte subsetimmunophenotyping
188
LN22 Flow Cytometry CalVer/Lin
113
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 265
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
CD20 PM3 Immunohistochemistry 237CD34 CBT Cord Blood Testing 198
X FL4 Flow Cytometry CD34+ 189SCP Stem Cell Processing 198
CD45 CBT Cord Blood Testing 198X FL, FL1 Lymphocyte subset
immunophenotyping188
FL4 Flow Cytometry CD34+ 189SCP Stem Cell Processing 198
CD117 (c-kit) PM1 Immunohistochemistry 237CEA FLD Body Fluid 65
X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
Ceruloplasmin X S2, S4 Immunology, Special 181CFU-GM SCP Stem Cell Processing 198CH50 CH50 Total Hemolytic
complement186
CH100 CH50 CH100 186Chlamydia trachomatis X HC1 C. trachomatis by DFA 159
X HC3 C. trachomatis by EIA 159X HC6, HC6X C. trachomatis/GC by
Nucleic Acid Amp174
X HC7 C. trachomatis/GCDNA by NAA
174
VR1 Virology Culture 171Chlamydiophilapneumoniae
IDN, IDO Nucleic Acid Amp,Organisms
175
Chlordiazepoxide T Toxicology 86UT Urine Toxicology 86
Chloride X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
LN13C Blood Gas Cal Ver/Lin 111
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Chloride (cont.) POC10,POC11
POC Competency BloodGases
45
Chloride, sweat X SW1, SW2,SW3, SW4
Sweat Analysis Series 71
Chloride, urine LN6 Urine Chemistry CalVer/Lin
108
X U Urine Chemistry,General
61
Chloride, vitreous fluid VF Vitreous Fluid, Post-mortem
90
Chlorpheniramine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Chlorpromazine T Toxicology 86UT Urine Toxicology 86
Cholesterol ABL Accuracy-Based Lipids 98X C1, C3, C3X,
CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD Body Fluid 65X LCW Ltd Chem, Waived 58
LN2 Chemistry, Lipid,Enzyme Cal Ver/Lin
106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Chromium X R Trace Metals 70Chromium, urine TMU Trace Metals, Urine 92Chromosomalabnormalities
X CY, CYBK Cytogenetics 212
Citalopram T Toxicology 86UT Urine Toxicology 86
CK isoenzymes X CRTI Cardiac Markers 56CK-MB(immunochemical)
X CRT, CRTI Cardiac Markers 56
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
X PCARM,PCARMX
Plasma CardiacMarkers
59
POC12 Competency PlasmaCardiac Markers
45
CK2 (MB) IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
Analyte/Procedure Index
266 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
CK2 (MB) (cont.) LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Clinical PathologyImprovement Program
CPIP/CPIP1 Quality Management(Education)
16
Clomipramine T Toxicology 86UT Urine Toxicology 86
Clonazepam DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Clostridium difficile X D Bacteriology-AntigenDetection
152
GIP Gastrointestinal Panel 177SP, SPN Stool Pathogens- Rapid
and Molecular161
Clozapine T Toxicology 86UT Urine Toxicology 86ZE Therapeutic Drug
Monitoring, Extended54
CMV ID1 Nucleic Acid Amp,Viruses
176
LN38 CMV Viral Load CalVer/Lin
116
VLS, VLS2 Viral Load 173X VM3 Viral Markers-Series 3 201X VR1 Virology Culture 171X VR2 Viral Antigen Detection
by DFA171
X VR3 Infectious DiseaseSerology
178
CO2 X C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Cobalt TMU Trace Metals, Urine 92Cocaethylene FTC Forensic Toxicology,
Criminalistics93
T Toxicology 86UT Urine Toxicology 86
Cocaine DMPM Drug Monitoring forPain Management
95
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Cocaine (cont.) FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Codeine DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Compatibility testing X J, JAT Transfusion Medicine 192
JATE1 Transfusion MedicineAutomated, Educational
193
TMCA Transfusion Medicine,Competency Assessment
194
Complement C3 X IG/IGX Immunology, General 180LN7 Immunology Cal Ver/Lin 109
Complement C4 X IG/IGX Immunology, General 180LN7 Immunology Cal Ver/Lin 109
Complexed PSA X K/KK Ligand Assay, General 74Conductivity, sweat X SW1, SW2,
SW3, SW4Sweat Analysis Series 71
Connexin-26 X MGL3 Molecular Genetics 217Copper X R Trace Metals 70Copper, urine TMU Trace Metals, Urine 92Coproporphyrins X N/NX Urine Chemistry, Special 62Coronavirus ID2 Nucleic Acid Amp,
Respiratory176
IDR Infectious Disease,Respiratory Panel
177
Cortisol ABS Accuracy-BasedTestosterone andEstradiol
99
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
Cortisol, salivary SALC Salivary Cortisol 69
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 267
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Cortisol, urinary free X N/NX Urine Chemistry,Special
62
Cotinine T Toxicology 86UT Urine Toxicology 86
C-peptide X ING Insulin, Gastrin,C-Peptide, PTH
78
C-reactive protein (CRP) X CRP, IL Immunology 180LN12 C-Reactive Protein Cal
Ver/Lin110
C-reactive protein, high-sensitivity (hsCRP)
X HSCRP High-Sensitivity C-Reactive Protein
57
LN21 High-SensitivityC-Reactive Protein CalVer/Lin
113
Creatine kinase (CK) X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Creatinine X AQ2, AQ4 Aqueous Blood Gas 82AQ2Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD Body Fluid 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
LN24 Creatinine AccuracyCal Ver/Lin
114
SCO Serum Carryover 120Creatinine, urine ABU Accuracy-Based Urine 99
X BU Bone and Mineral,Urine
77
X CD Cadmium 92DAI Urine Drug Adulterant/
Integrity Testing88
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Creatinine, urine (cont.) LN6 Urine Chemistry CalVer/Lin
108
LN20 Urine Albumin CalVer/Lin
112
X U Urine Chemistry,General
61
UDC Forensic Urine DrugTesting, Confirmatory
89
X UMC Urine Albumin/Creatinine
138
Creatinine, vitreous fluid VF Vitreous Fluid, Post-mortem
90
Crossmatching EXM, EXM2 Electronic Crossmatch 195X J, JAT Transfusion Medicine 192X MX1B,
MX1C, MXB,MXC
HLA Analysis, Class I 206-207
X MX2B,MX2C, MXB,MXC
HLA Analysis Class II 206-207
TMCA Transfusion Medicine,Competency Assessment
194
Cryptococcal antigendetection
X F Mycology 164
X F1 Yeast 164Cryptosporidium GIP Gastrointestinal Panel 177Cryptosporidiumimmunoassay,preserved specimen
X P, P3, P4, P5 Parasitology 167
Crystals BFC Body Fluid Crystals 135UAA Automated Urinalysis 135URC Urine Crystals 135
CSF antigen detection X D Bacteriology 152C-telopeptide (CTX) BMV5 Bone Markers and
Vitamin77
BU Bone and Mineral,Urine
77
Cyclic citrullinatedpeptide antibody
CCP Anti-cyclic citrullinatedpeptide antibody
184
Cyclobenzaprine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Cyclosporine X CS ImmunosuppressiveDrugs
53
LN31 ImmunosuppressiveDrugs Cal Ver/Lin
115
CYP2C9 PGX Pharmacogenetics 219CYP2C19 PGX Pharmacogenetics 219CYP2D6 PGX Pharmacogenetics 219Cystatin C CYS Cystatin C 66
Analyte/Procedure Index
268 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
re In
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Cystic fibrosis X MGL2, MGL5
Molecular Genetics 217
Cytogenomic microarray CYCGH Cytogenomic Microarray Analysis
213
Cytology proficiency testing
See Cytopathology GYN proficiency testing
Cytomegalovirus (CMV) ID1 Nucleic Acid Amp, Viruses
176
LN38 CMV Viral Load Cal Ver/Lin
116
VLS, VLS2 Viral Load 173X VM3 Viral Markers- Series 3 201X VR1 Virology Culture 171X VR2 Virology by DFA 171X VR3 Infectious Disease
Serology178
Cytopathology GYN education
APEDK PAP Edu, Online, Indiv., SurePath
244
APEDL PAP Edu, Online, Indiv., Combination
244
APEDM PAP Edu, Online, Indiv., ThinPrep
244
FOVK/FOVK1
Fields of View SurePath 246
FOVM/FOVM1
Fields of View ThinPrep 246
PAPCE1 PAP Edu, Conventional 245PAPJE1 PAP Edu, All
Technologies245
PAPKE1 PAP Edu, SurePath 245PAPME1 PAP Edu, ThinPrep 245PEDK PAP Edu, Online, Lab,
SurePath244
PEDL PAP Edu, Online, Lab, Combination
244
PEDM PAP Edu, Online, Lab, ThinPrep
244
Cytopathology GYN proficiency testing
PAPCPT PAP PT, Conventional 243
PAPJPT PAP PT, Combination 243PAPKPT PAP PT, SurePath 243PAPLPT PAP PT, Combination 243PAPMPT PAP PT, ThinPrep 243PTGDK PAP PT, Sure Path 242PTGDM PAP PT, Thin Prep 242PTGDL PAP PT, Combination 242
Cytopathology, nongynecologic
FNA/FNA1 Fine- Needle Aspiration- online
249
FNAG/FNAG1
Fine- Needle Aspiration- glass
250
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Cytopathology, nongynecologic (cont.)
NGC/NGC1 Nongynecologic Cytopath Edu Prgm
248
Cytopreparation differential
HFC Hemocytometer Fluid Count
136
Dabigatran DBGN Anticoagulant Monitoring, Dabigatran
146
D- dimer, qualitative CGDF Coagulation, D- dimer/FDP
144
CGL Coagulation, Ltd 144WBDD Whole Blood D- dimer 149
D- dimer, quantitative X CGDF Coagulation, D- dimer/FDP
144
X CGL Coagulation, Ltd 144LN42 D- dimer Cal Ver/Lin 117
X PCARM, PCARMX
Plasma Cardiac Markers
59
POC12 Competency Plasma Cardiac Markers
45
Delta- 9- THC FTC Forensic Toxicology, Criminalistics
93
OFD Oral Fluid for Drugs of Abuse
90
T Toxicology 86UT Urine Toxicology 86
Delta- 9- THC- COOH DMPM Drug Monitoring for Pain Management
95
FTC Forensic Toxicology, Criminalistics
93
OFD Oral Fluid for Drugs of Abuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86UTCO Urine Toxicology
Carryover120
Deoxypyridinoline (DPD) BU Bone and Mineral, Urine
77
Dermatopathology DPATH/DPATH1
Online Digital Slide Program
231
Dermatophyte identification
X F Mycology 164
Desalkylflurazepam T Toxicology 86UT Urine Toxicology 86
Desipramine FTC Forensic Toxicology, Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
X ZT, ZZT TDM, Special 54Desmethylclomipramine T Toxicology 86
Discontinued
Discontinued
Discontinued
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 269
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Desmethylclomipramine(cont.)
UT Urine Toxicology 86
Desmethylcycloben-zaprine
FTC Forensic Toxicology,Criminalistics
93
Dextromethorphan T Toxicology 86UT Urine Toxicology 86
DHEA sulfate X Y/YY Ligand Assay, Special 75DIA (Dimeric inhibin A) X FP/FPX Maternal Screen 78Diazepam FTC Forensic Toxicology,
Criminalistics93
T Toxicology 86UT Urine Toxicology 86
Differential, automated X FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
Differential, manual BMD Bone Marrow CellDifferential
128
HFC, HFCI HemocytometerFluid Count
136
Digital slide program infine-needle aspiration,online
FNA/FNA1 Online Digital SlideProgram
249
Digoxin X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107Digoxin, free X CZ, CZ2X,
CZX, ZChemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Dihydrocodeine T Toxicology 86UT Urine Toxicology 86
Diltiazem T Toxicology 86UT Urine Toxicology 86
Dilute prothrombin time CGE/CGEX Coagulation, Extended 144Dilute Russell’s vipervenom time
CGE/CGEX Coagulation, Extended 144
Dimeric inhibin A (DIA) X FP, FPX Maternal Screen 78Diphenhydramine FTC Forensic Toxicology,
Criminalistics93
T Toxicology 86UT Urine Toxicology 86
Diphenylhydantoin See Phenytoin
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Direct antiglobulintesting
X DAT Direct AntiglobulinTesting
198
TMCAD Transfusion Medicine,Competency Assessment
194
Direct bilirubin X C1, C3,C3X, CZ,CZ2X, CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN2 Chemistry, Lipid,Enzyme Cal Ver/Lin
106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
X NB, NB2 Neonatal Bilirubin 58Disease Association/Drug Risk
DADR1,DADR2
Disease Associate/Drug Risk
209
Disopyramide X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
DMD/Becker X MGL2 Molecular Genetics 217DNA analysis X DL, DML HLA Molecular Typing 207
DNA, DNAF DNA Database 252FID, FIDM Forensic Identity 252
X ML HLA Molecular Typing 207MHO Molecular Oncology 225
X PARF Parentage/Relationship 204DNA content/cell cycleanalysis
FL, FL2 Flow Cytometry 188
DNA database DNA, DNAF DNA Database 252DNA extraction andamplification
MHO5 Molecular OncologyHematologic
225
DNA fingerprinting IDN, IDO Nucelic Acid Amp,Organisms
175
DNA Mismatch Repair MMR DNA Mismatch Repair 237DNA sequencing SEC, SEC1 DNA Sequencing 218Dopamine X N/NX Urine Chemistry,
Special62
Doxepin FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Doxylamine T Toxicology 86UT Urine Toxicology 86
Duloxetine T Toxicology 86UT Urine Toxicology 86
Ecgonine ethyl ester FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Analyte/Procedure Index
270 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Ecgonine methyl ester FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
E. coli O157 GIP Gastrointestinal Panel 177EGFR-Epidermal growthfactor receptor
EGFR Mutation testing 224
MTP Multigene Tumor Panel 224eGFR LN24 Creatinine Accuracy
CalVer/Lin114
Electronic crossmatch EXM, EXM2 Electronic Crossmatch 195Electrophoresis X HG Hemoglobinopathy 128
X LPE LipoproteinElectrophoresis
68
X M, OLI CSF Chemistry andOligoclonal Bands
66
X SPE Protein Electrophoresis 68UBJP Urinary Bence Jones
Protein68
Elution, antibody ELU Eluate 199TMCAE Eluate Competency
Assessment194
Embryology EMB Embryology 141Enterotoxigenic E. coli(ETEC)
GIP Gastrointestinal Panel 177
Enterovirus ID1 Nucleic Acid Amp,Viruses
176
IDR Infectious Disease,Respiratory Panel
177
X VR1 Virology Culture 171Eosinophils, urine SCM2 Special Clinical
Microscopy137
Ephedrine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Epidermal growth factorreceptor (EGFR)
EGFR Mutation testing 224
Epinephrine N/NX Urine Chemistry,Special
62
Epithelial cells, urine UAA1 Automated Urinalysis 135Epstein-Barr virus (EBV) ID1 Nucleic Acid Amp,
Viruses176
ISH In Situ Hybridization 222VLS, VLS2 Viral Load 173VR3 Antibody Detection-
Infectious DiseaseSerology
178
ER, PgR byimmunohistochemistry
X PM2 ER, PgR byimmunohistochemistry
239
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Erythrocytesedimentation rate
ESR, ESR1,ESR2, ESR3
ErythrocyteSedimentation Rate
124
Erythropoietin EPO Erythropoietin 77Escherichia coli O157 GIP Gastrointestinal Panel 177Estradiol ABS Accuracy-Based
Testosterone andEstradiol
99
LN8 ReproductiveEndocrinology CalVer/Lin
109
X Y/YY Ligand Assay, Special 75Estimated glomerularfiltration rate (eGFR)
LN24 Creatinine AccuracyCal Ver/Lin
114
Estriol, unconjugated(uE3)
X FP/FPX Maternal Screen 78
X Y/YY Ligand Assay, Special 75Estrogen receptors byimmunohistochemistry
X PM2 ER, PgR byImmunohistochemistry
239
Ethanol X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles
91
X AL2 Serum Alcohol/EthyleneGlycol/Volatiles
91
LN11 Serum Ethanol CalVer/Lin
110
LN14 Whole Blood EthanolCal Ver/Lin
111
UDS, UDS6 Urine Drug Screen 88Ethanol, vitreous fluid VF Vitreous Fluid, Post-
mortem90
ETEC(Enterotoxigenic E. coli)
GIP Gastrointestinal Panel 177
Ethosuximide X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Ethylene glycol AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles
91
AL2 Serum Alcohol/EthyleneGlycol/Volatiles
91
Ethyl glucuronide (EtG) ETB Ethanol Biomarkers 91Ethyl sulfate (EtS) ETB Ethanol Biomarkers 91Euglobulin Test CGE/CGEX Coagulation, Extended 144Everolimus EV Everolimus 53Factor II CGE/CGEX Coagulation, Extended 144Factor II mutation TPM Thrombophilia
Mutations219
Factor V CGE/CGEX Coagulation, Extended 144Factor V Leiden mutation X MGL1 Molecular Genetics 217
TPM ThrombophiliaMutations
219
Factor VII CGE/CGEX Coagulation, Extended 144
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 271
Analyte/Procedure Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Factor VIII X CGE/CGEX Coagulation, Extended 144X CGS3 Coag Special, Series 3 145
Factor VIII Inhibitor CGE/CGEX Coagulation, Extended 144Factor IX CGE/CGEX Coagulation, Extended 144Factor X CGE/CGEX Coagulation, Extended 144Factor XI CGE/CGEX Coagulation, Extended 144Factor XII CGE/CGEX Coagulation, Extended 144Factor XIII CGE/CGEX Coagulation, Extended 144Familial dysautonomia X MGL4 Molecular Genetics 217Fanconi anemia X MGL4 Molecular Genetics 217Fecal fat, qualitative FCFS Fecal Fat 67Fecal lactoferrin FLAC Fecal Lactoferrin 159Fentanyl DMPM Drug Monitoring for
Pain Management95
FTC Forensic Toxicology, Criminalistics
93
T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Fern test X CMMP Clinical Microscopy, Misc
133
Ferritin X C3, C3X, CZ, CZ2X, CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check, Chemistry and TDM
53
X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, Siemens Cal Ver/Lin
108
Fetal fibronectin X FF Fetal Fibronectin 77Fetal hemoglobin (gastric fluid)
APT Fetal Hemoglobin 136
Fetal hemoglobin identification
X HG Hemoglobinopathy 128
Fetal lung maturity X LM, LM1 Lung Maturity 68Fetal membrane rupture ROM1 Rupture of Fetal
Membrane137
Fetal red cell quantitation
X HBF Fetal Red Cell Detection 199
TMCAF Transfusion Medicine, Competency Assessment
194
Fetal screen (Rosette testing)
X HBF Fetal Red Cell Detection 199
TMCAF Transfusion Medicine, Competency Assessment
194
Fibrin monomer CGE/CGEX Coagulation, Extended 144Fibrinogen X CGL Coagulation, Ltd 144Fibrinogen antigen CGE/CGEX Coagulation, Extended 144
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Fibrinogen degradation products, plasma
CGDF Coagulation, D- dimer/FDP
144
CGL Coagulation, Ltd 144Fibrinogen degradation products, serum
CGDF Coagulation, D- dimer/FDP
144
Fibrinogen degradation products, serum
CGL Coagulation, Ltd 144
Fields of view FOVK/FOVK1
Fields of View SurePath 246
FOVM/FOVM1
Fields of View ThinPrep 246
Fine- needle aspiration, digital slide program
FNA/FNA1 Online Digital Slide Program
249
Fine- needle aspiration, glass slides
FNAG/FNAG1
Fine- Needle Aspiration 250
FISH for breast carcinoma hybridization and interpretation on site (HER2 gene amplification)
X CYH Fluorescence In Situ Hybridization- Breast Cancer
213
FISH for brain/glioma CYJ Fluorescence In Situ Hybridization, Brain/Glioma Tissue
213
FISH for constitutional and hematologic disorders
CYF Fluorescence In Situ Hybridization
212
FISH for lymphoma CYL Fluorescence In Situ Hybridization, Lymphoma
213
FISH for paraffin- embedded tissue
CYH Fluorescence In Situ Hybridization- Breast Cancer
213
CYJ Fluorescence In Situ Hybridization, Brain/Glioma Tissue
213
CYK Fluorescence In Situ Hybridization, Sarcoma Tissue or Pediatric Neoplasm
213
CYL Fluorescence In Situ Hybridization, Lymphoma
213
FISH for sarcoma CYK Fluorescence In Situ Hybridization, Sarcoma Tissue or Pediatric Neoplasm
213
FISH for urothelial carcinoma hybridization and interpretation on- site
X CYI Fluorescence In Situ Hybridization, Urothelial Carcinoma
212
Flunitrazepam T Toxicology 86UT Urine Toxicology 86
Analyte/Procedure Index
272 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Fluorescent microscopecheck
I Instrumentation 118
Fluorescent polarizationassay
X LM, LM1 Lung Maturity 68
Fluoxetine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Flurazepam FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Folate, RBC X FOL RBC Folate 79Folate, serum X K/KK Ligand Assay, General 74
LN5 Ligand Assay CalVer/Lin
108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
Follicle-stimulatinghormone (FSH)
LN8 ReproductiveEndocrinology CalVer/Lin
109
X Y/YY Ligand Assay, Special 75Fondaparinux FNPX Anticoagulant
Monitoring,Fondaparinux
146
Forensic identity (DNA) FID, FIDM Forensic Identity 252Forensic pathology FR/FR1 Forensic Pathology 253Forensic toxicology FTC Forensic Toxicology,
Criminalistics93
Fragile X X MGL1 Molecular Genetics 217Free Beta hCG FP1B First Trimester Maternal
Screening, Free Beta78
Free testosterone X DY Ligand Assay, Special 75Friedreich ataxia X MGL2 Molecular Genetics 217Fructosamine FT Fructosamine 67Fungal culture CBT Cord Blood Testing 198
SCP Stem Cell Processing 198Fungal serology FSER Fungal Serology 165Fungus identification X F Mycology 164
X F1 Yeast 164X F3 Candida culture 165
Gabapentin ZE Therapeutic DrugMonitoring, Extended
54
Galactomannan FGAL Galactomannan 165Gamma globulin M, OL1 CSF Chemistry 66
SPE Serum Electrophoresis 68Gamma glutamyltransferase (GGT)
X C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Gamma glutamyltransferase (GGT) (cont.)
IFS Interfering Substances 119
LN2 Chemistry, Lipid,Enzyme Cal Ver/Lin
106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Gamma hydroxybutyrate FTC Forensic Toxicology,Criminalistics
93
Gardnerella vaginalis,DNA Probe
X VS Vaginitis Screen 162
Gastric occult blood GOCB Gastric Occult Blood 136Gastric pH GOCB Gastric Occult Blood 136Gastrin X ING Insulin, Gastrin,
C-Peptide, PTH78
GATA3 PM5 ImmunohistochemistryTMA
238
Gaucher disease X MGL4 Molecular Genetics 217Genomic copy numberarray
CYCGH CytogenomicMicroarray Analysis
213
Gentamicin X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107Giardia GIP Gastrointestinal Panel 177Giardia immunoassay,preserved specimen
X P, P3, P4, P5 Parasitology 167
Giemsa stain X BP Blood Parasite 168X P Parasitology 167
Glioma by FISH CYJ Fluorescence In SituHybridization,Brain/Glioma Tissue
213
Glucose X AQ2, AQ4 Aqueous Blood Gas 82AQ2Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD Body Fluid 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
LN13C Blood Gas Cal Ver/Lin 111
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 273
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Glucose, CSF X M, OLI CSF Chemistry andOligoclonal Bands
66
Glucose, urine X CMP, CMP1 Clinical Microscopy 133LN6 Urine Chemistry Cal
Ver/Lin108
POC3 POC Urine DipstickCompetency
44
X U Urine Chemistry,General
61
Glucose, vitreous fluid VF Vitreous Fluid, Post-mortem
90
Glucose, whole blood X HCC Waived Combination 59X LCW Ltd Chem, Waived 58
LN17 Whole Blood GlucoseCal Ver/Lin
112
POC2 POC GlucoseCompetency
44
POC7 POC/Waived Glucoseand HemoglobinCompetency
44
X WB2 Whole Blood Glucose,3 challenges
59
X WBG Whole Blood Glucose 59Glucose-6-phosphatedehydrogenase
G6PDS Glucose-6 PhosphateDehydrogenase
67
Glutaraldehyde, urine DAI Urine Drug Adulterant/Integrity Testing
88
Glycated Serum albumin GSA Glycated SerumAlbumin
57
Glycogen storagedisease type 1A
X MGL4 Molecular Genetics 217
Glycohemoglobin X GH2, GH5,GH5I
Hemoglobin A1c 57
LN15 Hemoglobin A1c CalVer/Lin
111
Glycosaminoglycans(mucopolysaccharides)
BGL Biochemical Genetics 215
Gram stain X D Bacteriology 152X D2, D3, D7 Throat, Urine, GC
Cultures154
X D4 Bacteriology, Ltd 154X D5 Gram Stain 155
VGS1 Virtual Gram StainBasic
155
VGS2 Virtual Gram StainAdvanced
155
VS2 Vaginitis Screen, VirtualGram stain
162
Group A Streptococcusantigen detection
X D Bacteriology 152
X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Group A Streptococcusantigen detection (cont.)
X D9 Rapid Group A Strep,Waived
156
POC4 POC Strep ScreenCompetency
44
Group B Streptococcus X D8 Group B Strep 156Growth hormone X Y/YY Ligand Assay, Special 75Gyn cytopathology See Cytopathology
GYN proficiency testingGyn cytopathologyeducation
See CytopathologyGYN education
Haptoglobin X IG/IGX Immunology, General 180X S2/S4 Immunology, Special 181
HBeAg X VM2 Viral Markers-Series 2 201HBsAg X VM1 Viral Markers-Series 1 201HBV HBVL, HBVL5 Hepatitis Viral Load 173
X NAT Nucleic Acid Testing 203HCV HCVN,
HCV2Hepatitis Viral Load,Genotyping andQualitative
173
X NAT Nucleic Acid Testing 203HDL cholesterol ABL Accuracy-Based Lipid 98
X C1, C3, C3X,CZ, CZ3X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X LCW Ltd Chem, Waived 58LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Heavy Chain/LightChain Analysis
HCA Heavy Chain/LightChain Analysis
185
Helicobacter pylori X HPS H. pylori Antigen, Stool 159X S2, S4 H. pylori IgG Antibody 181X S5 H. pylori IgG Antibody 181X VR3 H. pylori IgG Antibody 178
Hematocrit X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
CBT Cord Blood Testing 198X FH1-FH4,
FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
Analyte/Procedure Index
274 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Hematocrit (cont.) FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
X HE, HEP Basic Hematology 124POC10,POC11
POC Competency BloodGases
45
SCP Stem Cell Processing 198X SO Blood Oximetry 84
SOQ Quality Cross Check,Blood Oximetry
84
Hematology case studies EHE1 Expanded VirtualPeripheral Blood Smear
131
BMD Bone Marrow CellDifferential
128
VPBS Virtual Periperal BloodSmear
130
HematopathologyOnline Education
HPATH,HPATH1
HematopathologyOnline Education
132
Hemochromatosis X MGL1 Molecular Genetics 217Hemocytometerfluid count
X HFC, HFCI HemocytometerFluid Count
136
Hemoglobin CBT Cord Blood Testing 198X FH1-FH4,
FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
X HCC Waived Combination 59X HE, HEP Basic Hematology 124
LN9 Hematology Cal Ver/Lin 110POC7 POC/Waived Glucose
and HemoglobinCompetency
44
SCP Stem Cell Processing 198X SO Blood Oximetry 84
SOQ Quality Cross Check,Blood Oximetry
84
Hemoglobinelectrophoresis
X HG Hemoglobinopathy 128
Hemoglobin, estimated X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Hemoglobin, estimated(cont.)
POC10,POC11
POC Competency BloodGases
45
Hemoglobin, plasma PHG Plasma Hemoglobin 69Hemoglobin, urine X CMP, CMP1 Clinical Microscopy 133
POC3 POC Urine DipstickCompetency
44
Hemoglobin A1c X GH2 57X GH5, GH5I Hemoglobin A1c 57
LN15 Hemoglobin A1c CalVer/Lin
111
Hemoglobin A2 X HG Hemoglobinopathy 128Hemoglobin F X HG Hemoglobinopathy 128
SCS Sickle Cell Screen 129Hemoglobin S/C HGM Hemoglobinopathies
Genotyping216
MGL2 Molecular Genetics 217Hemolytic complement,total
CH50 Total HemolyticComplement
186
Hemosiderin, urine SCM1 Special ClinicalMicroscopy
137
Heparin assay CGS4 Coag Special, Series 4 145Heparin-inducedthrombocytopenia
CGE/CGEX Coagulation, Extended 144
CGS5 Coag, Special, HIT 145CGS6 Coagulation Special 145
Heparin, low molecularweight
LN36 Heparin Cal Ver/Lin 116
Heparin, unfractionated LN36 Heparin Cal/Ver Lin 116Heparin/platelet FactorIV
CGS5 Coag, Special, HIT 145
CGS6 Coagulation Special 145Hepatitis B virus HBVL, HBVL5 Hepatitis Viral Load 173Hepatitis C virus HCVN,
HCV2Hepatitis Viral Load,Genotyping andQualitative
173
HER2, gastric GHER2 Gastric HER2 239HER2 gene amplificationby ISH
X ISH2 In Situ Hybridization 222
HER2 gene amplificationby FISH, hybridizationand interpretation on site
X CYH Fluorescence In SituHybridization-BreastCancer
213
HER2 byimmunohistochemistry
X HER2 HER2 byImmunohistochemistry
239
Herpes simplex virus(HSV)
X HC2 HSV by DFA 172
X HC4 HSV Culture 172ID1 Nucleic Acid Amp,
Viruses176
X VR1 Virology Culture 171X VR2 Viral Antigen by DFA 171
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 275
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Herpes simplex virus(HSV) (cont.)
X VR3 Antibody Detection-Infectious DiseaseSerology
178
HHV6 ID1 Nucleic Acid Amp,Viruses
176
VLS2 Viral Load 173HHV8 ID1 Nucleic Acid Amp,
Viruses176
High molecular weightkininogen
CGE/CGEX Coagulation, Extended 144
High-sensitivityC-reactive protein
X HSCRP hsCRP 57
LN21 High-SensitivityC-Reactive Protein CalVer/Lin
113
Histotechnology qualityimprovement
HQIP,HQIPBX,HQBX1,HQBX2,HQBX3,HQIHC
HistoQIP 234-236
HIV X HIV, HV2 HIV Viral Load 173LN39 HIV Viral Load Cal
Ver/Lin116
X NAT Nucleic Acid Testing 203HIV genotyping HIVG HIV Viral Genotyping 173HIV-1 p24 antigen X VM3 Viral Markers-Series 3 201HIV-1 p24 antigen,Anti HIV 1/2
X VM6 Viral Markers-Series 6 202
HLA-A,B,C antibodyidentification
X MX1B,MX1C,MX1E, MXB,MXC
HLA Analysis, Class I 206-207
X MX2B,MX2C,MX2E, MXB,MXC
HLA Analysis, Class II 206-207
HLA-(Class I/II)crossmatching
X MX1B,MX1C,MX1E, MXB,MXC
HLA Analysis, Class I 206-207
X MX2B,MX2C,MX2E, MXB,MXC
HLA Analysis, Class II 206-207
HLA-(Class I/II) antibodyscreen
MX1B,MX1C,MX1E,MX2B,MX2C,MX2E, MXB,MXC
HLA Analysis, Class I/II 206-207
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
HLA-A,B,C typing(serologic)
X HLAS,HLAS1
HLA Serologic Typing 207
HLA-B27 typing X B27 HLA-B27 Typing 208HLA-B*57:01 PGX2 Pharmacogenetics 219
DADR1 Disease Association,Drug Risk
209
HLA-B*57:01 DADR1 Disease Association,Drug Risk
209
HLA-B*58:01 DADR1 Disease Association,Drug Risk
209
HLA-DQA1*03/DQB1*03:02
DADR2 Disease Association,Drug Risk
209
HLA-DQA1*05/DQB1*02
DADR2 Disease Association,Drug Risk
209
HLA-DR, DQ typing(serologic)
X HLAS HLA Serologic Typing 207
HLA molecular typing X DL, DML, ML HLA Molecular Typing 207Homocysteine X HMS Homocysteine 58
LN16 Homocysteine CalVer/Lin
112
Homovanillic acid X N/NX Urine Chemistry,Special
62
HPV (cytology), high-risk
X CHPVD Digene SpecimenTransport Medium
246
X CHPVJ Mixed Medium 246X CHPVK SurePath Preservative
Fluid Transport Medium246
X CHPVM ThinPrep PreservCytTransport Medium
246
X HPV Digene Hybrid CaptureTechnology Only
174
ISH In Situ Hybridization 222HSV X HC2 HSV by DFA 172
X HC4 HSV Culture 172ID1 Nucleic Acid Amp,
Viruses176
X VR1 Virology Culture 171X VR2 Viral Antigen by DFA 171X VR3 Antibody Detection-
Infectious DiseaseSerology
178
Human chorionicgonadotropin (hCG),serum
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X FP/FPX,FP1T
Maternal Screen 78
X HCG, IL Immunology 180X K/KK Ligand Assay, General 74
LN5 Ligand Assay CalVer/Lin
108
Analyte/Procedure Index
276 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Human chorionicgonadotropin (hCG),serum (cont.)
LN5S Ligand Assay, SiemensCal Ver/Lin
108
LN8 ReproductiveEndocrinology CalVer/Lin
109
SCO Serum Carryover 120Human chorionicgonadotropin (hCG),urine
X CMP, CMP1 Clinical Microscopy 133
POC1 POC hCG Competency 44POC3 POC Urine Dipstick
Competency44
Human herpesvirus 6 ID1 Nucleic Acid Amp,Viruses
176
VLS2 Viral Load 173Human herpesvirus 8 ID1 Nucleic Acid Amp,
Viruses176
Human immuno-deficiency virus (HIV)
X HIV, HV2 HIV Viral Load 173
HIVG HIV Genotyping 173LN39 HIV Viral Load Cal
Ver/Lin116
Humanmetapneumovirus
ID2 Nucleic Acid Amp,Respiratory
176
IDR Infectious Disease,Respiratory Panel
177
Human papillomavirus(cytology) high-risk
X CHPVD Digene SpecimenTransport Medium
246
X CHPVJ Mixed Medium 246X CHPVK SurePath Preservative
Fluid Transport Medium246
X CHPVM ThinPrep PreservCytTransport Medium
246
X HPV Digene Hybrid CaptureTechnology Only
174
ISH In Situ Hybridization 222Human papillomavirus(cytology) high-riskgenotyping
CHPVD Digene SpecimenTransport Medium
246
CHPVJ Mixed Medium 246CHPVK SurePath Preservative
Fluid Transport Medium246
CHPVM ThinPrep PreservCytTransport Medium
246
Huntington disease X MGL2 Molecular Genetics 217Hydrocodone DMPM Drug Monitoring for
Pain Management95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Hydrocodone (cont.) T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Hydromorphone DMPM Drug Monitoring for
Pain Management95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Hydroxyzine T Toxicology 86
UT Urine Toxicology 86Ibuprofen T Toxicology 86
UT Urine Toxicology 86IDH1 GLI Glioma 224IDH2 GLI Glioma 224IgA X IG/IGX Immunology, General 180
LN7 Immunology Cal Ver/Lin 109X SPE Protein Electrophoresis 68
IgA kappa and lambda HL Heavy Chain/LightChain Analysis
IgD S2, S4 Immunology, Special 181IgE X IG/IGX Immunology, General 180
X K/KK Ligand Assay, General 74X SE Diagnostic Allergy 185
IgE allergen-specific,quantitative
SE Diagnostic Allergy 185
IgE multi-allergen screen X SE Diagnostic Allergy 185IGF-1 (somatomedin C) X BGS Bone and Growth 76
X Y/YY Ligand Assay, Special 75IgG X IG/IGX Immunology, General 180
LN7 Immunology Cal Ver/Lin 109S2, S4 Immunology, Special 181
X SPE Protein Electrophoresis 68IgG, CSF X M, OLI CSF Chemistry and
Oligoclonal Bands66
IgG subclass proteins S2, S4 Immunology, Special 181IgM X IG/IGX Immunology, General 180
LN7 Immunology Cal Ver/Lin 109X SPE Protein Electrophoresis 68
IL-2 CTKN Cytokines 184IL-6 CTKN Cytokines 184IL-8 CTKN Cytokines 184IL-10 CTKN Cytokines 184IL28B PGX1 Pharmacogenetics 219Imipramine FTC Forensic Toxicology,
Criminalistics93
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 277
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Imipramine (cont.) T Toxicology 86UT Urine Toxicology 86
X ZT, ZZT TDM, Special 54Immature granulocyteparameter
FH9, FH9P Hematology, Auto Diff 125
Immunohistochemistry GHER2 Gastric HER2 239X HER2 HER2 by
Immunohistochemistry239
MK Immunohistochemistry 237MMR DNA Mismatch Repair 237PM1 CD117 by
Immunohistochemistry237
X PM2 ER, PR byImmunohistochemistry
239
PM3 CD20 byImmunohistochemistry
237
PM5 ImmunohistochemistryTMA
238
India ink IND India Ink 166Infectiousmononucleosis (IM)
X IL, IM Immunology 180
X IMW InfectiousMononucleosis, Waived
181
Influenza virus ID2 Nucleic Acid Amp,Resp
176
IDR Infectious Disease,Respiratory Panel
177
POC8 POC Influenza A/B Ag 44X VR1 Virology Culture 171X VR2 Viral Antigen Detection
by DFA171
X VR4 Viral Antigen Detectionby EIA and Latex
172
In situ hybridization X ISH In Situ Hybridization 222X ISH2 In Situ Hybridization
HER2222
Instrument function I Instrumentation 118Instrument linearity I Instrumentation 118
LN2 Chemistry, Lipid,Enzyme Cal Ver/Lin
106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
LN3 TDM Cal Ver/Lin 107LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
LN6 Urine Chemistry CalVer/Lin
108
LN7 Immunology Cal Ver/Lin 109
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Instrument linearity(cont.)
LN8 ReproductiveEndocrinology CalVer/Lin
109
LN9 Hematology Cal Ver/Lin 110LN11 Serum Ethanol Cal
Ver/Lin110
LN12 C-Reactive Protein CalVer/Lin
110
LN13 Blood Gas Cal Ver/Lin 111LN13C Blood Gas Cal Ver/Lin 111LN14 Whole Blood Ethanol
Cal Ver/Lin111
LN15 Hemoglobin A1c CalVer/Lin
111
LN16 Homocysteine CalVer/Lin
112
LN17 Whole Blood GlucoseCal Ver/Lin
112
LN18, LN19 Reticulocyte Cal Ver/Lin 112LN20 Urine Albumin Cal
Ver/Lin112
LN21 High-SensitivityC-Reactive Protein CalVer/Lin
113
LN22 Flow Cytometry CalVer/Lin
113
LN23 PSA Cal Ver/Lin 113LN24 Creatinine Accuracy
Cal Ver/Lin114
LN25 Troponin I Cal Ver/Lin 114LN27 Troponin T Cal Ver/Lin 114LN30 BNP Cal Ver/Lin 114LN31 Immunosuppressive
Drugs Cal Ver/Lin115
LN32 Ammonia Cal Ver/Lin 115LN33 Serum Myoglobin Cal
Ver/Lin115
LN34 Tumor Markers CalVer/Lin
115
LN35 Thrombophilia CalVer/Lin
116
LN36 Heparin Cal Ver/Lin 116LN37 von Willebrand Factor
Ag Cal Ver/Lin116
LN38 CMV viral load CalVer/Lin
116
LN39 HIV Viral Load CalVer/Lin
116
LN40 Vitamin D Cal Ver/Lin 116LN41 Procalcitonin Cal
Ver/Lin117
Analyte/Procedure Index
278 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Instrument linearity(cont.)
LN42 D-Dimer Cal Ver/Lin 117
Insulin X ING Insulin, Gastrin,C-Peptide, PTH
78
Interferon (IFN) gamma CTKN Cytokines 184Interleukin (IL)-1 beta CTKN Cytokines 184International normalizedratio (INR)
X CGL Coagulation, Ltd 144
CGS1 Coag Special, Series 1 145CGS4 Coag Special, Series 4 145POC5 POC PT/INR, i-STAT 44POC6 POC PT/INR,
CoaguChek XS Plus44
X WP3, WP4,WP6, WP9
Whole BloodCoagulation
148
X WP10 Whole BloodCoagulation
148
Ionized calcium X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
X C3, CZ, CZX Chemistry and TDM 50-52POC10,POC11
POC Competency BloodGases
45
LN13C Blood Gas Cal Ver/Lin 111Iron X C1, C3, C3X,
CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Isopropanol X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles
91
X AL2 Serum Alcohol/EthyleneGlycol/Volatiles
91
JC virus ID1T Nucleic Acid Amp, JCand BK
176
Jo-1 (antihistidyl t-RNAsynthetase)
RDS Rheumatic DiseaseSpecial
186
JWH-018 N-(4-hydroxypentyl)metabolite
SCDD Synthetic Cannabinoid/Designer Drugs
94
JWH-018 N-(5-hydroxypentyl)metabolite
SCDD Synthetic Cannabinoid/Designer Drugs
94
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
JWH-018 N-PentanoicAcid
SCDD Synthetic Cannabinoid/Designer Drugs
94
JWH-073 N-(3-hydroxybutyl) metabolite
SCDD Synthetic Cannabinoid/Designer Drugs
94
JWH-073 N-(4-hydroxybutyl) metabolite
SCDD Synthetic Cannabinoid/Designer Drugs
94
JWH-073 N-ButanoicAcid
SCDD Synthetic Cannabinoid/Designer Drugs
94
JWH-122 N-(4-hydroxypentyl)metabolite
SCDD Synthetic Cannabinoid/Designer Drugs
94
JWH-122 N-(5-hydroxypentyl)metabolite
SCDD Synthetic Cannabinoid/Designer Drugs
94
Kaolin activated APTT CGE/CGEX Coagluation, Extended 144Kaolin activated CT CGE/CGEX Coagluation, Extended 144Kappa/lambda X ISH In Situ Hybridization 222Kappa/lambda ratio IG/IGX Immunology, General 180
S2, S4 Immunology, Special 181Free Kappa/Lambdaratio
SFLC Serum Free LightChains
187
Karyotype nomenclature X CY, CYBK Cytogenetics 212Kearns-Sayre syndrome IMD1 Mitochondrial DNA
Deletion Syndromes218
Ketamine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Ketones, serum KET Ketones 58Ketones, urine X CMP, CMP1 Clinical Microscopy 133
POC3 POC Urine DipstickCompetency
44
Kidney stone assessment KSA Kidney StoneAssessment
62
KIT/PDGFRA KIT KIT/PDGFRA 224KOH prep X CMMP Clinical Microscopy,
Misc133
FSM Fungal Smear 165KRAS KRAS Colorectal Cancer
Mutation224
MTP Multigene Tumor Panel 224Laboratory PreparednessExercise
LPX LaboratoryPreparedness Exercise
159
Lactate X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 279
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Lactate (cont.) X C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD Body Fluid 65POC10,POC11
POC Competency BloodGases
45
LN13C Blood Gas Cal Ver/Lin 111Lactate, CSF X M, OLI CSF Chemistry and
Oligoclonal Bands66
Lactate dehydrogenase(LD)
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD Body Fluid 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
SCO Serum Carryover 120Lactate dehydrogenase(LD), CSF
X M, OLI CSF Chemistry andOligclonal Bands
66
Lamellar body count LBC Lamellar Body Count 137Lamotrigine T Toxicology 86
UT Urine Toxicology 86ZE Therapeutic Drug
Monitoring, Extended54
Large unclassified cells(LUC)
FH4, FH4P Hematology, Auto Diff 125
LD isoenzymes X CRTI Cardiac Markers 56LD1/LD2 ratio X CRTI Cardiac Markers 56LDL cholesterol ABL Accuracy-Based Lipid 98LDL cholesterol,calculated
C1, C3,C3X, CZ,CZ2X, CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LDL cholesterol,measured
X C1, C3,C3X, CZ,CZ2X, CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LDL cholesterol, waived X LCW Ltd Chem, Waived 58Lead (blood) X BL Blood Lead 92Lead, urine TMU Trace Metals, Urine 92Leber hereditary opticneuropathy
IMD3 Mitochondrialcytopathies
218
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Lecithin:sphingomyelin(L:S) ratio
LM, LM1 Lung Maturity 68
Legionella pneumophila IDN, IDO Nucleic Acid Amp,Organisms
175
Legionella X LBAS Legionella Ag 157Leigh syndrome IMD1 Mitochondrial DNA
Deletion Syndromes218
Leukemia/lymphomaimmunophenotype
FL3, FL3CD Flow Cytometry 188
Leukemia/lymphomainterpretation only
FL5 Flow CytometryInterpretation Only
189
Leukocyte esterase, urine X CMP, CMP1 Clinical Microscopy 133POC3 POC Urine Dipstick
Competency44
Leukocyte-reducedplatelets
TRC Transfusion-Related CellCount
200
Leukocyte-reduced RBC TRC Transfusion-Related CellCount
200
Leukocyte, stool, Wright-Giemsa
X CMMP Clinical Microscopy,Misc
133
Levetiracetam ZE Therapeutic DrugMonitoring, Extended
54
Lidocaine X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107T Toxicology 86UT Urine Toxicology 86
Lipase X C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Lipids ABL Accuracy-Based Lipid 98X C1, C3, C3X,
CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN2 Chemistry, Lipid,Enzyme Cal Ver/Lin
106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Analyte/Procedure Index
280 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Lipoprotein (a) X ABL Accuracy-Based Lipid 98X C1, C3,
C3X, CZ,CZ2X, CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Lipoprotein-associatedphospholipase
PLA Lp-PLA2 67
Lipoproteinelectrophoresis
LPE LipoproteinElectrophoresis
68
Lithium X C1, C3, C3X,CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107Liver-kidney microsomalantibody
LKM Liver-KidneyMicrosomal Antibody
186
Lorazepam DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Lorazepam glucuronide DMPM Drug Monitoring for
Pain Management95
Lupus anticoagulant(screen, conf)
CGE/CGEX Coagulation, Extended 144
CGS1 Coag Special, Series 1 145Luteinizing hormone (LH) LN8 Reproductive
Endocrinology CalVer/Lin
109
X Y/YY Ligand Assay, Special 75Lyme disease TTD Tick-Transmitted
Disease178
Lymphocyteimmunophenotyping
X FL, FL1 Flow Cytometry 188
Lymphoma by FISH CYL Fluorescence InSitu Hybridization,Lymphoma
213
Lysergic aciddiethylamide (LSD)
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Magnesium X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Magnesium (cont.) CZQ Quality Cross Check,Chemistry and TDM
53
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Magnesium, ionized X AQ, AQ2 Aqueous Blood Gas 82AQQ,AQ2Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
LN13C Blood Gas Cal Ver/Lin 111POC10,POC11
POC Competency BloodGases
45
Magnesium, urine X U Urine Chemistry,General
61
Malaria RMAL Rapid Malaria 168Manganese R Trace Metals 70
TMU Trace Metals, Urine 92Maprotiline T Toxicology 86
UT Urine Toxicology 86MCAD IMD2 MCAD 218MCH FH1-FH4,
FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
MCHC FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check ,Automated HematologySeries
126
MCV FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 281
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
MCV (cont.) FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
MECP2 genotyping RETT RETT SyndromeGenotyping
219
Mercury, urine TMU Trace Metals, Urine 92MEN2 X MGL3 Molecular Genetics 217Meperidine DMPM Drug Monitoring for
Pain Management95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Mephedrone SCDD Synthetic Cannabinoid/Designer Drugs
94
T Toxicology 86UT Urine Toxicology 86
Meprobamate DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Metabolic disease testing BGL Biochemical Genetics 215Metanephrine X N/NX Urine Chemistry,
Special62
Methadone DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Methadone metabolite(EDDP)
DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Methamphetamine DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Methamphetamine(cont.)
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Methanol X AL1 Whole Blood Alcohol/Ethylene Glycol/Volatiles
91
X AL2 Serum Alcohol/EthyleneGlycol/Volatiles
91
Methaqualone UDC Forensic Urine DrugTesting, Confirmatory
89
UDS, UDS6 Urine Drug Screen 88Methicillin-resistantStaphylococcus aureus(MRSA)
BCS1 Blood CultureStaphylococcus aureus
157
IDN, IDO Nucleic Acid Amp,Organisms
175
X MRS, MRS5 Methicillin-ResistantS. aureus
160
Methemoglobin X SO Blood Oximetry 84SOQ Quality Cross Check,
Blood Oximetry84
Methotrexate X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Methotrimeprazine T Toxicology 86UT Urine Toxicology 86
Methylenedioxy-amphetamine (MDA)
DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Methylenedioxyethyl-amphetamine (MDEA)
UDC Forensic Urine DrugTesting, Confirmatory
89
Methylenedioxymeth-amphetamine (MDMA)
DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
Analyte/Procedure Index
282 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Methylenedioxymeth-amphetamine (MDMA)(cont.)
UDS, UDS6 Urine Drug Screen 88
UT Urine Toxicology 86Methylenedioxy-pyrovalerone (MDPV)
SCDD Synthetic Cannabinoid/Designer Drugs
94
T Toxicology 86UT Urine Toxicology 86
Methylenetetra-hydrofolate reductase(MTHFR)
X MGL1 Molecular Genetics 217
Methylone SCDD Synthetic Cannabinoid/Designer Drugs
94
Methylphenidate T Toxicology 86UT Urine Toxicology 86
Metoprolol T Toxicology 86UT Urine Toxicology 86
MGMT GLI Glioma 224Microalbumin, urine LN20 Urine AlbuminCal
Ver/Lin112
X U Urine Chemistry 61X UMC Urine Albumin
(Microalbumin)/Creatinine
138
Microsatellite instability MSI Microsatellite Instability 222Microtiter plate readerlinearity
I Instrumentation 118
Minimal residual disease X MRD Minimal ResidualDisease, BCR/ABL1p210
225
X MRD1 Minimal ResidualDisease, BCR/ABL1p190
225
MRD2 Minimal ResidualDisease, PML/RARA
225
Mirtazapine T Toxicology 86UT Urine Toxicology 86
Mite identification TMO Ticks, Mites, and OtherArthropods
169
Mitochondrial DNA,forensic
DNA, DNAF DNA Database 252
FIDM Forensic Identity 252Mixing studies, PT CGE/CGEX Coagulation, Extended 144Mixing studies, APTT CGE/CGEX Coagulation, Extended 144
CGS1 Coag Special, Series 1 145Modified acid-fast stain X P, P3, P4, P5 Parasitology 167Mold identification X F Mycology 164
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Molecular genetics X MGL1,MGL2,MGL3,MGL4,MGL5
Molecular Genetics 217
Molecular HLA typing X DL, DML, ML HLA Molecular Typing 207Molecular hematologiconcology
MHO,MHO1,MHO2,MHO3,MHO5
Molecular HematologicOncology
225
Molecular typing IDN, IDO Nucleic Acid Amp,Organisms
175
Monitoring engraftment X ME Monitoring Engraftment 208Mononuclear cell count CBT Cord Blood Testing 198
SCP Stem Cell Processing 198Morphine DMPM Drug Monitoring for
Pain Management95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86M-protein (paraprotein)identification
X SPE Protein Electrophoresis 68
MRSA BCS1 Blood CultureStaphylococcus aureus
157
IDN, IDO Nucleic Acid Amp,Organisms
175
X MRS, MRS5 Methicillin-ResistantS. aureus
160
Mucolipidosis IV X MGL4 Molecular Genetics 217Mucopolysaccharide(Glycosaminoglycan)
X BGL Biochemical Genetics 215
Multiple endocrineneoplasia type 2 (MEN2)
X MGL3 Molecular Genetics 217
Mumps-IgG VR3M Virology 178Mycobacterial culture X E1 Mycobacteriology, Ltd 163Mycobacterialidentification
X E Mycobacteriology 163
Mycobacteriumtuberculosis
IDO Nucleic Acid Amp,Organisms
175
Mycobacteriumtuberculosis antibodydetection
QF M. tuberculosis InfectionDetection
186
Mycobacteriumtuberculosisidentification andresistance detection
MTBR Molecular MTBIdentification andResistance Detection
163
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 283
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Mycophenolic acid X MPA Mycophenolic Acid 53Mycoplasmapneumoniae
IDN, IDO Nucleic Acid Amp,Organisms
175
VR3 Antibody Detection-Infectious DiseaseSerology
178
Myoclonus epilepsywith ragged red fibers(MERRF)
IMD3 Mitochondrialcytopathies
218
Myoglobin X CRT, CRTI Cardiac Markers 56LN33 Serum Myoglobin Cal
Ver/Lin115
X PCARM,PCARMX
Plasma CardiacMarkers
59
POC12 Competency PlasmaCardiac Markers
45
Myoglobin, urine MYG Myoglobin, Urine 62Myotonic dystrophy X MGL2 Molecular Genetics 217N-acetylprocainamide(NAPA)
X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107N-desmethyltramadol DMPM Drug Monitoring for
Pain Management95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Naproxen T Toxicology 86UT Urine Toxicology 86
Nasal smears,eosinophil
X CMMP Clinical Microscopy,Misc.
133
Neisseria gonorrhoeae X D3 GC Cultures 154X D4 Bacteriology, Ltd 154X HC6/HC6X C. trachomatis/GC by
Nucleic Acid Amp174
X HC7 C. trachomatis/GCDNA by NAA
174
Neoplastic cellularity NEO Neoplastic Cellularity 223Neoplastic disorder byFISH
CYF Fluorescence In SituHybridization
212
Neuropathology NP/NP1 NeuropathologyProgram
241
Neutral fats FCFS Fecal Fat 67Next-GenerationSequencing
NGS Next-GenerationSequencing
221
Nicotine T Toxicology 86UT Urine Toxicology 86
Niemann-Pick disease X MGL4 Molecular Genetics 217Nitrite, urine X CMP, CMP1 Clinical Microscopy 133
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Nitrite, urine (cont.) DAI Urine Drug Adulterant/Integrity Testing
88
POC3 POC Urine DipstickCompetency
44
Nitrogen, total, urine U Urine Chemistry,General
61
Nongynecologiccytopathology
FNA/FNA1 Fine-NeedleAspiration-Digital
249
FNAG/FNAG1
Fine-NeedleAspiration-Glass
250
NGC/NGC1 NongynecologicCytopathologyEducation Program
248
Norbuprenorphine DMPM Drug Monitoring forPain Management
95
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Norchlordiazepoxide T Toxicology 86
UT Urine Toxicology 86Norcodeine T Toxicology 86
UT Urine Toxicology 86Norcyclobenzaprine T Toxicology 86
UT Urine Toxicology 86Nordiazepam DMPM Drug Monitoring for
Pain Management95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Nordoxepin FTC Forensic Toxicology,
Criminalistics93
T Toxicology 86UT Urine Toxicology 86
Norepinephrine X N/NX Urine Chemistry,Special
62
Norfentanyl DMPM Drug Monitoring forPain Management
95
T Toxicology 86UT Urine Toxicology 86
Norfluoxetine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Norketamine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Analyte/Procedure Index
284 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Normeperidine DMPM Drug Monitoring forPain Management
95
T Toxicology 86UT Urine Toxicology 86
Normetanephrine X N/NX Urine Chemistry Special 62Norovirus GIP Gastrointestinal Panel 177
SP1 Stool Pathogens 161Noroxycodone DMPM Drug Monitoring for
Pain Management95
Noroxymorphone DMPM Drug Monitoring forPain Management
95
Norpropoxyphene DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Norsertraline FTC Forensic Toxicology,
Criminalistics93
T Toxicology 86UT Urine Toxicology 86
Nortrimipramine T Toxicology 86UT Urine Toxicology 86
Nortriptyline FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
X ZT, ZZT TDM, Special 54Norverapamil T Toxicology 86
UT Urine Toxicology 86NRAS MTP Multigene Tumor Panel 224nRBC FH3, FH3P,
FH9, FH9PHematology, Auto Diff 125
NT-pro B-type natriureticpeptides
X BNP B-Type NatriureticPeptides, 2 Chall
55
X BNP5 B-Type NatriureticPeptides, 5 Chall
55
BNPQ Quality Cross Check,B-Type NatriureticPeptides
55
LN30 BNP Cal Ver/Lin 114N-telopeptide (NTX) BMV6 Bone Markers and
Vitamin77
X BU Bone and Mineral,Urine
77
Nucleated cells, total CBT Cord Blood Testing 198SCP Stem Cell Processing 198
Nucleated red cells, total ABF3 Automated Body Fluid 134CBT Cord Blood Testing 198
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Nucleated red cells, total(cont.)
SCP Stem Cell Processing 198
Nucleated red blood cellcount
FH3, FH3P,FH9, FH9P
Hematology, Auto Diff 125
Nucleic acidamplification
BSTE Bacterial Strain TypingEnterococcus
175
BSTN Bacterial Strain TypingGram-NegativeOrganisms
125
BSTS Bacterial Strain TypingStaphylococcus
175
HBVL, HBVL5HCVN,HCV2
Hepatitis Viral Load 173
X HC6/HC6X C. trachomatis/GC byNucleic Acid Amp
174
X HC7 C. trachomatis/GCDNA by NAA
174
X HIV, HV2 HIV Viral Load 173IDN, IDO Nucleic Acid Amp,
Organisms175
ID1, ID1T Nucleic Acid Amp,Viruses
176
ID2 Nucleic Acid Amp,Respiratory
176
X MRS, MRS5 Methicillin-ResistantS. aureus
160
SP, SPN, SP1 Stool Pathogens 161VLS, VLS2 Viral Load 173VRE Vancomycin-Resistant
Enterococcus162
Nucleic acid testing X NAT Nucleic Acid Testing 203O-desmethyltramadol T Toxicology 86
UT Urine Toxicology 86Occult blood OCB Occult Blood 137
POC9 POC Fecal Occult Blood 44Occult blood, gastric GOCB Gastric Occult Blood 136Ocular micrometer check I Instrumentation 118Olanzapine T Toxicology 86
UT Urine Toxicology 86Oligoclonal bands X OLI Oligoclonal Bands 66Opiate group DMPM Drug Monitoring for
Pain Management95
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86UTCO Urine Toxicology
Carryover120
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 285
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Organic acids, urinequalitative
X BGL Biochemical Genetics 215
Organic acids, urinequantitative
BGL Biochemical Genetics 215
Osmolality, measured X C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Osmolality, sweat X SW1, SW2,SW3, SW4
Sweat Analysis Series 71
Osmolality, urine X CMP, CMP1 Clinical Microscopy 133LN6 Urine Chemistry Cal
Ver/Lin108
POC3 POC Urine DipstickCompetency
44
X U Urine Chemistry,General
61
Osmometer check I Instrumentation 118Osteocalcin BGS Bone and Growth 76Oxazepam DMPM Drug Monitoring for
Pain Management95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Oxcarbazepinemetabolite
ZE Therapeutic DrugMonitoring, Extended
54
Oxidants, urine DAI Urine Drug Adulterant/Integrity Testing
88
Oxycodone DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Oxyhemoglobin X SO Blood Oximetry 84
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Oxyhemoglobin (cont.) SOQ Quality Cross Check,Blood Oximetry
84
Oxymorphone DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Pancreatic amylase X C1, C3, C3X,
CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
PAPP-A FP1B First Trimester MaternalScreening, Free Beta
78
FP1T First Trimester MaternalScreening, Total hCG
78
Parainfluenza virus ID2 Nucleic Acid Amp,Respiratory
176
IDR Infectious Disease,Respiratory Panel
177
X VR1 Virology Culture 171X VR2 Viral Antigen Detection
by DFA171
Paraproteinidentification
X SPE Protein Electrophoresis 68
Parasite identification X BP Blood Parasite 168X P, P3, P4, P5 Parasitology 167
Parathyroid hormone(PTH)
X ING Insulin, Gastrin,C-Peptide, PTH
78
Parentage/relationshiptesting
X PARF Parentage/Relationship 204
Paroxetine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Parvovirus B19 ID1 Nucleic Acid Amp,Viruses
176
PCO2 X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
POC10,POC11
POC Competency BloodGases
45
Analyte/Procedure Index
286 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
PCO2 (cont.) LN13,LN13C
Blood Gas Cal Ver/Lin 111
Pearson syndrome IMD1 Mitochondrial DNADeletion Syndromes
218
PerformanceImprovement Program inSurgical Pathology
PIP/PIP1,PIPW/PIPW1
PerformanceImprovement Programin Surgical Pathology
228-229
Peripheral blood smear,virtual
VPBS Virtual Peripheral BloodSmear
130
pH AFL Amniotic Fluid Leakage 134X AQ, AQ2,
AQ3, AQ4Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
FLD Body Fluid 65GOCB Gastric Occult Blood 136POC10,POC11
POC Competency BloodGases
45
LN13,LN13C
Blood Gas Cal Ver/Lin 111
pH, urine X CMP, CMP1 Clinical Microscopy 133DAI Urine Drug Adulterant/
Integrity Testing88
POC3 POC Urine DipstickCompetency
44
UDC Forensic Urine DrugTesting, Confirmatory
89
pH meters I Instrumentation 118Phencyclidine FTC Forensic Toxicology,
Criminalistics93
OFD Oral Fluid for Drugs ofAbuse
90
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Phenethylamine FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Pheniramines T Toxicology 86UT Urine Toxicology 86
Phenobarbital X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FTC Forensic Toxicology,Criminalistics
93
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Phenobarbital (cont.) LN3 TDM Cal Ver/Lin 107T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Phentermine FTC Forensic Toxicology,
Criminalistics93
T Toxicology 86UT Urine Toxicology 86
Phenylephrine T Toxicology 86UT Urine Toxicology 86
Phenylpropanolamine T Toxicology 86UT Urine Toxicology 86
Phenytoin X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FTC Forensic Toxicology,Criminalistics
93
LN3 TDM Cal Ver/Lin 107SCO Serum Carryover 120T Toxicology 86UT Urine Toxicology 86
Phenytoin, free X CZ, CZ2X,CZX, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Phosphatidylglycerol(PG)
X LM, LM1 Lung Maturity 68
Phosphorus X C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Phosphorus, urine LN6 Urine Chemistry CalVer/Lin
108
X U Urine Chemistry,General
61
PIK3CA MTP Multigene Tumor Panel 224Pinworm prep X CMMP Clinical Microscopy,
Misc133
Pipette calibration-gravimetric
I Instrumentation 118
Plasma hemogloblin PHG Plasma Hemoglobin 69Plasminogen antigen CGE/CGEX Coagulation, Extended 144
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 287
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Plasminogen activatorinhibitor
CGE/CGEX Coagulation, Extended 144
Plasminogen activatorinhibitor (PAI)-1
MGL1 Molecular Genetics 217
Platelet aggregation PF Platelet Function 147Platelet calculator TRC Transfusion-Related Cell
Count200
Platelet inducedaggregation
PIA Platelet Function 149
Platelet antibodydetection
X PS Platelet Serology 199
Platelet count X FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
X HE, HEP Basic Hematology 124LN9 Hematology Cal Ver/Lin 110
Platelet count (Platelet-rich plasma)
X TRC Transfusion-Related CellCount
200
Platelet crossmatch PS Platelet Serology 199Platelet function PF1 Platelet Function 147Platelet mapping PLTM Platelet Mapping 149Platelet morphology EHE1 Expanded Virtual
Peripheral Blood Smear131
PML/RARA MRD2 Minimal ResidualDisease
225
PNA FISH-Enterococcus PNA3 PNA FISH forEnterococcus
158
PNA FISH-Gram-Negative Rods
PNA4 PNA FISH for Gram-Negative Rods
158
PNA FISH-Staphylococcus
PNA1 PNA FISH forStaphylococcus
158
PNA FISH-Yeast PNA2 PNA FISH for Yeast 158Pneumocystis detection PCP1 Pneumocystis jiroveci,
Calcofluor White Stain166
PCP2 Pneumocystis jiroveci,DFA Stain
166
PCP3 Pneumocystis jiroveci,Giemsa Stain
166
PCP4 Pneumocystis jiroveci,GMS Stain
166
PNH immunophenotype PNH Paroxysmal NocturnalHemoglobinuria, RBC
189
PO2 X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
PO2 (cont.) AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
LN13,LN13C
Blood Gas Cal Ver/Lin 111
POC10,POC11
POC Competency BloodGases
45
Porphobilinogen, Urine UPBG Porphobilinogen, Urine 63Postanalytical DNAsequencing
SEC DNA Sequencing Count 218
Postvasectomy spermcount
X PV Postvasectomy SpermCount
140
Potassium X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
LN13C Blood Gas Cal Ver/Lin 111POC10,POC11
POC Competency BloodGases
45
Potassium, urine LN6 Urine Chemistry CalVer/Lin
108
X U Urine Chemistry,General
61
Potassium, vitreous fluid VF Vitreous Fluid, Post-mortem
90
PRA MX1B,MX1C,MX1E, MXB,MXC
HLA Analysis, Class I 206-207
MX2B,MX2C,MX2E, MXB,MXC
HLA Analysis, Class II 206-207
Prader-Willi/AngelmanSyndrome
X MGL1 Molecular Genetics 217
Analyte/Procedure Index
288 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Prealbumin(transthyretin)
X C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X S2, S4 Immunology, Special 181Prekallikrein CGE/CGEX Coagulation, Extended 144Predictive markers byimmunohistochemistry
X HER2 HER2 byImmunohistochemistry
239
GHER2 Gastric HER2 239PM1 CD117 by
Immunohistochemistry237
X PM2 ER, PgR byImmunohistochemistry
239
PM3 CD20 byImmunohistochemistry
237
PM5 ImmunohistochemistryTMA
238
Primidone X CZ, CZX,CZ2X, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107Pro B-type natriureticpeptides
X BNP B-Type NatriureticPeptides, 2 Chall
55
X BNP5 B-Type NatriureticPeptides, 5 Chall
55
BNPQ Quality Cross Check,B-Type NatriureticPeptides
55
Procainamide X CZ, CZX,CZ2X, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107Procalcitonin LN41 Procalcitonin Cal
Ver/Lin117
PCT Procalcitonin 69Progesterone LN8 Reproductive
Endocrinology CalVer/Lin
109
X Y/YY Ligand Assay, Special 75Progesterone receptorsby immunohistochemistry
X PM2 ER, PgR byImmunohistochemistry
239
Prolactin LN8 ReproductiveEndocrinology CalVer/Lin
109
X Y/YY Ligand Assay, Special 75Propoxyphene DMPM Drug Monitoring for
Pain Management95
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Propoxyphene (cont.) FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86UTCO Urine Toxicology
Carryover120
Propranolol T Toxicology 86UT Urine Toxicology 86
Prostate-specific antigen(PSA)
X K/KK Ligand Assay, General 74
LN23 PSA Cal Ver/Lin 113Prostate-specific antigen,complexed (cPSA)
X K/KK Ligand Assay, General 74
Prostate-specific antigen,free (PSA, free)
X K/KK Ligand Assay, General 74
Prostatic acidphosphatase (PAP)
X K/KK Ligand Assay, General 74
Protein electrophoresis,serum, interpretation
X SPE Protein Electrophoresis 68
Protein C CGE/CGEX Coagulation, Extended 144CGS2 Coag Special, Series 2 145LN35 Thrombophilia Cal
Ver/Lin116
Protein S CGE/CGEX Coagulation, Extended 144CGS2 Coag Special, Series 2 145
Protein, total X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD Body Fluid 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
SPE Lipoprotein and ProteinElectrophoresis
68
Protein, CSF X M, OLI CSF Chemistry andOligoclonal Bands
66
Protein, urine X CMP, CMP1 Clinical Microscopy 133DSC Dipstick Confirmatory 135LN6 Urine Chemistry Cal
Ver/Lin108
POC3 POC Urine DipstickCompetency
44
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 289
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Protein, urine (cont.) X U Urine Chemistry,General
61
Prothrombin mutation X MGL1 Molecular Genetics 217TPM Thrombophilia
Mutations219
Prothrombin fragment1.2
CGE/CGEX Coagulation, Extended 144
Prothrombin time X CGL Coagulation, Ltd 144CGS1 Coag Special, Series 1 145CGS4 Coag Special, Series 4 145DBGN Anticoagulant
Monitoring, Dabigatran146
FNPX AnticoagulantMonitoring,Fondaparinux
146
POC5 POC PT/INR, i-STAT 44POC6 POC PT/INR,
CoaguChek XS Plus44
RVBN AnticoagulantMonitoringRivaroxaban
146
X WP3, WP4,WP6, WP9
Whole BloodCoagulation
148
Prothrombin time, dilute CGE/CGEX Coagulation, Extended 144Provider-performedmicroscopy
X CMMP Clinical Microscopy,Misc
133
Pseudocholinesterase X C7 Pseudocholinesterase 69Pseudoephedrine FTC Forensic Toxicology,
Criminalistics93
T Toxicology 86UT Urine Toxicology 86
Pyridinoline (PYD) BU Bone and Mineral,Urine
77
Q-MONITORS QM1 Quality ManagementTools
42
Q-PROBES QP151 Quality ManagementTools
27
QP152 Quality ManagementTools
28
QP153 Quality ManagementTools
29
QP154 Quality ManagementTools
30
Q-TRACKS QT1-5 Quality ManagementTools
33-34,39
QT7, 8, 10 Quality ManagementTools
35-36
QT15-17,19
Quality ManagementTools
37-38,40
Quetiapine T Toxicology 86UT Urine Toxicology 86
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Quinidine X CZ, CZX,CZ2X, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107T Toxicology 86UT Urine Toxicology 86
Quinine T Toxicology 86UT Urine Toxicology 86
Ranitidine T Toxicology 86UT Urine Toxicology 86
Rapamycin (sirolimus) X CS ImmunosuppressiveDrugs
53
Rapid Group A Strep X D Bacteriology 152X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156X D9 Rapid Group A Strep,
Waived156
RBC count ABF1, ABF2,ABF3
Automated Body Fluid 134
X FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
X HE, HEP Basic Hematology 124X HFC, HFCI Hemocytometer
Fluid Count136
LN9 Hematology Cal Ver/Lin 110RBC count, urine UAA, UAA1 Automated Urinalysis 135RBC folate X FOL RBC Folate 79RBC morphology EHE1 Expanded Virtual
Peripheral Blood Smear131
RDW H1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
HE, HEP Basic Hematology 124
Analyte/Procedure Index
290 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Red blood cell antigendetection
J, J1 Transfusion Medicine 192
Red blood cell antigengenotyping
RAG Red blood cell antigengenotyping
199
Red blood cell antigentyping
RBCAT Red blood cell antigentyping
200
Reducing substance,urine
X CMP, CMP1 Clinical Microscopy 133
POC3 POC Urine DipstickCompetency
44
Refractometer check I Instrumentation 118Renin X RAP Renin and Aldosterone 79Reptilase time CGE/CGEX Coagulation, Extended 144Respiratory syncytialvirus (RSV)
ID2 Nucleic Acid Amp,Respiratory
176
IDR Infectious Disease,Respiratory Panel
177
X VR1 Virology Culture 171X VR2 Viral Antigen Detection
by DFA171
X VR4 Virology AntigenDetection by EIA andLatex
172
Reticulocyte count,percent
LN18, LN19 Reticulocyte Cal Ver/Lin 112
X RT, RT2, RT3,RT4
Reticulocyte 129
Reticulocyte count,absolute
X RT, RT2, RT3,RT4
Reticulocyte 129
RETT Syndrome RETT RETT SyndromeGenotyping
219
RhD X MGL2 Molecular Genetics 217RhD typing X J, J1 Transfusion Medicine 192
X JAT Transfusion Medicine,Automated
192
JATE1 Transfusion Medicine,Automated, Educational
193
TMCA Transfusion Medicine,Competency Assessment
194
Rheumatoid factor X IL, RF/RFX Immunology 180Rhinovirus ID2 Nucleic Acid Amp,
Respiratory176
IDR Infectious Disease,Respiratory Panel
177
Rotavirus GIP Gastrointestinal Panel 177SP, SPN Stool Pathogens 161
X VR4 Viral Antigen Detectionby EIA and Latex
172
RSV ID2 Nucleic Acid Amp,Respiratory
176
X VR1 Virology Culture 171
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
RSV (cont.) X VR2 Viral Antigen Detectionby DFA
171
X VR4 Viral Antigen Detectionby EIA and Latex
172
Rubella antibody, IgG X IL, RUB/RUBX
Immunology 180
Rubeola antibody(English measles)
X VR3 Antibody Detection-Infectious DiseaseSerology
178
Rupture of FetalMembranes
ROM1 Rupture of FetalMembranes
137
Russell’s viper venomtime, dilute
CGE/CGEX Coagulation, Extended 144
Salicylate X CZ, CZX,CZ2X, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107X SDS Serum Drug Screen 91
T Toxicology 86UT Urine Toxicology 86
Salmonella GIP Gastrointestinal Panel 177Sarcoma by FISH CYK Fluorescence In Situ
Hybridization213
Sarcoma translocation SARC Sarcoma Translocation 223Scl-70 (anti-DNAtopoisomerase)
RDS Rheumatic DiseaseSpecial
186
Secobarbital FTC Forensic Toxicology,Criminalistics
93
UDC Forensic Urine DrugTesting, Confirmatory
89
Selenium X R Trace Metals 70Selenium, urine TMU Trace Metals, Urine 71Semen analysis X ASA, SC,
SV, PVSemen Analysis 140
SC1, SM Semen Analysis 140SMCD,SM1CD,SM2CD
Semen Analysis,CD-ROM
140
Sertraline FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Serum free light chains SFLC Serum Free LightChains
187
Sex hormone-bindingglobulin (SHBG)
X DY Ligand Assay, Special 75
Shiga toxin SP Stool Pathogens-Rapidand Molecular
161
ST Shiga Toxin 161
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 291
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Shiga-like toxinproducing E. coli (STEC)
GIP Gastrointestinal Panel 177
Shigella GIP Gastrointestinal Panel 177Sickle cell screen X HG Hemoglobinopathy 128
X SCS Sickle Cell Screen 129Sirolimus (Rapamycin) X CS Immunosuppressive
Drugs53
Sodium X AQ, AQ2,AQ3, AQ4
Aqueous Blood Gas 82
AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
X C1, C3, C3X,CZ, CZ2X,CZX
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
LN13C Blood Gas Cal Ver/Lin 111POC10,POC11
POC Competency BloodGases
45
Sodium, sweat X SW1, SW2,SW3, SW4
Sweat Analysis Series 71
Sodium, urine LN6 Urine Chemistry CalVer/Lin
108
X U Urine Chemistry,General
61
Sodium, vitreous fluid VF Vitreous Fluid, Post-mortem
90
Soluble transferrinreceptor
STFR Soluble TransferrinReceptor
72
Somatomedin C (IGF-1) X Y, YY Ligand Assay, Special 75Specific gravity X CMP, CMP1 Clinical Microscopy 133
DAI Urine Drug Adulterant/Integrity Testing
88
POC3 POC Urine DipstickCompetency
44
UDC Forensic Urine DrugTesting, Confirmatory
89
Spectrophotometerlinearity
I Instrumentation 118
Sperm count X SMCD Semen Analysis,CD-ROM
140
Sperm count, automated SC1 Semen Analysis 140
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Sperm count, manual X SC Semen Analysis 140X PV Postvasectomy Sperm
Count140
Sperm morphology SM Semen Analysis 140SM1CD Semen Analysis,
CD-ROM140
Sperm motility SMCD Semen Analysis,CD-ROM
140
Sperm viability SM2CD Semen Analysis,CD-ROM
140
X SV Semen Analysis 140Spinal fluid meningitispanel
X D Bacteriology 152
Spinal muscular atrophy X MGL2 Molecular Genetics 217Spinocerebellar ataxia X MGL2 Molecular Genetics 217Split fats FCFS Fecal Fat 67Staphylococcus aureus-blood culture
BCS1 Blood CultureStaphylococcus aureus
157
STEC (Shiga-like toxinproducing E. coli)
GIP Gastrointestinal Panel 177
Strep screen POC4 POC/Waived StrepScreen Competency
44
Streptococcusagalactiae
X D8 Group B Strep 156
Streptococcuspneumoniae
X SBAS S. pneumoniae AgDetection
157
Streptococcus pyogenes X D Bacteriology 152X D1, D7 Throat, Urine Cultures 154X D4 Bacteriology, Ltd 154X D6 Rapid Group A Strep 156X D9 Rapid Group A Strep,
Waived156
Strychnine T Toxicology 86UT Urine Toxicology 86
Sulfosalicylic acid (SSA) DSC Dipstick Confirmatory 135Surgical pathology DPATH/
DPATH1Online Digital SlideProgram
231
PIP/PIP1,PIPW/PIPW1
PerformanceImprovement Programin Surgical Pathology
228-229
PCSP, PCSP1 Practicum in CancerSurgical Pathology
233
VBP/VBP1 Online Virtual BiopsiesProgram
230
Synthetic Cannabinoid/Designer Drugs
SCDD Synthetic Cannabinoid/Designer Drugs
94
Syphilis X G Syphilis Serology 186T3, free(triiodothyronine)
ABTH Harmonized Thyroid 100
Analyte/Procedure Index
292 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
T3, free(triiodothyronine) (cont.)
X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74T3, total(triiodothyronine)
ABTH Harmonized Thyroid 100
X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
T3 uptake & relatedtests
X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74T4, free (thyroxine, free) ABTH Harmonized Thyroid 100
X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74T4, total (thyroxine,total)
ABTH Harmonized Thyroid 100
X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
Tacrolimus X CS ImmunosuppressiveDrugs
53
LN31 ImmunosuppressiveDrugs Cal Ver/Lin
115
Tay Sachs X MGL4 Molecular Genetics 217tCO2 AQ, AQ2,
AQ3, AQ4Aqueous Blood Gas 82
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
tCO2 (cont.) AQQ,AQ2Q,AQ3Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
POC10,POC11
POC Competency BloodGases
45
Temazepam DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UDC Forensic Urine Drug
Testing, Confirmatory89
UT Urine Toxicology 86Teriflunomide ZE Therapeutic Drug
Monitoring, Extended54
Testosterone ABS Accuracy-BasedTestosterone andEstradiol
99
LN8 ReproductiveEndocrinology CalVer/Lin
109
X Y/YY Ligand Assay, Special 75Testosterone,bioavailable
DY Ligand Assay, Special 75
Testosterone, free X DY Ligand Assay, Special 75Thallium, urine TMU Trace Metals, Urine 71Theophylline X CZ, CZX,
CZ2X, ZChemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107Throat culture X D1, D7 Throat, Urine Cultures 154
X D4 Bacteriology, Ltd 154Thrombin time CGE/CGEX Coagulation, Extended 144
CGS4 Coag Special, Series 4 145DBGN Dabigatran 146
Thrombin-antithrombin CGE/CGEX Coagulation, Extended 144Thromboelastogram TEG Thromboelastogram 147Thrombophilia Mutations TPM Thrombophilia
Mutations219
Thyroglobulin X TM/TMX Tumor Markers 80Thyroid-stimulatinghormone (TSH)
ABS Accuracy-BasedTestosterone andEstradiol
99
ABTH Harmonized Thyroid 100X C1, C3, C3X,
CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 293
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Thyroid-stimulatinghormone (TSH) (cont.)
X K/KK Ligand Assay, General 74
LN5 Ligand Assay CalVer/Lin
108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
Thyroxine, free ABTH Harmonized Thyroid 100X C1, C3, C3X,
CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74Thyroxine, total ABTH Harmonized Thyroid 100
X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
Tick identification TMO Ticks, Mites, and OtherArthropods
169
Tissue parasiteidentification
X BP Blood Parasite 168
X P Parasitology 167Tissue plasminogenactivator
CGE/CGEX Coagulation, Extended 144
Tobramycin X CZ, CZX,CZ2X, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107Total bile acids TBLA Total Bile Acid 70Total bilirubin X C1, C3, C3X,
CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LM1 Lung Maturity 68LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
X NB, NB2 Neonatal Bilirubin 58
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Total bilirubin, urine X CMP, CMP1 Clinical Microscopy 133DSC Dipstick Confirmatory 135
Total free fatty acids FCFS Fecal Fat 67Total hCG X FP1T First Trimester Maternal
Screening, Total hCG78
Total hemolyticcomplement
CH50 Total HemolyticComplement
186
Total iron bindingcapacity, measured and% saturation
X C3, C3X, CZCZX, CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Total nitrogen, urine U Urine Chemistry,General
61
Total nucleated cells CBT Cord Blood Testing 198SCP Stem Cell Processing 198
Total nucleated red cells CBT Cord Blood Testing 198SCP Stem Cell Processing 198
Total protein X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD Body Fluid 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
SPE Protein Electrophoresis 68Total protein, CSF X M, OLI CSF Chemistry and
Oligoclonal Bands66
Total protein, urine LN6 Urine Chemistry CalVer/Lin
108
X U Urine Chemistry,General
61
Total tricyclics X SDS Serum Drug Screen 91X ZT, ZZT TDM, Special 54
Touch imprint/Crushprep
TICP, TICP1 Touch Imprint/CrushPrep
247
Toxicology, serum,qualitative
X SDS Serum Drug Screen 91
X T Toxicology 86Toxicology, urine,qualitative
X T Toxicology 86
X UDS, UDS6 Urine Drug Screen 88X UT Urine Toxicology 86
Toxicology, urine,qualitative/quantitative
X UDC Forensic Urine DrugTesting, Confirmatory
89
Analyte/Procedure Index
294 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Toxoplasma gondii X VR3 Antibody Detection-Infectious DiseaseSerology
178
Tramadol DMPM Drug Monitoring forPain Management
95
FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Transferrin X C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN7 Immunology Cal Ver/Lin 109X S2, S4 Immunology, Special 181
Transfusion medicine ETME1 Expanded TransfusionMedicine Exercises
193
EXM, EXM2 Electronic Crossmatch 195X J, J1 Transfusion Medicine 192X JAT Transfusion Medicine,
Automated192
JATE1 Transfusion Medicine,Automated
193
JE1 Transfusion Medicine,Education
192
TMCA Transfusion Medicine,Competency Assessment
194
TMCAD Transfusion Medicine,Competency Assessment
194
TMCAE Transfusion Medicine,Competency Assessment
194
TMCAF Transfusion Medicine,Competency Assessment
194
X TRC Transfusion-Related CellCount
200
Trazodone FTC Forensic Toxicology,Criminalistics
93
T Toxicology 86UT Urine Toxicology 86
Treponema pallidum X G Syphilis Serology 186Trichomonas vaginalis X VS, VS1 Vaginitis Screen 162Tricyclic group T Toxicology 86
UDS, UDS6 Urine Drug Screen 88UT Urine Toxicology 86
Tricyclics, total X SDS Serum Drug Screen 91X ZT, ZZT TDM, Special 54
Triglycerides ABL Accuracy-Based Lipid 98X C1, C3, C3X,
CZ, CZX,CZ2X
Chemistry and TDM 50-52
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Triglycerides (cont.) CZQ Quality Cross Check,Chemistry and TDM
53
FCFS Fecal Fat 67FLD Body Fluid 65
X LCW Ltd Chem, Waived 58LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Triiodothyronine (T3) ABTH Harmonized Thyroid 100X C1, C3, C3X,
CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
Triiodothyronine (T3),Free
ABTH Harmonized Thyroid 100
X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
X K/KK Ligand Assay, General 74Trimipramine T Toxicology 86
UT Urine Toxicology 86Troponin I, plasma X PCARM,
PCARMXPlasma CardiacMarkers
59
POC12 Competency PlasmaCardiac Markers
45
Troponin I, serum X CRT, CRTI Cardiac Markers 56LN25 Troponin I Cal Ver/Lin 114
Troponin T, serum LN27 Troponin T Cal Ver/Lin 114TNT Troponin T 56
X TNT5 Troponin T, 5 challenge 56Tumor necrosis factor(TNF)-alpha
CTKN Cytokines 184
UGT1A1 PGX Pharmacogenetics 219Unsaturated iron bindingcapacity, measured
X C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
UR-144 N-(4-hydroxypentyl)metabolite
SCDD Synthetic Cannabinoid/Designer Stimulant
94
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 295
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
UR-144 N-(5-hydroxypentyl)metabolite
SCDD Synthetic Cannabinoid/Designer Stimulant
94
UR-144 N-pentanoicacid metabolite
SCDD Synthetic Cannabinoid/Designer Stimulant
94
Urea nitrogen X AQ2, AQ4 Aqueous Blood Gas 82AQ2Q,AQ4Q
Quality Cross Check,Critical Care AqueousBlood Gas Series
83
X C1, C3, C3X,CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Urea nitrogen, urine LN6 Urine Chemistry CalVer/Lin
108
X U Urine Chemistry,General
61
Urea nitrogen, vitreousfluid
VF Vitreous Fluid, Post-mortem
90
Urease X RUR Rapid Urease 160Uric acid X C1, C3, C3X,
CZ, CZX,CZ2X
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
FLD2 Body Fluid Chemistry 2 65IFS Interfering Substances 119LN2 Chemistry, Lipid,
Enzyme Cal Ver/Lin106
LN2BV Chemistry, Lipid, Enzymeall Beckman except AU,Vitros Cal Ver/Lin
106
Uric acid, urine LN6 Urine Chemistry CalVer/Lin
108
X U Urine Chemistry,General
61
Urine albumin LN20 Urine albumin Cal Ver/Lin
112
X U Urine Chemistry,General
61
X UMC Urine AlbuminCreatinine
138
Urine albumin:creatinine ratio
ABU Accuracy-Based Urine 99
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Urine albumin:creatinine ratio (cont.)
U Urine Chemistry,General
61
UMC Urine AlbuminCreatinine
138
Urine crystals UAA Automated Urinalysis 135URC Crystals 135
Urine culture X D2, D7 Throat, Urine Cultures 154X D4 Bacteriology, Ltd 154
Urine dipstick POC3 POC/Waived UrineDipstick Competency
44
Urine drug screen X UDS, UDS6 Urine Drug Screen 88Urine sediment, colorphotographs
X CMP, CMP1 Clinical Microscopy 133
Urobilinogen X CMP, CMP1 Clinical Microscopy 133POC3 POC Urine Dipstick
Competency44
Uroporphyrin X N/NX Urine Chemistry,Special
62
Urothelial carcinoma byFISH, hybridization andinterpretation on-site
X CYI Fluorescence InSitu Hybridization,Urothelial Carcinoma
212
Vaginal wetpreparations
X CMMP Clinical Microscopy,Misc.
133
Vaginitis screen BV Bacterial Vaginosis 161X VS BD Affirm VP III Antigen
Detection162
X VS1 Genzyme OSOMTrichomonas
162
VS2 Vaginitis Screen, VirtualGram Stain
162
Valproic acid X CZ, CZX,CZ2X, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107T Toxicology 86UT Urine Toxicology 86
Valproic acid, free X CZ, CZX,CZ2X, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
Vancomycin X CZ, CZX,CZ2X, Z
Chemistry and TDM 50-52
CZQ Quality Cross Check,Chemistry and TDM
53
LN3 TDM Cal Ver/Lin 107Vancomycin-resistantEnterococcus
IDN, IDO Nucleic Acid Amp,Organisms
175
VRE Vancomycin-resistantEnterococcus
162
Analyte/Procedure Index
296 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Ana
lyte
/Pro
cedu
reIn
dex
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
Vanillylmandelic acid X N/NX Urine Chemistry,Special
62
Varicella-zoster virus(VZV)
ID1 Nucleic AcidAmplification
176
X VR1 Virology Culture 171X VR2 Viral Antigen Detection
by DFA171
X VR3 Antibody Detection-Infectious DiseaseSerology
178
Vascular endothelialgrowth factor (VEGF)
CTKN Cytokines 184
Venlafaxine T Toxicology 86UT Urine Toxicology 86
Verapamil T Toxicology 86UT Urine Toxicology 86
Viability CBT Cord Blood Testing 198SCP Stem Cell Processing 198
Viral antigen detection X HC2 HSV by DFA 172POC8 POC Influenza A/B Ag 44
X VR2 Viral Antigen Detectionby DFA
171
X VR4 Viral Antigen Detectionby EIA and Latex
172
Viral isolation/identification
X HC4 HSV Culture 172
X VR1 Virology Culture 171Virtual biopsy program,online
VBP/VBP1 Online Virtual BiopsiesProgram
230
Virtual Gram Stain VGS1 Virtual Gram StainBasic
155
VGS2 Virtual Gram StainAdvanced
155
Virtual peripheral bloodsmear
VPBS Virtual Peripheral BloodSmear
130
Viscosity V Viscosity 187Vitamin A BMV3 Bone Markers and
Vitamins77
Vitamin B12 X K/KK Ligand Assay, General 74LN5 Ligand Assay Cal
Ver/Lin108
LN5S Ligand Assay, SiemensCal Ver/Lin
108
Vitamin D, 25-OH X ABVD Accuracy-BasedVitamin D
76
LN40 Vitamin D Cal Ver/Lin 116X VITD 25-OH Vitamin D 76
Vitamin D, 1, 25Dihydroxy
BMV1 Bone Markers andVitamins
77
Vitamin E BMV4 Bone Markers andVitamins
77
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
VKORC1 PGX Pharmacogenetics 219Volatiles X AL1 Whole Blood Alcohol/
Ethylene Glycol/Volatiles91
X AL2 Serum Alcohol/EthyleneGlycol/Volatiles
91
von Willebrand factor CGE/CGEX Coagulation, Extended 144CGS3 Coag Special, Series 3 145LN37 von Willebrand Factor
Ag Cal Ver/Lin116
VZV ID1 Nucleic AcidAmplification
176
X VR1 Virology Culture 171X VR2 Viral Antigen Detection
by DFA171
X VR3 Antibody Detection-Infectious DiseaseSerology
178
Wavelength andphotometric calibration
I Instrumentation 118
WBC count ABF1, ABF2,ABF3
Automated Body Fluid 134
CBT Cord Blood Testing 198X FH1-FH4,
FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
FL4 Flow Cytometry CD34+ 189X HE, HEP Basic Hematology 124X HFC, HFCI Hemocytometer
Fluid Count136
LN9 Hematology Cal Ver/Lin 110X RWBC Rapid Total White
Blood Cell Count130
SCP Stem Cell Processing 198UAA, UAA1 Automated Urinalysis 135
WBC count (leukocyte-reduced platelets)
TRC Transfusion-Related CellCount
200
WBC count (leukocyte-reduced RBCs)
TRC Transfusion-Related CellCount
200
WBC differential EHE1 Expanded VirtualPeripheral Blood Smear
131
VPBS Virtual Peripheral BloodSmear
130
Analyte/Procedure Index
800-323-4040 | 847-832-7000 Option 1 | cap.org 297
Analyte/Procedure
Index
21
Analyte/Procedure LAP
ENR
Program
Code
Description Pg
WBC differential,automated
X FH1-FH4,FH6,FH9-FH12,FH1P-FH4P,FH6P, FH9P-FH12P
Hematology, Auto Diff 125
FH3Q,FH4Q,FH6Q,FH9Q
Quality Cross Check,Automated HematologySeries
126
WBC differential-bodyfluid
VBF Virtual Body Fluid 134
WBC morphology EHE1 Expanded VirtualPeripheral Blood Smear
131
West Nile virus X NAT Nucleic Acid Testing 203Worm identification WID Worm Identification 169Yeast identification X F Mycology 164
X F1 Yeast 164X F3 Candida culture 165
ZAP-70 ZAP70 ZAP-70 Analysis byFlow Cytometry
190
Zinc X R Trace Metals 70Zinc, urine TMU Trace Metals, Urine 71Zolpidem FTC Forensic Toxicology,
Criminalistics93
T Toxicology 86UT Urine Toxicology 86
Zonisamide ZE Therapeutic DrugMonitoring, Extended
54
Deliver the best in patient care when youintegrate the CAP’s proficiency testing,accreditation, and education programs• Provide comprehensive, scientifically endorsed laboratory
standards, proficiency testing/EQA, and educational programs• Offer a comprehensive view of the laboratory for ongoing
monitoring of quality performance• Educate laboratory staff with a complete offering of programs
supported by peer groups and scientific leaders that provide aunique balance of regulatory and educational coaching
• Take the guesswork out of laboratory compliance• Gain global quality recognition• Reduce the risk of inaccurate and unreliable test results
CAP accreditation programs customized to meet your patient careneeds include:• Laboratory Accreditation• Reproductive Laboratory Accreditation• Forensic Drug Testing Accreditation• Biorepository Accreditation• CAP 15189™ Accreditation
To learn more, visit cap.org and choose the LaboratoryImprovement Programs tab.
“Participating in CAPLaboratory ImprovementPrograms, which aredeveloped by leadingexperts, provides confidencethat your laboratory is doingthe right thing. The CAPaccreditation checklistsystem is an incredibleresource for keeping up withdaily management, newCLIA and CAP requirements,and ensuring that you’reperforming high qualitytesting. No other proficiencytesting provider developsprograms for the newesttechnologies as rapidly andeffectively as the CAP.”
Elizabeth Wagar, MD, FCAPProfessor & Chair,Department ofLaboratory MedicineThe University of Texas MDAnderson Cancer Center
Accreditation ProficiencyTesting/EQA
CAP Education
22 | Program Code Page Index
ProgramCode
PageIndex
22
“What we really like it is the span of the programsthat the CAP offers. Within each of these areas wecan see how we can become more efficient.”
Program Code Page IndexPr
ogra
m C
ode
Page
Inde
x
22
300 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Program Code Pg
APTGDM 242AQ 82AQ2 82AQ2Q 83AQ3 82AQ3Q 83AQ4 82AQ4Q 83AQQ 83ARP 183ASA 140ASC 183ASO 180AUCD 240AUCD1 240B27 208BCP 124BCR 135BCS 157BCS1 157BDP 197BDP5 197BDPV 197BDPV5 197BFBRG 131BFC 135BGL 215BGL1 215BGS 76BL 92BLM 96BMD 128BMV1 77BMV2 77BMV3 77BMV4 77BMV5 77BMV6 77BNP 55BNP5 55BNPQ 55BP 168BRAF 224BSTE 175BSTN 175BSTS 175BU 77
Program Code Page Index
Program Code Pg
AAT 216ABF1 134ABF2 134ABF3 134ABL 98ABO 207ABS 99ABT 196ABT1 196ABT2 196ABT3 196ABTH 100ABU 99ABVD 76ACA 182ACE 64ACL 183ADL 64AFL 134AG 64AHIV 202AHIVW 202AHT 182AL1 91AL2 91AL2M 96AMH 76ANA 180APAPCE 245APAPCPT 243APAPJE 245APAPJPT 243APAPKE 245APAPKPT 243APAPLE 245APAPLPT 243APAPME 245APAPMPT 243APC 182APEDK 244APEDL 244APEDM 244APOE 216APS 183APT 136APTGDK 242APTGDL 242
Program Code Pg
BV 161C1 50–52C3 50–52C3X 50–52C7 69CAMP 158CBT 198CCP 184CD 92CES 184CGDF 144CGE 144CGEX 144CGL 144CGM 150CGS1 145CGS2 145CGS3 145CGS4 145CGS5 145CGS6 145CH50 186CHPVD 246CHPVJ 246CHPVK 246CHPVM 246CMMP 133CMP 133CMP1 133CPIP 16CPIP1 16CRP 180CRT 56CRTI 56CS 53CT 146CT1 146CT2 146CT3 146CT5 146CTKN 184CY 212CYBK 212CYCGH 213CYF 212CYH 213CYI 212
Program Code Pg
CYJ 213CYK 213CYL 213CYM 214CYS 66CZ 50–52CZ2X 50–52CZQ 53CZVM 60CZX 50–52D 152D1 154D2 154D3 154D4 154D5 155D6 156D7 154D8 156D9 156DADR1 209DADR2 209DAI 88DAT 198DBGN 146DEX 153DL 207DML 207DMPM 95DNA 252DNAF 252DPATH 231DPATH1 231DSC 135DY 75E 163E1 163EGFR 224EHE1 131ELU 199EMB 141EPO 77ESR 124ESR1 124ESR2 124ESR3 124ETB 91
Program Code Pg
ETME1 193EV 53EXM 195EXM2 195F 164F1 164F3 165FCFS 67FCN 182FF 77FGAL 165FH1 125FH1P 125FH2 125FH2P 125FH3 125FH3P 125FH3Q 126FH4 125FH4P 125FH4Q 126FH5 125FH5P 125FH6 125FH6P 125FH6Q 126FH7 125FH7P 125FH8 125FH8P 125FH9 125FH9P 125FH9Q 126FH10 125FH10P 125FH11 125FH11P 125FH12 125FH12P 125FID 252FIDM 252FL 188FL1 188FL2 188FL3 188FL3CD 188FL4 189
Discontinued
Discontinued
Discontinued
Program Code Page IndexProgram
Code Page Index
22
800-323-4040 | 847-832-7000 Option 1 | cap.org 301
Program Code Pg
FL5 189FLAC 159FLD 65FLD2 65FNA 249FNA1 249FNAG 250FNAG1 250FNPX 146FOL 79FOVK 246FOVK1 246FOVM 246FOVM1 246FP 78FP1B 78FP1T 78FPX 78FR 253FR1 253FSER 165FSM 165FT 67FTC 93G 186G6PDS 67GH2 57GH5 57GH5I 57GHER2 239GIP 177GLI 224GNBC 158GOCB 136GPBC 158GSA 57H 182HBF 199HBRG 125HBVL 173HBVL5 173HC1 159HC2 172HC3 159HC4 172HC6 174HC6X 174HC7 174HCA 185HCC 59
Program Code Pg
HCG 180HCV2 173HCVN 173HE 124HEP 124HER2 239HFC 136HFCi 136HG 128HGM 216HIV 173HIVG 173HLAS 207HLAS1 207HMS 58HPATH 132HPATH1 132HPS 159HPV 174HQBX1 236HQBX2 236HQBX3 236HQIHC 235HQIP 234HQIPBX 235HSCRP 57HV2 173I 118ID1 176ID1T 176ID2 176IDN 175IDO 175IDR 177IFS 119IG 180IGX 180IL 180IM 180IMD1 218IMD2 218IMD3 218IMW 181IND 166ING 78ISH 222ISH2 222J 192J1 192JAT 192
Program Code Pg
JATE1 193JE1 192K 74KET 58KIT 224KK 74KRAS 224KSA 62KVM 80LBAS 157LBC 137LCW 58LDM 121LKM 186LLM 121LM 68LM1 68LN2 106LN2BV 106LN2VM 121LN2VM1 121LN3 107LN5 108LN5S 108LN6 108LN7 109LN8 109LN9 110LN11 110LN12 110LN13 111LN13C 111LN14 111LN15 111LN16 112LN17 112LN18 112LN19 112LN20 112LN21 113LN22 113LN23 113LN24 114LN25 114LN27 114LN30 114LN31 115LN32 115LN33 115LN34 115
Program Code Pg
LN35 116LN36 116LN37 116LN38 116LN39 116LN40 116LN41 117LN42 117LPE 68LPX 159LUM 121M 66MBRG 166MBT 153ME 208MGL1 217MGL2 217MGL3 217MGL4 217MGL5 217MHO 225MHO1 225MHO2 225MHO3 225MHO5 225MK 237ML 207MMR 237MPA 53MRD 225MRD1 225MRD2 225MRS 160MRS5 160MSI 222MTBR 163MTP 224MVM 72MX1B 206MX1C 206MX1E 206MX2B 206MX2C 206MX2E 206MXB 207MXC 207MYG 62N 62NAT 203NB 58
Program Code Pg
NB2 58NEO 223NGC 248NGC1 248NGS 221NP 241NP1 241NVM 63NX 62OCB 137OFD 90OLI 66P 167P3 167P4 167P5 167PAPCE 245PAPCPT 243PAPJE 245PAPJPT 243PAPKE 245PAPKPT 243PAPLE 245PAPLPT 243PAPME 245PAPMPT 243PARF 204PBRG 168PCARM 59PCARMX 59PCP1 166PCP2 166PCP3 166PCP4 166PCSP 233PCSP1 233PCT 69PEDK 244PEDL 244PEDM 244PF 147PF1 147PGX 219PGX1 219PGX2 219PHG 69PIA 149PIP 228PIP1 228PIPW 229
Discontinued
Program Code Page IndexPr
ogra
m C
ode
Page
Inde
x
22
302 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Program Code Pg
PIPW1 229PLA 67PLTM 149PM1 237PM2 239PM3 237PM5 238PNA1 158PNA2 158PNA3 158PNA4 158PNH 189POC1 44POC2 44POC3 44POC4 44POC5 44POC6 44POC7 44POC8 44POC9 44POC10 45POC11 45POC12 45POC14 45POC15 45POC16 45PS 199PTGDK 242PTGDL 242PTGDM 242PV 140QF 186QM 42QP151 27QP152 28QP153 29QP154 30QT1 33QT2 33QT3 34QT4 34QT5 39QT7 35QT8 35QT10 36QT15 37QT16 37QT17 38QT19 40
Program Code Pg
R 70RAG 199RAP 79RBCAT 200RDS 186RETT 219RF 180RFAV1 190RFX 180RHCVW 202RMAL 168ROM1 137RT 129RT2 129RT3 129RT4 129RUB 180RUBX 180RUR 160RVBN 146RWBC 130S2 181S4 181S5 181SALC 69SARC 223SBAS 157SC 140SC1 140SCDD 94SCM1 137SCM2 137SCO 120SCP 198SCS 129SDS 91SE 185SEC 218SEC1 218SFLC 187SM 140SM1CD 140SM2CD 140SMCD 140SO 84SOQ 84SP 161SP1 161SPE 68SPN 161
Program Code Pg
ST 161STFR 72SV 140SW1 71SW2 71SW3 71SW4 71T 86TBLA 70TBX 149TEG 147TICP 247TICP1 247TM 80TMCA 194TMCAD 194TMCAE 194TMCAF 194TMO 169TMU 92TMX 80TNT 56TNT5 56TPM 219TRC 200TTD 178U 61UAA 135UAA1 135UABRG 138UBJP 68UDC 89UDS 88UDS6 88UDSM 96UMC 138UPBG 63URC 135UT 86UTCO 120UVM 63V 187VBF 134VBP 230VBP1 230VF 90VGS1 155VGS2 155VITD 76VLS 173
Program Code Pg
VLS2 173VM1 201VM2 201VM3 201VM4 202VM5 202VM6 202VPBS 130VR1 171VR2 171VR3 178VR3M 178VR4 172VRE 162VS 162VS1 162VS2 162WB2 59WBDD 149WBG 59WID 169WP3 148WP4 148WP6 148WP9 148WP10 148Y 75YVM 80YY 75Z 50–52ZAP70 190ZE 54ZT 54ZZT 54
Discontinued
Notes
800-323-4040 | 847-832-7000 Option 1 | cap.org 303
Notes
Notes
304 College of American Pathologists 2015 Surveys & Anatomic Pathology Education Programs
Notes